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Abstract  
 
There is a strong relationship between non-specific neck pain (NS-NP) and upper limb 
disability (ULD). Optimal management of NS-NP should incorporate upper limb (UL) 
rehabilitation and therefore include evaluation of ULD using suitable UL outcome 
measure (OM) in the assessment and during the management process. However, there is 
no clear guidance regarding the suitability of available measures alongside a lack of 
information on how physiotherapists in the United Kingdom (UK) measure and 
rehabilitate their patients with NS-NP. The purpose of this thesis was to explore the 
clinical measurement and management of ULD in patients with NS-NP.   
 
The quantitative research approach adopted by this thesis enabled the researcher to gain 
a deeper understanding of the clinical measurement and in turn rehabilitation of ULD in 
patients with NS-NP, and build on knowledge acquired throughout the period of study. 
In order to support this methodology, a positivist philosophical stance was adopted.    
 
A systematic review was completed to identify all available UL OMs that were used for 
patients with neck pain (NP) and to make recommendations about those that are suitable 
for use in clinical practice and research. A survey with a national sample of 
physiotherapists was completed to establish current physiotherapeutic management of 
NS-NP and ULD in the UK. This was followed by a validation study aimed at exploring 
the acceptability and feasibility of the Single Arm Military Press (SAMP) test. 
Subsequently, a second validation study was completed to explore the reliability and 
validity of the SAMP test in female patients with NS-NP and healthy subjects.      
 
The systematic review identified five measures but quality issues prevented a clear 
recommendation for any of the identified instruments. The survey highlighted 
substantial gaps in current evidence-based practice of UK physiotherapists regarding the 
measurement of patients with NS-NP and associated deficits in the measurement and 
management of ULD in this population. Subsequently, a validation study established 
the acceptability and feasibility of the SAMP test using a 1-kg hand weight in female 
patients with NS-NP. In the second validation study, the SAMP test was found to be a 
reliable and valid UL instrument for female patients with NS-NP. 
 
This thesis provided preliminary evidence that the SAMP test is an acceptable, feasible, 
valid and reliable measure of ULD for female patients with NS-NP and of its suitability 
for use in clinical practice and research. The SAMP test can be used by clinicians to 
improve their assessment of UL functional capacity and to suggest management 
strategies for patients with NS-NP. Further longitudinal studies are required to evaluate 
the further validity and reliability of the SAMP test in older and younger female 
patients, and male patients using additional examiners and additional populations. 
Further studies are required to establish the responsiveness of the SAMP test in patient 
populations with all types of NP.   
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Chapter 1: Overview of the thesis 
1.1 Introduction 
The overall aim of this programme of research was to investigate the clinical 
measurement and management of ULD in adult, female patient populations with NS-
NP. This chapter provides an introduction and a justification for undertaking the 
research, including its overall aims, philosophical framework, ethics, structure and an 
overview of the studies that were conducted as part of the research. A summary of the 
thesis chapters and a list of published and proposed peer reviewed publications and 
conference presentations relating to the PhD are provided.   
 
1.2 Neck pain (NP)  
In the 21st century, NP is a common musculoskeletal condition that causes substantial 
pain and disability. The Bone and Joint Decade 2000 - 2010 Task Force on NP and its 
associated disorders systematically reviewed the published literature on NP between 
1980 - 2006 to produce a best evidence synthesis on the burden and determinants of NP 
(Hogg-Jonson et al. 2008). Evidence from the 101 included studies identified that the 
NP incidence rates range between 15.5 and 213 per 1000 - person years, while the 1-
year prevalence of pain rates range around 30 - 50% with 1.7 - 11.5% of people 
experiencing disability because of their NP annually. NP was found to have higher 
prevalence for females than males with ratio ranging from 3.4:1.1. Furthermore, females 
demonstrated higher rates of visits to healthcare centres seeking treatment for their NP 
(males: 2.6 visits per 1000, 95% CI, 2.1 - 3.0; females: 3.5 visits per 1000, 95% CI, 3.0 
– 4.0).  
 
In another large and well-designed study, Hoy and colleagues (2010) collected data 
relating to the incidence, remission and prevalence of NP from all published and 
unpublished population-based studies conducted between 1980 - 2009 inclusive, which 
was for the purpose of assessing the global burden of NP throughout the world (Hoy et 
al. 2010). Surveys that had mainly focussed on general population with mild, moderate 
or severe NP were used to provide data with no language, age, gender or setting 
restriction. The findings provide evidence that the 1-year incidence of NP ranged from 
10.4% to 21.3%, while the remission of NP, which was defined in the study as the rate 
at which NP has been completely resolved, at 1-year ranged from 33% to 65%. The 
overall prevalence of NP in the general population ranged between 0.4% and 86% 
(mean: 23.1%), point prevalence ranged from 0.4% to 41.5% (mean: 14.4%), and the 1-
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year prevalence ranged from 4.8% to 79.5% (mean: 25.8%). This study also provided 
evidence that the incidence of NP is higher among females with an increased risk of 
developing NP until the 35-49-year age group alongside those with history of low back 
pain, poor psychological status, low job satisfaction, sedentary work posture, poor 
physical work environment and smoking. Subsequently, Hoy and colleagues (2014) 
collected data to estimate the global burden of NP in relation to its associated disability 
(Hoy et al. 2014). The prevalence of NP in 2010 was estimated to be 4.9% (95% CI: 4.6 
to 5.3) and the disability YLDs (years of life lived with disability) had increased from 
23.9 million (95% CI: 16.5 to 33.1) in 1990 to 33.6 million (95% CI: 23.5 to 46.5) in 
2010. Disability because of NP was found to be higher in female patients (mean: 5.8%, 
95% CI: 5.3 to 6.4) than in male patients (mean: 4.0%, 95% CI: 3.7 to 4.4) and the 
prevalence peaked at 45 years of age. This study reported that out of 291 
musculoskeletal conditions, NP was ranked 4th highest in terms of disability when 
measured by YLDs and 21st in terms of overall burden.  
 
In their epidemiological study, Thomas and colleagues (2004) collected data relating to 
the presence of pain and pain interference (disability) in older age people (50+ years) 
from three primary care general practice in the North Staffordshire (UK). Postal 
questionnaires were mailed to 11230 patients, of whom 7878 provided data regarding 
any pain with adjusted response rate of 71.3%. Of those providing data 22.8% in the age 
group (50-59), 22.9% in the age group (60-69), 17.7% in the age group (70-79) and 
14.9% in the age group (80+) experienced NP which limited their daily activity 
(disability) at some point during the previous month. The study reported that pain and 
its associated disability were higher in female older patients than males. In another 
recent study, Scarabottolo and colleagues (2017) conducted a large-scale trial, in which 
1011 adolescents between 10-17 years of age completed questionnaires relating to their 
back and neck pain. Of those who completed the questionnaires, 17.4% experienced NP 
at some point during the previous week. The prevalence estimates of NP were higher in 
older adolescents compared to younger adolescents but reasonably similar across 
gender.  
 
There is strong epidemiological evidence that NP is also a common and disabling 
musculoskeletal condition in the UK. NP affects approximately 31% of the UK adult 
population at any one time with the majority experiencing recurrent or chronic 
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symptoms and 7.5 to 14% of those patients appear to experience some degree of 
disability because of their NP (Croft et al. 2001, Webb et al. 2003). 
  
Whilst no studies have specifically explored the financial burden of NP and its 
associated disability in the UK, Borghouts and colleagues (1999) reported that the total 
annual cost of NP in the Netherland estimated US$ 686.2 million, which represent 
approximately 1% of the healthcare budget and 0.1% of the total GDP (Gross Domestic 
Product) in the Netherland (Borghouts et al.1999). Since both the Netherland and the 
UK are developed Western European countries, it would be reasonably acceptable to 
suggest that a similar proportion of healthcare and societal expenditure may be 
attributed to NP in the UK. These findings indicate that it is apparent that NP results in 
significant healthcare cost, work absenteeism and loss of productive capacity; NP is 
therefore a substantial socioeconomic burden for patients, employers, insurers and 
society.  
 
For a majority of patients with NP, a pathoanatomical cause cannot be identified 
(Hoving et al. 2002, Walker-Bone et al. 2003, Binder 2007). Consequently, a wide 
variety of classification approaches has emerged. One such example of a classification 
system is patients with (1) serious spinal pathology requiring urgent medical attention, 
(2) neurological involvement and (3) non-specific neck pain (NS-NP) (Moffett and 
McLean 2006). NS-NP, which comprises approximately 80% of all NP patients, will be 
the focus of this thesis and is defined as “pain perceived as arising from anywhere 
within the region bounded superiorly by the superior nuchal line, inferiorly by the 
transvers line through the tip of the first thoracic spinous process, and laterally by the 
sagittal plans tangential to the lateral border of the neck” (Merskey and Bogduk 1994). 
This pain is not caused by any serious acute trauma, systematic disease, neurological 
disorder, or inflammatory conditions (Huisstede et al. 2007). Given that NP is more 
common in females (Thomas et al. 2004, Hog-Jonson et al. 2008, Haldeman et al. 2010, 
Hoy et al. 2010, Hoy et al. 2014) and female patients tend to have higher rate of seeking 
physiotherapy treatment for their NP (Freburger et al. 2005, Hog-Jonson et al. 2008), 
much of the research in this thesis focussed on female patients. 
 
1.3 Upper limb disability (ULD) and neck pain (NP)  
UL dysfunction is a common musculoskeletal condition (Walker-Bone et al. 2002). The 
prevalence of UL dysfunction at any given point of time has been estimated as 20% and 
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50% in the working population of Western industrial countries and the lifetime 
prevalence of UL dysfunction is greater than 70% (Walker-Bone et al. 2004, Huisstede 
et al. 2006). ULD can arise from a spectrum of clinical conditions, including NP 
(Huisstede et al. 2009). An extreme example of this is cervical radiculopathy which can 
lead to pain, motor weakness, sensory deficit and loss of function in the neck, shoulder, 
upper arm or forearm (Polstone 2007, Rhee et al. 2007). NS-NP has also been shown to 
have a considerable impact on UL function (Frank et al. 2005). In 2007, McLean and 
colleagues investigated the relationship between NS-NP and ULD in 151 patients with 
NS-NP who were recruited from four National Health Service (NHS) physiotherapy 
departments in the UK (McLean et al. 2007). A positive correlation was observed 
between the score of the Northwick Park Neck Pain Questionnaire (NPQ) that was used 
to measure the baseline of the NS-NP and the score of the Disability of Arm, Shoulder 
and Hand Questionnaire (DASH) that was used to measure the baseline of the ULD 
(Pearson’s r=0.799, p<0.001, n=142). Furthermore, Stepwise Linear Regression 
analysis revealed that after adjusting for a range of other potential confounding 
variables, higher NPQ score (B = 0.743) and lower pain self-efficacy (B = - 0.489) 
predicted increased severity of the ULD (R2=0.713; p<0.001, n=100). Subsequently, 
Osborn and Jull (2013) conducted a cross-sectional survey in adult Australian patients 
presenting for physiotherapy rehabilitation in the general community (n-103) which 
explored the proportion of NS-NP patients who experienced ULD and the nature of 
those UL activity. Moderate-high correlation were observed between the NDI score and 
the DASH score (p = 0.669; p < 0.001). In both studies approximately 80% of the NS-
NP patients reported ULD in relation to activity that involve loading the UL such as 
lifting and repetitive overhead movement. These findings provide evidence of a strong 
relationship between NS-NP and ULD and that patients with the most severe NS-NP 
report the greatest severity of ULD. Both studies also recommended additional 
evaluation of UL functional capacity using suitable UL OM in the assessment and 
during the management of patients with NS-NP.  
 
The mechanisms which cause NS-NP and ULD to co-exist are not clear but may relate 
to the mechanical attachment between the neck and the UL via skeletal, muscular and 
neural structures (McLean et al. 2011). For example, mechanical loading or repetitive 
movement of the UL may increase the mechanical load to the articular and ligamentous 
structures of the neck which may in turn provoke NP or create protective neck muscle 
spasms (Gorski and Schwartz 2003). Another possible mechanism is that patients with 
 20 
NP may limit the functional use of their ULs because of neck provocation or poor pain 
self-efficacy (McLean et al. 2007, McLean et al. 2011). Consequently, a deconditioning 
effect may occur leading to a reduction in cardiovascular capacity and reduced strength 
and endurance in the neck/UL muscles, and this may lead to compensatory activity and 
excessive loading on the cervical structures (Smeets et al. 2006). Further investigation 
of these causal relationships is required, but to do this valid and reliable measures of 
ULD in patients with NP are required.  
 
Clinical textbooks on the examination of patients with NS-NP often recommend simple 
screening of shoulder range of motion in order to rule in/out the presence of shoulder 
problems or ULD (Petty 2011). Since range of motion does not correlate conclusively 
with disability, this may not be sufficient (Olsen et al. 2000, Poitras et al. 2000, Kwak et 
al. 2005). The studies presented above suggest that appropriate management of patients 
with NS-NP requires thorough evaluation of ULD using suitable UL OM during the 
assessment and management process (McLean et al. 2011, Osborn and Jull 2013). This 
would enable physiotherapists to identify and quantify any ULD and include UL 
rehabilitation in the management plan, if indicated. Ongoing evaluation using the same 
UL OM would facilitate monitoring the progression of ULD and allow evaluation of the 
effectiveness of the ULD rehabilitation. Since the presence of a shoulder problem is 
known to increase the risk for recurrent, persistent or disabling problems in patients 
who have NS-NP (McLean et al. 2007), it is hypothesised that appropriate management 
of any ULD as part of a holistic management plan, in patients with NS-NP may help to 
improve the overall effectiveness of that management plan. However, there is no clear 
guidance regarding the availability and suitability of ULD OMs for patients with NS-
NP.  
 
Physiotherapists play a key role in the management of patients with NS-NP and this 
usually involves a multimodal approach to management, which incorporates a wide 
range of possible conservative treatment approaches. This could include active 
treatment approaches such as therapeutic exercise, the McKenzie method and patient 
education, and passive treatment approaches such as manual therapy, electrotherapy and 
acupuncture (Moffett and McLean 2006). Limited evidence suggests that UK-based 
physiotherapists rarely consider UL rehabilitation when managing their patients with 
NS-NP (McLean et al. 2010b, McLean et al. 2013). In addition, to date there is no 
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empirical evidence that has investigated current clinical UK physiotherapy practice in 
relation to the measurement or management of patients with NS-NP.  
 
1.4 The Single Arm Military Press (SAMP) test 
Although there are a variety of measures that evaluate UL functional capacity in 
patients with NP, the SAMP test, as far as the author is aware, is the only performance-
based instrument that was designed to specifically measure ULD in female patients with 
NS-NP (McLean et al. 2010a). Female patients with NS-NP were the focus of the 
SAMP test because they are more commonly affected by NP and they tend to have 
higher rates of using physiotherapy services (Hogg-Jonson et al. 2008, Cote et al. 2008, 
Sahin et al. 2008, Hoy et al. 2010, Hoy et al. 2014).  
 
The SAMP test performance consists of tasks of functional relevance (i.e. carrying, 
lifting and repetitive overhead activity), which challenge the UL (neck, shoulder, elbow, 
arm and hand) and often impaired in patients with NS-NP (McLean et al. 2011, Osborn 
and Jull 2013). It uses readily available and inexpensive equipment (one dumbbell) and 
it is very easy to score (repetition count within 30 seconds). The SAMP test is 
conducted with the patient in the standing position with their feet positioned at shoulder 
width. The patient is asked to carry a dumbbell and to lift it, using their dominant 
hand/other hand, to shoulder level (see Figure 1.1A). The patient is requested to raise 
their hand with the dumbbell directly overhead by extending through the elbow (see 
Figure 1.1B) and repeat this process as fast and as frequently as possible for 30 seconds 
(McLean et al 2010a). These tasks evaluate the strength and endurance of the UL, with 
expectation that the difficulty in sustaining overhead activity within 30 seconds would 
discriminate between NS-NP patients with varying degrees of ULD. Therefore, the 
SAMP test performance has a greater likelihood of accurately identifying and 
quantifying any UL functional limitation in patients with NS-NP (Curb et al. 2006, 
Pinheiro et al. 2016). In addition, the SAMP test is a simple test that can be efficiently 
administered by physiotherapists, clinicians, and/or individuals with varying experience 
in any setting using the minimum of equipment (i.e. a single dumbbell) in less than 2 
minutes. Therefore, it has the capacity and characteristics to be very useful for use in 
day-to-day busy clinical practice as well as research practice. The SAMP test was 
developed and validated in a series of preliminary studies and demonstrated excellent 
reliability and validity. However, these studies were conducted on female, non-patient 
populations using a 3-kg hand weight in the SAMP’s practical application, which is 
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considered to be unsuitable (too heavy) for the patient group. Therefore, the suitability, 
measurement and practical properties of the SAMP test in patient populations with NP 
are still unclear.  
 
 
1.5 Summary and research questions  
In summary, there is a strong association between NS-NP and ULD, and optimal 
management of NS-NP might incorporate UL rehabilitation and therefore should 
include evaluation of the UL functional capacity using a suitable ULD OM. However, 
there is no clear guidance regarding the availability and suitability of UL OMs for 
patients with NS-NP. In addition, there is no information available on how UK 
physiotherapists measure or rehabilitate their patients with NS-NP and ULD. The 
SAMP test is a potentially useful performance-based OM that was designed to measure 
ULD in patients with NS-NP. It is simple, quick, inexpensive, easy to administer in any 
setting and has the characteristics to be very useful in clinical practice as well as in 
research practice, however it still requires validation in patient groups with NS-NP. 
Therefore, this thesis was designed to answer the following research questions (RQ):  
1. What are the measurements and practical properties of all available ULD OMs 
that have been developed or validated for patients with NS-NP? 
2. What are UK physiotherapists’ current measurement and management strategies 
for patients with NS-NP?  
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3. What are the acceptability and feasibility of the SAMP test in female patients 
with NS-NP?  
4. What are the reliability and validity of the SAMP test in female patients with 
NS-NP and healthy subjects?  
This work provides empirical evidence regarding the suitability of currently available 
upper limb OMs for patients with NS-NP, which reveals the need for a suitable upper 
limb OM for patients with NS-NP (RQ1) and supports the selection of the SAMP test 
for further adequate validation in patients with NS-NP (RQ 3 & 4). In addition, this 
work provides an insight into UK physiotherapists’ use of measurement and 
management strategies for NS-NP and ULD (RQ 2) and ultimately provides a measure 
(SAMP test) which might facilitate that measurement and management.  
 
1.6 Philosophical framework: Positivism  
Research philosophy is a system of theories, ideas, principles and assumptions about the 
development of knowledge (Klee 1997). Shepard and colleagues (1993) observed that at 
every stage of research, a number of types of assumption will be made. These include 
assumptions about reality and its nature (ontological assumptions); human knowledge, 
what is considered acceptable knowledge and what kinds of contribution to knowledge 
can be made (epistemological assumptions); and the role of values and ethics within the 
research process (axiological assumptions). It is recognised that consistent and well-
planned assumptions will constitute a robust research philosophy, which in turn will 
facilitate identifying the most appropriate methodological approaches that will answer 
the research question comprehensively (Crotty 1998).  Philosophical approaches are 
scattered between two opposing extremes: positivism and phenomenology (Tashakkori, 
and Teddlie 2010). Positivistic researchers often aim to discover objective reality that 
can be answered by formulating and testing one or more testable hypotheses that reflect 
anticipated answers to questions about the relationship between cause and effect 
(Phillips 1987). The main assumptions underlying positivism are that the phenomenon 
need to be measured; verification or hypotheses testing requires deductive processes; 
and therefore, the key methodological approach is experimentation via direct 
manipulation and observation (Trochim 2002). Conversely, the phenomenologist is the 
researcher who tries to understand human activity from the perspective of the individual 
being studied (Cohen 1987). The main assumptions underlying phenomenology are that 
reality is socially constructed by individual and thus multiple realities exist; 
understanding the unknown phenomenon requires inductive processes; and therefore, 
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the key methodological approach is exploration of pure subjectivity using qualitative 
methodologies (Landsheere 1988).  
  
Previous research on measuring ULD in patients with NS-NP has been conducted 
within a positivist paradigm underpinned by an objectivist epistemology. In addition, 
the objective research focussing on exploring the clinical measurement and 
management of ULD in patients with NS-NP fall within the positivist philosophical 
framework. Therefore, this thesis adopted positivistic ontological position based on the 
fact that ULD can be precisely and accurately measured using OMs in all populations 
with NS-NP, which demonstrates that there is a single and external reality. This in turn 
led to adopting an objectivist epistemological approach and incorporating deductive 
reasoning research. A positivist philosophical approach utilising quantitative methods 
and designs makes: 1) exploration of the suitability of all available ULD OMs for 
patients with NS-NP; 2) gaining an insight into UK physiotherapists’ use of 
measurement and management strategies for NS-NP and ULD; and 3) further validation 
of the performance-based OM (SAMP) test precisely and accurately possible. 
Therefore, a positivism philosophical framework of inquiry is appropriate for this thesis. 
Consequently, the systematic review method, quantitative survey design and 
quantitative evaluation of the measurement and practical properties of the SAMP test 
were identified as the most appropriate to comprehensively answer the research 
question.  
 
1.7 Research ethics and governance approval  
Research ethics and governance permission from Sheffield Hallam University Research 
Ethics and Governance Committee to develop this programme of research was gained 
on 06/09/2013. The specific ethical concerns to each chapter of this thesis have been 
discussed within the individual chapters of the thesis. A single ethical approval was 
sought and gained for the survey in chapter four on 17/02/2015 from the Health & 
Wellbeing Faculty Ethics Committee at Sheffield Hallam University. The letter of 
ethics approval is at appendix 4. The validation studies in chapters five and six were 
conducted on Egyptian female patients with NS-NP and healthy subjects. Initially 
research approval was sought for these studies on 08/06/2015 and gained on 06/07/2015 
from Tanta Universal Teaching Hospital following submission of an application form, 
research protocol, questionnaires, research information sheet, research participants 
consent form, CV for the researcher and CV for the director of study. This allowed 
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Tanta Universal Teaching Hospital (Rheumatology and Physical Therapy Department) 
to participate in the research. Subsequently, ethical approval was sought and gained on 
26/10/2015 from the Health & Wellbeing Faculty Ethics Committee at Sheffield Hallam 
University to conduct these studies in Egypt. Letters of ethics approval are at appendix 
7 and 8.  
 
Overall, the main ethical concern in this thesis relates to conducting these validation 
studies in Egypt. Egyptian research ethics guideline exist; however, it has numerous 
deficiencies in their stated protections to research participants in relation to clinical and 
experimental research (Alahmad et al. 2012). Therefore, these studies were conducted 
in accordance with the UK guideline for health and social care research in order to meet 
international ethical standards. The following principles were considered when 
conducting the research: (1) the safety and well-being of participants; (2) competence of 
staff involved in conducting the research; (3) integrity, quality and transparency of the 
research; (4) research protocol; (5) benefits and risks for the individual participants; (6) 
gaining approval before commencing; (7) information about the research; (8) providing 
choice to participants without reprisal;  (9) and respect of privacy as all information 
collected was recorded, handled and stored appropriately so that it can be utilised while 
the confidentiality of participants remain protected. In addition, religious and cultural 
issues were considered when assessing and testing Muslim female patients.  
 
1.8 Structure of the thesis  
The PhD project was designed in five parts using four distinct research methods (see 
Figure 1.2 below). In order to answer the research questions identified in section 1.5 
above. Part one was a systematic review that aimed to identify, summarise and critically 
examine all available studies on the measurement and practical properties of all 
available ULD OMs that were used for patients with NP and make recommendations 
about those that are suitable for use in clinical practice and research (RQ 1). Part two 
was a literature review to explore current evidence-based management practice within 
the scope of physiotherapy for patients with NS-NP. The findings of this literature 
review and the systematic review were used to inform the development of the 
subsequent national survey of UK physiotherapists’ measurement and management of 
patients with NS-NP (Part three) (RQ 2). In the context of this programme of research, 
the particular area of interest was related to the utilisation of OMs in the assessment and 
during the management of NS-NP as well as whether or not UK physiotherapists 
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consider ULD rehabilitation when managing their patients with NS-NP. Part four was a 
cross-sectional study that investigated the acceptability and feasibility of the SAMP test 
at lower weight (½-kg, 1-kg, 1½-kg) in Egyptian female patients with NS-NP, identified 
from the Rheumatology and Physical Therapy Medicine Department at Tanta Universal 
Teaching Hospital (Egypt) (RQ 3). Part five was a validation study that investigated the 
reliability and validity of the SAMP test in Egyptian female patients with NS-NP and 
healthy subjects (RQ 4). The structure and content of the reminder of thesis are 
summarised below.  
 
Chapter 2: Measures of upper limb function for people with neck pain: A 
systematic review of the measurement and practical Properties.  
 
This chapter identifies and reviews the measurement and practical properties of all 
available ULD OMs that were developed or validated for patients with NP. This chapter 
addresses RQ 1. 
 
Chapter 3: Evidence of the currently recommended treatment approaches for 
nonspecific neck pain: A literature review. 
 
This chapter describes a literature review exploring current evidence-based management 
practice within the scope of physiotherapy for patients with NS-NP. The findings of this 
literature review were used to inform the development of the subsequent survey. 
 
Chapter 4: Physiotherapy management of patients with non-specific neck pain: A 
national survey of current UK practice. 
 
This chapter describes a national survey investigating UK physiotherapists’ 
measurement and management of patients with NS-NP to establish the current 
utilisation patterns of OMs in the assessment and during the management of NS-NP as 
well as the treatment approaches that are most often used alongside ULD rehabilitation. 
This chapter addresses RQ 2. 
 
Chapter 5: Measuring upper limb disability in neck pain population: Evaluation of 
the acceptability and feasibility of the Single Arm Military Press (SAMP) test. 
 
This chapter describes a study investigating the acceptability and feasibility of the 
SAMP test from both the patients’ and clinicians’ perspectives using lower weight (½- 
kg, 1-kg, 1½-kg) in the practical application of the SAMP test. This chapter addresses 
RQ 3. 
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Chapter 6: Measuring upper limb disability in Egyptian female patients with 
nonspecific neck pain: Evaluation of the reliability and validity of the Single Arm 
Military Press (SAMP) test. 
 
This chapter describes a study investigating the reliability (inter- and intra-rater and 
measurement error) and the construct validity (convergent and discriminate) of the 
SAMP test in patient populations with NS-NP. This chapter addresses RQ 4. 
 
Chapter 7: Summary, discussion and conclusion 
This chapter summarises the key findings of the thesis and provides recommendations 
about how to prevent ULD in patient populations with NS-NP. 
 
 
1.9 Publications and presentations  
1.9.1 Publications in peer reviewed journals  
The following peer-reviewed papers, incorporating research from this PhD project have 
been published:  
• ALRENI. A., HARROP D., GUMBER A., MCLEAN S. (2015). Measures of 
upper limb function for people with neck pain: a systematic review of the 
measurement and practical properties (protocol). Systematic Review, 4 (43), 
0034-39. 
 
• ALRENI A., HARROP D., LOWE A., POTIA T., KILNER K., MCLEAN S. 
(2017). Measure of upper limb function for people with neck pain. A systematic 
review of the measurement and practical properties. Musculoskeletal Science 
and Practice, 29, 155-163. 
 28 
 
 
1.9.2 Conference presentations  
 
• ALRENI, A. (2016). Measures of upper limb function for people with neck 
pain: A systematic review of measurement and practical properties. Poster 
presentation at IFOMPT, Glasgow, Jul 2016. 
 
• ALRENI, A. (2017). Managing non-specific neck pain: A national survey of 
current UK physiotherapy practice. Oral presentation at The Annual General 
Meeting of The Society for Back Pain Research, Northampton UK, Nov 2017. 
 
• ALRENI, A. (2017). Outcome measures utilisation in managing non-specific 
neck pain: A national survey of current physiotherapy practice in the UK. Poster 
presentation at Physiotherapy UK (CSP Conference & Trade Exhibition), 
Birmingham UK, Nov 2017. 
 
• ALRENI, A. (2018). Measuring upper limb disability in patients with neck pain: 
Evaluation of the acceptability and feasibility of the Single Arm Military Press 
(SAMP) test. Poster presentation at Physiotherapy UK (CSP Conference & 
Trade Exhibition), Birmingham UK, 2018. 
 
• ALRENI, A. (2018). Measuring upper limb disability in patients with neck pain: 
Evaluation of the reliability and validity of the Single Arm Military Press 
(SAMP) test. Oral presentation at Physiotherapy UK (CSP Conference & Trade 
Exhibition), Birmingham UK, 2018. 
 
 
1.9.3 Manuscript under preparation 
 
• ALRENI, A, HARROP, D., KILNER, K., DEMACK, S., MCLEAN, S. (2018). 
Outcome measures utilisation in managing non-specific neck pain: A national 
survey of current physiotherapy practice (Manuscript under preparation to be 
submitted to an appropriate Journal) 
 
• ALRENI, A, HARROP, D., KILNER, K., DEMACK, S., MCLEAN, S. (2018). 
Managing non-specific neck pain: A national survey of current UK 
physiotherapy practice (Manuscript under preparation to be submitted to an 
appropriate Journal) 
 
• ALRENI, A, HARROP, D., KILNER, K., MCLEAN, S. (2019). Managing 
nonspecific neck pain: Reporting the Social Media Strategy that was used in the 
UK national survey of neck pain recruitment and administration (Manuscript 
under preparation to be submitted to an appropriate Journal) 
 
• ALRENI, A, HARROP, D., KILNER, K., MCLEAN, S. (2019). Measuring 
upper limb disability in neck pain population: Evaluation of the acceptability 
and feasibility of the Single Arm Military Press (SAMP) test (Manuscript under 
preparation to be submitted to an appropriate Journal) 
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• ALRENI, A, HARROP, D., KILNER, K., MCLEAN, S. (2019). Measuring 
upper limb disability in neck pain population: Evaluation of the reliability and 
validity of the Single Arm Military Press (SAMP) test (Manuscript under 
preparation to be submitted to an appropriate Journal).  
 
 
The chapter as follows addresses the first research question and describes the systematic 
review completed to identify, summarise and critically examine all available studies on 
the measurement and practical properties of all available OMs that have been developed 
or validated to measure ULD in patient populations with NS-NP. 
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Chapter 2: Measures of upper limb function for people with neck pain: 
A systematic review of the measurement and practical properties. 
 
2.1 Introduction  
This chapter forms part one of the thesis and describes a narrative systematic review 
completed to answer research question one of the PhD project (see section 1.5): to 
identify, summarise and critically examine all available studies on the measurement and 
practical properties of all available OMs developed or validated to measure ULD for 
patients with NP. The aim and objectives of the systematic review are summarised 
alongside definitions of the measurement properties of an OM according to the 
“COnsensus-based Standards for the selection of health Measurement INstruments” 
(COSMIN) checklist (Mokkink et al. 2010a, Terwee et al. 2012). The methods used in 
the systematic review are described and then the results of the review are presented and 
discussed.  
 
2.1.1 Aim  
The aim of this systematic review was to explore all existing outcome measures that were 
developed or validated to measure ULD in patents with NP. The Objectives were to:  
1. Identify all OMs used to measure ULD in patients with NP 
2. Summarise and critically appraise the methodological quality of all available 
studies on the measurement and practical properties of the identified OMs.  
3. Provide recommendations about the relevance and suitability of OM for 
application in clinical practice and research.  
 
2.1.2 Measurement properties of outcome measure 
Clinically, OMs are used for a variety of purposes: (1) before interventions for screening 
of symptoms/function, capturing the aspects of health that matter most to patients, 
classifying patients into meaningful sub-groups, assisting clinical reasoning and setting 
treatment goals (diagnosis and prognosis) (Lansky et al. 1992, Kramer and Holthaus, 
2006, Kyte et al. 2015), (2) during interventions to monitor condition progression and 
detect changes in pain/disability (Richard et al., 1992; Garland et al., 2003; Bot et al., 
2007; Nordin et al., 2008) and (3) after interventions to determine the effectiveness, 
efficiency and cost-effectiveness of the interventions used and monitoring patient valued 
outcomes (CSP 2012, van Dulmen et al. 2017). The measurement properties (e.g. 
reliability, validity and responsiveness) of an OM should be adequate as any failures of 
these measurement properties would lead to imprecise evaluation and incongruous 
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decisions regarding the management. The measurement properties definitions from the 
COSMIN taxonomy study (Mokkink et al. 2010b) were used in this thesis as the 
foundation for providing definitions for terminology of the measurement properties.  
 
Measurement properties of an OM are divided according to the COSMIN taxonomy study 
into three domains: (1) reliability, (2) validity and (3) responsiveness. Interpretability was 
considered to be sufficiently important by the COSMIN panel to be included in the 
COSMIN taxonomy despite that it is not a measurement property for quality testing (see 
Figure 2.1) (Mokkink et al. 2010b).  
 
2.1.2.1 Reliability  
It is a fundamental requirement that all OMs incorporated into clinical practice and 
research are reliable, and this is to ensure the accuracy of scores under different 
conditions when a patient is stable (de Vet et al. 2011). Reliability as a domain is 
defined by the COSMIN panel as “the extent to which scores for patients who have not 
changed are the same for repeated measurement under several conditions (e.g. using 
different sets of items from the same multi-item measurement instrument (internal 
consistency), over time (test-retest), by different persons in the same occasion (inter-
rater) or by the same person in different occasions (intra-rater)” (Mokkink et al. 2010b). 
Internal consistency, reliability and measurement error are the measurement properties 
associated with the reliability domain.  
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Internal consistency is defined as the extent to which items in a questionnaire are 
interrelated (Mokkink et al. 2010b). It is a measure of the extent to which items assess 
the same construct in a unidimensional scale of a multi-item instrument (de Vet et al. 
2011). Cronbach’s alpha is the parameter frequently used to assess the level of internal 
consistency, in which Cronbach’s alpha values between 0.70 and 0.90 represent a well-
accepted guideline of internal consistency (de Vet et al. 2011). Internal consistency is a 
redundant measurement property for objective or performance-based OMs.  
 
Reliability as a measurement property is described as the proportion of the total variance 
in the measurement resulting in the consistency of the scores (Mokkink et al. 2010b). 
Reliability is considered the consistency of the results obtained from (test-retest, inter-
and intra-rater) and expressed in correlations using the Interclass Correlation 
Coefficient (ICC) or Kappa (de Vet et al. 2011). The ICC range is between 0.0 to 1.0, 
where values close to 0.0 indicate poor reliability and ICC values close to 1.0 suggest 
high reliability (Portney and Watkins 2009).  
 
Measurement error is defined as the error which is not attributed to true changes in the 
construct measured but resulted in the systematic and random error of a patient’s score 
(Mokkink et al. 2010b). It is the absolute measurement error over repeated 
administration of the test when the patients are stable and it is represented by the 
Standard Error of Measurement (SEM), in which a low level of SEM indicates high 
levels of score accuracy and a high level of SEM indicates low levels of score accuracy 
(Vincent and Weir 2012).   
 
2.1.2.2 Validity  
Validity is an essential measurement property that should be possessed by an OM since 
it determines the true association between the OM and the construct of interest (de Vet 
et al. 2011). The domain validity is defined as the extent to which OMs truly measure 
the construct which they are expected to measure (Mokkink et al. 2010b). The validity 
domain, according to the COSMIN taxonomy, is divided into the three measurement 
properties as follows.  
 
Content validity is defined as the extent to which the content items/tasks of an OM is an 
adequate reflection of the construct to be measured and examines the extent to which 
the constructs of interest are comprehensively represented by those items/tasks 
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(Mokkink et al. 2010b). Face validity which is considered an aspect of content validity 
in the respect that it concerns the degree to which an OM appears as though it is an 
adequate reflection of the construct being assessed. Content validity is assessed to 
ensure that the OM adequately represents the construct under study; this emphasises the 
importance of a good description of the construct to be measured and implies that OM 
items/tasks should be both relevant and comprehensive (de Vet et al. 2011). Relevance 
is assessed by answering the following three questions. First, do all items/tasks refer to 
the relevant aspect of the construct of interest? Second, are all items/tasks relevant to 
the study population (e.g. age, gender, disease characteristics, languages, countries, 
setting)? Third, are all items/tasks relevant for the purpose (e.g. discrimination 
“distinguish between patients in one occasion”, evaluation “assess change over time” or 
prediction “predict future change”) of the application of the OM? (Terwee et al. 2007).  
 
Criterion validity is defined as the degree to which the scores of an OM are an adequate 
reflection of a gold standard (Mokkink et al. 2010b). Gold standard OMs which 
represent the true state of the construct of interest seldom exist in practice (de Vet et al. 
2011). Patient-Reported Outcome Measures (PROMs) which always acquire subjective 
information, often lack a gold standard. However, in circumstance such as when one 
wants to develop a shorter questionnaire for a construct, when a long version of this 
questionnaire already exists (i.e. DASH and QuickDASH), the long version is 
considered an adequate gold standard for the shorter version (Mokkink et al. 2010b). 
For objective or performance-based OMs, a gold standard usually is an OM or reliable 
assessment criteria for the construct under study that has been accepted and is regarded 
by experts in the field as ideal to identify a condition and/or measure its severity (de Vet 
et al. 2011). Criterion validity is sub-divided by the COSMIN taxonomy to: (1) 
concurrent validity (that is the assessment by comparing the score of the OM under 
study and the gold standard at the same time, which is usually assessed for OMs to be 
used for evaluative and diagnostic purposes), and (2) predictive validity (that is, the 
assessment of whether the OM under study predicts the gold standard in the future, 
which is usually measured for OMs to be used in predictive applications) (Mokkink et 
al. 2010b). Assessing criterion validity requires comparing the scores of the OM under 
study with the scores obtained from the criterion OM. This is often determined by the 
level of measurement for the OM under study and the criterion. For example, Sensitivity 
and Specificity are adequate parameters when both OMs have a dichotomous outcome 
and are expressed by the same unit of measurement. The Receiver Operator Curve 
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(ROCs) is adequate when the OM under study has an ordinal or continuous scale with 
dichotomous criterion and different unit of measurement. Bland and Altman limits of 
agreement (LoA) or Interclass Correlation Coefficient (ICC) should be used when both 
OMs have a continuous scale and are expressed by the same units of measurement (de 
Vet et al. 2011).  
 
Construct validity should be used to provide evidence of the validity of an OM when a 
gold standard of the construct to be measured is not available. It concerns the degree to 
which the scores of the instrument under study are consistent with clearly and a priori 
formulated hypotheses regarding the relationship with the scores of other instruments 
that should be measuring the same construct and it is often assessed using the Pearson 
correlation coefficient (Mokkink et al. 2010b). Construct validity is sub-divided by the 
COSMIN taxonomy into the following three properties. First, structural validity, which 
is defined as the extent to which the scores of an OM are an adequate reflection of the 
dimensionality of the construct being measured (Mokkink et al. 2010b). It is assessed 
using factor analysis to confirm the number of subscales presented in a questionnaire 
(de Vet et al. 2011). Consequently, it is relevant to PROMs and redundant for objective 
or performance-based OMs. Second, hypothesis testing, which is the basic principle of 
construct validity since it is described based on the idea that hypotheses are formulated 
about the relationship of scores on the OM under study and scores on other OMs 
measuring similar or dissimilar constructs, or differences on the OM scores between 
sub-groups of patients (Mokkink et al. 2010b). Hypotheses should be as specific as 
possible, formulated prior to data collection and reported together with their 
justification to allow for assessment of their plausibility (de Vet et al. 2011). 
Formulated hypotheses have then to be tested and assessed based on their expected level 
and direction of correlation with the comparative OMs (Terwee et al. 2007). Third, 
cross-cultural validity is the extent to which items in a questionnaire can mirror the 
performance of the same items when the questionnaire translated into another language 
or adapted to reflect the lifestyle of a different culture (Mokkink et al. 2010b). It is often 
assessed after the translation of a PROM questionnaire by evaluating the construct 
validity of the translated version. This is to examine whether the translated OM 
demonstrates the expected correlations with related constructs, and it has the capability 
to discriminate between the relevant sub-groups of patients. Consequently, this 
measurement property is relevant only to the PROMs and it is redundant for objective 
or performance-based OMs.  
 35 
 
2.1.2.3 Responsiveness  
The domain responsiveness is defined by the COSMIN taxonomy as the ability of an 
OM to detect changes over time in the construct being measured (Mokkink et al. 
2010b). Consequently, evaluative OMs used in clinical practice and research practice 
should have the capability to detect and quantify changes in health status overtime in 
the construct of interest (de Vet et al. 2011). Responsiveness is assessed using the same 
methodological principle as validity since it is an aspect of validity, however the only 
difference is that responsiveness emphasises the validity of change scores, while 
validity emphasises the validity of single scores (Mokkink et al. 2010b). This implies 
that a longitudinal study is required, in which two measurements should be taken in 
order to calculate change scores and changes in the construct of interest are expected 
(i.e. at least some proportion of patients would improve or deteriorated). This is because 
if no change on the OM was detected, it would be difficult to determine whether this 
was because the patients really did not change, or if the OM was not responsive (de Vet 
et al. 2011).  
 
2.1.2.4 Interpretability  
Interpretability is defined by the COSMIN taxonomy as the degree to which clinician 
can assign qualitative meaning to an OM’s quantitative scores (Mokkink et al. 2010b). 
It is not a measurement property, as reliability and validity, since it does not refer to the 
quality of an OM but it refers to what the scores on an OM means. Adequate 
interpretability of a score is necessary before considering the use of an OM in clinical 
practice and research (de Vet et al. 2011). Interpretability can be assessed by examining 
the distribution of scores, the occurrence of floor and ceiling effects and the availability 
of scores and change scores for the relevant sub-groups as well as the calculation of the 
Minimal Important Change (MIC) or the Minimal Important Difference (de Vet et al. 
2011).  
 
2.1.3 Practical properties of outcome measure  
Practical properties are those related to the practicality and burden of patients (patients’ 
acceptability and feasibility), and the practicality and burden of clinicians (clinicians’ 
acceptability and feasibility) as well as precision of an OM (Selby and Robertson 1987, 
Erikson et al. 1995, Kessler and Mroczek 1995). These practical properties were first 
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highlighted in 1998 as essential properties which should be possessed by an OM that is 
considered for use in clinical practice and research (Fitzpatrick et al. 1998).  
 
Patients’ acceptability is defined as the ability and willingness of a patient from the 
target population to complete questions or tasks related to an OM (Fitzpatrick et al. 
1998). Meanwhile, patients’ feasibility (burden) is described as the time and effort 
required from a patient to complete questions/tasks and the proportion of patients who 
find these questions/tasks difficult or impossible to complete for any reason (Selby and 
Robertson 1987). Patients’ acceptability and feasibility comprised two main 
components. First, reasons for non-completion: if a patient was unable to complete the 
questions in a PROM or tasks in a performance-based OM because of difficulties or 
distress, this is an indication of unacceptability and/or unfeasibility of this OM unless 
other reasons such as health status deterioration or other disabilities were involved 
(Fitzpatrick et al. 1998). Second, completion time is often considered to be a 
determinant of an instrument’s acceptability and feasibility (the shorter the time it takes 
to complete, the more acceptable and feasible the OM is to the patient) (Nelson et al. 
1990).  
 
Clinicians’ acceptability is frequently related to the difficulty clinicians encounter 
during the administration of an OM, such as the length and complexity of the overall 
testing procedure. Clinicians’ feasibility (burden) is related to the resources required 
from the clinicians to compete the testing procedure, and this includes the time and cost 
of administration, speed and ease of scoring and feedback of information and 
interpretation (Fitzpatrick et al. 1998). This suggests that brevity, simplicity in 
administration and ease of the scoring system alongside free access to OMs is an 
indication of greater clinicians’ feasibility (Read et al. 1987, Feeny and Torrance 1989, 
Nelson et al. 1990). Both patients’ and clinicians’ acceptability and feasibility of an OM 
are essential properties and should be established prior to the testing of other 
measurement properties such as reliability, validity and responsiveness (Sprangers et al. 
1993). They can be assessed by obtaining the qualitative opinion of patients as well as 
clinicians regarding their experience with the OM under study directly after 
administration (Fitzpatrick et al. 1998).  
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2.2 Methods  
2.2.1 Design  
narrative two-phase systematic review was undertaken to explore all OMs that were 
developed or validated to assess ULD in patient populations with NP. Phase one 
identified all OMs that have been used to assess ULD in patients with NP. Phase two 
identified all available studies investigating the measurement and practical properties of 
the identified OMs. The methodological quality of the developmental and/or evaluative 
studies of those identified OMs were assessed against the “COnsensus-based Standards 
for the selection of health Measurement INstruments” (COSMIN) checklist (Mokkink et 
al. 2010a, Terwee et al. 2012). The Preferred Reporting Items for Systematic Reviews 
and Meta-Analysis (PRISMA) guideline for systematic reviews was followed in 
reporting this study (Liberati et al. 2009, Moher et al. 2009).  
 
2.2.2 Phase one – identification of measures  
2.2.2.1 Data source and search strategy  
The bibliographic databases as follows were searched from their inception until March 
2016: Allied and Complementary Medicine Database (AMED) (OvidSP), CINAHL 
Complete (EBSCO), Cochrane Library (Wiley), MEDLINE (EBSCO), PubMed (US 
National Library of Medicine), PsycINFO (ProQuest), SPORTDiscus (EBSCO), Web 
of Science (Thomson Reuters). 
 
The search strategy in this phase of the study comprised terms relating to ULD and NP. 
These terms were combined with Boolean logic terms. Other terms were incorporated to 
limit the search to OMs, psychometric properties or measurement properties. The 
searches were undertaken in February and March 2016. All search terms were looked 
for in the title and abstract fields and controlled vocabulary terms were used where 
available. The Boolean operators AND and OR were used, alongside truncation, phrase 
searching and proximity operators. The search strategy for MEDLINE (EBSCO) is as 
follows (see Box 2.1). The search syntax detailed below were adapted for use on other 
information resources used in the search.  
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Box 2.1: Search strategy for phase 1 
(“upper limb”[ti,ab] OR “upper extremity”[ti,ab] OR function* [ti,ab] OR 
dysfunction*[ti,ab] OR abilit*[ti,ab] OR disabilit*[ti,ab] OR capacity*[ti,ab] OR 
disorder*[ti,ab] OR problem*[ti,ab] OR pain*[ti,ab] OR deficit*[ti,ab] AND neck[ti,ab] 
OR “cervical spine”[ti,ab] OR cervicogenic*[ti,ab] OR pain*[ti,ab] OR function*[ti,ab] 
OR dysfunction*[ti,ab] OR abilit*[ti,ab] OR disabilit*[ti,ab] OR problem*[ti,ab] OR 
disc*[ti,ab] OR “degenerative disc”[ti,ab] OR degeneration*[ti,ab] OR disease*[ti,ab] 
OR disorder*[ti,ab] OR deficit*[ti,ab] AND “outcome measure*” n5[ti,ab] OR 
“outcome assessment*”[ti,ab] OR psychometr*[ti,ab] OR clinimetr*[ti,ab] OR 
“observer variation*”[ti,ab] OR reproducib*[ti,ab] OR reliab*[ti,ab] OR unreliab*[ti,ab] 
OR valid*[ti,ab] OR discriminant*[ti,ab] OR coefficient*[ti,ab] OR correlation*[ti,ab] 
OR selection*[ti,ab] OR reduction*[ti,ab] OR agreement*[ti,ab] OR precision*[ti,ab] 
OR imprecision*[ti,ab] OR test-retest*[ti,ab] OR interrater*[ti,ab] OR intrarater*[ti,ab] 
OR inter-rater*[ti,ab] OR intra-rater*[ti,ab] OR kappa*[ti,ab] OR “minimal important 
change*”[ti,ab] OR “multitrait scaling analysis*”[ti,ab] OR “factor analysis*”[ti,ab] OR 
“known group*”[ti,ab] OR responsive*[ti,ab]. 
Note: (ti) = title field, (ab) = abstract field, (/) = MeSH, asterisk (*) denotes any 
character, (“”) = phrase search, (n5) = adjacency within five words. 
 
2.2.2.2 Study selection  
Inclusion criteria  
All studies yielded from the literature search were eligible for inclusion in this review 
without restriction of study design or publication date provided the article: (1) was a 
full-text original primary quantitative study (e.g. clinical trials, observational studies, 
case-controlled studies or case studies), (2) was published in the English language, (3) 
involved adult ≥ 18years of age with NP, which is defined here as “pain perceived as 
arising from anywhere within the region bounded superiorly by the superior nuchal line, 
inferiorly by the transverse line through the tip of the first thoracic spinous process, and 
laterally by the sagittal planes tangential to the lateral border of the neck (Merskey and 
Bogduk, 1994), and (4) contained at least one OM to measure ULD. For the purpose of 
this study ULD is defined as the difficulties or limitation an individual may have when 
executing tasks/activities using their ULs such as carrying, lifting and overhead 
activities (ICF 2001).   
 
Exclusion criteria  
Articles were excluded if: (1) they did not use primary quantitative data, (e.g. 
systematic reviews, meta-analysis, qualitative studies, reportage or opinion pieces), (2) 
they did not include at least one OM to measure ULD, or (3) involved patients with 
disorders other than NP.  
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Screening  
After completion of the search process, the results were initially reviewed by one 
reviewer (ASEA) to exclude any duplication and obviously irrelevant studies. This was 
followed by a two-phase screening strategy to identify the studies to be reviewed. 
Firstly, two reviewers (ASEA and AL) independently screened the title and abstract of 
the articles retrieved against the inclusion and exclusion criteria and selected all 
potentially relevant studies. Finally, the full-text articles were retrieved and the 
aforementioned reviewers independently screened each of the retrieved articles to 
further determine their eligibility for inclusion in this review. In the case of a 
disagreement between the two reviewers as to whether an article should be included or 
excluded, a consensus was sought through discussion, and if required a third reviewer 
(SMc) made the final decision. Reference lists of all included studies were also 
scrutinised independently by the two reviewers to identify additional relevant articles.  
 
2.2.3 Phase two – identification of the developmental and/or evaluative studies  
A second search was performed, using the databases identical to those searched in phase 
one. The name of each OM identified in phase one was searched for using all fields 
search function and was used to identify all articles related to the development or 
validation of the measurement and practical properties of this OM. A sensitive search 
filter (Terwee et al. 2009), was used to locate articles reporting the measurement and 
practical properties of each identified OM. Furthermore, the authors and/or developers 
of specific OMs were contacted to request additional published and/or unpublished 
evidence of measurement evaluation.  
 
2.2.4 Data extraction   
A data extraction form (Appendix 1) informed by earlier reviews from Haywood et al. 
(2013), Haywood et al. (2014) and the COSMIN checklist (Mokkink et al. 2010a, 
Terwee et al. 2012) was used to capture study specific (population, intervention, and 
setting) and measurement specific information: reliability (internal consistency, test-
retest, intra-/inter tester, measurement error), validity (face/content, structural validity 
(dimensionality), construct validity (evidence of explicit hypothesis testing, 
discriminant/discriminative), criterion validity (concurrent, predictive), responsiveness 
(criterion approach, construct approach), interpretability (for example, evidence of 
minimal important change), data precision (data quality, end effect), and evidence of 
where Item Response Theory (IRT) models where applied. Extraction of practical 
properties included acceptability (relevance and respondent burden) and feasibility 
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(clinician burden, including cost, time to complete/score). The extent of patient 
involvement in measurement development and/or application was also sought 
(Haywood et al. 2014).  Two reviewers (ASEA and TP), independently performed the 
data extraction for all included studies. In the case of disagreement about a study, a 
consensus was reached between the two reviewers via discussion. A third reviewer 
(SMc) was available to make the final decision, if necessary.  
 
2.2.5 Quality assessment of studies  
Articles that were included for methodological quality, data analysis and data synthesis 
were those related to the development and/or validation of the measurement and 
practical properties of all available ULD OMs for patient populations with NP. Two 
reviewers (ASEA and TP), independently performed the methodological quality of 
studies selected for inclusion in this review. In case of disagreement, a consensus was 
reached through discussion. A third reviewer (SMc) was available to make the final 
decision, if required. Each identified OM was evaluated for its development or 
validation methodology, and measurement and practical properties. The methodological 
quality assessment was undertaken using the COSMIN checklist (Mokkink et al. 2010a, 
Terwee et al. 2012).  
 
2.2.5.1 Rational for COSMIN  
The COSMIN checklist (Mokkink et al. 2010a, Terwee et al. 2012) was used to 
critically appraise the quality of all studies included in this review. The checklist is a 
comprehensive and rigorous quality assessment tool, developed specifically to focus on 
the measurement properties and methodological quality of health-related OMs. It also 
incorporates a standardised rating system alongside multilevel grading for each 
measurement property. In addition, provides an overall quality rating for the 
methodological quality of a study in relation to each measurement property being 
assessed within that study.  The COSMIN associative taxonomy study (Mokkink et al. 
2010b) facilitates agreement between reviewers when a measurement property is 
reported using different terminology across multiple studies. It provides extensive 
guidelines to facilitate interpretation of items and score levels for each measurement 
property box. Further, it provides detailed standards regarding adequacy of design and 
statistical methods within studies evaluating the measurement properties of health-
related OMs. Finally, the COSMIN checklist provides a grading for each measurement 
property rather than the OM as a whole, which informs decision-making regarding 
specific limitations of an OM.  
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2.2.5.2 COSMIN checklist  
The COSMIN checklist (Mokkink et al. 2010a, Terwee et al. 2012) is a four-point scale 
(excellent, good, fair or poor) comprising twelve boxes out of which nine boxes are 
used to assess the methodological quality of the measurement properties of an OM 
(Terwee et al. 2012). In each measurement property box, there are a variety of criteria 
that are rated on the aforementioned 4-point rating scale. These include criteria such as 
sample size, the methods used to manage missing data and the statistical analysis used. 
The internal consistency property comprises 11-items, reliability 14-items, 
measurement error 11-items, face/content validity 5-items, structural validity 7-items, 
cross-cultural validity 15-items, hypothesis testing 10-items, criterion validity 7-items, 
and responsiveness comprises 18-items. A study’s methodological quality is rated for 
each measurement property evaluated within the study and determined by the lowest 
rate “worst score counts”. For example, the methodological quality of a measurement 
property is considered excellent if all criteria related to that property are adequate and 
rated excellent. However, the methodological quality of a measurement property will be 
rated poor if at least one criterion related to that property was inadequate and rated as 
poor (Appendix 2) (Terwee et al 2012).  
 
2.2.6 Data analysis  
Data was qualitatively synthesised using a best evidence synthesis to determine the 
overall quality and acceptability of each identified measure (Haywood et al. 2013, 
Haywood et al. 2014). Different studies on the measurement properties of each 
identified measure were summarised by combining their results on: (1) the number of 
studies in which the measurement property was assessed, (2) their methodological 
quality (COSMIN score), and (3) the consistency of the result for each study was also 
examined and considered positive (+), negative (-) or indeterminate (?) following the 
criteria reported by (Terwee et al. 2007) (see Table 2.1). This was presented alongside 
the level of evidence suggested by the Cochrane Back Review Group, in which the 
possible level of evidence for a measurement property is “strong”, “moderate”, 
“limited”, “conflicting” or “unknown” (van Tulder et al. 2003, Furlan et al. 2009) (see 
Table 2.2). This level of evidence strategy has been employed by multiple systematic 
reviews of OMs and is now established practice (Schellingerhout et al. 2011, 
Schellingerhout et al. 2012). The methodological quality ratings for the measurement 
properties of each identified instrument were accompanied by the strength of the results 
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and the level of evidence in order to enable inference on the relative robustness of 
evidence for each available instrument.  
 
Table 2.1: Quality criteria for measurement properties (Terwee et al. 2007). 
Property Rating†  Quality Criteria 
Reliability    
Internal consistency 
+  (Sub)scale unidimensional AND Cronbach's alpha(s) ≥ 0.70 
?  Dimensionality not known OR Cronbach's alpha not determined 
-  (Sub)scale not unidimensional OR Cronbach's alpha(s) < 0.70 
Reliability 
+  ICC / weighted Kappa ≥ 0.70 OR Pearson’s r ≥ 0.80 
?  Neither ICC / weighted Kappa, nor Pearson’s r determined 
-  ICC / weighted Kappa < 0.70 OR Pearson’s r < 0.80 
Measurement error 
+  MIC > SDC OR MIC outside the LOA 
?  MIC not defined 
-  MIC ≤ SDC OR MIC equals or inside LOA 
Validity    
Content validity 
+ 
 All items are considered to be relevant for the construct to be measured, for the 
target population, and for the purpose of the measurement AND the 
questionnaire is considered to be comprehensive 
?  Not enough information available OR no target population involvement 
- 
 Not all items are considered to be relevant for the construct to be measured, for 
the target population, and for the purpose of the measurement OR the 
questionnaire is considered not to be comprehensive 
Construct validity    
 -Structural validity 
+  Factors should explain at least 50% of the variance 
?  Explained variance not mentioned 
-  Factors explain < 50% of the variance 
- Hypothesis testing 
+ 
 Correlations with instruments measuring the same construct ≥ 0.50 OR at least 
75% of the results are in accordance with the hypotheses AND correlations with 
related constructs are higher than with unrelated constructs 
?  Solely correlations determined with unrelated constructs 
- 
 Correlations with instruments measuring the same construct < 0.50 OR  
< 75% of the results are in accordance with the hypotheses OR correlations with 
related constructs are lower than with unrelated constructs 
 +  No differences in factor structure OR no important DIF between language versions 
- Cross-cultural validity ?  Multiple group factor analysis not applied AND DIF not assessed 
 -  Differences in factor structure OR important DIF between language versions 
Criterion validity 
+  Convincing arguments that gold standard is “gold” AND correlation with gold standard ≥ 0.70 
?  No convincing arguments that gold standard is “gold” 
-  Correlation with gold standard < 0.70 
Responsiveness    
Responsiveness 
+ 
 Correlation with changes on instruments measuring the same construct ≥ 0.50 
OR at least 75% of the results are in accordance with the hypotheses OR AUC 
≥ 0.70 AND correlations with changes in related constructs are higher than with 
unrelated constructs 
?  Solely correlations determined with unrelated constructs 
- 
 Correlations with changes on instruments measuring the same construct < 0.50 
OR < 75% of the results are in accordance with the hypotheses OR AUC < 0.70 
OR correlations with changes in related constructs are lower than with unrelated 
constructs 
Notes: MIC: Minimal Important Change, SDC: Smallest Detectable Change, LOA: 
Limits of Agreement, ICC: Interclass Correlation Coefficient, AUC: Area Under the 
Curve, (+) = positive rating, (-) = negative rating, (?) = indeterminate rating. 
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Table 2.2: Level of evidence for the overall quality of measurement property (van 
Tulder et al. 2003, Furlan et al. 2009). 
Level Rating† Criteria 
strong +++ or --- 
Consistent findings in multiple studies of good 
methodological quality OR in one study of excellent 
methodological quality 
moderate ++ or -- 
Consistent findings in multiple studies of fair 
methodological quality OR in one study of good  
methodological quality 
limited + or - One study of fair methodological quality 
conflicting +/- Conflicting findings 
unknown ? Only studies of poor methodological quality 
(+) = positive result, (-) = negative result, (?) = indeterminate results. 
 
2.3 Results  
2.3.1 Phase one  
The search strategy in this phase resulted in a total of 1382 unique records being 
identified from the database searches, reducing to 982 after the removal of duplicates. 
Following the title and abstract screening process another 928 articles were excluded. 
The full-text of 54 articles were retrieved and reviewed against the inclusion and 
exclusion criteria. This resulted in the exclusion of 5 articles (not primary quantitative), 
1 article (foreign language study), 21 articles (other than NP population), 8 articles (the 
OM does not measure ULD) and 14 articles (not OM’s developmental or evaluative 
study). Screening the reference lists from the five retained articles resulted in 15 
additional potentially relevant articles, of which one article met the inclusion criteria for 
this review. From this phase, six developmental and/or evaluative articles for five 
clearly described and reproducible ULD OMs for NP patients were included in the 
review.  
 
2.3.2 Phase two  
Evidence for the measurement and practical properties were sought for those identified 
five OMs in phase one. However, the database searches did not uncover any new 
records. Contacting the developers of specific measures resulted in six additional 
articles, of which one was excluded (not OM’s developmental or evaluative study) and 
five of these were retained for inclusion in the review.  
 
2.3.3 Results from phase one and phase two  
In total, 11 articles on the developmental/evaluative of the five instruments were 
included in this review. Figure 2.2 shows the phase one and phase two outcomes at each 
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stage of selection and screening process as well as the reasons for exclusions. Since 
there was 97% agreement between the two reviewers (ASEA and AL) regarding the 
inclusion and exclusion of studies and consensus was reached through discussion for the 
remaining 3%, the third reviewer (SMc) was not used. These 11 articles provide 
evidence for five clearly defined and reproducible outcome measures of upper limb 
disability in the context of neck pain. Three are patient-reported questionnaires: The 
Disability of Arm, Shoulder and Hand (DASH) (Hudak et al. 1996); the Quick 
Disability of Arm, Shoulder and Hand (QuickDASH) (Beaton et al. 2005); and the 
Neck and Upper Limb Index (NULI) (Stock et al. 2003). One is clinician-reported: The 
Shoulder Functional Assessment (SFA) (Lomond and Cote 2009). One is a 
performance-based test: The Single Arm Military Press (SAMP) (McLean et al. 2010).  
 
The general characteristics of the 11articles are presented in Table 2.3. A summary of 
the quality of the measurement properties that were tested in each study is presented in 
(Appendix 3). The methodological quality of each study per measurement property is 
presented in Table 2.4. A synthesis of the results for each instrument, alongside their 
level of evidence is presented in Table 2.5. Since there was 95% agreement between the 
two reviewers (ASEA and TP) on the individual COSMIN items reviewed and 
consensus was reached through discussion for the remaining 5%, the third reviewer 
(SMc) was not used. A summary of the measurement properties for each identified 
instrument follows.  
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Figure 2.2 PRISMA Flow Chart of phase One and Phase Two. 
Records identified through 
databases searching 
(Phase 1: n=1382) 
Additional records identified through other 
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(Phase 1: n=15 reference lists) + 
(Phase 2: n=6 unpublished studies) 
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(Phase 1: n=982+15=997) + (Phase 2: n=6)  
(Total n=1003) 
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Records excluded 
(n=942) 
Full-text articles assessed for 
eligibility 
(Phase 1: n=55) + (Phase 2: n=6)  
(Total n= 61)  
Full-text excluded 
(n=50) 
 
Not primary 
quantitative study (n=5) 
 
Foreign language study 
(n=1) 
 
Not adult subjects (n=0) 
Other than neck pain 
population (n=21) 
 
The instrument does not 
measure upper limb 
function (n=8) 
 
Not outcome measure’s 
developmental or 
evaluative study (n=15) 
 
Included measures 
Phase 1: n=5 
Included articles  
(Phase1: n=6) + (Phase2: n=5)  
 (Total n=11) 
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Table 2.3: Characteristics of the included studies 
Study Sample 
Size 
Mean age ± SD 
(range) 
Population Country Setting Recruitment 
methods 
Outcome measures 
used in the study 
Measurement 
property assessed 
Huisstede (2009) N=679 44.4 ± 11.4 (18-64) Neck, shoulder, and/or 
arm pain 
Netherland Dutch General 
Practices (GPs) 
Convenience DASH 
SF-12 
Severity of complaint 
Persistence of complaint 
Hypothesis testing 
Responsiveness 
Mehta (2010) N=66 40.6 ± 14.2 Neck pain with/without 
arm pain, headache and 
whiplash disorders level 
2&3 
Canada  Canadian Physical 
Therapy Clinics   
Convenience DASH 
QDASH  
NDI 
VAS 
CSOQ 
Hypothesis testing 
Concurrent validity   
 
Fan (2008) N=733 
 
 
Total Sample: 
N=733 39.5 ± 0.05 
 
Clinical-Cases:  
N=231 43.2 ± 0.7 
  
Symptomatic 
Only: 
N=175 39.3 ± 0.8 
Neck Or Upper Extremity 
Musculoskeletal Disorders 
(UEMSDs) 
USA Workplace 
walkthrough at 12 
manufacturing and 
service work sites in 
Washington State 
Convenience QDASH 
SF-12 
Symptoms severity 
Hypothesis testing  
Concurrent validity 
Predictive validity 
Fan (2011) N= 465 
 
Incident Cases: 
N=50 35.3 ± 10.2 
(S)  
N=18 42.6 ±10.9 
(C)  
Recovered Cases: 
N=46 35.5 ± 10.2 
(S) 
N=41.9 ± 11.3 (C) 
Excluded Case: 
N=317 41.1 ± 10.7 
Neck Or Upper Extremity 
Musculoskeletal Disorders 
(UEMSDs) 
USA Workplace 
walkthrough at 12 
manufacturing and 
service work sites in 
Washington State 
Convenience QDASH 
SF-12 
QDASH work module 
Severity  
Responsiveness  
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Stock (2003) Ontario 
N=119 
Quebec 
N=93 
Ontario: 39.7 ± 
10.1 
Quebec: 41.1 ± 
10.0 
Workers with neck and 
upper limb dysfunction  
Canada Workers from 
community private 
physiotherapy clinics  
Convenience NULI 
SIP  
SF-36 
Internal consistency 
Reliability 
Structural validity  
Hypothesis testing  
Responsiveness 
Lomond (2009) N=32 N=16 40.1 ± 12.1 
N=16 39.7 ± 13.2 
  
Chronic neck and shoulder 
pain 
Canada Institutional 
rehabilitation 
programme, 
advertisement, 
research centre staff 
and social network  
Convenience SFA 
SPADI 
NDI 
NRS  
The Borg CR-10 scale 
Test-retest, inter, intra-
rater reliability  
Measurement error 
Hypothesis testing  
Patekar (2010) N=98 42.2 ± 7.85 (30-60) Non-patient subjects with 
and without neck 
symptoms   
UK Institutional staff and 
students 
(institutional 
campus) 
Convenience SAMP Hypothesis testing 
Darne (2010) N=95 44.53 ± 7.9 (30-60) Non-patient subjects with 
and without neck 
symptoms   
UK Institutional staff and 
students 
(institutional 
campus)  
Convenience  SAMP  
DASH 
Hypothesis testing  
Toulassidharane 
(2010) 
N=190  41.8 ± 8.1 (30-59) Non-patient subjects with 
and without neck 
symptoms   
UK Institutional staff and 
students 
(institutional 
campus)  
Convenience SAMP 
DASH 
Hypothesis testing  
Kulkarni (2010) N=95 38.95 ± 7.22 (30-
60)  
Non-patient subjects with 
and without neck 
symptoms   
UK Institutional staff and 
students 
(institutional 
campus)  
Convenience SAMP 
DASH 
Test-retest, inter, intra-
rater reliability  
Jain (2010) 
 
 
 
 
N=95 44.5 ± 7.9 (30-60 Non-patient subjects with 
and without neck 
symptoms   
UK Institutional staff and 
students 
(institutional 
campus) 
Convenience SAMP 
DASH 
Test-retest, inter, intra-
rater reliability 
Notes: DASH: Disability of Arm, Shoulder and Hand, QDASH: Quick Disability of Arm, Shoulder and Hand, SAMP: The Single Arm Military Press, 
NULI: The Neck and Upper Limb Index, (S): Symptomatic Cases, (C): Clinically Confirmed Cases, UK: United Kingdom, USA: United State of 
America.   
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Table 2.4: Methodological qualities of each study per measurement property  
Notes: DASH: Disability of Arm, Shoulder and Hand, QDASH: Quick Disability of Arm, Shoulder and Hand, SAMP: The Single Arm Military Press, 
NULI: The Neck and Upper Limb Index, * This study is mentioned twice because of evaluating measurement properties of two instruments.   
 
 
Study Internal 
consistency 
Test-
retest, 
inter, 
intra-rater 
Measurement 
error 
Content 
validity 
Structural 
validity 
Hypothesis 
testing 
Criterion Validity 
 
Responsiveness   
Concurrent Predictive 
DASH 
Huisstede (2009)      Poor   Poor 
Mehta (2010) *      Poor  Good   
QDASH 
Fan (2008)      Poor Poor  Poor  
Fan (2011)         Poor 
Mehta (2010) *      Poor  Good   
NULI 
Stock (2003)  Fair Fair  Excellent  Fair Fair    Poor 
SFA 
Lomond (2009)  Fair Fair     Poor      
SAMP 
Patekar (2010)       Fair     
Darne (2010)      Poor    
Toulassidharane (2010)       Poor    
Kulkarni (2010)  Fair        
Jain (2010)  Fair         
 49 
Table 2.5: Quality of measurement properties per instrument for populations with NP 
(+++) or (---) strong evidence positive/negative results, (++) or (--) moderate evidence positive/negative results, (+) or (–) limited evidence 
positive/negative results, (±) conflicting evidence, (?) unknown, due to poor methodological quality, (na) no information available, (C) Concurrent, (P) 
Predictive. 
 
 
 
 
 
 
Instrument Internal 
consistency 
Reliability Measurement 
error 
Content 
validity 
Structural 
validity 
Hypothesis 
testing 
Criterion 
validity 
Responsi
veness 
Practical properties 
(C) (P) Precision Acceptability Feasibility 
DASH na na na na na ? ? na ? na na na 
             
QDASH na na na na na ? ? ? ? na na na 
             
NULI + + na na + + na na ? na na na 
             
SFA  na + + na na ? na na na na na na 
             
SAMP test na ++ na na na + na na na na na na 
 50 
2.3.4 Summary of measures  
2.3.4.1 The Disability of Arm, Shoulder and Hand (DASH)  
The DASH is a multidimensional PROM that was developed to evaluate the upper limb 
(hand, wrist, elbow and shoulder) disability and/or symptoms as a single functional unit 
(Hudak et al. 1996). The instrument uses 30-items related to difficulty when performing 
activity using the upper limb. The dimension physical function comprised 21-items, 
pain 5-items, emotional and social function 4-items. Each item is scored on a 1-5 scale. 
A total score is calculated by summing item scores and transforming them into a score 
from 0-100 where 0 equals no disability and 100 equals the most severe disability 
(Hudak et al., 1996).  
 
Development and validation of the DASH  
The development of the DASH was initially for the purpose of measuring ULD and was 
conducted in three phases (Hudak et al. 1996). First, the item generation phase, in which 
clinical experts and methodologists generated a list of 821 items after reviewing all the 
items included in 13 different questionnaires that were regularly used to address the 
health-related quality of life for patient populations with upper limb disorders. Second, 
the item reduction phase in which a set of 78-items was identified and field-tested in a 
cross-sectional study of 407 patients with different upper limb disorders in 20 centres in 
the USA, Canada and Australia. Equi-discriminative item total correlations 
supplemented with the patients rating of difficulty and importance were used to 
formulate the final 30-items DASH questionnaire. The measurement properties of the 
DASH were then extensively tested for a variety of upper limb (hand, wrist, elbow and 
shoulder) disorders and translated, culturally adapted, into over 40 languages (Westphal 
et al. 2002, Veehof et al. 2002, Soohoo et al. 2002, Offenbacher et al. 2003, Greenslade 
et al. 2004, Liang et al. 2004, Raven et al. 2008).    
 
Subsequently, the DASH was validated to measure ULD in patients with NP in the 
following two studies. First, Huisstede et al. (2009) recruited 679 patients with NS-NP 
to investigate the validity and responsiveness of the DASH questionnaire. Participants 
were allocated into six sub-groups based on the location of their complaints and 
completed the DASH alongside the SF-12 (physical component summary scale (PCS) 
and mental component summary scale (MCS), severity of complaints, and persistence 
of complaints questionnaires at the baseline and at 6 months follow-up. Correlations 
were observed between the DASH and the other measures for all the sub-groups at the 
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baseline and 6 months follow-up. More than 75% of the hypotheses, which were 
formulated a priori for construct validity and responsiveness, were confirmed alongside 
an acceptable responsiveness ratio, and this suggested that the DASH questionnaire is 
valid and responsive measure of ULD for patients with NS-NP. Second, Mehta et al. 
(2010) investigated the validity of the DASH questionnaire in comparison with Quick 
Disability of Arm, Shoulder and Hand (QuickDASH), the Neck Disability Index (NDI) 
questionnaire, the Cervical Spine Outcome Questionnaire (CSOQ) and the Visual 
Analogue Scale (VAS) in patients with NP (n=66). The DASH showed high correlation 
and agreement with the QuickDASH alongside high correlation with the NDI, moderate 
correlations with the CSOQ and VAS, and this supported the validity of the DASH as a 
measure of ULD for patients with NP.  
 
Measurement properties  
Reliability: there were no studies investigating the reliability of the DASH in a 
population with neck pain. The construct validity of the DASH was assessed using 
Pearson correlations and the highest correlation, as expected and in the anticipated 
direction, was observed between the DASH score and the SF-12 (PCS) score at the 
baseline (range r = 0.57 and 0.63) when compared with the correlations between the 
DASH scores and the SF-12 (MCS) (range r = 0.10 and 0.33) and severity (range r = 
0.44 and 0.55) (Huisstede et al. 2009). Construct validity was assessed again using the 
Pearson correlation and high correlation was observed between the DASH and the NDI 
(r = 0.83) and moderate correlation between the DASH and VAS (r = 0.68) (Mehta et 
al. 2010). The COSMIN 4-point checklist for construct validity was rated as ‘poor’ 
across these studies (see Table 2.4) because there was no information available on the 
measurement properties of the comparator OMs (see Appendix 3, Item 8 in Tables 1 
and 2).  
 
The measurement property criterion validity (concurrent) that met the COSMIN 
definition was assessed using the Bland and Altman plot to examine the level of 
agreement between the DASH and the QuickDASH in patients with NP. The mean 
differences between the DASH and QuickDASH alongside 2 standard deviation limits 
were 2.77 ± 10, which presented in a graph (Mehta et al. 2010). The COSMIN 4-point 
checklist for criterion validity was rated as ‘good’ (see Table 3.4) because of including 
moderate sample size (see Appendix 3, Item 3 in Table 2). 
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Responsiveness of the DASH questionnaire was assessed using the Guyatt’s 
responsiveness ratio, which was over 1 for all the sub-groups (Huisstede et al., 2009). 
The COSMIN 4-point checklist for responsiveness was rated as ‘poor’ (see Table 3.4) 
because there was no information on the measurement properties of the comparator 
OMs, and the statistical methods applied (Guyatt’s responsiveness ratio) were 
inappropriate for establishing responsiveness (see Appendix 3, Items12, 13 and 14 in 
Table 1). 
 
2.3.4.2 The Quick Disability of Arm, Shoulder and Hand (QuickDASH) 
Development and validation of the QuickDASH 
The QuickDASH questionnaire is an 11-item PROM that was derived from the DASH 
questionnaire and designed to be a shorter measure of the disability and/or symptoms 
related to the upper limb (hand, wrist, elbow and shoulder) (Beaton et al. 2005). It is 
similar to the DASH, in that each item is scored on a 1-5 scale and the total score is 
derived by summing item scores and transforming them into a score from 0-100, where 
0 equals no disability and 100 equals the most severe disability. The QuickDASH was 
also extensively tested for a variety of upper limb (hand, wrist, elbow and shoulder) 
disorders (Beaton et al. 2005, Gummesson et al. 2006, Matheson et al. 2006, Beaton et 
al. 2007, Mintken et al. 2009, Angst et al. 2009, Fayad et al. 2009, Gabel et al. 2009, 
Niekel et al. 2009, Poson et al. 2010, Angst et al. 2011, Franchignoni et al. 2011, Haas 
et al. 2011, Mardani-Kivi et al. 2013, Quatman-Yates et al. 2013, Nakamoto et al. 
2014). The QuickDASH was recently updated to account for modern technology by 
replacing three items from its standard version with three other items related to the use 
of technology: (1) text or dial with your smart phone, (2) type on a keyboard and (3) use 
a computer mouse (Moradi et al. 2016). 
 
The QuickDASH was also validated to measure ULD in patients/workers with NP in 
the following three studies. First, Mehta et al. (2010) investigated the construct and 
criterion validity of the QuickDASH against the DASH, NDI, CSOQ and VAS (n=66). 
The QuickDASH demonstrated high correlations and agreement with the DASH, high 
correlation with the NDI and moderate correlations with CSOQ and VAS, and this 
supports the validity of the QuickDASH for patients with NP (Mehta et al. 2010). 
Second, Fan et al. (2008) recruited 231 workers with a specific clinical diagnosis of 
neck or upper limb disorders alongside 175 workers with symptoms only (non-patient) 
to investigate the construct (discriminate) and criterion (concurrent and predictive) 
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validity of the QuickDASH in comparison with the SF-12 (PCS and MCS). The 
QuickDASH was administered by trained interviewers, in which participants rated their 
function capacity using the 11-item and the 4-item QuickDASH work questionnaire. 
The SF-12 was self-completed by all participants right after the interview. The 
QuickDASH demonstrated the ability to discriminate between workers in the two 
groups as well as between those with different symptom severity in the clinical cases 
group. A moderate correlation was observed between the Quick DASH and SF-12 
(PCS) on workers with neck or upper limb disorder (clinical cases), and this supports 
the use of the QuickDASH as a valid measure of ULD for workers with NP (Fan et al. 
2008). Third, Fan et al. (2011) investigated the responsiveness of the QuickDASH as 
well as the SF-12 (PCS and MCS) to change in active workers with neck or upper limb 
disorders (clinical cases) alongside symptomatic and non-symptomatic workers in a 
one-year follow-up. The standard QuickDASH and the work module demonstrated the 
ability to detect change for all the sub-groups of workers, which support the 
responsiveness of the QuickDASH for workers with NP (Fan et al. 2011). 
 
Measurement properties  
No studies investigated the reliability of the QuickDASH in a NP population. 
Construct validity was evaluated using Pearson correlation, and high correlation was 
observed between the QuickDASH and the NDI (r = 0.82), and moderate correlations 
were observed between the QuickDASH and the CSOQ components (neck pain, 
shoulder and arm pain, physical symptoms, functional disability and psychological 
distress) and VAS (r = 0.65, 0.57, 0.68, 0.59, 0.58 and 0.64) respectively. These 
relationships were statistically significant (p < 0.01) (Mehta et al. 2010). Construct 
validity was assessed against the SF-12 using the two-factor analysis of variance 
(ANOVA), in which the standard QuickDASH and the work module scores were higher 
when compared with the SF-12 (PCS) in the clinical cases with neck or upper limb 
disorders (Fan et al. 2008). The COSMIN 4-point checklist for construct validity was 
rated as ‘poor’ in both studies (see Table 3.4) because there was no information 
available on the measurement properties of the comparator OMs in the first study, it was 
unclear what was expected and the statistical methods applied were inappropriate in the 
second study (see Appendix 3, Items 8 in Table 2 and item 4 in Table 3). 
 
Criterion validity (concurrent) was evaluated using the Bland and Altman plot to 
examine the agreement between the QuickDASH and the DASH in patients with NP. 
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The mean differences between the DASH AND QuickDASH alongside 2 standard 
deviation limits were 2.77 ± 10, which presented in a graph (Mehta et al. 2010). 
Criterion validity (concurrent and predictive) was assessed using Spearman rank 
correlation between QuickDASH and the SF-12 for concurrent validity and the odds 
ratios for predictive validity (Fan et al. 2008). The COSMIN 4-point checklist for 
criterion validity was rated as ‘good’ in the first study because of the sample size and 
rated as ‘poor’ in the second study because the criterion used cannot be considered as a 
reasonable gold standard (see Table 3.4), (see Appendix 3, Item 3 in Table 2 and Item 4 
in Table 3). 
 
Responsiveness of the QuickDASH was assessed using the Effect Size (ES) and the 
Standard Response Mean (SRM) for the QuickDASH and SF-12. The ES and the SRM 
for the QuickDASH were > 0.08, and this indicates large change between the workers in 
all groups but one sub-group (self-reported symptomatic case) had moderate ES and 
SRM. Meanwhile, the scores for the SF-12 (PCS) decreased as expected (Fan et al. 
2011). The COSMIN 4-point checklist for responsiveness was rated as ‘poor’ (see Table 
3.4) because the statistical methods applied were inappropriate measures of 
responsiveness (see Appendix 3, Items 14 in Table 4). 
 
2.3.4.3 The Neck and Upper Limb Index (NULI)  
The NULI questionnaire is a short English and French language multidimensional 
Patient-Reported Outcome Measurement (PROM) which was developed to measure the 
functional status for workers with NP and ULD (Stock et al. 2003). The questionnaire 
uses a 20-item index to evaluate the impact of neck and upper limb disorders on 
physical function, work, psychosocial limitations and sleep. The dimension physical 
function/physical activity dimension comprised 7 items, work comprised 4 items, 
psychosocial comprised 6 items, sleep comprised 2 items and 1 item related to the 
iatrogenic effect of assessment and treatment (Stock et al. 2003). Section A of the 
questionnaire, questions 1-11 are scored on a 1-7 scale, where 1 equals no difficulties at 
all and 7 equals cannot do. Section B, questions 12-20 are scored on a 1-7 scale where 1 
equals never and 7 equals all the time (stock et al. 2003). 
 
Development and validation of the NULI  
The development of the NULI started with item generation, in which a comprehensive 
review of all the relevant scientific literature was carried out to identify all available 
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outcome measures. This stage involved the participation of researchers and clinicians 
who were working with patients with NP and ULD. This led to the generation of 
175items which fell into 12-dimensions and which were thought to be affected by the 
NP and ULD. 
 
The item reduction stages involved interviewing workers with NP and ULD (n=33) as 
well as surveying clinicians (physiotherapists, occupational therapists, rheumatologists, 
physiatrist, orthopaedic surgeons and doctors managing patients with NP and ULD) 
(n=30). Participating patients and clinicians were requested to identify and list all 
activities that were frequently affected by the NP and ULD. This led to the formulation 
of the 20-item NULI questionnaire. 
 
The NULI questionnaire was developed and validated in a single study. Stock et al. 
(2003) recruited 119 English-speaking and 93 French-speaking workers from eight 
different private physiotherapy clinics in Quebec (Canada) to investigate the reliability, 
validity and responsiveness of the NULI. The NULI demonstrated strong reliability 
(test-retest), good content, convergent and discriminate validity as well as 
responsiveness. This provides support for the use of the NULI questionnaire for 
workers with NP and ULD. 
 
Measurement properties  
Reliability (internal consistency) was evaluated, in which Cronbach alpha was 
calculated for the English-speaking participants (0.90), French-speaking participants 
(0.92) and the final 20-item NULI (0.93). Factor analysis was used to evaluate the 
dimensionality of the NULI, in which the first factor correlated between 0.74 and 0.87 
with the 4-item work construct, the second factor correlated between 0.47 and 0.78 with 
the 6-item construct about physical activity (excluding the question about activity of 
leisure), the third factor correlated between 0.32 and 0.87 with the 6-item psychosocial 
construct and the fourth factor correlated between 0.87 and 0.82 with the 2-item sleep 
construct (Stock et al. 2003). The COSMIN 4-point checklist for internal consistency 
was rated as ‘fair’ in this study (see Table 3.4), and this was because it was unclear how 
missing items were handled (see Appendix 3, Item 3 in Table 5). The test-retest and 
inter-rater reliability were assessed using the Interclass Correlation Coefficient (ICC). 
For English-speaking subjects ICC = 0.88, French-speaking ICC = 0.85 and the final 
NULI ICC = 0.83 (Stock et al. 2003). The COSMIN 4-point checklist for this 
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measurement property was rated as ‘fair’ in this study (see Table 3.4) because it was 
unclear how missing items were handled and it was also unclear if patients were stable 
in the interim period on the construct to be measured (see Appendix 3, Items 2 and 7 in 
Table 5). 
 
Content validity of the NULI was examined by asking participants (workers with NP 
and ULD) and clinicians (physiotherapists, occupational therapists, rheumatologists, 
physiatrists, orthopaedic surgeons and doctors treating patients with NP and ULD) to 
identify items related to function which were affected by NP and ULD (Stock et al. 
2003). The COSMIN 4-point checklist for content validity was rated as ‘excellent’ in 
this study (see Table 3.4) as all items were adequate (see Appendix 3, Items 1, 2, 3, 4 
and 5 in Table 5). 
 
The structural validity of the NULI was assessed using confirmatory factor analysis and 
correlation was observed between the four items about work and the first factor (range 
0.74 and 0.87). The six items about physical activity (excluding the question about 
leisure activity) correlated with the second factor (range 0.47 and 0.78). Correlations 
were also observed between the six items about psychological effect and the third factor 
(range 0.32 and 0.87) and finally between the two items about sleep and the fourth 
factor (range 0.87 and 0.82) (Stock et al. 2003). The COSMIN 4-point checklist for 
structural validity was rated as ‘fair’ in this study (see Table 3.4) because it was unclear 
how missing items were handled and it was unclear if patients were stable between 
measurements (see Appendix 3, Items 3 and 7 in Table 6). 
 
Convergent validity of the NULI was evaluated using Pearson correlation analysis and 
revealed significant moderate correlations between the NULI, the Sickness Impact 
Profile (SIP) (r = 0.66 P < 0.001) and the SF-36 (r = 0.50 p< 0.001) (Stock et al. 2003). 
The COSMIN 4-point checklist for convergent validity was rated as ‘fair’ in this study 
(see Table 3.4) because it was no adequate description for the measurement properties 
of the comparator OMs (see Appendix 3, Item 8 in Table 5). 
 
Responsiveness of the NULI was examined in this study using the Standard Response 
Mean (SRM) that was 1.48 (95% CI:1.1 – 1.8) for English-speaking subjects and 1.63 
(95%CI: 1.3 – 2.0) for French-speaking subjects (Stock et al. 2003). The COSMIN 
4point checklist for responsiveness was rated as ‘poor’ (see Table 3.4) due to the 
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statistical methods applied being inappropriate measures of responsiveness (see 
Appendix 3, Item 14 in Table 5). 
 
2.3.4.4 The Shoulder Functional Assessment (SFA)  
The SFA is a clinician-reported (objective) OM designed to quantify the upper limb 
functional capacity in workers with neck and shoulder pain. The SFA protocol consists 
of tasks involving shoulder range of motion (ROM) in both flexion and abduction and 
cumulative power output (PO) accumulated over 10 seconds during a repetitive arm 
pushing/pulling task on a horizontal plane at shoulder level. These tasks were included 
since they represent movements that are often impaired in people with chronic neck and 
shoulder pain (Donovan and Paulos 1995, Hoozemans et al. 2002). The tasks were 
assessed before and after performing a repetitive arm task until scoring 8 on the Borg 
CR10 scale or an 11-point numeric pain rating scale. The scoring system is determined 
by the average repetitive task duration with expectation that the shorter duration 
represents poor performance and therefore a higher level of NP and ULD (Lomond and 
Cote 2009). 
 
Development and validation of the SFA 
The SFA protocol is conducted using the Baltimore Therapeutic Equipment Work 
Simulator II (Sim II) (BTE-Tech©, Baltimore, MD), which is a functional capacity 
evaluation tool commonly used to measure upper limb functional capacity (Bhambhani 
et al. 1993, Trossman et al. 1990). Sim II was introduced in 1979 to be used as an 
assessment instrument and therapy tool for workers with ULD (Coleman et al. 1996). 
Sim II consists of a software-based controller interface, a position adjustable exercise 
head with resistance control, and a set of interchangeable attachments to simulate a 
variety of work tasks. 
 
The SFA was validated in a single study. Lomond and Cote (2009) recruited 16 workers 
with chronic neck/shoulder pain and matched 16 healthy subjects to investigate the test-
retest reliability and measurement error, as well as the discriminant validity of the SFA 
in workers with neck/shoulder pain and healthy subjects. There was no significant 
difference in the cumulative power output (PO) task between groups or testing sessions, 
suggesting that workers with neck/shoulder pain were able to perform that task as 
effectively as the healthy subjects. This indicates poor discriminant validity of the SFA 
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in relation to the PO task. The SFA showed good to excellent reliability in both groups 
(Lomond and Cote 2009). 
 
Measurement properties 
Reliability (test-retest) of the SFA was examined using the ICC. For the flexion task 
ICC was 0.95 (control group) and 0.92 (pain group), for abduction ICC was 0.85 
(control group) and 0.87 (pain group) and for cumulative power output ICC was 0.94 
(control group) and 0.53 (pain group) (Lomond and Cote 2009). The measurement error 
for the SFA was assessed using the Standard Error of Measurement (SEM) and the 
Minimal Detectable Change (MDC). For the flexion task, SEM was 4.72 (control 
group) and 14.76 (pain group), abduction SEM was 6.06 (control group) and 24.35 
(pain group), cumulative power output SEM was 7.52 (control group) and 30.25 (pain 
group). For flexion, MDC was 11.01 (control group) and 34.44 (pain group), abduction 
MDC was 14.15 (control group) and 56.81 (pain group), and cumulative power output 
MDC was 17.54 (control group) and 70.59 (pain group) (Lomond and Cote 2009). The 
COSMIN 4-point checklist for reliability and measurement error were rated as ‘fair’ in 
this study (see Table 3.4) due to moderate sample size being used and it was unclear 
whether participants were stable in the interim period on the construct to be measured 
(see Appendix 3, Items 3 and 7 in Table 6). 
 
Construct validity of the SFA was assessed by evaluating the SFA’s sensitivity to 
discriminate between workers with neck/shoulder pain and healthy subjects (Lomond 
and Cote 2009). The COSMIN 4-point checklist for construct validity was rated as 
‘poor’ in this study (see Table 3.4) as there were no hypotheses formulated a priori 
regarding the correlations or differences and it was unclear what was expected (see 
Appendix 3, Item 4 in Table 6). 
 
2.3.4.5 The Single Arm Military Press (SAMP) test  
The SAMP test is a performance-based test developed specifically to evaluate the upper 
limb functional capacity in populations with NS-NP (McLean et al., 2010a). The SAMP 
test, which is a strength and endurance-based test, involves repeatedly lifting a 3kg 
hand-weight overhead from the shoulder level for 30 seconds. The test score is the 
number of repetitions correctly completed within the 30 seconds, with higher scores 
representing a lower level of NS-NP and ULD (McLean et al., 2010a). 
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Development and validation of the SAMP test  
The SAMP test was developed following findings which showed that there was a strong 
association between NP and ULD, with patients reporting the greatest difficulties with 
heavy household chores, gardening, carrying heavy objects and overhead activities 
(McLean 2007, McLean et al. 2010). In addition, there was no performance-based 
measure available to evaluate the ULD when assessing patients with NP and the DASH 
questionnaire, which was poorly validated for NP patients, but was the only available 
OM at that time (McLean 2007). 
 
The SAMP test was validated in a series of preliminary unpublished studies. Kulkarni 
(2010) recruited 95 female participants with/without neck symptoms to investigate the 
reliability (inter-and intra-rater) of the SAMP test. Almost perfect inter-and intra-rater 
reliability and agreement were found in both symptomatic and asymptomatic 
participants. This indicates that the SAMP test is a reliable measure of ULD (Kulkarni 
2010). Jain (2010) also recruited a cohort of 95 female participants with/without neck 
symptoms to investigate the reliability (inter-and intra-rater) of the SAMP test. Similar 
to the previous study, almost perfect reliability was found for both symptomatic and 
asymptomatic participants, which, again, supports the reliability of the SAMP test as a 
measure of ULD (Jain 2010). Patekar's (2010) study recruited 98 female subjects 
with/without neck symptoms to investigate the construct (discriminate) validity of the 
SAMP test versus the DASH. Symptomatic and asymptomatic female participants 
performed the SAMP test using their dominant hand with a 3-kg hand weight. 
Correlation was observed and the asymptomatic participants were significantly better 
than those symptomatic participants in the SAMP performance, and this indicates that 
the SAMP test has the capacity to discriminate between symptomatic and asymptomatic 
populations (Patekar 2010). A study by Darne (2010) recruited 95 female subjects 
with/without neck symptoms to investigate the construct (convergent) validity of the 
SAMP test. Participants in this study completed the DASH questionnaire and performed 
the SAMP test in a single session. A highly significant negative correlation, as 
expected, was observed between the SAMP performance and the DASH score in the 
anticipated direction. This indicates that the SAMP test is a valid measure of ULD 
(Darne 2010). Finally, Toulassidharane (2010) recruited a cohort of 95 female subjects 
with/without neck symptoms to investigate the construct (convergent) validity of the 
SAMP test. Participants in this study also completed the DASH questionnaire before 
performing the SAMP test. A highly significant negative correlation, as expected, was 
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also observed between the SAMP performance and the DASH score, which supports the 
validity of the SAMP test as a measure of ULD (Toulassidharane 2010). 
 
Measurement properties  
Reliability was assessed using the ICCs; this revealed a high level of inter-rater 
reliability, with a 95% Confidence Interval (CI) (ICC = 0.99), while for intra-rater 
reliability (ICC = 0.94) in a symptomatic population of women (Kulkarni 2010). 
Reliability was assessed again using the ICCs and also revealed a high level of interrater 
reliability, with a 95% CI (ICC = 0.98), while for intra-rater reliability (ICC = 0.99) in 
an asymptomatic population of women (Jain 2010). The COSMIN 4-point checklist for 
reliability was rated as ‘fair’ in the two studies (see Table 3.4) as it was unclear if 
patients were stable in the interim period (see Appendix 3, Item 7 in Tables 7 and 8). 
 
Construct (discriminate) validity was assessed using the unpaired t-test, which revealed 
that asymptomatic female participants significantly and substantially out-performed 
those symptomatic participants (mean SAMP scores asymptomatic participants=30, 
mean SAMP scores symptomatic participants=18, p<0.001, n=98) (Patekar 2010). 
Construct (convergent) validity was assessed using Pearson correlation and highly 
significant negative correlation was observed between the SAMP performance and the 
DASH score (r = -0.800, p<0.001, n=95) (Darne 2010). Construct (convergent) validity 
was assessed, again using Pearson correlation, which also revealed a highly significant 
negative correlation between the SAMP performance and the DASH score (r = -0.814, 
p<0.001, n=95) (Toulassidharane 2010). The COSMIN 4-point checklist for construct 
validity was rated as ‘fair’ in the first study because hypotheses were not formulated a 
priori, but it is possible to deduce what was expected (see Appendix 3, Item 4 in Table 
9). Construct validity was rated as ‘poor’ in the other two studies because there was no 
information on the measurement properties of the comparator OMs (see Appendix 3, 
Item 8 in Tables 10 and 11). 
 
2.4 Discussion  
2.4.1 Summary and discussion of the main findings  
The overall aim of this review was to identify, summarise and critically examine all 
available studies on the measurement properties of all available OMs that have been 
developed or validated to measure ULD for patient populations with NP. This was done 
in order to make recommendations regarding relevant OMs and provide the background 
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and justification for future research needs. In total 11 studies evaluating the 
measurement properties of five clearly defined and reproducible OMs were included 
within this review. To recommend OMs that can enable clinicians to identify and 
quantify ULD when assessing and managing their patients with NP, it is essential that 
sufficient information is available regarding the development process of this OM and 
the measurement model, if relevant, alongside adequate evaluation of all relevant 
measurement and practical properties in the target population. However, synthesis of the 
results demonstrated a paucity of high-quality evidence and significant methodological 
and quality issues, as well as missing evidence for relevant and essential measurement 
and practical properties. This prevented a clear recommendation for any of the five 
included OMs. Evidence for the five identified and included OMs was limited, 
unknown or unavailable. 
 
Critical appraisal of all the included OMs using the COSMIN 4-point checklist 
demonstrated that other than content validity for the NULI questionnaire and concurrent 
validity for the DASH/QuickDASH; none of the identified and reviewed OMs reported 
an ‘excellent or good’ rating in its measurement properties. The measurement model, 
which indicates whether an OM is based on a formative or reflective model, was not 
described in the three identified questionnaires (DASH, QuickDASH and NULI). 
Information regarding the measurement model has implications when evaluating the 
measurement properties of a PROM as internal consistency and structural validity are 
relevant for evaluation only if the OM is based on a reflective model (Mokkink et al. 
2010a). Other than the NULI, evidence for face/content validity and the practical 
properties including acceptability and feasibility was not identified for any of the 
reviewed OMs. Acceptability and feasibility of OMs for patients and clinicians are 
necessary for the clinical utility of an OM (Fitzpatrick et al. 1998). There was no 
evidence of patient involvement as a research partner in the development/evaluation of 
any of the OMs, with the exception of the NULI. Patient involvement as a research 
partner is considered essential to ensure the relevance, comprehensiveness and validity 
of patient-centred outcome assessment (Mayer 2012, Staniszewska et al. 2012). One 
clinician-reported (objective) measure (SFA) was developed for workers only and 
involves the use of expensive equipment. This is likely to limit its use in clinical 
practice (Fitzpatrick et al. 1998). Since brevity is crucial in clinical practice, the 
QuickDASH, NULI and the SAMP test are promising clinical measures if adequately 
 62 
validated. However, the SAMP test is the only performance-based measure that was 
developed specifically to measure ULD for patient populations with NP. 
 
2.4.2 Evaluation of identified outcome measures  
There is substantial evidence that the DASH and QuickDASH well performing 
measures in patients with upper limb (hand, wrist, elbow and shoulder) 
disability/symptoms only (Huang et al. 2015, Kennedy et al. 2013). Limited evidence 
indicated that the NULI and SFA are reliable and valid measures for workers with neck 
and upper limb disorders (Lomond and Cote 2009, Stock et al. 2003). 
 
2.4.2.1 Development  
The development of the DASH, QuickDASH and NULI questionnaires incorporated the 
same techniques, which included item generation and item reduction before formulating 
and testing the final version. Sufficient information was available for each stage and 
both patients and clinicians participated in the item generation and in the item reduction 
stages. This demonstrates excellent acceptability, feasibility and face/content validity 
for these measures. However, the development of the DASH and QuickDASH did not 
involve patients with NP (the target population), and the development of the NULI 
included Canadian workers only (English/French-speaking). The SFA and the SAMP 
test do not provide sufficient information on their respective development processes. 
Application of an instrument for a purpose and/or population other than which it was 
intended coupled with inadequate levels of validation, limits meaningful interpretation 
and recommendations that can be made about the clinical utility of these measures 
(Fitzpatrick et al. 1998, de Vet et al. 2011). 
 
2.4.2.2 Reliability 
Internal consistency was reported only for the NULI questionnaire and rated as ‘fair’. 
This rating was influenced by a lack of information on the percentage of missing items 
or how missing items were handled. A large number of missing items in a questionnaire 
can introduce bias in the results and have a significant impact on the OM’s scores 
(Mokkink et al. 2010a). Reliability (test-retest, inter- and intra-rater) was not assessed 
for the DASH, QuickDASH in the target population (patients with NP). The NULI 
questionnaire, SFA and the SAMP test each received a ‘fair’ rating for reliability. It has 
been suggested that patients involved in a reliability study should be stable in the period 
between administrations on the construct being measured (de Vet et al. 2011). This is to 
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facilitate the decision regarding consistency of scores for the OM under study. This was 
not the case for the NULI, SFA and the SAMP test and it was unclear whether patients 
were stable between administrations. In addition, the moderate sample size used in the 
SFA affected the rating for reliability. Measurement error, which is an extension of the 
reliability domain, often mirrored the results of the reliability (Mokkink et al. 2010a). 
Measurement error was assessed for the SFA only and rated as ‘fair’. Similar to 
reliability, moderate sample size affected the rating of measurement error. In a 
reliability study, adequate sample size is crucial to obtaining an acceptable confidence 
interval (CI) around the calculated Interclass Correlation Coefficient (ICC) when 
evaluating reliability and/or measurement error (de Vet et al. 2011). 
  
2.4.2.3 Validity  
Face/content validity was not reported for the DASH, QuickDASH, SFA or the SAMP 
test. The NULI questionnaire evaluated face/content validity, which was the only 
measurement property that received an ‘excellent’ rating in this review. This rating was 
influenced by the adequate judgement of relevance and the 
comprehensiveness/coverage of items using experts (researcher/clinicians) as well as 
the targeted populations in the development stages (Mokkink et al. 2010a). Structural 
validity is part of the measurement property, construct validity. It is relevant for 
evaluation only if the OM under study is a PROM and based on a reflective model (de 
Vet et al. 2011). Structural validity was reported only for the NULI questionnaire and 
was rated as ‘fair’. This was affected by a lack of information about missing items and 
how missing items were handled. A large number of missing items can introduce bias in 
the results and have a significant impact on the scores of the OM (Mokkink et al. 
2010a). Hypothesis testing was the only measurement property which was investigated 
in all five included OMs. Hypothesis testing was rated as ‘fair’ and/or ‘poor’ in all the 
identified OMs. This rating was affected mostly by the lack of adequate description of 
the measurement properties on the comparator OMs. In convergent validity, to 
determine whether negative results are due to poor validity of the OM under study; the 
comparator OMs should be appropriately described regarding their construct and 
adequately validated in the target population (Mokkink et al. 2010a). Criterion validity 
was evaluated for the DASH and QuickDASH and rated as ‘poor’ because the criterion 
cannot be considered an adequate gold standard. Using criterion validity to assess the 
validity of an OM primarily requires identifying criterion that are an adequate gold 
standard and a priori formulation of a hypothesis that the OM under study is as good as 
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the gold standard (de Vet et al. 2011). Gold standard criterion is defined here as the OM 
which represents the true state of the construct of interest (de Vet et al. 2011). However, 
there is no gold standard which exists for health-related PROMs because they are 
subjective tools, which often measure patients’ perceptions and opinions about their 
pain and/or disability (Mokkink et al. 2010a). Consequently, with the exception of the 
QuickDASH, with the DASH as a gold standard comparator, there is no expectation that 
any of these ULD OMs should have criterion validity. 
 
2.4.2.4 Responsiveness  
Responsiveness is considered a longitudinal validity, which indicates that the OM under 
study should be administered at least twice during a longitudinal study. The comparator 
OM, preferably a gold standard, should be administered at the same time to confirm the 
change score in the construct of interest. In addition, applied statistical methods should 
be appropriate to determine the validity of the change score. This was not the case for 
all studies reporting responsiveness in this review. The DASH, QuickDASH and NULI 
questionnaires were evaluated for responsiveness and received a ‘poor’ rating. This 
rating was primarily influenced by a lack of reporting description regarding the 
validation of the comparator OMs coupled with the application of inappropriate 
statistical methods, such as the Guyatt’s responsiveness ratio and the Effect Size (ES). 
Guyatt’s responsiveness ratio calculates the Minimal Important Change (MIC) on the 
OM under investigation, divided by the Standard Deviation (SD) of the change score 
(Guyatt et al. 1987). This provides information on the interpretability/meaning of 
change score rather than the validity of change score (de Vet et. 2011). ES calculates the 
mean change score divided by the SD and measures the magnitude of change score 
rather than the validity of change score (de Vet et al. 2011). 
 
2.4.3 Strengths of the review  
The major strengths of this review include the comprehensive search strategies 
developed; the wide scope of the search, including grey literature and contacting authors 
and/or developers of specific measures for other published or unpublished studies; the 
independent appraisal of the methodological quality of the included studies and the data 
extraction; use of the COSMIN checklist (Mokkink et al. 2010a, Terwee et al. 2012) as 
well as the reporting of the review in accordance with the PRISMA statement (Liberti et 
al. 2009, Moher et al. 2009). In addition, this is the first systematic review that has 
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sought to identify and evaluate the measurement properties of all available ULD OMs 
developed or validated for use in patients with NP. 
 
2.4.4 Limitations of the review  
Although the search strategies in this review were limited to English-language 
publications, English-language abstracts for non-English publications were reviewed 
and one study only was excluded, and this was due to irrelevance not language. This 
suggests that the likelihood of selection bias is low. The level of evidence criteria in 
Table 3.2 that was suggested by the Cochrane Back Review Group (van Tulder et al. 
2003, Furlan et al. 2009) was originally proposed for systematic reviews conducted on 
clinical trials. However, it has been used in similar studies and found to be applicable to 
reviews investigating the measurement properties of health-related OMs 
(Schellingerhout et al. 2011, Schellingerhout et al. 2012). 
 
2.4.5 Clinical implications  
Clinically, it is recognised that there is a strong relationship between NP and ULD and 
the presence of NP is a risk factor for the development of ULD (Walker-Bone et al. 
2004, Frank et al. 2005, Bot et al. 2005, Huisstede et al. 2006, Rasmussen et al. 2008, 
Feleus et al. 2008). In addition, co-existing shoulder problems may lead to NP 
becoming recurrent, persistent or disabling (Eriksen et al. 1999, Bot et al. 2005, 
McLean et al., 2010a). Routine utilisation of standardised ULD OMs in the assessment 
and during the management of patients with NP is essential since it may play an integral 
part in influencing clinical outcomes (McLean et al. 2011, Osborn and Jull 2013). The 
findings from this review highlighted that promising ULD OMs exist; however, they 
have significant methodological and quality issues as well as missing evidence for 
relevant and very important measurement and practical properties. Consequently, at this 
time, none of these measures can be formally recommended for use in a clinical context. 
 
The SAMP test was the only identified performance-based measure that was developed 
specifically to identify and quantify ULD in the assessment of patient populations with 
NP and to monitor its progress during rehabilitation (McLean et al. 2010a). It is a 
physical performance test that requires a patient to use multiple joints to perform a task, 
which represents some construct of function including strength and endurance. 
Therefore, it has a greater likelihood of accurately measuring the upper limb functional 
capacity more than PROMs (Curb et al. 2006, Pinheiro et al. 2016). The SAMP test also 
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has the advantage of being able to be efficiently administered by individual/clinicians of 
varying experience, in any setting, using minimal equipment within less than 2-minutes. 
The SAMP test therefore, is convenient, efficient and inexpensive. However, the SAMP 
test has been validated as a 3-kg hand weight for non-patient populations with NS-NP 
and healthy subjects. Given that patients with NS-NP and ULD are likely to experience 
greater severity of their symptoms (McLean et al. 2011, Osborn and Jull 2013), a 3-kg 
hand weight is perhaps too heavy for their use. Therefore, at this time, the 3-kg SAMP 
test, in spite of its potential utility, cannot be recommended for use in a patient 
population with NP and ULD. 
 
2.4.6 Research implications  
Further adequate validation is required for at least one of the three promising measures 
(QuickDASH, NULI and the SAMP test) incorporating the COSMIN recommendations. 
The SAMP test was selected for further validation in this thesis. It requires adequate 
validation, which should investigate the acceptability and feasibility of the weight used 
in its practical application on populations with NP and ULD. This is to improve its 
clinical utility for this patient group. Furthermore, important measurement properties 
such as the reliability and validity of the SAMP need to be explored in the same patient 
group. These measurement and practical properties will be further investigated in 
chapters 5 and 6. 
 
2.5 Conclusion  
In the absence of high-quality studies and inadequate reporting of essential 
measurement and practical properties, application of the identified ULD OMs cannot be 
recommended in populations with NP until acceptable evidence is established. Further 
research should incorporate COSMIN recommendation during the design of 
developmental or evaluative studies of these OMs. The involvement of key 
stakeholders, including patients and clinicians is essential to ensure that the OM is 
relevant, acceptable and feasible. 
 
The next chapter is a review of the literature relating the current evidence-based 
management practice within the scope of physiotherapy for patients with NS-NP. It 
considers a wide range of treatment approaches that are routinely available to 
physiotherapists. 
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Chapter 3: Evidence of the currently recommended treatment 
approaches for the management of non-specific neck pain: A literature 
review. 
 
3.1 Introduction 
This chapter describes a narrative literature review that explored current evidence-based 
management practice within the scope of physiotherapy for patients with NS-NP. This 
was based primarily on recent evidence-based guidelines and systematic reviews. The 
findings were used to inform the development of the subsequent UK national survey of 
neck pain reported in chapter 4.  
 
Various physiotherapy treatment approaches have been described and tested for the 
management of patients with NS-NP. The general classification of these treatment 
approaches can be divided into “active” modalities (that is, an active physical 
movement in which the patients engage muscles of an injured part of their body to 
create that movement), where patients also take control of their rehabilitation under the 
supervision of physiotherapists (Capersen et al. 1985), and this includes all the types of 
exercise, patient education programmes and the McKenzie method. Passive modalities, 
in which the patient depends on an external stimulus (the physiotherapist) to apply 
movement or treatment to an injured part of their body, and this includes manual 
therapy, electrotherapy, massage therapy acupuncture and traction (McLean and Moffett 
2006).     
 
The most frequently used treatment approaches have frequently been examined for their 
effectiveness when used in isolation. However, they have also been increasingly 
investigated when used as part of a multimodal treatment approach, which combines at 
least two treatment approaches with exercise being a key component of any 
combination (Gross et al. 2007, Hurwitz et al. 2008). Multimodal approaches to 
management of NS-NP are categorised in this thesis into three common different 
packages: (1) exercise, manual therapy and any form of patient education, (2) exercise 
and manual therapy and (3) exercise and any other treatment approach.  
 
3.1.1 Aim  
This comprehensive literature review has scoped the most recent high-quality evidence 
of the recommended physiotherapy approaches, which are frequently used for managing 
patients with NS-NP. This aim was addressed by meeting the following objectives: 
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1. To determine current recommended non-invasive treatment approaches for NS-
NP. 
2. To determine the effectiveness of these approaches when used in isolation or 
when used as part of a multimodal approach.  
 
3.2 Methods  
3.2.1 Data source  
The following databases were searched to identify all relevant systematic reviews, 
randomised controlled trials (RCTs), or controlled clinical trials (CCTs) related to neck 
function and treatment approaches: MEDLINE (EBSCO), CINAHL (EBSCO), 
SPORTDiscus (EBSCO), PsycINFO (ProQuest), PubMed (NLM), AMED (OvidSP), 
the Cochrane Library (Cochrane Database of Systematic Reviews, Cochrane Central 
Register of Controlled Trials, Cochrane Methodology Register, Health Technology 
Assessment Database, NHS Economic Evaluation Database, and Cochrane 
Collaboration) (Wiley), Web of Science (Thomson Reuters), and Google Scholar 
(Google). A RefWork database was used to manage all references.   
 
3.2.2 Search strategy  
A search strategy combining title/abstract words and database subject headings, where 
available, relating to neck function and treatment approaches was used to capture all 
relevant systematic reviews, RCTs, or CCTs. The search comprised two facets: (1) 
terms relating to neck function and (2) terms relating to treatment approaches. To 
capture the phrase “neck function”, title/abstract words, all possible synonyms and 
database subject headings (e.g. MeSH) for neck were combined with those for function 
using the Boolean operators AND and OR, alongside truncation, phrase searching and 
proximity operators. The search strategy for MEDLINE (EBSCO) is as follows. This 
search syntax detailed below were adapted for use on other information resources used 
in the search. 
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Box 3.1: Search strategy 
Function terms: words in title and abstract: function*, pain*, dysfunction*, disability*, 
disorder*, problem*, disc*, diseas*, “neck” n5 Function* ti,ab.  “neck” n5 pain*. ti.ab. 
“neck” n5 dydfunction*. ti.ab.  “neck” n5 disabilit*. ti,ab. “neck” n5 disorder*. ti,ab. 
“neck” n5 problem*. ti,ab. “neck” n5 disc*. ti,ab. OR “neck” n5 diseas*. To restrict the 
search to the context of treatment approaches, the above searches using the conjunction 
AND was combined with the following search terms/synonymous and database subjects 
headings: massage*, “cognitive behavioural therapy” “CPT”, electrotherapy*, traction*, 
collar*, advice* “back school*”, education*, “manual therapy”, mobilization*, 
manipulation*, exercise*, stretching*, strengthen*, OR “physical modalit*.       
Note:(ti) = title field, (ab) = abstract field, (/) = MeSH, asterisk (*) denotes any 
character, (“”) = phrase search, (n5) = adjacency within five words.    
 
3.2.3 Study selection  
All published systematic reviews, RCTs, or CCTs, in the English language from 1995 
onwards were considered for inclusion if: (1) the sample involved an adult population 
with NS-NP, (2) involved a physiotherapeutic intervention, which is defined here as any 
non-invasive, non-surgical and non-pharmacological treatment used for the 
management of NP. Studies that involved participants with any serious pathology, 
systemic disease, neurological deficit, major trauma, any inflammatory condition, or 
incorporated non-physiotherapeutic intervention were excluded. 
 
3.3 Findings  
A total of 31 systematic reviews and 8 RCTs were located and informed the findings set 
out below. A table of included studies indicating the modalities investigated is shown 
below in Table 3.1. 
 
The findings as follows are divided into four sections. First, passive treatment 
approaches including manual therapy (manipulation and mobilisation), massage 
therapy, electrotherapy, acupuncture and traction. Second, active treatment approaches 
including therapeutic exercise, the McKenzie method and Feldenkrais. Third, patient 
education. Finally, the multimodal management approach packages are discussed. 
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Table 3.1: The modalities investigated 
Name Study Type 
Manual 
Therapy 
Massage 
Therapy 
Electro-
therapy Acupuncture Traction 
Exercise 
Therapy MDT Feldenkrais PE 
Multimodal 
Approach 
Bearman and 
Shafarman 1999 RCT        √   
Lundblad et al. 
1999 RCT        √   
Gross et al. 2002 SR √         √ 
Sarig-Bahat 2003 SR      √     
Gross et al. 2004 SR √         √ 
Clare et al. 2004 SR       √    
Vernon et al. 2005 SR √          
Kay et al. 2005 SR      √    √ 
Sarigiovannis and 
Hollins 2005 SR √          
Kroeling et al. 
2005 SR   √        
Gemmell and 
Miller 2006 SR √          
Haraldsson et al. 
2006 SR  √         
Trinh et al. 2006 SR     √       
Vas et al. 2006 RCT    √       
Graham et al. 2006 SR     √      
Vernon and 
Humphreys 2007 SR √          
Vernon et al. 2007 SR √ √       √  
Ezzo et al. 2007 SR  √         
Macaulay et al. 
2007 SR  √          
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Itoh et al. 2007 RCT    √       
Gross et al. 2007 SR  √ √ √ √ √   √ √ 
O’Leary et a. 2007 SR      √     
Ylinen et al. 2007  SR      √     
Graham et al. 2008 SR     √      
Hurwitz et al. 2008 SR   √   √   √ √ 
Haines et al. 2008 SR         √  
Bernaards et al. 
2008 RCT         √  
Hakkinen et al. 
2008 SR      √     
Graham et al. 2008 SR     √      
Fu et al. 2009 SR    √       
Gross et al. 2010 SR √  √ √       
Miller et al. 2010 SR           √ 
Liang et al. 2011 RCT    √       
Kay et al. 2012 SR      √    √ 
Bertozzi et al. 2013 SR      √     
Kroeling et al. 
2013 SR   √        
O’Riordan et al. 
2014 SR      √     
Perez et al. 2014 RCT √          
Sherman et al. 
2014 RCT   √         
SR: Systematic Review, RCT: Randomised Controlled Trial, MDT: Mechanical Diagnostic and Therapy, PE: Patient Education.  
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3.3.1 Passive treatment approaches  
3.3.1.1 Manual therapy (manipulation and mobilisation)  
Manual therapy (manipulation and mobilisation) is a commonly used intervention either 
alone or combined with different therapy modalities for patients with NS-NP (Gross et 
al. 2002). Cervical manipulation is a passive technique applied to a joint in the cervical 
spine by incorporating localised high velocity with low amplitude thrust to reduce pain, 
improve function and restore optimal joint range of motion (Herzog 2010). Meanwhile, 
cervical mobilisation is any manual therapy technique that incorporates a sequence of 
passive movement with varying speed and amplitude to a joint in the cervical spine for 
the purposes of reducing pain and increasing range of motion (Gross et al. 2004). 
 
Manual therapy was investigated in 9 systematic reviews and one recently published 
trial of a non-invasive intervention for NS-NP. The effectiveness of manipulation or 
mobilisation remains inconclusive when used as a single intervention for the 
management of patients with NS-NP (Gross et al. 2004, Vernon et al. 2005, 
Sarigiovannis and Hollins 2005, Gemmell and Miller 2006, Vernon and Humphreys 
2007, Vernon et al. 2007, Macaulay et al. 2007). In their updated review, Gross et al. 
(2010) identified 27 trials (n=1522) that assessed the effectiveness of manipulation and 
mobilisation when compared with no treatment, a sham treatment or another 
intervention such as medication, acupuncture, heat, electrotherapy and massage. 
Moderate quality evidence suggested that manipulation and mobilisation demonstrated 
similar effects on pain, function and patient satisfaction and they were found to be as 
effective as medication and acupuncture but better than a control and TENS at 
immediate and short-term follow up. Consequently, manual therapy is recommended for 
use in clinical practice (Child et al. 2008, Gross et al. 2010). A recent RCT compared 
the effectiveness of three manual therapy techniques: high velocity, low amplitude 
(HVLA), mobilisation and sustained natural apophyseal glide (SNAG) in patients with 
chronic neck pain (n=51) (Perez et al. 2014). At three months follow-up, all groups had 
a reduction of pain and disability. However, there was no statistically significant 
differences in the mean change between the groups. The authors concluded that there 
was no superiority of HVLA, mobilisation or SNAG in the short term (3 months) for 
patients with NS-NP. 
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3.3.1.2 Massage therapy  
Massage is one of the oldest therapeutic remedies and uses the manipulation of the soft 
tissue as the main therapeutic tool (Sherman et al. 2014). Massage was investigated for 
pain and function for patients with NS-NP in four systematic reviews (Haraldsson et al. 
2006, Vernon et al. 2007, Gross et al. 2007, Ezzo et al. 2007). These reviews found no 
strong or moderate evidence to support the effectiveness of massage for the 
management of patients with NS-NP. Major methodological issues such as lack of 
uniform definition of the massage technique, dosage and the mode of performance were 
often identified. Consequently, massage is not recommended for use as a single 
intervention when managing patients with NS-NP, it may be useful however if massage 
is utilised in combination with other active approaches such as exercise (Moffett and 
McLean 2006). One additional recent RCT (Sherman et al. 2014) investigated the ideal 
dose of massage on pain and function and concluded that 1 hour of massage 2-3 times a 
week was found to be the optimal dose for patients with mild NS-NP. 
 
3.3.1.3 Electrotherapy  
Electrotherapy is an umbrella term encompassing a number of physical modalities, such 
as Galvanic Current, Electrical Nerve Stimulation (ENS), Transcutaneous Electrical 
Nerve Stimulation (TENS), Pulsed Electromagnetic Fields Therapy (PEMF), and 
Repetitive Magnetic Stimulation (rMS). Electrotherapy methods were investigated for 
pain and function for patients with NS-NP in five systematic reviews (Kroeling et al. 
2005, Gross et al. 2007, Hurwitz et al. 2008, Gross et al. 2010, Kroeling et al. 2013). 
Limited evidence supported the effect of rMS on pain and function in chronic NS-NP as 
a short-term treatment option, and inconsistent evidence supported the benefits of TENS 
for chronic NS-NP (Hurwitz et al. 2008). Meanwhile, limited evidence supported the 
benefits of PEMF at extremely low frequencies and high frequencies on pain reduction 
in patients with acute or chronic NS-NP immediately post treatment (Kroeling et al. 
2005). Very low-quality evidence from a recent Cochrane review found that PEMF, 
rMS, and TENS are more effective than a placebo for pain reduction, while no benefit 
was found for all the other electrotherapeutic modalities (Kroeling et al. 2013). Overall, 
the effectiveness of electrotherapeutic treatment modalities remains uncertain when 
used as a single intervention for the management of NS-NP due to problems related to 
low methodological quality and funding bias (Gross et al. 2007; Hurwitz et al. 2008, 
Kroeling et al. 2013). 
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3.3.1.4 Acupuncture  
Acupuncture is considered to be an alternative and complementary approach for the 
management of NS-NP, which requires the insertion of needles into the body for the 
purposes of pain reduction and/or to induce anaesthesia. Various approaches related to 
different countries including China, Japan and Korea have been proposed and tested 
(Trinh et al. 2006). Acupuncture was investigated for pain and function for patients with 
NS-NP in four systematic reviews (Trinh et al. 2006, Gross et al. 2007, Fu et al. 2009, 
Gross et al. 2010). Trigger point acupuncture was found to be more effective than other 
types of acupuncture on pain relief in the immediate post treatment phases and at short-
term follow up (Itoh et al. 2007). Meanwhile strong to moderate evidence supported the 
effectiveness of acupuncture when compared to other inactive treatment approaches for 
pain relief immediately after treatment and at short-term follow up in patients with 
chronic NS-NP (Trinh et al. 2006, Vas et al. 2006, Gross et al. 2007). In addition, 
moderate evidence from a recent systematic review and one high quality RCT supported 
the effectiveness of acupuncture when compared to a control and a placebo on pain in 
the immediate post treatment phase and at short-term follow up (Fu et al. 2009, Liang et 
al. 2011). Overall, there is evidence to support the efficacy of using acupuncture to treat 
pain at short-term follow-up, but important clinical information such as the frequency 
and exact points to be acupunctured were not available. Consequently, it is not 
recommended as a single intervention for the management of patients with NS-NP 
(Moffett and McLean 2006, Child et al. 2008). 
 
3.3.1.5 Traction  
Traction is a passive treatment approach that involves a longitudinal stretch to the 
cervical spine. This stretch can be applied manually or mechanically for a specific 
period of time (continuous or static) or intermittently (on/off mode) (Graham et al. 
2008). Cervical traction was investigated in three systematic reviews, which reported 
limited or no evidence to support the effectiveness of traction for NS-NP, and therefore 
any possible benefits of traction remain uncertain (Graham et al. 2006, Gross et al. 
2007, Graham et al. 2008). Cervical traction is not recommended as a single 
intervention for the management of patients with NS-NP (Moffett and McLean 2006, 
Child et al. 2008). 
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3.3.2 Active treatment approaches  
3.3.2.1 Therapeutic exercise  
Therapeutic exercise is the execution of pre-arranged physical movement and activity 
related to the cervical spine region for the purposes of pain reduction, restoration of 
function and improved quality of life for patients suffering from NS-NP (Kay et al. 
2005). It is an integral part of any rehabilitation programme and should be a key 
element for any physiotherapy approach when managing any musculoskeletal 
conditions including NS-NP (Child et al. 2008, Jull et al. 2008). Therapeutic exercise is 
frequently classified into general exercise for the neck and upper limb, cervical 
strengthening, cervical stretching, stabilising, endurance, balance and proprioception 
exercise. These components have been investigated as possible interventions for NS-NP 
in several systematic reviews (Sarig-Bahat 2003, Kay et al. 2005, Gross et al. 2007, 
Hurwitz et al. 2008). Moderate strength evidence supported the effectiveness of 
stretching and strengthening exercises for the neck and upper limb in the short and 
longterm on pain and function for chronic NS-NP (Kay et al. 2005, Gross et al. 2007, 
O'Leary et al. 2007, Ylinen et al. 2007, Hurwitz et al. 2008). Low to moderate strength 
evidence from a high-quality review suggested that strengthening exercises demonstrate 
optimal improvement in all outcomes (Kay et al. 2012). The addition of stretching 
and/or aerobic exercise should enhance a treatment programme for sub-acute and 
chronic NS-NP (Bertozzi et al. 2013). In their recent review and meta-analysis, 
O’Riordan et al. (2014) reported that active strengthening, stretching and aerobic 
exercise 3 times a week for approximately 30 to 60 minutes with 80% of maximum 
muscles voluntary contraction demonstrated the optimal benefits on pain, function and 
quality of life for patients with NS-NP (O’Riordan et al. 2014). Moderate strength 
evidence supported the short-term benefits of eye-fixation and neck proprioceptive 
exercise on pain and patient satisfaction (Sarig-Bahat 2003, Kay et al. 2005, Gross et al. 
2007). Conflicting evidence were found regarding the effectiveness of home exercise 
(not supervised), group exercise and neck school (Kay et al. 2005, Gross et al. 2007, 
Hakkinen et al. 2008, Hurwitz et al. 2008).  
 
3.3.2.2 The Mechanical Diagnostic and Therapy (MDT)  
MDT, sometimes known as the McKenzie approach, is a comprehensive diagnostic and 
treatment approach commonly utilised for the management of back and neck pain. The 
approach is based on the individual’s response to repeated movement or sustained 
posture in a specific direction (Clare et al. 2004). Self-management is the main 
 76 
objective and the patient is educated with regards to the beneficial effects of repeated 
movement in a specific direction and the adverse effects of any movement in the 
opposite direction (Klaber Moffett et al., 2006). Despite the popularity of the McKenzie 
approach among UK physiotherapists (Foster et al. 1999), it was investigated in one 
systematic review (Clare et al. 2004). Research supporting the effectiveness of the 
McKenzie approach is limited (Moffett et al. 2006), which does not support or refute its 
effectiveness for patients with NS-NP. 
 
3.3.2.3 Feldenkrais  
Feldenkrais is an alternative and complementary treatment often used for managing 
chronic physical conditions including NS-NP. The theory of this approach is based on 
that patients with musculoskeletal conditions should have positive attitude towards 
function in order to reduce the potential for the development of chronic pain (Bearman 
and Shafarman 1999, Lundblad et al. 1999). The effectiveness of Feldenkrais remains 
unclear due to the limited research regarding its benefits for patients with NS-NP. 
 
3.3.3 Patient education  
Therapeutic patient education is a treatment approach, in which different techniques 
such as oral, written, or audio-visual techniques are used to provide patients with the 
necessary information and skills to manage their life with a disease (WHO 2001). 
Various education programmes, which were delivered orally or in a written/audio-visual 
form have been tested in a number of reviews and RCTs as an intervention for patients 
with NS-NP (Gross et al. 2007, Vernon et al. 2007, Hurwitz et al. 2008, Haines et al. 
2008, Bernaards et al. 2008). Moderate evidence supported the benefits of education 
and/or counselling on pain and disability in the short- and medium-term follow up for 
female computer workers with NS-NP (Vernon et al. 2007). No evidence was found to 
support the benefits of traditional neck school when compared to no treatment for 
patients with NS-NP (Gross et al. 2007, Haines et al. 2008, Hurwitz et al. 2008). 
Overall, there is no evidence to support the effectiveness of patient education as a single 
intervention for the management of patients with NS-NP (Haines et al. 2008, Gross et 
al. 2012). However, clinical guidelines recommended that patient education should be 
used as part of a multimodal approach in the holistic management for patients with 
NSNP (Child et al. 2008). 
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3.3.4 Multimodal management approach  
A multimodal approach to management is a combination of at least two interventions, 
with therapeutic exercise being a key component of any combination for the 
management of patients with NS-NP (Gross et al. 2007, Hurwitz et al. 2008). Overall, a 
multimodal management approach that combines stretching/strengthening exercise 
(supervised) and manual therapy (manipulation/mobilisation) with/without patient 
education is the optimal approach with strong evidence of effectiveness on pain 
reduction, improved function and patient satisfaction in the short- and long-term 
benefits for patients with NS-NP (Gross et al. 2002, Gross et al. 2004, Kay et al. 2005, 
Gross et al. 2007, Hurwitz et al. 2008, Kay et al. 2012). Moderate evidence suggested 
that a multimodal approach combining manual therapy and electrotherapy, medication 
or any other non-invasive approach demonstrated no difference on pain, function or 
patient satisfaction (Gross et al. 2004). A multimodal modal approach combining 
manual therapy with patient education or home exercise demonstrated no benefits on 
pain or function in patients with NS-NP (Gross et al. 2007, Hurwitz et al. 2008). 
Moderate evidence supported the effectiveness of a multimodal approach that includes 
exercise and manual therapy on pain and quality of life when compared with either 
exercise of manual therapy alone at the short-term follow up (Miller et al. 2010). 
 
3.4 Conclusion  
This review was conducted to establish current recommended non-invasive and 
nonsurgical treatment approaches for the management of patients with NS-NP as well 
as determining the effectiveness of these approaches when used as a single intervention 
or when combined in a multimodal management approach. Various active and passive 
treatment approaches are currently recommended for the management of patients with 
NS-NP, alongside the multimodal management approach which utilises at least two 
different approaches concurrently for the management of patients with NS-NP. 
However, strong evidence of effectiveness was only found for the multimodal approach 
which incorporate supervised stretching/strengthening neck and upper limb exercise and 
manual therapy (manipulation and mobilisation) with/without a patient education 
programme for acute/sub-acute or chronic NS-NP. The effectiveness of passive 
treatment approaches such as manual therapy, electrotherapy, massage, acupuncture or 
traction remains uncertain when used as a single intervention. In addition, it is not 
recommended to utilise these passive approaches in isolation, since they may lead to 
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patient passivity, inactivity, which consequently may contribute to disability behaviour 
(Swenson 2003, Moffett and McLean 2006). 
 
The next chapter is a national survey which addresses the second research question of 
this thesis (see Section 1.5) and describe current UK physiotherapy practice in relation 
to the measurement and management of NS-NP. The findings of this current chapter 
informed the development of the survey instrument. 
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Chapter 4: Physiotherapy management of patients with non-specific 
neck pain: A national survey of current UK practice.  
 
4.1 Introduction  
This chapter describes a national survey investigating physiotherapy management and 
measurement of patients with non-specific neck pain (NS-NP).  
 
Information about current physiotherapy practice in relation to the management and 
measurement of NS-NP is important for three reasons. First, to understand which 
management approaches are preferred by UK physiotherapists and the extent to which 
these approaches are supported by evidence of effectiveness. Second, to gain an insight 
into the current level of measurement in the assessment and during the management of 
patients with NS-NP (e.g. which OMs are most often used, which of the relevant 
constructs are frequently measured and what are the reasons for using or not using OMs 
when assessing or rehabilitating patients with NS-NP), and to determine the extent of 
the use of standardised OMs for NS-NP. For the purpose of this study OM is defined as 
an instrument, tool, task or questionnaire that is used in clinical practice or research to 
determine the presence of a condition/disease and measure its severity (Nelson and 
Berwick 1989, Duckworth 1999, Haigh et al. 2001). Moreover, this instrument should 
have the capability to objectively and/or subjectively detect and quantify changes in the 
construct of interest during and after rehabilitation (Abrams et al. 2006, Jette et al. 
2009).  Finally, the knowledge about current UK physiotherapy practice for NS-NP 
would highlight the impact of evidence on clinical practice and could be used to 
determine the extent of evidence-based dissemination and identify barriers to 
implementation. This could facilitate the development of new strategies to disseminate 
and/or implement evidence-based practice, if required, and enable the recommendation 
of priorities for future research. 
 
Chapter 3 of this thesis summarised evidence of currently recommended treatment 
approaches for the management of NS-NP. Strong evidence of the benefits was found 
for therapeutic exercise of specific types when used in combination with other 
management approaches. A multimodal management approach is a combination of at 
least two interventions, with therapeutic exercise being a key component of any 
combination (Gross et al. 2007, Hurwitz et al. 2008). Multimodal management 
approaches are frequently categorised as: (1) exercise, manual therapy and patient 
education; (2) exercise and manual therapy; and (3) exercise and any other management 
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approach. Despite the commonality and burden of NS-NP, and the availability of a wide 
range of management approaches, there is limited information regarding the patterns of 
incorporating these approaches into UK physiotherapy practice. 
 
Upper limb disability (ULD) is frequently associated with NS-NP (Daffner et al. 2003, 
Falla et al. 2004, Frank et al. 2005, Bot et al. 2005). Optimal rehabilitation of NS-NP 
requires evaluation of the upper limb using suitable OMs and should include ULD 
rehabilitation in the management plan if indicated (McLean et al. 2011, Osborn and Jull 
2013). Chapter two of this thesis investigated all available OMs that have been used to 
measure UL functional capacity in patients with NP. The findings reported that there are 
four promising instruments, however significant methodological and quality issues 
prevented a clear recommendation for any of these OMs (Alreni et al. 2017). Limited 
evidence suggested that UK physiotherapists may be inadequately evaluating their 
patients with NS-NP (McLean et al. 2011). The extent to which validated NP, ULD, or 
other potentially relevant OMs are used by UK physiotherapists when managing NS-NP 
is unknown. 
 
4.1.1 Aim  
The overall aim of this national survey was to investigate current UK physiotherapy 
practice in relation to the measurement and management of NS-NP. The objectives were 
to: 
1. Describe current UK physiotherapists with regard to their management of 
patients with NS-NP, utilisation patterns of the multimodal management 
approaches and rehabilitation of the ULD. 
2. Describe current practice of UK physiotherapists with regard to their utilisation 
of OMs. Specifically of interest within this thesis is utilisation of ULD OMs in 
the assessment and during the rehabilitation of patients with NS-NP. 
3. Exploring the relationship between demographic characteristics of participants 
and management strategies utilised as well as OMs utilised. 
 
4.2 Methods  
4.2.1 Design  
This online web-based survey explored UK-based physiotherapists’ use of management 
approaches and OMs utilisation for patients with NS-NP. The survey instrument was 
designed and extensively evaluated to ensure robust face and content validity as well as 
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acceptability and feasibility. An extensive online methodology utilising Social 
Networking Sites including Twitter, Facebook and LinkedIn was used in the survey to 
optimise recruitment of participants. The survey was conducted from March 2016 to 
November 2016 and approved by Sheffield Hallam University, Faculty Research Ethics 
Committee (see Appendix 4). 
 
4.2.2 Rational for online web-based survey  
In order to meet the aim of this investigation, an online web-based survey was used to 
develop a coherent picture of current UK physiotherapeutic management and 
measurement of NS-NP. This research method was used in this national survey for four 
main reasons. First, it provides the necessary cost-effective method of data collection, in 
which a large sample size can be achieved at very low cost compared to other survey 
methods, such as a postal survey or a telephone survey (Couper 2000, Dillman 2000, 
Shannon et al. 2001). This large sample size can lower the sample variance and provide 
the potential for sub-group analysis, which can strengthen the power of the study and 
thus the validity of the findings (Cook et al. 2000, Couper et al. 2004, Manfreda et al. 
2008). Second, it saves time and provides the required speed as well as coverage over a 
wide geographical area for data collection, since it enables instant distribution and 
continuous data collection (i.e. it can reach respondents wherever they are and at 
whatever time is most convenient to them) (Couper et al. 2001). Third, it provides the 
needed speed and accuracy of data analysis, since it allows instant access to 
participants’ responses that can be automatically downloaded to an electronic database 
or statistical package, eliminating human error in data coding and data entry (Crawford 
et al. 2005, Dillman 2007). Finally, it enables innovative questionnaire design to be 
developed using advanced and interactive features (e.g. screen design, text, question 
presentation, respondents’ response format and the survey navigation). In addition, it 
allows the use of drop-down boxes, pop-up windows, routing systems (i.e. the system 
enables respondents to skip portion of the survey which is not relevant to their practice) 
and progress indicators in the design, features which are not always available with the 
other survey modes. 
 
These features provide a dynamic survey process that ensures the acceptability, 
feasibility, simplicity and brevity of the survey instrument and have been shown to 
increase survey response rates (Dillman et al. 1998, Fricker and Schonlau 2002, 
Dillman and Smyth 2007, Manfreda et al. 2008). 
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4.2.3 Disadvantages of web-based survey  
4.2.3.1 Access to the internet  
Missing out respondents who do not have internet access is the first challenge facing 
this approach. However, in the last decade, the internet has become a key component in 
the navigation of everyday life (Hughes et al. 2012). Meanwhile, the data produced by 
the UK Office for National Statistics annual report for the year 2016 estimated that 
87.9% (45.9 million) of the population had recently (in the last 3 months) used the 
internet; almost all adults aged 16-24 years were recent internet users (99.2%); 89.4% of 
men (22.8 million) and 86.4% of women (23.1 million) were recent internet users 
(Office for National Statistics 2016). Furthermore, evidence from the literature 
suggested that the majority of healthcare professionals in the UK including 
physiotherapists are using popular Social Networking Sites such as the Facebook, 
Twitter, LinkedIn and YouTube for social interaction and information exchange as well 
as business advertising (Ahmed et al. 2012). This indicates that the majority of 
UKbased physiotherapists are likely to be internet users and thus overcomes the first 
main reported challenge regarding internet access. 
 
4.2.3.2 Low response rate  
Web-based surveys tend to have poorer response rate, which is reported to be 
approximately 11% lower than that of other survey modes such as postal surveys or 
telephone surveys (Couper 2000, Fan and Yan 2010). Poor response rate is a major 
challenge threatening the validity of the survey’s findings (Couper et al. 2004). In order 
to overcome this challenge, and to maximise the number and diversity of respondents 
the following steps were taken. Firstly, the survey instrument was developed and 
designed in accordance with the Web-Based Survey Design Standards reported by 
Crawford et al. (2005), which provide guidance for developing a robust web-based 
survey design that ensure acceptability and feasibility of the survey instrument. This 
includes standards to be used when designing the visual display of questions, responses 
and the supporting survey materials to the respondents; question presentation; 
respondents’ input/response formats; and the survey navigation/interaction. In addition, 
an extensive online methodology incorporating popular Social Networking Sites 
including Twitter, Facebook and LinkedIn was developed and implemented in the 
survey procedure (see section 4.2.6). 
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4.2.4 Sampling  
4.2.4.1 Sampling method  
The main UK physiotherapy professional bodies, the Health and Care Professional 
Council (HCPC) and the Chartered Society of Physiotherapy (CSP) do not allow access 
to their registrants for the purpose of recruiting participants for research projects or 
surveys. Meanwhile, accessing physiotherapists working in the NHS which comprised 
approximately 60% of all UK-physiotherapists requires approval from each selected 
National Health Services (NHS) Trust prior to the survey administration, which is time 
consuming and is also not representative of the total population of physiotherapists. 
Furthermore, other UK physiotherapy organisations such as the Musculoskeletal 
Association of Chartered Physiotherapists (MACP) and the Physiotherapy Pain 
Association (PPA) are also not representative of the total population and therefore not 
considered feasible for a national survey. Hence, a non-probability sampling approach 
was used in this PhD national survey. In to reduce the likelihood of sampling bias and 
to recruit a large sample, the survey procedure utilised an extensively pre-designed 
innovative online methodology incorporating popular social networking sites including 
Twitter, Facebook and LinkedIn. The rationale and details of the online methodology 
used in Twitter, where the majority of responses were achieved is presented in section 
4.2.6. 
 
4.2.4.2 Sampling frame  
There are 48,611 physiotherapists registered in the UK (HCPC, 2016). More than 98% 
of these registrants are also members of the Chartered Society of Physiotherapists 
(CSP), (the professional, educational, and trade union representing UK 
physiotherapists). Approximately 60% of these chartered physiotherapists work for the 
publicly funded NHS in the UK. The remaining 40% work in a variety of settings, such 
as private clinics, private hospitals, military hospitals, sports clubs, or teaching in higher 
education institutes. UK-based musculoskeletal physiotherapists who are involved in 
the management of NS-NP were the sample frame (target population) in this national 
survey, though the size of this sampling frame is unclear. 
 
4.2.4.3 Sampling procedure  
Physiotherapists were eligible to participate in this survey if they were: currently a 
member of the HCPC; working in either an NHS setting, non-NHS setting (e.g. private 
clinics, private hospitals, military hospitals or sports clubs), or a combination of NHS 
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and non-NHS settings; and have seen at least one case of neck pain (NP) in the last 6 
months. Physiotherapists working in areas such as intensive care, mental health, 
respiratory care, paediatrics, stroke services, elderly care or inpatient settings; currently 
not involved in the management of patients with NP; or not practicing in the UK were 
ineligible to participate. From the sampling approach used in this survey, there was no 
way of identifying those UK musculoskeletal physiotherapists who are involved in the 
management of NP. Therefore, eligibility conditions were indicated in the survey’s 
invitation and the eligibility decision was left to the discretion of participants. Written 
consent was not sought from each participant; however, consent was assumed if 
physiotherapists completed the survey (Crawford et al. 2005). 
 
4.2.4.4 Sample size  
The sampling method (non-probability) used in this survey meant that the number of 
potential participants could not be reliably determined, and consequently it was not 
possible to estimate the sample size and/or response rate. However, an innovative online 
methodology was used in the survey procedure to maximise the number as well as the 
diversity of participants in this survey. 
 
4.2.5 Survey instrument  
For the purpose of this study a new survey instrument was developed and designed to 
capture information regarding current UK physiotherapy measurement and management 
of NS-NP. The survey instrument (see Appendix 5) included a participant information 
sheet and thereafter comprised questions divided into three sections: (1) demographic 
characteristics of physiotherapists, (2) treatment approaches that are used when 
managing NS-NP, and (3) OMs that are used in the assessment and/or management of 
NS-NP. The rationale and details about each section are presented in sections 4.2.5.3 to 
4.2.5.5. The development and validation of the survey instrument were iterative with 
multiple revisions and piloting procedures to ensure face and content validity (Dillman 
et al. 1998, Couper 2000, Couper et al. 2001, Dillman 2007, MacDermid et al. 2013, 
Carlesso et al. 2014). 
 
Two reviews of the literature were undertaken to inform the preliminary development of 
the survey instrument. First, a literature review of all available treatment approaches for 
the management of NS-NP was conducted to determine what conservative, non-
invasive, management approaches have been investigated and currently recommended 
for clinical practice (see Chapter 3). Available management approaches were 
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thematically grouped to produce an appropriate number of items and response options 
that represent the range of interventions currently used in clinical practice for patents 
with NS-NP. Details are presented in section 4.2.5.4. Second, a systematic review of all 
available upper limb OMs for patients with NP (see Chapter 2) was conducted to 
identify, critically examine and recommend a list of suitable upper limb OMs developed 
or validated for patients with NP. Furthermore, evidence from additional systematic 
reviews, development and/or validation studies of all available OMs for patients with 
NP were sought (Pietrobon et al. 2002, de Koning et al. 2008, Dvir and Prushansky 
2008, Siva et al. 2010, Terwee et al. 2011, Schellingerhout et al. 2012, Horn et al. 
2012). All the identified OMs of ULD for patients with NP alongside all available NP 
OMs were collated and thematically grouped to represent the spectrum of OMs for NP 
and its associated ULD. Details are presented in section 4.2.5.5. 
 
4.2.5.1 Development  
The survey instrument was developed in accordance with the Web-Based Survey 
Design Standards reported by Crawford et al. (2005), which published standards 
developed from theory and practice with regard to the screen design, text, question 
presentation, respondents’ input/response formats, and survey navigation/interaction to 
ensure acceptability and feasibility as well as simplicity and brevity of a survey, which 
has been shown to increase the response rate of web-based surveys (Baruch 1999, Baker 
et al. 2003, Couper et al. 2004, Couper et al. 2007, Fan and Yan 2010). Figure 4.1 
shows the procedure that was used in the development and validation of the survey 
instrument. 
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4.2.5.2 Validation  
The survey instrument underwent two rounds of revision and three rounds of pilot 
testing. The initial revision stage emphasised the content and clarity of each individual 
item and response option and resulted in the inclusion of additional definitions and 
examples for each OM in section 3. In addition, the wording was modified for 2 
questions and 5 response options in sections 2 and 3. The final revision stage 
emphasised the logical grouping, sequencing of items and routing (filter) questions that 
enabled respondents to skip portions of the survey which were not relevant to their 
practice. This stage resulted in the re-ordering of several items and response options in 
sections 2 and 3. 
 
The initial pilot testing was conducted in three stages: stage 1 (n=15) and stage 2 
(n=20), involved experts/clinical physiotherapists from the target audience. Participants 
were asked to review the survey instrument with regard to the electronic format, the 
routing questions and the functionality of the web-page design and programming. 
Finally, field testing was conducted involving physiotherapists, experts, working in 
clinical practice and research practice, alongside clinical physiotherapists from the 
target population (n=30). These experts and clinical physiotherapists were requested to 
review the survey instrument for accuracy, clarity, completeness and burden. Field 
testing resulted in several modifications to clarify the aim of each section, improve the 
wording of sentences and improve the organisation of the survey content. 
 
Participants in this survey were able to select all the management approaches (section 2) 
and the OMs (section 3) that they would use most often when managing their patients 
with NS-NP. This was to enable the identification of UK physiotherapists who were 
using multimodal management and/or measurement approaches. Progress indicators 
were used at the bottom of each screen to inform respondents of their progress 
throughout the questionnaire and to prevent drop out before completing the survey 
(Jeavons 1998, Couper et al. 2001). Closed questions only were used in this survey to 
reduce the time burden (Crawford et al. 2005). However, respondents were able to 
identify any 'other’ management approaches or OMs that they would use but which 
were not identified in the response option lists. 
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4.2.5.3 Section 1 demographic characteristics  
Questions about physiotherapists’ demographic characteristics were included in the 
survey instrument to permit a full description of the sample, examine the diversity of the 
sample, compare the sample to the total population and finally to enable examination of 
possible associations between demographic characteristics and the selection of 
management approaches and/or utilisation of OMs. The demographic characteristics of 
physiotherapists (e.g. gender, setting, years of experience, nation where physiotherapists 
were clinically practicing, postgraduate training level, caseload information and special 
interest in NS-NP) were obtained using standard closed format questions. Drop down 
boxes allowing one answer only were used to provide the response options. 
 
4.2.5.4 Section 2 management approaches  
Questions about management approaches were included in the survey to enable full 
description of current UK physiotherapy practice in the management of NS-NP, which 
is the first objective of this national survey (see Section 4.1.1). Selection of the items 
relating to upper limb management strategies were used to evaluate/establish the level 
of upper limb rehabilitation undertaken during the management of NS-NP. Section 2 
was launched with a statement clarifying the aim of the section “In this section, we are 
interested in identifying the management approach/approaches you typically use for 
patients with NS-NP”. This was followed by a clear definition of NS-NP, “NS-NP is 
defined here as a dysfunction in the cervical structure NOT caused by any serious acute 
trauma (e.g. Whiplash Associated Disorder), systemic disease, neurological disorder 
(e.g. Cervical Radiculopathy, Nerve Root Compression) or inflammatory condition”. 
This section enabled respondents to select as many management approaches as they 
would most often use to identify those respondents who use multimodal management 
approaches. Selecting management approaches such as therapeutic exercise, manual 
therapy and/or electrotherapy triggered another question and response options, via a 
drop-down box, requesting those respondents to select the component/method they 
typically used most often “Which component/components – method/methods do you 
use regularly for patients with NS-NP?”. Response options in this section were 
presented as follows: therapeutic exercise followed by its main components (e.g. 
general aerobic/ strengthening/endurance exercise, cervical strengthening exercise, 
upper limb strengthening exercise, cervical stretching exercise, upper limb stretching 
exercise, cervical stabilising exercise, upper limb stabilising exercise, balance exercise, 
proprioception exercise for the eyes, proprioception exercise for the cervical spine and 
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proprioception exercise for the upper limb); manual therapy followed by its main 
methods (e.g. Maitland, Mulligan, Society of Orthopaedic Medicine and Manipulation 
(grade V); and electrotherapy modalities followed by its main methods (e.g. Galvanic 
Current (DC), Electrical Nerve Stimulation (ENS), Pulsed Electromagnetic Fields 
(PEMF), Transcutaneous Nerve Stimulation (TENS) and Repetitive Magnetic 
Stimulation (rMS)). These management approaches were followed by other 
interventions such as the McKenzie method; therapeutic patient education; massage 
therapy (all types); acupuncture; traction; heat/cold; taping/strapping; hydrotherapy; 
Feldenkrais; and other management approach/approaches. 
 
4.2.5.5 Section 3 outcome measures (OMs) 
Questions about OMs were included in this survey to permit a full description of current 
UK physiotherapy practice in the measurement of NS-NP, which is the second objective 
of this national survey (see Section 4.1.1). Selection of items relating to 
physical/functional upper limb OMs were used to establish the level of upper limb 
evaluation undertaken in the assessment and during the management of NS-NP. This 
section was launched with a routing question to reduce the time burden and prompt 
brevity of the survey instrument “do you use OMs in the assessment/management of 
patients with NS-NP?”. If respondents selected NO, they were asked, using a dropdown 
box, to indicate their reasons for not using OMs and then routed to the end of the survey 
where they were thanked for participating in the survey. Selecting YES triggered 
another 3 questions and response options, using a drop-down box, requesting those 
respondents to select the reasons for using OMs, the frequency with which they use any 
measures (i.e. routinely = >70% of cases, regularly = 51-70% of cases, sometimes = 
1150% of cases and rarely = <10% of cases) and the OMs that they use most often as 
well as the patterns of use. Response options in this final section were structured and 
presented as follows: routinely = >70% of cases, regularly = 11-70% of cases, rarely = 
1-10% of cases and never = 0% of cases (Crawford et al. 2005). 
 
Items in this section were presented as follows: first, Patient-Reported OMs (PROMs) 
(i.e. pain measures, physical functioning OMs, work status OMs, psychological distress 
OMs and quality of life OMs [global OMs and generic multidimensional OMs]). 
Second, Performance-Based OMs (PBOMs) (i.e. pain threshold perception, motion 
OMs, muscle function OMs and functional performance OMs). 
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4.2.6 Survey procedure  
A domain name “UK-neckpainsurve.com” and hosting web were purchased. A webpage 
and associated database were designed and programmed for data collection in this web-
based survey. An extensive and innovative online methodology incorporating popular 
social networking sites including Twitter, Facebook and LinkedIn was developed and 
implemented for the recruitment and administration of this national survey between 
August 2016 and November 2016. This was to increase the number, as well as the 
diversity, of participants. Details of the strategy used in Twitter, where the majority of 
responses were achieved, are presented in the paragraph below. 
 
Strategy development was an iterative process with up-front loaded online materials. 
First, a credible and professional public Twitter profile as a PhD student at Sheffield 
Hallam University was created using a friendly bio name (@ResearchingNeck) and a 
JPEG photo of the researcher. A public Twitter profile was used to enable all Twitter 
users to view and interact with the tweets. Second, a banner containing Sheffield 
Hallam University’s logo, JPEG photo of the director of study (Dr Sionnadh McLean) 
and another JPEG photo of the researcher alongside a concise, friendly and professional 
survey invitation were designed (see Appendix 16). Third, influential UK-based 
individuals, groups and organisations associated with Musculoskeletal Physiotherapy, 
as well as a high number of UK-based Musculoskeletal Physiotherapists on Twitter 
were identified using the Social Media Analytics Software (Followerwonk – A Moz 
App) and then followed by the researcher. Fourth, several Twitter posts using wording 
suitable for each identified individual, group or organisation were created using other 
public Twitter accounts after gaining permission from the account holders. Fifth, key 
posting times (that is, the times of the day when UK-based physiotherapists have just 
signed-in Twitter) were identified using the aforementioned analytics software. Finally, 
tweets were posted to these identified and followed individuals, groups and 
organisations followed on a daily basis for 3 months. 
 
In Twitter, a tweet could contain a maximum of 140-characters (in the time when the 
survey was conducted) but JPEG and GIF photos did not count towards the character 
limit. Thus, a banner was included, which contained a GIF photo and JPEG photos of 
the researcher and the director of study alongside the survey invitation in every tweet. 
All tweets began with an @username of one of the identified influential individuals, 
groups or organisations. This was to enable their followers to immediately see the tweet 
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in their home timeline. Individuals, groups and organisations were also asked to retweet 
or quote tweet the tweet (that is, retweet with added comment requesting followers to 
complete the survey). Since Twitter users often miss tweet posted when they are not 
online, particular times of the day were targeted; for example, when physiotherapists 
have just have signed-in (that is, 7:10am, 10:40am, 17:45 and 21:50). A tweet begins 
with @username, a friendly request to complete and retweet the survey, the survey 
obtained google link http://goo.gl/OynKlq and the survey’s banner was posted to every 
identified individual, group and organisation. Since groups and organisations were 
being asked to retweet and/or quote the tweet about this study, the process repeated was 
repeated every two weeks. The researcher performed “like” to every retweet or quote 
tweet in the following day after retweeting at one of the key posting times. The 
researcher also posted a thank you tweet to those who retweet or quote tweeted the 
original tweet in the second day after retweeting or quote tweeting the original tweet at 
one of the key posting times. 
 
In this strategy, posting tweets to the identified influential individuals, groups and 
organisations was considered to constitute recruitment of participants and 
administration of the survey instrument since those tens of thousands of 
physiotherapists who follow these individuals, groups and organisations should have 
seen/received the tweet associated with the study, which included all the materials about 
the survey, in their home timeline immediately after posting. “like” by the researcher to 
the tweet or quote tweet in the following day was considered to be the first reminder 
since it enabled the survey to be seen/received again in the home timeline of those 
followers. “thanks” tweet, which was posted by the researcher in the second day was 
considered to be the second reminder since it enabled the survey to be seen/received 
again, for the third time, in the home timeline of the followers. “like” to our “thanks” 
tweet by the individual, group and organisation, which always happened, was 
considered to be the third reminder since it enabled the survey to be seen/received again 
for the fourth time, in the home timeline of the followers. Overall, this recruitment 
strategy supported access to a national population of UK physiotherapists with a wide 
range of demographic characteristics. 
 
4.2.7 Ethical consideration  
In survey research methods, two main ethical issues always arise with regard to 
anonymity and consent. In this PhD national survey, registration to complete the survey 
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was not required, information which enables identification of respondents such as name, 
email address, telephone number and/or place of work were not requested at any stage 
of the data collection, and written consent from each respondent was not sought in order 
to ensure anonymity of the survey. The eligibility decision was left to the discretion of 
participants and consent was assumed if physiotherapists completed the survey (Couper 
2000). 
 
4.2.8 Data analysis  
At the end of the survey period, data were collated and transferred from the web-based 
database into Microsoft Excel 2016 where data were checked. Subsequently, the data 
were transferred into SPSS (IBM SPSS Statistical Software, version 23.0) for statistical 
analysis. 
 
In order to meet the objectives of this survey, descriptive analysis (frequencies, and 
percentages) was used to present the demographic information, the utilisation patterns 
of the management approaches and the utilisation patterns of OMs in the assessment 
and during the management of NS-NP. Subsequently, the utilisation patterns of 
multimodal management and measurement approaches, the reasons for using or not 
using OMs, and the patterns of evaluating and rehabilitating ULD were descriptively 
analysed. 
 
Chi-square test, Phi and Cramer’s V tests were used to examine the strength and 
significance of any association/differences in clinical practice between groups of UK 
physiotherapists (e.g. physiotherapists with different gender, years of experience, 
setting, postgraduate training level or practicing clinically in different nation), the 
utilisation patterns of multimodal management approach packages and OMs (Altman, 
1991). 
 
4.3 Results  
4.3.1 Demographic characteristics  
In total, 2101 physiotherapists who were members of the HCPC, practicing in the UK 
and involved in the management of patients with NS-NP completed the survey. The 
demographic characteristics of those physiotherapists are summarised in Table 4.1. 
Respondents were predominately female (57%), of which the majority (67%) were 
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working within the NHS (either exclusively in the NHS, or in a combination of NHS 
and non-NHS settings). A substantial component (44%) of respondents had 6-10 years 
of experience and the largest subgroup of physiotherapists practiced in England (66%). 
A slim majority were without postgraduate training and of the 48.7% of 
physiotherapists who reported that they had completed postgraduate training, 72.5% had 
completed an MSc, whereas 8.5% had completed a PhD. More than 40% of respondents 
had a caseload which included 25-50% patients with NS-NP and 65.1% of the sample 
reported that they had no special interest in NS-NP. In the item relating to “years of 
practice”, because of small numbers, the categories “less than 2 years” and “2-5 years” 
were combined to create the category “0-5 years”. Similarly, in the item relating to 
“proportion of patients with NS-NP”, the categories “51-75%” and “75+%” 
were combined to create category “≥51%”. 
 
Table 4.1: Demographic characteristics of physiotherapists  
Variables N % 
Gender  
Female 
Male  
 
1193 
908 
 
56.8 
43.2  
Setting  
Exclusively in the NHS 
Exclusively in Non-NHS 
Combination of NHS & Non-NHS 
Other settings 
 
1005 
628 
464 
4 
 
47.8  
29.9 
22.1 
0.2 
Years of Practice  
0-5 Years 
6-10 Years 
11-15 Years 
15+ Years 
 
313 
928 
395 
465 
 
14.9 
44.2 
18.8 
22.1 
Nation  
England  
Scotland  
Wales  
Northern Ireland  
 
1398 
297 
285 
121 
 
66.5 
14.1 
13.6 
5.8 
Postgraduate Training  
With  
Without 
 
1024 
1077 
 
48.7 
51.3 
Proportion of Patients with NP 
<25% 
25-50% 
≥51% 
 
881 
925 
295 
 
41.9 
44.1 
14 
Special Interest in NP 
No 
Yes 
 
1367 
734 
 
65.1 
34.9 
Notes: NHS: National Health Services, NP: Neck Pain 
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4.3.1.1 Demographic characteristics distribution  
Demographic and participant characteristics (e.g. gender, setting and the nation, where 
physiotherapists practicing clinically) of the survey sample alongside the total UK 
physiotherapy population (HCPC, 2016) are presented in Table 4.2. Comparison 
between the survey sample and the UK physiotherapy population regarding the above 
demographics indicated a slightly higher proportion of the sample worked at least partly 
in the NHS (69.9%) compared with what is reported by the HCPC (60%). The sample 
had a lower proportion of female physiotherapists (56.8%) compared with those 
reported by the HCPC (78.2%). The sample was more balanced across the four UK 
nations with fewer located in England (66.5%) compared with the HCPC figures 
(83.3%). Since there was no demographic data available from the HCPC and/or the CSP 
regarding UK physiotherapists who are working in combination between NHS and non- 
NHS settings; in this survey, physiotherapists who reported working partly in the NHS 
were combined with those who reported working exclusively in the NHS. However, 
physiotherapists who reported working in other settings were combined with those who 
reported working exclusively in non-NHS during the above comparison. Overall, whilst 
the sample does not perfectly reflect the HCPC figures, a clear consistency is evident 
with the majority working in the NHS, being female and practicing clinically in 
England. 
 
Table 4.2: Demographics of the survey population vs the UK physiotherapy population  
 
Variables  UK (physiotherapy population) Survey sample 
Total number of physiotherapists 
Setting                                               NHS 
Non-NHS 
N=48611 
60.0% 
40.0% 
N=2101 
69.9 
30.1 
Gender: N (%)                              Female  
Male 
38012 (78.2) 
10596 (21.8) 
1193 (56.8) 
908 (43.2) 
Gender distribution in each nation: N (%) 
England                           Total population 
Female 
Male 
 
40455 (83.3) 
31375 (77.5) 
9080 (22.5) 
 
1398 (66.5) 
712 (50.9) 
686 (49.1) 
Scotland: N (%)             Total population 
Female 
Male 
4198 (8.5) 
3515 (83.7) 
683 (16.3) 
297 (14.1) 
243 (81.8) 
54 (18.2) 
Wales: N (%)                  Total population 
Female 
Male 
2189 (4.5) 
1706 (77.9) 
483 (22.1) 
285 (13.6) 
213 (74.7) 
72 (25.3) 
Northern Ireland (NI): N (%)   
Total population 
Female 
Male 
 
1766 (3.6) 
1416 (80.2) 
350 (19.8) 
 
121 (5.8) 
25 (20.7) 
96 (79.3) 
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4.3.2 Utilisation of management approaches  
The management approaches that UK physiotherapists reported that they would use 
most often when managing their patients with NS-NP are summarised in Table 4.3. 
Therapeutic exercise of various kind was the most frequently used management 
approach, with 84.3% (n=1771) of physiotherapists reporting that they would use it 
most often when managing this patient group. However, 40.4% (n=716) of 
physiotherapists who were using therapeutic exercise reported that they would use it in 
combination with manual therapy and patient education programmes (multimodal 
approach package 1), 16.6% (n=294) of physiotherapists reported that they would use it 
in combination with manual therapy only (multimodal approach package 2), 28.7%% 
(n=508) of physiotherapists reported that they would use it in combination with any 
other management approach (multimodal approach package 3) and the remaining 14.3% 
(n=253) of physiotherapists reported that they would use therapeutic exercise as a 
standalone management approach when rehabilitating their patients with NS-NP (see 
Figure 4.2). The majority (60.7%) of respondents reported that they would use patient 
education programmes most often when managing patients with NS-NP. However, all 
physiotherapists who were using patient education reported that they would use it in 
combination with therapeutic exercise and manual therapy. Manual therapy methods 
were the most prevalent passive (hands-on) management approach, with 58.7% 
(n=1233) reporting that they would use it most often. However, 82% (n=1010) of 
physiotherapists who were using manual therapy reported that they would use it in 
combination with therapeutic exercise with/without patient education programmes, 
whereas 18% (n=223) of physiotherapists who were using manual therapy reported that 
they would use it as standalone management for their patients with NS-NP. Other active 
and passive management approaches (e.g. the McKenzie approach, massage therapy, 
acupuncture, heat/cold, taping/strapping and traction) were less commonly used. The 
electrotherapy methods, hydrotherapy and Feldenkrais, were not used by 
physiotherapists in this survey.  
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Table 4.3: Management approaches (N=2101)  
Approaches  N Percentage of Cases 
Therapeutic Exercise 1771 84.3% 
Therapeutic Patient Education 1275 60.7% 
Manual Therapy 1233 58.7% 
Massage Therapy 578 27.5% 
Acupuncture 411 19.6% 
Heat/cold 343 16.3% 
Taping/Strapping 265 12.6% 
The McKenzie Method 215 10.2% 
Traction 158 7.5% 
Other Management Approach 41 2.0% 
Electrotherapy 0 0% 
Hydrotherapy 0 0% 
Feldenkrais 0 0% 
Other Management Approaches Reported: Advice on Remaining Active = 4, Bobath = 
2, Breathing Awareness practice = 1, Cognitive Functional Therapy (CFT) = 12, 
Depending on Presentation and Patient responses to Previous Treatment = 1, 
Education = 1, Intramuscular Trapezius Injections if is Warranted = 1, Psychological 
Intervention = 5, Relaxation Techniques = 6, Thoracic Spine 
Manipulation/Mobilisation = 1. 
 
4.3.2.1 Therapeutic exercise  
The types of therapeutic exercise that physiotherapists reported that they would use 
most often in the management of patients with NS-NP are summarised in Table 4.4. In 
this survey, 15.7% (n=330) of physiotherapists reported that they would not use any 
type of therapeutic exercise when managing patients with NS-NP. The majority of the 
84.3% (n=1771) of physiotherapists who were using therapeutic exercise reported that 
they would use cervical strengthening, stretching and general 
aerobic/strengthening/endurance exercise most often in the management of NS-NP. A 
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substantial proportion, 40.5% (n=717), of physiotherapists reported that they would use 
upper limb strengthening exercise when managing patients with NS-NP. Therapeutic 
exercise types such as cervical stabilising, proprioception for the cervical spine, upper 
limb stabilising, upper limb stretching and balance exercise were less commonly used. 
No “other” exercise components/types were identified. 
 
Table 4.4: Breakdown of therapeutic exercise components used 84.3% (N=1771) 
Components N Percentage of Cases 
Cervical strengthening exercise 1348 76.1% 
General aerobic/strengthening/endurance exercise 1222 69.0% 
Cervical stretching exercise 1031 58.2% 
Upper limb strengthening exercise 717 40.5% 
Cervical stabilising exercise 629 35.5% 
Proprioception exercise for the cervical spine 376 21.2% 
Upper limb stabilising exercise 339 19.1% 
Upper limb stretching exercise 289 16.3% 
Proprioception exercise for the eyes 243 13.7% 
Balance exercise 241 13.6 
Proprioception exercise for the upper limb 146 8.2% 
Other Components 0 0% 
 
4.3.2.2 Manual Therapy  
The manual therapy methods that UK physiotherapists reported that they would use 
most often when managing patients with NS-NP are summarised in Table 4.5. In this 
survey, 41.3% (n=868) of physiotherapists reported that they would not use any manual 
therapy method in the management of NS-NP. The Majority (73.3%) of 
physiotherapists who were using manual therapy reported that they would use the 
Maitland approach, whilst 45.5% reported that they would use the Mulligan approach 
most often when managing their patients with NS-NP. Other manual therapy 
approaches (e.g. Grade V manipulation, Kaltenborn, Cyriax and and the Society of 
Orthopaedic Medicine) were less commonly used. No “other” manual therapy methods 
were identified.  
 
Table 4.5: Breakdown of manual therapy methods used 58.7% (N=1233) 
Methods N Percentage of Cases 
Maitland  891 72.3% 
Mulligan 561 45.5% 
Manipulation (Grade V) 124 10.1% 
Kaltenborn 74 6.0% 
Cyriax 54 4.4% 
Society of Orthopaedic Medicine 51 4.1% 
Other Methods 0 0% 
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4.3.3 Utilisation of OMs  
Physiotherapists’ current practice regarding their utilisation of OMs in the assessment 
and/or during the management of NS-NP is shown in Figure 4.3. One-third (34.7%, 
n=730) of physiotherapists in this survey reported that they would not use any OMs in 
the assessment/management of patients with NS-NP. However, 22.4% (n=471) of 
physiotherapists reported that they would use a multimodal measurement approach, 
which is a combination of Patient-Reported OMs (PROMs) and Performance-Based 
OMs (PBOMs). Meanwhile, 35.7% (n=749) of physiotherapists reported that they 
would use PROMs only, whereas only 7.2% (n=151) of physiotherapists reported that 
they would use PBOMs alone in the assessment/management of patients with NS-NP.  
 
4.3.3.1 Utilisation of PROMs  
The PROMs that UK physiotherapists reported that they would use most often in the 
assessment/management of their patients with NS-NP are summarised in Table 4.6. 
Selection of ULD PROMs was used to determine the utilisation of ULD PROMs in the 
assessment and/or during the management of NS-NP. All of the PROMs were rarely 
used, although the most commonly utilised OMs were single dimensional numeric pain 
rating scales (i.e. the Visual Analogue Scale (VAS) and the Numeric Rating Scale 
(NRS). Quality of life OMs (i.e. Euro-Qol/EQ5D, WHOQOL-Brief and SF-36/SF-12), 
physical function OMs (e.g. NDI and PSFS), psychological distress OMs (e.g. fear of 
movement scale and depression/anxiety scale) were rarely, if ever, used. ULD PROMs 
(e.g. Disability of Arm, Shoulder and Hand (DASH/QuickDASH) and Neck and Upper 
Limb Index (NULI)) were almost always never used.  
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Table 4.6: Utilisation of PROMs 59.3% (N=1246) 
Measures Utilisation 
 Routinely 
>70% 
Regularly 
11-70% 
Rarely 
1-10% 
Never 
0% 
Visual Analogue Scale (VAS) 36.9% 1.2%   3.4%   58.4%  
Numeric Rating Scale (NRS) 18.4%   4.1%   0%  77.5%  
Euro-Qol/EQ5D 14.8%  3.4%   1.3%  80.5%  
Patient Specific Functional Scale (PSFS) 9.2%   4.7%  3.8%  82.3%  
Neck Disability Index (NDI) 5.9%  3.2%  5.9%  85%  
Fear of Movement Scales 7.9%  3.3%  2.8%  86.0%  
Time Lost from Work 3.5%  4.5%  1.6%  90.4%  
Depression/Anxiety Scale 3.6%  1.1%  4.6%  90.7%  
Disability of Arm, Shoulder and Hand 
(DASH)/QuickDASH) 
2.3%  1.0%  5.0%  91.6%  
Pain Catastrophizing Scale (PCS) 1.1%   3.5%  1.1%  94.2%  
Patients Global Perceived Rating of 
Improvement or Satisfaction 
3.5%  1.3%  0%  95.2% 
“Other” PROM scale (Orebro) 4.6%   0%  0%  95.4%  
SF-36/SF12 0%  3.4%  1.1%  95.5%  
Whiplash Disability Questionnaire 2.2%  0%  2.3%  95.5%  
WHO-Brief 1.1%  0%  1.2%  97.7%  
Bournemouth Questionnaire (BQ) 1.2%  0%  0%  98.8%  
Neck and Upper Limb Index (NULI) 0%  1.2%  0%  98.8%  
Pain Distress Scale 1.1%  0%  0%  98.9%   
Northwick Park Neck Pain (NPQ) 0%  0%  0%  100%  
Rapid Upper Limb Assessment (RULA) 0%  0% 0%  100%  
Work Limitation Scale 0%  0%  0%  100%  
Work Distress Scale 0%  0%  0%  100%  
Nottingham Health Profile (NHP) 0%  0%  0%  100%  
Other PROMs: Orebro=4.6% routinely, 0%=regularly and rarely 
 
4.3.3.2 Utilisation of PROMs  
Nearly 70% (n=1469) of physiotherapists in the survey reported that they would not use 
any PBOMs when assessing and/or managing NS-NP. The PBOMs which UK 
physiotherapists reported that they would use most often in the assessment/management 
of patients with NS-NP are summarised in Table 4.7. Selection of ULD PBOMs was 
used to determine the utilisation of ULD PBOMs in the assessment and/or management 
of NS-NP. The selection of instruments was variable but most PBOMs were never used 
and the single dimensional range of motion scales such as Goniometric measurement of 
neck motion (18.7%), Quantitative sensory tests (QST) (8.1%) and Rating of segmental 
joint mobility (8.1%) were the most commonly used PBOMs. Pain threshold perception 
tests (i.e. pain algometry), muscles function scales (e.g. neck muscles strength tests and 
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neck muscles endurance tests) and functional performance tests (e.g. functional 
performance test and functional capacity assessment) were almost always never used.  
 
Table 4.7: Utilisation of PBOMs 30.1% (N=632) 
Measures Utilisation  
Routinely: 
>70% of 
cases 
Regularly: 11-
70% of cases 
Rarely: 1-10% 
of cases 
Never: 0% 
of cases 
Goniometric Measure of Neck 
Motion 
18.7%  1.1%   0%  80.2%  
Quantitative Sensory Test 
(QST) 
8.1%  3.3%  1.1%  87.4% 
Rating of Segmental Joint 
Mobility  
8.1%  3.4%  0%  88.4%  
Neural dynamic testing  3.4%  5.8%  2.2%  88.6%  
Neck Muscle Strength test  6.9%  3.5%  0%  89.6%  
Neurological exam  6.8%  2.3%  0%  90.9%  
Posture alignment measures  3.5%  4.5%  0%  92.0%  
Proprioception test  1.1%  1.1%  4.7%  93.1%  
Neck muscle endurance testing  2.3%  3.5%  0%  94.2%  
Neck muscle stability testing  1.1%  2.3%  1.1%  95.4%  
Pain Algometry  2.3%  1.1%  0%  96.6% 
Upper extremity muscle 
strength/endurance  
1.1%  1.1%  1.1%  96.6%  
Movement Diagram 1.2%  1.1%  0%  97.7%  
Functional performance tests  1.1%  1.1%  0%  97.8% 
Inclinometer of Neck Motion 1.1%  0%  0%  98.9% 
Functional capacity assessment  0%  0%  1.1%  98.9%  
Other physical or functional 
measure/measures 
0%  0%  0%  100%  
 
4.3.3.3 Physiotherapists’ reported reasons for utilising OMs  
The reasons that UK physiotherapists cited for using OMs in the assessment and/or 
management of NS-NP are summarised in Table 4.8. Two-thirds 65.3% (1371) of 
physiotherapists in this survey reported reasons for using OMs when rehabilitating their 
patients with NS-NP. Amongst physiotherapists, the reasons for doing so were variable, 
with setting treatment goals being the most prevalent reason for using OMs. 
Communicating with patient, fulfilling charting/documentation and communicating 
with other healthcare professionals were also commonly reported reasons for using 
OMs. However, documentation requirement, research, marketing and other reasons 
were less commonly cited reasons for using OMs. 
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Table 4.8: Reasons for utilising OMs 65.3% (N=1371) 
Reasons  Frequencies Percentage of cases 
Setting treatment goals 1106 81.2% 
Communicating with patients 975 71.6% 
Fulfilling charting/documentation 526 39.4% 
Communicating with other healthcare professionals 508 37.3% 
Medicolegal documentation requirement 268 19.7% 
Research 157 11.5% 
Other reasons 74 5.4% 
Marketing 48 3.5% 
Other Reasons: Assessment of Treatment Progress = 3, Audit of Service Efficacy = 23, 
Monitoring Progression = 8, Prognosis = 35, Requirement Commissioners = 1, Sub-
Groups, Better Patient Understanding = 1, No Reasons Mentioned = 3.  
 
4.3.3.4 Physiotherapists’ reported reasons for not utilising OMs  
One-third 34.7% (n=730) of physiotherapists in this survey reported that they would not 
use OMs when rehabilitating NS-NP. The reported reasons are diverse, as shown in 
Table 4.9. The most endorsed reasons for not using OMs were a lack of clear guidance 
about the suitability of available OMs and a lack of time. Lack of access to 
information/knowledge about OMs, there is no need to use OMs, lack of resources (e.g. 
expensive to purchase) and other reasons were less commonly cited reasons.   
 
Table 4.9: Reasons for NOT utilising OMs 34.7% (n=730) 
Reasons  Frequencies  Percentage of cases 
Lack of clear guidance about suitability of available OMs 579 82.1% 
Lack of time 549 77.9% 
Lack of access to information/knowledge about OMs 103 14.6% 
There is no need to use OMs 88 12.5% 
Lack of resources (e.g. expensive to purchase)   15 2.1% 
Other Reasons 3 0.4% 
Other Reasons: I feel that outcome measures fail to reflect patients=1, I have not 
looked into validity of specific measures=1, I use them when I think an improvement 
will be=1.  
 
4.3.4 Comparison between groups of physiotherapists  
Although the main focus of this survey was to describe current UK physiotherapy 
practice in relation to the utilisation of management approaches and OMs when 
rehabilitating patients with NS-NP. Additional objectives (see Section 4.1.1) were to 
explore whether the utilisation of multimodal management approach packages and/or 
OMs were associated with any of the demographic characteristics (see Sections 4.3.4.1 
and 4.3.4.2).    
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4.3.4.1 Utilisation of multimodal management approach packages  
There were statistically significant association between the multimodal management 
approach packages used and the majority of demographic characteristics of the UK 
physiotherapists as shown in Table 4.10. Package 1 was significantly more likely to be 
utilised by female physiotherapists, those with a greater number of years of clinical 
practice, those who manage a smaller proportion of patients with NP and those with no 
special interest in NP. Physiotherapists with the least experience, those from Northern 
Ireland or Scotland, those managing the largest proportion of patients with NS-NP and 
those with a special interest in NP were significantly less likely to be delivering a 
multimodal management strategy.  
 
Table 4.10: Utilisation of multimodal management approach packages (N=2101) 
Variables  
Multimodal 
“Package 1” 
34.1% (N=716) 
Multimodal 
“Package 2” 
14% (N=294) 
Multimodal 
“Package 3” 
24.2% (N=508) 
Multimodal 
“Not used” 
27.7% (N=583) 
Gender  
Male 
 
 28.4% (N=258) 
 
 21.6% (N=196) 
 
22.1% (N=201) 
 
27.9% (N=253) 
Female 38.4% (N=458) 8.2% (N=98) 25.7% (N=307) 27.7% (N=330) 
Setting  
Exclusively in the NHS 
 
32.4% (N=326) 
 
10.1% (N=102) 
 
28.2% (N=283) 
 
29.3% (N=294) 
Exclusively in Non-NHS 35.7% (N=224) 14.8% (N=93) 21.5% (N=135) 28.0% (N=176) 
Combination of NHS & Non-NHS 35.8% (N=166) 20.5% (N=95) 19.4% (N=90) 24.4% (N=113) 
Other Setting    0.0% (N=0) 100.0% (N=4) 0.0% (N=0) 0.0% (N=0) 
Years of Practice  
0-5 Years 
 
24.6% (N=77) 
 
13.7% (N=43) 
 
19.5% (N=61) 
 
42.2% (N=132) 
6-10 Years  23.8% (N=221)  18.0% (N=167) 28.0% (N=260) 30.2% (N=280) 
11-15 Years 32.4% (N=128) 10.4% (N=41) 24.3% (N=96) 32.9% (N=130) 
15+ Years    62.4% (N=290) 9.2% (N=43) 19.6% (N=91) 8.8% (N=41) 
Nation 
Scotland 
 
32.0% (N=95) 
 
8.8% (N=26) 
 
23.6% (N=70) 
 
35.7% (N=106) 
Northern Ireland  25.6% (N=31) 22.3% (N=27) 16.5% (N=20) 35.5% (N=43) 
Wales  19.3% (N=55) 6.0% (N=17) 60.0% (N=171) 14.7% (N=42) 
England 38.3% (N=535) 16.0% (N=224) 17.7% (N=247) 28.0% (N=392) 
Postgraduate Training (PGT)  
Without PGT    
 
32.7% (N=352) 
 
15.8% (N=170) 
 
26.1% (N=281) 
 
25.4% (N=274) 
With PGT 35.5% (N=364) 12.1% (N=124) 22.2% (N=227) 30.2% (N=309) 
Proportion of Patients with Neck Pain 
<25% 
 
44.6% (N=393) 
 
 12.9% (N=114) 
 
18.7% (N=165) 
 
23.7% (N=209) 
25-50% 27.1% (N=251) 17.3% (N=160) 27.4% (N=253) 28.2% (N=261) 
>51% 24.4% (N=72) 6.8% (N=20) 30.5% (N=90) 38.3% (N=113) 
Special Interest in Neck Pain (SI) 
‘No’ to SI   
 
38.4% (N=525) 
 
16.2% (N=222) 
 
20.5% (N=280) 
 
24.9% (N=340) 
‘Yes’ to SI   26.0% (N=191) 9.8% (N=72) 31.1% (N=228) 33.1% (N=243) 
Multimodal Package 1 = Therapeutic Exercise + Manual Therapy + Patient Education, 
Multimodal Package 2 = Therapeutic Exercise + Manual Therapy, Multimodal 
Package 3 = Therapeutic Exercise + Any Other Approach, OMs = Outcome Measures. 
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4.3.4.2 Utilisation of OMs  
There were statistically significant associations between OMs utilisation and the 
majority of the demographic characteristics as shown in Table 4.11. OMs were 
significantly more likely to be used by male physiotherapists, those working in non-
NHS and other settings, those with 6-15 years of clinical practice, those without 
postgraduate training and those with no special interest in NP. Physiotherapists with the 
least experience, female physiotherapists, those practicing in Wales or England, those 
working for the NHS, those with postgraduate training, those with a very small 
proportion or a very high proportion of patients with NP and those with a special 
interest in NP were significantly less likely to incorporate OMs when rehabilitating their 
patients with NS-NP.    
 
Table 4.11:  Utilisation of OMs (N=2101)   
Variables  Respondent (N=2101) 
Responded ‘Yes’ 
To Using OMs 
65.3% (N=1371) 
Responded ‘No’ 
To Using OMs 
34.7% (N=730) 
Gender  
Male  
 
43.2% (N=908) 
 
70.0% (N=636)  
 
30.0% (N=272) 
Female 56.8% (N=1193) 61.6% (N=735)  38.4% (N=458)  
Setting  
Exclusively in the NHS 
 
47.8% (N=1005) 
 
58.9% (N=592)  
 
41.1% (N=413)  
Exclusively in Non-NHS 29.9% (N=628) 72.9% (N=458)  27.1% (N=170) 
Combination of NHS & Non-NHS 22.1% (N=464) 68.3% (N=317)  31.7% (N=147)  
Other Setting    0.2% (N=4) 100.0% (N=4) 0.0% (N=0) 
Years of Practice  
0-5 Years 
 
14.9% (N=313) 
 
60.5 % (N=190) 
 
39.5 % (N=123) 
6-10 Years  44.2% (N=928) 70.9% (N=658)  29.1% (N=270) 
11-15 Years 18.8% (N=395)  44.3% (N=175) 55.7% (N=220) 
15+ Years    22.1% (N=465) 74.8% (N=348) 25.2% (N=117) 
Nation 
Scotland 
 
14.1% (N=297) 
 
57.2% (N=170) 
 
42.8% (N=127) 
Northern Ireland  5.8% (N=121) 40.5% (N=49) 59.5% (N=72) 
Wales  13.6% (N=285) 41.1% (N=117) 58.9% (N=168) 
England 66.5% (N=1398) 74.0% (N=1035) 26.0% (N=363) 
Postgraduate Training (PGT)  
Without PGT    
With PGT 
 
51.3% (N=1077) 
 
67.0% (N=722) 
 
33.0% (N=355) 
48.7% (N=1024) 63.4% (N=649) 36.6% (N=375) 
Proportion of Patients with Neck Pain 
<25% 
 
41.9% (N=881) 
 
72.1% (N=635) 
 
27.9% (N=246) 
25-50% 44.1% (N=925) 63.2% (N=585) 36.8% (N=340) 
≥51% 14% (N=295) 51.2% (N=151) 48.8% (N=144) 
Special Interest (SI) in Neck Pain 
  ‘No’ to SI   
 
65.1% (N=1367) 
 
71.8% (N=982) 
 
28.2% (N=385) 
‘Yes’ to SI   34.9% (N=734) 53.0% (N=389) 
 
47.0% (N=345) 
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4.4 Discussion  
This national survey has captured information in relation to UK physiotherapists’ 
current clinical measurement and management of patients with NS-NP and has provided 
data regarding their utilisation of multimodal management and measurement 
approaches. More specifically, the survey has led to insight into the current 
measurement and management of ULD in patients with NS-NP. Consequently, the aim 
and objectives of this investigation have been met. A total of 2101 responses were 
achieved from a wide range of physiotherapists practicing in the four nations of the UK. 
Participants had a varied length of experience and postgraduate training level and 
worked in a range of healthcare settings. The reminder of this section will present: 
• Summary and discussion of the main findings  
• Strengths of the study 
• Limitations of the study 
• Clinical implications  
• Research implications  
• Conclusion 
 
4.4.1 Summary and discussion of the main findings  
4.4.1.1 Management approaches  
The survey findings indicate that a wide range of management approaches are currently 
used in UK physiotherapy practice for patients with NS-NP. However, the findings also 
indicate that the majority of participants were adopting an evidence-based approach to 
the management of patients with NS-NP. It appears that in line with the findings of 
recent systematic reviews and the recommendations of current guideline, the majority of 
physiotherapists in the UK reported using management approaches that are supported 
by strong evidence of effectiveness (Child et al. 2008, Kay et al. 2012, Bertozzi et al. 
2013, O’Riordan et al. 2014). The multimodal management approach packages that 
incorporate a combination of therapeutic exercise and manual therapy with/without 
patient education programmes, delivered concurrently, are utilised to a high extent when 
rehabilitating patients with NS-NP. This is consistent with the current evidence-base 
that advocates the use of a multimodal management approach in physiotherapy 
rehabilitation (see Chapter 3 section 3.3). Further, the largest volume of neck related 
clinical management evidence recommended the use of a multimodal management 
approach and considered that a combination of exercise, manual therapy and patient 
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education is the optimal strategy to be used with this patient group (Gross et al. 2002, 
Kay et al. 2005, Gross et al. 2007, Hurwitz et al. 2008).  
 
Therapeutic exercise was the most commonly used intervention as more than 80% of 
physiotherapists in this survey reported that they would use exercise when rehabilitating 
NS-NP. The majority of those who were utilising therapeutic exercise favoured exercise 
components (such as strengthening, stretching and general aerobic exercise), and this 
also is in a substantial agreement with the current guidelines which reported that 
therapeutic exercise is a fundamental component of physiotherapy rehabilitation of 
patients with NS-NP (Child et al. 2008). In addition, recent systematic reviews found 
moderate to strong evidence to support the use of specific exercise components (e.g. 
strengthening, stretching and general aerobic/strengthening/endurance exercise) 
alongside manipulation and/or mobilisation with some form of patient education for the 
short-and long-term benefits on pain, function and patient satisfaction for NS-NP (Kay 
et al. 2005, Gross et al. 2007, O’Leary et al. 2007, Ylinen et al. 2007, Hurwitz et al. 
2008, Kay et al. 2012, Bertozzi et al. 2013, O’Riordan et al. 2014, Fredin and Loras 
2017). It is also encouraging that management approaches such as electrotherapy 
methods, hydrotherapy, Feldenkrais and traction, which have limited or no evidence of 
effectiveness for patients NS-NP, were rarely or never utilised by UK physiotherapists 
when rehabilitating patients with NS-NP (Gross et al. 2007, Hurwitz et al. 2008). 
 
However, one-third of UK physiotherapists in this survey appeared to be utilising lone 
management approaches that are not supported by strong evidence of effectiveness, 
such as massage therapy or acupuncture, or are utilising a multimodal approach package 
that is sub-optimal (e.g. exercise with any other intervention) (Trinh et al. 2006, 
Haraldsson et al. 2006, Ezzo et al. 2007, Gross et al. 2007, Vernon et al. 2007). In 
addition, the majority (60%) of physiotherapists in this survey reported that they do not 
consider upper limb rehabilitation when managing patients with NS-NP, and this seems 
inconsistent with the current evidence-base which suggests that there is a strong 
relationship between NS-NP and ULD. Given that the presence of NS-NP is a potential 
risk factor for the development and progression of ULD, and upper limb dysfunction 
may lead to NS-NP becoming recurrent, persistent or disabling (Eriksen et al. 1999, 
Daffner et al. 2003, Falla et al. 2004, Frank et al. 2005, Bot et al. 2005). Several studies 
point to the potential importance of incorporating upper limb rehabilitation strategies 
during the management of patients with NS-NP (McLean et a. 2011, Osborn and Jull 
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2013). For example, Osborn and Jull (2013) conducted a cross-sectional survey of 
patients with NS-NP (n=193) presenting for physiotherapy rehabilitation in an 
Australian general community. The purpose of the study was to establish the proportion 
of NS-NP patients who concurrently reporting ULD. Patient aged between 18 – 70 
years and currently experiencing NP were included, but patients with cervical 
radiculopathy (clinical neurological signs) as well as neck or upper limb pathology were 
excluded. The study identified that 80% of patients with NS-NP reported ULD with one 
or more upper limb tasks because of the NS-NP. The study also found that there is a 
correlation between the severity of NS-NP and the level of ULD, in which higher 
severity of NS-NP was associated with higher ULD. The study concluded that the 
majority of patients with NS-NP often reported ULD, and this suggests that 
physiotherapists and clinicians involved in the management of patients with NS-NP 
should carefully evaluate the upper limb functional capacity using suitable OMs while 
assessing NS-NP to identify and quantify any ULD and include ULD rehabilitation in 
the management plan, if indicated (Osborn and Jull 2013).  
 
There is no comparable study that has investigated UK physiotherapy practice regarding 
the management of patients with NS-NP to assist in the interpretation of this survey’s 
findings. However, one recent international multi-professional survey which included 
physiotherapists (38%) was found (Carlesso et al. 2014). This cross-sectional study 
surveyed 360 clinicians from 17 countries, including the UK, to determine the practice 
patterns of clinicians involved in the management of patients with NP. Similar to the 
current survey, the findings indicate that exercise was the most frequently used 
intervention by physiotherapists and chiropractors for the management of NP. 
Furthermore, the findings also indicate that management approaches with low or very 
low evidence of effectiveness including traction were not being used. Another survey 
which investigated current practices of physiotherapists working in Swedish Primary 
Care and involved in the management of patients with low back pain, NP and sub-
acromial pain was also found (Bernhardsson et al. 2015). This study validated and used 
a web-based questionnaire to survey 419 physiotherapists working in Primary Care in 
Western Sweden. Similar to the current survey, the findings indicated that exercise and 
patient education (advice) were found to be the most commonly used interventions 
when rehabilitating patients with NP. In addition, interventions with limited or no 
evidence of effectiveness such as electrotherapy and acupuncture were used to a great 
extent, as compared to the research carried out as part of this study (Trinh et al. 2006, 
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Kroeling et al. 2009). However, the survey undertaken as part of this research 
programme differs from other surveys because it captured information on the utilisation 
patterns of the multimodal management approach packages and the level of ULD 
rehabilitation during the management of patients with NS-NP.   
 
In summary, this research found that around 40% of physiotherapists are undertaking 
optimal evidence-based practice in the management of patients with NS-NP. Despite 
this, there is considerable room for optimising the management of NS-NP, by increasing 
the use of multimodal management packages of treatment, and by incorporating ULD 
rehabilitation where indicated for patients with NS-NP.   
 
4.4.1.2 Utilisation of OMs  
The survey findings indicate that OMs are poorly incorporated by UK physiotherapists 
in the assessment and during the management of patients with NS-NP. Physiotherapists 
in the UK appeared to be either not utilising OMs or utilising inappropriate OMs when 
evaluating their patients with NS-NP. A third of physiotherapists in this survey reported 
that they never utilise OMs when evaluating patients with NS-NP. The most commonly 
reported reasons for not utilising OMs were a lack of clear guidance about the 
suitability of available OMs and a lack of time. This is inconsistent with the clinical 
guidelines and professional bodies recommendations regarding the utilisation of OMs. 
Clinical guidelines and professional bodies suggest that routine utilisation of 
standardised OMs is a fundamental part of physiotherapy rehabilitation and considered 
to be the optimal way to facilitate evidence-based practice (Hammond 2000, Rudd et al. 
2000, CSP 2005, College of Occupational Therapists 2007, American Occupational 
Therapy Association 2010). In addition, UK organisations such as the HCPC, CSP and 
the NHS explicitly recommend routine utilisation of standardised OMs wherever 
practicable (NHS 2010, CSP 2012, HCPC 2013). Meanwhile, in standard 12 of the 
Standards of Proficiency for Physiotherapists (HCPC 2013), the HCPC suggest that 
physiotherapists must be able to collect and document qualitative and quantitative data 
on their patient’s condition by using standardised OMs. This is to assure the quality of 
clinical practice by meeting the patient’s needs and changes in health, demonstrating the 
significance of physiotherapy by enabling physiotherapists to prove their impact and 
cost-effectiveness (HCPC 2013).  
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Routine utilisation of standardised OMs is important since it can be used for a variety of 
purposes in clinical practice. First, before an intervention for screening of 
symptoms/function for diagnosis and prognosis purposes (Lansky et al. 1992), 
classifying patients into meaningful sub-groups and setting treatment goals (Kramer and 
Holthaus 2006). Second, during an intervention to monitor condition progression, detect 
changes in pain and disability and facilitate communication between physiotherapists 
and patients and other healthcare professionals (Garland et al. 2003, Bot et al. 2007, 
Nordin et al. 2008). Finally, after an intervention, they can be used to determine the 
effectiveness, efficiency and cost-effectiveness of the intervention (CSP 2012). 
 
The findings also indicate that nearly all physiotherapists in this survey reported that 
they do not utilise any OM to evaluate the upper limb functional capacity when 
assessing/managing patients with NS-NP. Given the relationship between the presence 
of NP and the presence of ULD (McLean et al. 2011, Osborn and Jull 2013), indicating 
that many patients with NS-NP are likely to present with associate ULD, the author 
strongly recommend that physiotherapists should routinely evaluate upper limb 
functional capacity using suitable OMs in the assessment and during the management of 
patients with NS-NP. This is to identify and quantify any ULD and create a rationale for 
including upper limb rehabilitation in the management plan, if indicated.    
 
The majority of the two-thirds of UK physiotherapists who were utilising OMs reported 
that they would consistently use single dimensional numeric pain and range of motion 
rating scales such as the Visual Analogue Scale (VAS) or Numeric Rating Scale (NRS) 
and Goniometric measurement of neck motion. Single dimensional scales such as pain 
and range of motion are narrow parameters of NS-NP and cannot capture information in 
relation to constructs such as physical function, psychological, social capacity and 
quality of life (Mintken et al. 2009). However, these constructs, including physical and 
functional limitations, psychological distress and reduced quality of life, that are often 
associated with NS-NP, were rarely or never measured by UK physiotherapists when 
evaluating patients with NS-NP. Limited utilisation of OMs to measure valid constructs 
in the assessment and during the management of patients with NS-NP is inconsistent 
with the evidence-based and may contribute to inadequate evaluation of patients with 
NS-NP (Borghouts et al. 1998, Hoving et al. 2004, Bot et al. 2005, Binder 2007, 
Haldeman et al. 2008) and may be one of the factors that contribute to suboptimal 
management of NS-NP (McLean et al. 2011, Osborn and Jull 2013). 
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There is no comparable study that investigated UK physiotherapy practice regarding 
OMs utilisation in the assessment and during the management of NS-NP to assist in the 
interpretation of this survey’s findings. However, Jetta et al. (2009) investigated the 
extent of current utilisation of standardised OMs as well as the perceptions of physical 
therapists regarding the benefits and barriers to OMs use. They surveyed 1000 physical 
therapists who were randomly selected from a list of all members of the American 
Physical Therapists Association (APTA). Similar to the current survey, a substantial 
proportion of respondents reported not utilising OMs when managing patients with 
musculoskeletal conditions and lack of time as well as confusion regarding the selection 
of OM were reported as the main barriers to OMs utilisation (Jette et al. 2009). Another 
survey, investigating OMs utilisation in the management of NP in various disciplines 
such as chiropractors, manual therapists, massage therapists, physicians and 
physiotherapists, was also found (MacDermid et al. 2013). This international survey 
recruited 381 clinicians, of which physiotherapists comprised 32% of respondents, who 
completed an online questionnaire. Similar to this study, the findings established the 
poor utilisation of standardised OMs across all the included disciplines in the 
management of patients with NP. However, the survey undertaken as part of this 
research differs from these surveys, in that it offers additional insight on the current 
evaluation of upper limb functional capacity in the assessment and during the 
management of patients with NS-NP as well as identifying those UK physiotherapists 
who were utilising a multimodal measurement approach that combines the utilisation of 
PROMs and PBOMs. 
 
4.4.2 Strengths of the survey  
This study robustly developed a survey instrument designed in accordance with the 
Web-Based Survey Design Standard (Crawford et al. 2005). The design (web-based) 
incorporated advanced and iterative features, provided a dynamic survey process which 
facilitated the simplicity and brevity of the survey instrument, and this in turn 
contributed to achieving fast and accurate low-cost data collection and data analysis 
along with a large sample size.  An innovative online methodology that was used in the 
recruitment of participants and administration of the survey instrument potentially 
contributed to the large sample size. The large sample size achieved (4.3% of the whole 
UK physiotherapy population), which is broadly comparable in demographic 
characteristics to the total UK physiotherapy population, points to the validity of these 
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findings (Morgan and Harmon 1999). This is the first study to describe current UK 
physiotherapy practice with regard to the management and measurement of NS-NP. In 
addition, this is the first study, in the UK or internationally, to investigate the current 
level of measurement or management of ULD in patients with NS-NP.  
 
4.4.3 Limitation of the survey  
This web-based survey has several possible limitations. This survey will not have 
gained responses from physiotherapists who do not have access to or do not use the 
internet. However, the internet has become a fundamental vehicle in the navigation of 
everyday life (Hughes et al. 2012), and the majority of adults living in the UK now have 
access to the internet according to the UK office for National Statistics annual report for 
2016 (Office for National Statistics 2016). In addition, evidence suggests that a 
substantial component of the UK healthcare professionals including physiotherapists are 
regularly using popular Social Networking Sites such as Facebook, Tweeter, LinkedIn 
and YouTube for social interaction and information exchange as well as business 
advertising (Ahmed et al. 2012). The risk of missing out physiotherapists who do not 
have internet access may have been present but it is considered to be of low risk.  
 
A simple random sampling procedure (probability sampling), in which each population 
person/member has a known non-zero chance of being selected for inclusion in the 
sample, is considered to be the optimal approach to produce a representative survey 
from which the findings can be generalised to the wider population (Morgan and 
Harmon 1999). This was not possible in this survey. At present, the necessary list 
(sample frame) of UK physiotherapists is not available. From the sampling methods 
used in this survey (non-probability) there was no reliable way to determine potential 
participants, estimate the sample size and/or estimate the true response rate. 
Consequently, there was no way to identify non-respondents or to assess whether the 
respondents were different to the national physiotherapy population. Consequently, non-
respondent bias may be present (Bosniak et al. 2005). However, a large sample size 
(4.3% of the whole UK physiotherapy population) was obtained, diversity between 
participants was achieved and the survey population was similar on many demographic 
characteristics to the UK population of physiotherapists (see Section 4.3.1.1). 
Consequently, it is likely that the findings are generalisable to the UK physiotherapists 
who manage patients with NS-NP.   
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Measuring physiotherapists’ current practice was self-reported clinical behaviour based 
on direct questions for a clearly defined condition (NS-NP). Consequently, social 
desirability bias may be present, since we cannot be completely confident how items 
were interpreted and whether the management approaches and OMs instrument names 
were interpreted the same way across respondents from different UK nations, working 
in many different settings and have variety of training levels. Within practice, utilisation 
of management approaches or OMs may therefore be different. However, the survey 
instrument was extensively piloted by clinicians in order to try to ensure that items were 
easy to understand and interpret by clinicians. The survey findings provide a rough 
indicator of practice in the UK and may not reflect nuanced practice or decision-making 
process that inform practice. It is possible that physiotherapists may have wanted further 
information in order to make more informed clinical decisions regarding the 
measurement and management of their patients with NS-NP. However, more in-depth 
qualitative studies would be required to support a survey of this nature and to make 
those determinations.  
 
Finally, psychological and relaxation interventions were identified by some respondents 
as “other” interventions. It is possible that more respondents might have reported 
utilising these interventions if they had been incorporated as standard items on the 
survey instrument. Consequently, utilisation of these “other” interventions may be 
under-reported.  
 
4.4.4 Clinical implications  
4.4.4.1 Management 
This survey demonstrated that the majority of physiotherapists in the UK are utilising 
management approaches that are supported by strong evidence of effectiveness, 
consistently utilise active approaches and the multimodal management approach 
packages 1 and 2. However, a third of physiotherapists in the UK are utilising either a 
lone intervention which is not supported by strong evidence of effectiveness or 
multimodal management approach package 3 which is sub-optimal. The reasons of this 
are likely to be multifactorial, including patient and physiotherapist preferences and 
interactions regarding the selection of interventions (Child et al. 2008). Physiotherapists' 
preferences for the management of NS-NP were found to be primarily influenced by the 
level and place of their training, the setting and the type of working place, availability of 
resources, special interest and possibly the stage of healing. Meanwhile patients’ 
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preferences were found to be primarily influenced by their previous experiences 
(Tsakitzidis et al. 2013, Carlesso et al. 2014). Updating and disseminating clinical 
guidelines may facilitate clinician education on how to reset a patient’s preferences, 
increase the use of multimodal approach packages 1 and 2 and reduce the use of 
interventions that have been shown to be ineffective. 
 
Two-thirds of physiotherapists in the UK do not incorporate upper limb rehabilitation 
strategies in the management of patients with NS-NP. The reasons for this may be 
related to how physiotherapists evaluate the upper limb functional capacity during the 
assessment of patients with NS-NP. Simple screening of shoulder range of motion is 
often recommended and used by UK physiotherapists to rule in/out the presence of co-
existing shoulder or upper limb dysfunction (Petty 2011), and this is insufficient since 
range of motion does not correlate conclusively with disability (Olson et al., 2000; 
Poitras et al., 2000; Kwak et al., 2005). Failure to sufficiently evaluate the upper limb 
functional capacity in the assessment of patients with NS-NP could lead to the 
development and progression of ULD which may contribute to NS-NP become a 
recurrent, persistent or disabling condition. This process may contribute to poor 
treatment outcomes and reduced quality of life for patients with NS-NP.  Clinicians 
should give careful consideration as to how best to evaluate upper limb functional 
capacity using standardised measures and include upper limb rehabilitation, if indicated.   
 
4.4.4.2 Measurement  
The findings of this survey, which are consistent with the findings of other recent 
comparative surveys (Jette et al. 2009, MacDermid et al. 2013), established the current 
poor utilisation of OMs in the assessment and during the management of patients with 
NS-NP. This suggests that physiotherapists in the UK appear to be inadequately 
evaluating their patients with NS-NP. Inadequate evaluation of patients with NS-NP 
before an intervention may result in failing to recognise deficits that would classify 
patients into meaningful subgroups and facilitate the clinical reasoning process which 
may in turn lead to the development of the most appropriate management plan. 
Meanwhile, failure to make ongoing evaluations during the management process could 
be a barrier to evaluating the impact, effectiveness and efficiency of the given 
intervention, which may also contribute to poor treatment outcomes and reduced quality 
of life for patients with NS-NP. 
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Standardised OMs that evaluate valid and relevant constructs for NS-NP including 
physical and functional limitations, psychological distress, and reduced quality of life 
were rarely or never utilised; instead single dimensional impairment marking scales 
such as VAS, NRS and the goniometric measure of neck motion were frequently 
utilised in the assessment and during the management of patients with NS-NP. This 
could be because these scales are generic, easy to use, quick to administer and interpret 
(verbally), and therefore may be seen as feasible scales for use in busy clinical practice 
(Mintken et al., 2009). However, this is insufficient since these scales cannot capture 
information in relation to the aforementioned valid and relevant constructs and reporting 
bias is often present when administered by the clinician (MacDermid et al. 2013). 
Furthermore, these scales have less reliability and lacked responsiveness to change in 
the patient’s condition (Mintken at al. 2009). Another reason for this could be that 
physiotherapists in the UK do not differentiate between impairment scales and OMs.    
 
In this survey, pragmatic reasons such as a lack of clear guidance regarding the 
availability of suitable OMs and a lack of time were frequently found to impede the 
utilisation of OMs. The reason for this could be because there are a wide variety of OMs 
available and that clinical guidelines and professional bodies which explicitly 
recommended and advocated routine utilisation of OMs in clinical practice rarely 
specify which OM should be used, and this causes uncertainty among physiotherapists 
(Connell and Tyson 2012). In addition, the majority of the available standardised OMs 
are patient-reported questionnaires that require resources (e.g. time, pen and papers) and 
proficiency in English for completion, making them impractical for busy clinical 
practice for majority of physiotherapists. Therefore, it is important to identify OMs that 
are easy for patients and clinicians to use and interpret.  
 
Upper limb functional capacity is poorly evaluated in the assessment and during the 
management of patients with NS-NP. Failure to adequately evaluate the upper limb 
functional capacity by using suitable upper limb OMs often lead to the development and 
progression of ULD. ULD could have a detrimental cyclical effect on the neck and may 
contribute to chronic and persistent neck and upper limb problems. This may lead to 
reduced quality of life for patients with NS-NP. 
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4.4.5 Research implication  
4.4.5.1 Management  
The findings of this survey highlighted that there is a gap between evidence-based and 
current practice when evaluating and rehabilitating patients with NS-NP, and this 
suggests the need for better evidence-based dissemination and knowledge translation. 
Further research is required to address how to promote the use of a multimodal 
management approach for patients with NS-NP, and how to increase physiotherapists’ 
awareness regarding the importance of including upper limb rehabilitation during the 
management of patients with NS-NP. Investigation of the effectiveness of treatment 
approaches, for which evidence is limited or conflicting but still used in practice, may 
be also required. Further information is also needed regarding the management 
preferences and treatment choices for physiotherapists and patients alongside strategies 
to match intervention preference with the evidence-based practice (Sackett et al. 1996, 
Sackett et al. 1997). This would facilitate appropriate allocation of healthcare resources 
and minimise expenditure for ineffective interventions.     
 
4.4.5.2 Measurement  
Despite the importance of evaluating patients with NS-NP, physiotherapists in the UK 
are still insufficiently evaluating their patients with NS-NP. Pragmatic reasons often 
impede the utilisation of OMs as well as the lack of clinical OMs. This highlights the 
need for an efficient OM collection system which ensures the successful incorporation 
of standardised OMs. Further, this system should provide clear guidance on the choice 
of OMs and remove barriers such as lack of knowledge and confidence in selecting and 
utilising standardised OMs. This should facilitate to overcome the complexity of 
establishing a culture of routine data collection using standardised OMs.  
 
Further research is also required to provide a valid and reliable clinical ULD OM that 
will support the recommended assessment and management of patients with NS-NP. 
Such a measure, which can accurately examine upper limb functional capacity in the 
assessment stage and monitor the progress of patients during the rehabilitation 
programme, will enable physiotherapists and clinicians involved in managing patients 
with NS-NP to deliver safe, effective, and efficient treatment for this patient group.  
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4.5 Conclusion 
This chapter has described current physiotherapy practice regarding the management 
and measurement of patients with NS-NP. It has demonstrated that the most frequently 
reported management approaches for NS-NP are those that also have strong evidence 
for their effectiveness. It has also indicated variable use of management approaches 
with low or unclear evidence of efficacy. This suggests the urgent need for updated 
clinical guidelines to support physiotherapists to reduce the use of ineffective 
management approaches and prompt the use of the multimodal management approach. 
The results of section 4.3.3.1 of this survey (OMs utilisation) established the poor 
utilisation of OMs as well as the limited evaluation and rehabilitation of ULD in 
patients with NS-NP. This suggests that further research is needed to establish a core 
outcome set, and outcome measures that are standardised, valid and suitable for use in 
clinical practice. Innovative strategies are also needed to prompt the implementation of 
OMs in clinical practice. This might further support targeted, tailored interventions for 
patients with NS-NP.  
 
The findings from this chapter together with the findings from chapter 2 (the systematic 
review) of this thesis have underlined the gap in research regarding ULD OMs that are 
suitable, standardised and adequately validated for use in clinical practice and research 
practice for patients with NP. In addition, it justifies the further development of the 
Single Arm Military Press (SAMP) test, which is performance-based, brief, easy to 
administer, score and interpret, and therefore has the potential to be useful in clinical 
practice to accurately examine the upper limb functional capacity and monitor the 
progress of patients during their rehabilitation programmes. This should facilitate to 
reduce the potential for ULD to have detrimental cyclical effect on the neck by 
undertaking early upper limb rehabilitation, and this will enable physiotherapists to 
deliver safe, effective and efficient treatment for patients with NS-NP. 
 
The next chapter is a validation study which addresses the third research question (see 
Section 1.5) and describes the evaluation of the acceptability and feasibility of the 
SAMP test at lower weights (½-kg, 1-kg, 1½-kg) in a cohort of Egyptian female 
patients with NS-NP. 
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Chapter 5: Measuring upper limb disability in a neck pain population: 
Evaluation of the acceptability and feasibility of the Single Arm 
Military Press (SAMP) test. 
 
5.1 Introduction 
This chapter describes a study that explored the acceptability and feasibility of the 
Single Arm Military Press (SAMP) test from both the patient and clinicians’ 
perspective. It is the first stage of research that evaluate the measurement and practical 
properties of this instrument and addresses the third question of this thesis (see Section 
1.5). 
 
The UK national survey of neck pain (described in Chapter 4 of this thesis) provided 
empirical evidence that the majority of the UK musculoskeletal physiotherapists do not 
include upper limb rehabilitation strategies when managing patients with non-specific 
neck pain (NS-NP). The survey also established that nearly all UK musculoskeletal 
physiotherapists reported not using any upper limb OMs when assessing and/or 
managing patients with NS-NP, and the most frequently reported reasons for this were a 
lack of clear guidance regarding the suitability of available OMs and a lack of time. 
This indicates the specific need for clinically suitable UL OMs that are simple, quick, 
inexpensive and easy to administer and interpret.      
 
The systematic review on the measurement and practical properties of OMs that were 
developed or validated to measure upper limb disability (ULD) in patients with NS-NP 
(see Chapter 2) highlighted the lack of good quality evidence for any of the identified 
OMs. Synthesis of the results suggested that the SAMP test is a promising ULD OM for 
patients with NS-NP (see section 2.4). Given that it is a performance-based test, it has 
the theoretical advantages of better reliability, greater sensitivity to change and low 
vulnerability to external variance, such as culture, cognition, language and level of 
education (Latham et al. 2008, de Vet et al. 2011). The SAMP test is also quick, 
inexpensive and easy to use; however, further validation in good quality studies is 
urgently required to improve its utility for clinical practice and research. 
 
The SAMP test has undergone a series of preliminary investigations, in which a 3-kg 
hand weight was used in its practical application (McLean et al. 2010a). However, 
anecdotal evidence (personal communication of the developer of the SAMP test and the 
Director of Studies, Dr Sionnadh McLean, for this PhD) suggested that a 3-kg weight 
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may be unsuitable (too heavy) and therefore unethical for patient populations with NP. 
Therefore, this study was undertaken to explore the acceptability and feasibility of the 
SAMP test at lower weights on patient populations with NS-NP.  
 
5.1.1 Aim  
The overarching aim of this study was to explore the acceptability and feasibility of the 
SAMP test using lower weights (½-kg, 1-kg, 1½-kg) in female patients with NS-NP. 
The objectives were to:  
• Explore the acceptability of the SAMP weight in female patients. 
• Explore patient willingness and ability to perform the SAMP test’s tasks 
despite their neck and upper limb symptoms. 
• Explore patient burden regarding the time and effort required for the SAMP 
test performance. 
• Explore the acceptability of the SAMP test in relation to its overall 
administration and completion for the examiners 
• Explore the burden for examiners in relation to the time and resources 
required when incorporating the SAMP test. 
 
5.1.2 Acceptability and feasibility: Concepts  
These properties have been overlooked by the vast majority of the literature and less 
frequently examined. However, Fitzpatrick et al. (1998) highlighted acceptability and 
feasibility as essential practical properties that should be possessed by all OMs. There is 
no consensus about the definitions of these terms and frequent overlap in the definition 
occur (e.g. acceptability and burden, feasibility and burden for patient and clinician). 
This suggests the need for a study similar to the COSMIN taxonomy (Mokkink et al. 
2010b) for these properties.       
 
5.1.2.1 Acceptability  
OMs need to be acceptable to patients in order to help to eliminate avoidable distress to 
those already coping with pain and/or disability, and to obtain a measurement score 
(Fitzpatrick et al. 1998). Therefore, it is necessary and should be established prior to 
other measurement properties such as reliability and validity (Selby and Robertson 
1987).  Acceptability is defined as the ability and willingness of a patient from the 
target population to complete questions or tasks related to an OM (Fitzpatrick et al. 
1998). It is also described as the difficulties a clinician may encounter during the 
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administration and/or interpretation of an OM (e.g. the length and complexity of the 
overall testing procedure) (Fitzpatrick et al. 1998). Direct assessment of acceptability, 
by obtaining both the patient and clinician’s opinion about the OM under study 
immediately after administration using interviews, is considered to be an optimal 
parameter of acceptability (Sprangers et al. 1993). The interview should include 
questions about whether the new OM was difficult, confusing, annoying, upsetting, 
distressing or whether items/tasks should be removed.   
 
5.1.2.2 Feasibility 
In addition to patient and clinician acceptability, it is essential to evaluate the impact 
and burden upon the patient and clinician when administrating an OM (Lansky et al. 
1992). Feasibility is described as the time, training and effort required from a clinician 
to measure patient outcomes using an OM (Erikson et al. 1995). The resources required 
(e.g. purchasing, extra staff, or extra training) and the time needed for the administration 
procedure are considered to be optimal parameters of feasibility (Fitzpatrick et al. 
1998). This suggests that free access, brevity, simplicity in administrating, scoring and 
interpreting the score of an OM indicates greater feasibility (Read et al., 1987; Feeny 
and Torrance, 1989; Nelson et al., 1990).  
 
5.2 Methods  
5.2.1 Study design  
A pragmatic randomised controlled validation study was designed to explore the 
acceptability and feasibility of the SAMP test at lower weight (½-kg, 1-kg, 1½-kg) on 
female patients with NS-NP. This study was conducted, analysed and interpreted in 
accordance with the International Society for Quality Of Life research (ISOQOL), 
which provides a minimum requirement checklist for the evaluation of the measurement 
and practical properties of an outcome measure (Reeve et al. 2013). A total of 70 
Egyptian female patients with NS-NP were randomly allocated into one of three testing 
groups. The stratification of patients was according to the severity of their neck and 
upper limb symptoms using the NDI scores; this was done to ensure balance between 
the three groups on important criteria. Patients were recruited from the Rheumatology 
and Physical Therapy Medicine Department at Tanta Universal Teaching Hospital 
(Egypt). This procedure was carried out on six days between 30th November 2015 and 
26th December 2015.  
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5.2.2 Ethical consideration  
This study was approved by Tanta Universal Teaching Hospital (Rheumatology and 
Physical Therapy Department) (see Appendix 7). Subsequently, approval was sought 
and gained from the Health & Wellbeing Faculty Ethics Committee at Sheffield Hallam 
University to conduct this study in Egypt (SHUREC) (see Appendix 8).  
 
5.2.3 Study setting  
This study took place in the Rheumatology and Physical Therapy Department at Tanta 
Universal Teaching Hospital, which is a new Universal Teaching Hospital located in the 
El-Gharbia province. This hospital serves over 1.5 million people every year via self-
referral from four different provinces in the heart of Egypt. Anecdotal reports suggest 
that approximately 10% of these 1.5 million people are patients with NP.  
 
5.2.4 Training and information delivered to staff  
Twenty-four hours prior to the face-to-face assessment of patient participants and 
SAMP testing, clinical staff who were involved in the data collection in this study 
attended a 30-minutes practical training and information giving session at the 
Rheumatology and Physical Therapy Department at Tanta Universal Teaching Hospital 
(Egypt). The session was delivered by the researcher (AA)and covered the purpose of 
the study; a brief outline of the SAMP test description and practical application; 
standardised demonstration of the warm-up; standard utilisation of the SAMP test’s 
technique and how to recognise compensatory strategies that lead to ineligible lifts; and 
the SAMP scoring system.    
 
5.2.5 Participants recruitment 
The manager of the Rheumatology and Physical Therapy Department at Tanta 
Universal Teaching Hospital was approached and details of the study were explained to 
him. He agreed to host the study in the Rheumatology and Physical Therapy 
Department and also agreed to be involved alongside three clinical staff (physicians) 
from the same department. Subsequently, the researcher was provided with a list of 80 
patients who had visited the Rheumatology and Physical Therapy Medicine Department 
or were on the waiting list with a diagnosis indicating neck pain of non-specific origin.  
 
Ethics protocols usually insist that potential research participants in the UK are invited 
to consider participating in a research study by initially mailing them a letter containing 
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an invitation to participate in the study and requesting that interested participants 
contact a member of the research team. However, in Egypt, where this study was 
conducted, the mail services are unreliable and time consuming since houses in many 
provinces are identified by the nearest well-known shop or building rather than 
numbers. Furthermore, the obtained list included a patient’s name, gender, mobile 
number and/or landline telephone numbers as well as the area where this patient resided 
(that is, no accurate address was available). Therefore, potentially eligible patients were 
telephoned by the researcher who explained the aim of the study and conducted a phone 
screening to confirm their provisional eligibility, gain verbal consent and invite them to 
attend a single face-to-face assessment and testing session. A telephone checklist of 
clinical and demographic questions was completed for each patient to ensure 
standardisation of the information given and to cover the inclusion and exclusion 
criteria (see Appendix 9). If provisional eligibility was confirmed and verbal consent 
obtained, an appointment for the face-to-face assessment and SAMP testing was 
organised. In addition, a convenient method to send the patient information sheet was 
agreed (see Appendix 10). A private company was commissioned to deliver a hard copy 
of the patient information sheet to each verbally consented patient at least 48 hours 
before their assessment and testing session. Patients were asked to carefully read the 
study information sheet and discuss potential participation with their family and friends. 
Patients were also informed that participation in the study was entirely voluntary and 
that they could withdraw from the study at any time. 
 
5.2.5.1 Inclusion criteria  
Female patients were considered for inclusion in this study if they were: (1) an adult ≥ 
18 year of age, (2) attending or referred for physiotherapy treatment at Tanta Universal 
Teaching Hospital (Egypt), (3) experiencing NS-NP with/without referred symptoms 
into the head or upper limb, and (4) scoring at least 10 (out of 100) in the Neck and 
Disability Index (NDI) questionnaire. NS-NP is defined here as “pain perceived as 
arising from anywhere within the region bounded superiorly by the superior nuchal line, 
inferiorly by the transverse line through the tip of the first thoracic spinous process, and 
laterally by the sagittal planes tangential to the lateral border of the neck (Merskey and 
Bogduk 1994), and that the pain was not caused by any serious acute trauma (e.g. 
‘Whiplash Association Disorder), or neurological disorder (e.g. Cervical Radiculopathy, 
Nerve Root compression). 
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5.2.5.2 Exclusion criteria 
Patients were excluded from this study if they: (1) had a neck condition that required 
urgent treatment, (2) had any potentially serious condition systemic disease, progressive 
or worsening neurological disorders, inflammatory conditions or major trauma, (3) had 
previous traumatic injury to the UL/shoulder girdle, (4) were unable/unwilling to do 
physical tasks using their UL, or (5) were unwilling to complete questionnaires.  
 
5.2.6 Allocation procedure  
In order to ensure balance between the three testing groups and accurate proportional 
representation of the sample, at first, patients were stratified into four groups based on 
their NDI score, (low, moderate, severe, extremely severe) (Vernon 1991). The first 
group comprised 20 patients who scored between 10-29 out of 100, second group had 
28 patients who scored between 30-49, third group had 17 patients who scored between 
50-68 and the final group had 5 patients who scored 69-100. Randomisation procedure 
in each of these groups was then used to allocate patients into the final three testing 
groups. This led to randomly allocating 23 patients in the first group for SAMP testing 
using ½-kg weight, 24 patients in the second group for SAMP testing using 1kg weight 
and 23 patients in the final group for SAMP testing using 1½-kg weight.  
   
5.2.7 SAMP test protocol  
The SAMP test protocol was designed to address tasks of functional relevance, which 
challenge the UL (neck, shoulder elbow, arm and hand) and are typically impaired in 
patients with NS-NP (i.e. carrying, lifting, and repetitive overhead movement) (McLean 
et al. 2007, McLean et al. 2011, Osborn and Jull 2013). The SAMP test uses readily 
available and inexpensive equipment (one dumbbell), and it is very easy to score 
(number of repetitions within 30 seconds). The task evaluates the strength and 
endurance of the UL, with the expectation that the difficulty in sustaining overhead 
activity within 30 seconds would discriminate between NS-NP patients with varying 
degrees of UL functional limitations. The SAMP test is conducted with the patient in 
the standing position with their feet positioned at shoulder width. The patient is asked to 
carry a dumbbell and to lift it, using their dominant hand, to shoulder level (see Figure 
5.1A). The patient is requested to raise their hand with the dumbbell directly overhead 
by extending through the elbow (see Figure 5.1B) and to repeat this process as fast and 
as frequently as possible for 30 seconds (McLean et al. 2010a). 
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5.2.8 Study protocol  
Patients who were found provisionally eligible and verbally consented to take part in the 
study were booked to attend a single assessment and SAMP testing session at Tanta 
Universal Teaching Hospital (Egypt). The session took up to 45-minutes, in which 
patients completed the NDI questionnaire (Arabic version) on their arrival (see 
Appendix 11), after which stratification based on the NDI score was executed. Patients 
were then invited to the face-to-face assessment with the researcher and/or the 
department manager in a designated room, in which the patient’s weight and height 
were recorded, and a subjective examination was carried out using standardised clinical 
questions (see Appendix 12). Patients were then randomly allocated into one of the 
three testing groups and requested to meet immediately with the relevant examiner for 
the SAMP testing, if they were found to be eligible, happy to proceed and consented in 
writing (see Appendix 13). Each testing group in the study was led by one examiner in a 
designated room. The SAMP testing was done for each patient individually and started 
with a brief warm-up, which included shoulder shrugs and flexion exercises as well as 
range of movement exercises for the neck and UL (see Appendix 14). This was 
followed by an explanation/description and demonstration of the SAMP test procedure 
by the examiner (see Appendix 15). The patient was then instructed by the examiner to 
perform the SAMP test. At the end of the testing procedure, patients were directed back 
to the researcher to complete the data collection process (see Section 5.2.9 below). 
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5.2.9 Data collection  
A total of three examiners, physicians, with at least 3-years of experience of working 
with musculoskeletal patients were involved in the data collection of this study. The 
department manager who is a professor and member of teaching staff in the faculty of 
medicine at Tanta University was involved in the face-to-face assessment of all patients. 
One member of staff (BH) collected the SAMP data from the 23 patients who were 
allocated to be tested using ½-kg dumbbell and formed group one; a second member of 
staff (GE) collected the SAMP data from the 24 patients who were allocated to be tested 
using the 1-kg dumbbell and formed group two; and a third member of staff (HA) 
collected the SAMP data from the final 23 patients who were allocated to be tested 
using the 1½-kg dumbbell and formed group three. All examiners completed the data 
collection sheet (see Appendix 16) for each patient in their group regarding the SAMP 
score (that is, the number of valid SAMP reputations within 30 seconds); administration 
time (that is, description, demonstration of the SAMP procedure by the examiner as 
well as instruction and the SAMP performance by patient); and the completion time 
which included the warm-up and the administration time. Patients who competed the 
SAMP testing were immediately directed back to the researcher who first, measured 
their neck and UL symptoms severity (immediately after testing) using a 0-10 scale of 
pain severity where 0 indicates no symptoms and 10 indicates the worst possible 
symptoms (see Appendix 17). Second, acceptability of the weight used in the SAMP 
testing in their group was measured using a 1-9 Likert scale, where 1 indicates 
extremely light weight and 9 indicates extremely heavy weight (see Appendix 18). 
Third, acceptability of the SAMP test instruction and performance was measured using 
a 1-9 Likert scale where 1 indicates extremely easy to understand and perform and 9 
indicates extremely difficult to understand and perform (see Appendix 18). Fourth, 
acceptability regarding patients’ ability to perform the physical tasks required in the 
SAMP test was measured using a 1-9 Likert scale where 1 indicates extremely easy to 
do and 9 indicates extremely difficult to do (see Appendix 18). Finally, the feasibility of 
the SAMP test was assessed from the patient perspective in relation to the time and 
effort required using a 1-9 Likert scale where 1 indicates highly suitable and 9 indicates 
highly unsuitable (see Appendix 18). Patients were then discharged and telephoned the 
following day by the researcher (ASEA) to monitor and measure the severity of their 
neck and upper limb symptoms (24 hours after testing) on the 0-10 scale of pain 
severity as mentioned above (see Appendix 17). 
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Following completion of the SAMP testing, the three examiners involved in the data 
collection were requested to record their qualitative input regarding the SAMP test 
procedure. They recorded their opinion regarding the SAMP test’s explanation, 
demonstration and instruction that they provided to each patient as well as the overall 
administration and completion using a 1-9 Likert scale where 1 indicates extremely easy 
and 9 indicates extremely difficult (see Appendix 19). Examiners were also requested to 
record qualitative responses regarding the resources required (e.g. time and cost) when 
using the SAMP test using a 1-9 Likert scale where 1 indicates highly appropriate and 9 
indicates highly inappropriate (see Appendix 19). Furthermore, examiners were asked 
about whether there was a need for: (1) extra training to understand the application of 
the SAMP test’s procedure, (2) extra staff to support the application of the SAMP test’s 
procedure, and/or (3) technological support to facilitate the application of the SAMP 
test procedure on a 1-5 Likert scale where 1 indicates strongly agree and 5 indicates 
strongly disagree (see Appendix 19). 
 
5.2.10 Outcome assessment  
The primary outcomes for this study were the acceptability and feasibility of the SAMP 
test procedure from both the patient and clinicians’ perspective.  
 
Patient acceptability was evaluated in terms of the difficulty of using the weight 
provided in the practical application of the SAMP test, as well as understanding the 
instruction to correctly perform the test. Feasibility (patient burden) was assessed in 
terms of the time and effort required to complete the SAMP test (Fitzpatrick et al. 
1998). This was determined by assessing each patient's view using a structured 
qualitative exit feedback interview (Sprangers et al. 1993). The interview questions 
explored the patient’s experience of the weight used (extremely light - extremely 
heavy), the difficulties of understanding the instruction (extremely easy - extremely 
difficult), and the time and effort required (highly suitable – completely unsuitable) (see 
Appendix 18). To ensure the accuracy and precision of the patient experience when 
assessing acceptability and feasibility, a Likert scale with nine response categories (1-9) 
was used for each question (Avis and Smith 1994). In addition, the Visual Analogue 
Scale (VAS) with eleven response categories (0-10) was used to measure the impact of 
the SAMP testing procedure on patients when using different weights, as this may 
influence their perception of acceptability and feasibility of the SAMP procedure 
(Remington et al. 1979). Both Likert and VAS scales have been extensively validated 
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and found to be reliable, valid and responsive in measuring symptom severity as well as 
participant satisfaction and acceptability (Bond and Lader 1974, Scott and Huskisson 
1977, Remington et al. 1979, McCormack et al. 1988, Wewers and Lowe 1990, 
Jaeschke et al. 1990, Bowling 1995, Bolton and Wilkinson 1998, Vickers 1999, van 
Dijk et al. 2002). Meanwhile, the NDI questionnaire, which is a standardised OM for 
measuring disability due to NP, was used to measure the neck symptoms at the baseline 
to confirm eligibility and to stratify the patients into four groups according to the degree 
of their symptom severity.  
 
Acceptability to clinicians was evaluated in terms of the difficulty clinicians encounter 
during the administration of the SAMP test, such as the length and complexity of the 
overall testing procedure (Fitzpatrick et al. 1998). Meanwhile, feasibility (clinician 
burden) was assessed in terms of the resources required (cost and time) and whether or 
not there was a need for extra training, extra staff or unusual experimental conditions 
when administering the SAMP test (Feeny and Torrance 1989, Aaronson 1992, Lansky 
et al. 1992, Erickson et al. 1995). This was established using a qualitative feedback 
interview for each examiner, in which questions explored the examiner’s experience 
with the SAMP testing procedure; e.g. providing explanation, demonstration, and 
instructions to each patient in their group, and the time and resources required if they 
would like to use the SAMP test in their practice (see Appendix 19) (Read et al. 1987). 
Similar to patients, a validated Likert scale with nine response categories (1-9) was used 
for each question (Avis and Smith 1994). 
 
5.2.11 Sample size  
No example of sample size estimation for the evaluation of the practical properties 
(acceptability and feasibility) of physical performance OMs were identified in the 
literature. The COSMIN checklist suggests that a small sample size (15-30) is sufficient 
in this phase of validating a newly developed OM (de Vet et al. 2011). However, the 
SAMP test is a physical performance test and it is unethical and inappropriate to use it 
to test one group of participants three times since this could create avoidable distress to 
them as they are already coping with NS-NP and possible ULD (Henley and Frank 
2006). It was also impractical to request the participants to attend three different 
sessions. Therefore, it was proposed to recruit a larger sample size and to use a stratified 
sampling procedure to allocate theses participants into three balanced groups, in 
demographic characteristics and symptoms severity, and SAMP testing each group 
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using one of the proposed weights only in a single testing session. Consequently, a list 
of 80 potential participants was obtained from the Rheumatology and Physical Therapy 
Department at Tanta Universal Teaching Hospital, of which 70 patients were found 
eligible and willing to participate in the study, and thus included in the analysis.    
 
5.2.12 Data analysis  
Data was transferred into SPSS (IBM SPSS Statistical Software, version 24.0) for 
statistical analysis. In order to meet the objectives of this study, simple descriptive 
analysis using frequencies, percentages, means, standard deviations (SD), minimum and 
maximum scores were used to present: demographic information (e.g. occupation, NS-
NP duration, weight and height), the severity of the neck and UL symptoms (before 
testing, immediately after testing and 24 hours after testing), and the NDI scores. The 
SAMP test scores using the three proposed weights (½-kg, 1-kg, 1½-kg) and the 
patient's view after SAMP testing were descriptively analysed to: (1) determine the 
most appropriate weight to be used in the practical application of the SAMP test, which 
addressed the first objective (see Section 5.1.1), (2) assess the patients’ acceptability 
regarding the instruction and performance of the SAMP test and (3) assess the 
feasibility (patients’ burden) regarding the time and effort required when performing the 
SAMP test. The examiners’ opinions after testing were descriptively analysed to assess 
their acceptability regarding the length and complexity of the SAMP tasks as well as the 
feasibility (clinicians’ burden) regarding the resources required when using the SAMP 
test. 
 
5.3 Results  
The flow of participants through each stage is presented in Figure 5.2. A list of 80 
patients was obtained from the Rheumatology and Physical Therapy Department at 
Tanta Universal Teaching Hospital. Following the phone screening, 70 out 80 patients 
were eligible. Eight patients were ineligible and 2 patients declined to participate. 
Following the face-to-face assessment, all 70 patients were eligible for SAMP testing, 
happy to participate in the study and consented in writing. 
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5.3.1 Demographic characteristics  
Following the stratification procedure, the 70 participants were randomly allocated to 
one of three groups for SAMP testing, with each group using a different weight (½-kg, 
1-kg, 1½-kg). Demographic and participant characteristics (e.g. age, occupation, weight 
and height) alongside the duration of NS-NP are presented in Table 5.1. Comparison 
between the three groups regarding demographic characteristics indicated that the mean 
age was slightly, but not significantly, higher in group 3 (40.87 years) compared with 
the mean age in group 1 (39.13 years) and group 2 (39.92 years), but the standard 
deviation and minimum/maximum of age were almost identical. The sample was 
balanced across the three testing groups. However, group 1 had a higher proportion of 
participants with acute NS-NP (13%) compared with those in groups 2 (0%) and 3 
(0%). Group 3 had a slightly higher proportion of participants with chronic NS-NP 
(78.2%) compared with group 1 (56.7%) and group 2 (62.5).  
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Table 5.1 Demographic characteristics 
Variables Group 1 Tested 
Using (½kg) 
N=23 
Group 2 Tested 
Using (1kg) 
N=24 
Group 3 Tested 
Using (1½kg) 
N=23 
Age (Years) 
Mean 
SD 
 Minimum 
Maximum 
 
39.13  
4.576 
34 
50 
 
39.92 
4.403 
35 
50 
 
40.87 
4.818 
35 
50 
Occupation: Frequencies (%)  
 House-Wife 
Office Clerk 
Techer 
 
8 (34.8) 
14 (60.9) 
1 (4.3) 
 
9 (37.5) 
14 (58.3) 
1 (4.2) 
 
10 (43.5) 
13 (56.5) 
0 (0) 
NS-NP Duration: Frequencies (%)  
0-5 Weeks (acute pain) 
6-11 Weeks (sub-acute pain) 
 12+Weeks 
 
3 (13) 
7 (30.3) 
13 (56.7) 
 
0 (0) 
9 (37.5) 
15 (62.5) 
 
0 (0) 
5 (21.8) 
18 (78.2) 
Weight (kg): Frequencies (%)  
74-80 
81-85 
86-90 
91+ 
 
2 (8.7) 
2 (8.7) 
7 (30.6) 
12 (52) 
 
0 (0) 
2 (8.3) 
10 (41.7) 
12 (50) 
 
0 (0) 
0 (0) 
10 (43.5) 
13 (56.5) 
Height (cm): Frequencies (%) 
155-160 
161-165 
166+ 
 
13 (56.5) 
8 (34.9) 
2 (8.6) 
 
14 (58.3) 
10 (41.7) 
0 (0) 
 
18 (78.3) 
5 (21.7) 
0 (0) 
SD: Standard Deviation, NS-NP: Non-Specific Neck Pain.  
 
5.3.2 SAMP scores, symptoms severity, acceptability and feasibility for patients 
and examiners  
All participants in this study completed the NDI questionnaire (Arabic version) on their 
arrival, and the severity of their neck and upper limb symptoms were measured before 
testing, immediately after testing and 24 hours after testing. The acceptability and 
feasibility of the testing procedure were evaluated immediately after SAMP testing for 
all participants individually. Aggregated test data describing the SAMP scores, NDI 
scores, the neck and UL symptoms severity alongside patients’ acceptability and 
feasibility regarding the SAMP testing procedure across the three testing groups are 
presented in Table 5.2.     
 
Participants in group 1 who were tested using the ½-kg had a higher average score 21 
reps/30s in SAMP testing, whereas those in group 3 who were tested using 1½-kg 
recorded lower average scores 10 reps/30s in the SAMP testing. However, participants 
in group 2 who were tested using 1-kg reported an average score 16 reps/30s in the 
SAMP testing. The neck and UL symptoms severity increased immediately after testing 
on the VAS scale (0-10) across the three-testing groups. This was resolved 24 hours 
after testing for the participants who were tested using the ½-kg weight and 1-kg 
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weight, whereas those who were tested using the 1½-kg weight were still sore 24 hours 
after testing. Those who were tested using the 1-kg weight improved slightly with 
regard to the severity if their UL symptoms 24 hours after testing (before testing: 
mean=2, immediately after testing: mean=5, 24-hours after testing: mean=1).  
 
Participants in group 1 reported that the ½-kg weight was extremely light or moderately 
light when used in the SAMP testing, whereas those in group 3 reported that the 1½-kg 
weight was moderately heavy or neither heavy nor light when used in the SAMP 
testing. However, those in group 2 reported that the 1-kg weight was slightly light or 
neither heavy nor light when used in the SAMP testing. Participants across the three-
testing group reported that the SAMP testing procedure was extremely easy in relation 
to instruction and performance, and highly suitable in relation to the time and effort 
required regardless of the weight used.  
 
After testing, the examiners (n=3) involved in the data collection of this study were 
requested to provide their qualitative opinions about the SAMP testing procedure 
(acceptability and feasibility). They all confirmed that the SAMP test was extremely 
easy or very easy to use in relation to providing an explanation with demonstration, and 
the overall administration and completion. They also agreed that the SAMP test was 
highly appropriate regarding the resources required (e.g. time and cost) and that there 
was no need for additional training, or extra staff or technological support to facilitate 
the application of the SAMP testing procedure. Patients in group 1 had an average 
SAMP score of 21 reps/30 seconds and those in group 2 had average SAMP score of 16 
reps/30 seconds, whereas those in group 3 had an average SAMP score of 9 reps/30 
seconds.  The SAMP’s administration and completion time for groups 1 and 2 ranged 
between 50 to 60 seconds (administration) and 110 to 120 seconds (completion) 
respectively, whereas for group 3 it ranged between 30-60 seconds (administration) and 
90-120 seconds (completion).  
 
Descriptive data regarding the SAMP testing administration and completion time; the 
SAMP scores; NDI scores; and neck/UL symptoms severity before testing, immediately 
after testing and 24 hours after testing alongside both the participants’ and the 
examiners’ opinions about the SAMP testing procedure for the three groups of patients 
are presented in Appendix 20. 
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Table 5.2: SAMP scores, symptoms severity and patients’ acceptability/feasibility 
 Group 1:  
½-kg (N=23)  
Group 2: 1-
kg (N=24) 
Group 3: 1½-
kg (N=23)  
SAMP scores  
Mean (SD) 
Range 
Min 
Max 
 
21 R (7.064) 
23 R 
10 R 
33 R 
 
16 R (7.433) 
21 R 
6 R 
27 R 
 
10 R (5.579) 
20 R 
0 R 
20 R 
NDI Score: Total score=100  
Mean  
SD 
 
35/100  
15.254 
 
45/100 
17.107 
 
43/100 
15.111 
NDI severity categories (frequencies)  
Low  
Moderate  
Severe  
Extremely severe 
 
N=7 
N=10 
N=5 
N=1 
 
N=7 
N=9 
N=6 
N=2 
 
N=6 
N=9 
N=6 
N=2 
Neck symptoms severity: Mean (SD)   
VAS 0-10  
0=No Symptoms Before testing 
10=Worst Possible Symptoms Immediately after testing  
24 hours after testing 
 
 
4/10 (0.733) 
5/10 (1.041) 
3/10 (0.885) 
 
 
4/10 (0.721) 
5/10 (0.794) 
3/10 (0.776) 
 
 
4/10 (0.656) 
6/10 (0.778) 
5/10 (0.869) 
Upper limb symptoms: Mean (SD) 
VAS 0-10                                         Before testing 
0=No Symptoms                        Immediately after testing  
10=Worst Possible Symptoms         24 hours after testing   
 
2/10 (0.928) 
4/10 (0.853) 
2/10 (0968) 
 
2/10 (1.056) 
5/10 (1.142) 
1/10 (1.213) 
 
2/10 (0.728) 
6/10 (0.765) 
5/10 (0.984) 
Patient acceptability: Weight  
Likert scale 1-9                                           Range 
1=Extremely Light  Min  
9=Extremely Heavy Max 
 
3/9 
1/9 
4/9 
 
5/9 
2/9 
7/9 
 
5/9 
4/9 
9/9 
Patients acceptability: Willingness and ability  
Likert Scale 1-9                                          Range 
1=Extremely Easy Min  
9=Extremely Difficult Max 
 
4/9 
1/9 
5/9 
 
5/9 
2/9 
7/9 
 
4/9 
5/9 
9/9 
Patients acceptability: Instruction and 
performance  
 Likert Scale 1-9                                         Range 
1=Extremely Easy Min  
9=Extremely Difficult                                                 Max 
 
 
1/9 
1/9 
2/9 
 
 
0/9 
1/9 
1/9 
 
 
0/9 
1/9 
1/9 
Patients burden/feasibility: Time and effort  
Likert Scale 1-9                                           Rang 
1=Highly Suitable Min  
9=Completely Unsuitable Max 
 
2/9 
1/9 
3/9 
 
3/9 
1/9 
4/9 
 
3/9 
1/9 
4/9 
SD: Standard Deviation, SAMP: Single Arm Military Press, R: Repetition, NDI: Neck 
Disability Index, VAS: Visual Analogue Scale, Min: Minimum, Max: Maximum. 
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5.4 Discussion  
5.4.1 Summary and discussion of the main findings  
This chapter reports the findings from a pragmatic randomised controlled study that 
investigated the practical properties of the SAMP test. This study has captured 
information about the acceptability and feasibility of the SAMP test for both patients 
and clinicians. Consequently, the aim and objectives of this validation of the SAMP test 
have been met (see Section 5.1.1).    
 
Nearly all patients and clinicians involved in this study agreed that regardless of the 
weight used, the SAMP test hand weight was simple, quick, inexpensive and extremely 
easy to use in relation to instruction, performance, and time and effort required to 
administer the test and score performance. It would appear that the SAMP test is an 
acceptable physical performance test for patients as well as for clinicians. The 
feasibility of the SAMP test was established regarding the time and resources required. 
The reasons for this high acceptability and feasibility are that the SAMP test is 
convenient, since it can be efficiently administered by physiotherapists and/or any other 
individual of varying experience in any setting using minimum equipment (one 
dumbbell). Further, it is time effective as it only takes up to 2 minutes for 
administration and completion. However, the ½-kg hand weight was considered by the 
majority of patients in group 1 to be too light, hence they had a high SAMP average 
score. Using a light hand weight in the application of a physical performance test will 
risk missing out on the identification of patients with subtle/mild pain and disability 
(Fitzpatrick et al. 1998). This suggests that the ½-kg hand weight is unsuitable for use in 
female patients with NS-NP. Conversely, the 1½-kg hand weight was considered by the 
majority of patients in group 3 to be too heavy, and hence they had a low SAMP 
average score. In addition, some patients were either unwilling or unable to lift the 
weight and the majority of patients in group 3 had increased neck and UL symptoms 
immediately after testing, and they were still sore 24 hours after testing. Using a heavy 
hand weight in the application of a physical performance test will distress patients and 
risk aggravating pain and disability for a longer period after testing, which could lead to 
patient fear and avoidance of the intervention and consequently, non-adherence to 
rehabilitation (Ahuga 2015). The findings suggest that the 1½-kg hand weight is 
unsuitable for use in female patients with NS-NP. The 1-kg hand weight was considered 
by the majority of patients in group 2 to be neither too light nor too heavy, thus they had 
an average score in the SAMP testing. In addition, nearly all patients in group 2 
 131 
reported an improvement in their neck and UL symptoms severity 24 hours after testing. 
This indicates that the 1-kg hand weight is suitable for use in female patients with NS-
NP. The findings of this study lead to the conclusion that 1-kg SAMP test is acceptable, 
feasible and therefore suitable for use by female patients with NS-NP.  
 
The findings of this study are consistent with those of other studies which used 1-kg 
hand weights when examining the functional capacity of the UL for patients with 
shoulder pathology or NS-NP (MacDermid et al. 2007, Kumta et al. 2012, Constand 
and MacDermid 2013). In their validation study, MacDermid et al. (2007), developed 
the Functional Impairment Test-Hand, and Neck/Shoulder/Arm (FIT-HaNSA), a new 
PBOM for measuring the functional capacity of UL in patients with shoulder pathology. 
The test protocol consists of 3 subtasks, of which each task can be continued for up to 5 
minutes. In the first task, a shelf is placed at the participant’s waist level and a second 
shelf is placed 25 cm above it, while three 1-kg containers/bottles are placed 10 cm 
apart on the lower shelf. Using the affected arm, the participants are instructed to lift the 
3 containers, one at a time, from one shelf to the other. In the second task, the shelves 
are adjusted so one shelf is placed at the participant’s eye level and the second is placed 
25 cm below it. Using their affected arm, the patients are instructed again to lift the 
three 1-kg containers between the shelves. In the final task, a shelf is placed at the 
participant’s eye level with an attachable plate perpendicular to the shelf and projecting 
out towards the participant. Using their affected arm, participants are instructed to 
repeatedly screw and unscrew bolts in a specific pattern. The test was developed and 
different scores was observed when comparing the healthy subjects to either the 
surgical-list patients with shoulder impingement or a variety of mild shoulder pathology 
patients, and this indicates that the 1-kg hand weight was suitable when testing the 
functional capacity of the UL in patients with mild, moderate or severe shoulder 
pathology. 
 
In their case control study, Constand and MacDermid (2013) recruited 7 patients with 
NS-NP and 12 healthy subjects to investigate the level of difficulties patients with NS-
NP may experience when performing reaching overhead and reading tasks. Participants 
in this study completed two tasks that incorporated different types of neck movement, 
reach overhead tasks to represent upper cervical motion and long neck flexion, and 
reading tasks to represent lower cervical spine motion. In the first task, a shelf was 
placed 64 cm above the participant’s naval and a second shelf was placed slightly 
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higher than the participant’s head. Using their dominant hand, from the standing 
position, participants were instructed to reach overhead by moving a 1-kg container 
from the lower shelf and place it on the higher shelf repeatedly for 30 seconds. This 
indicates that the 1-kg hand weight was suitable when testing the UL functional 
capacity (overhead reaching) in patients with NS-NP.  
 
5.4.2 Strengths of the study 
This study was conducted, analysed and interpreted in accordance with the ISOQOL 
checklist recommendation for the evaluation of the measurement and practical 
properties of OMs (Reeve et al. 2013), alongside the new COnsensus-based Standards 
for the selection of health Measurement INstruments” (COSMIN) recommendations 
regarding the evaluation of content validity for health-related OMs (Terwee et al. 2018) 
in order to ensure a robust methodology. Key stakeholders, patients and clinicians were 
involved in this study, which is essential when validating OMs to ensure relevance, 
acceptability and feasibility (Fitzpatrick et al. 1998). The study achieved more than the 
recommended sample size (15-30) according to the COSMIN checklist (de Vet et al. 
2011). This could be because appropriate methods for Egyptian patients (phone 
screening) were used initially to invite patients to participate in the study. Another 
reason could be because participants were requested to attend one single assessment and 
testing session. The implementation of broad inclusion and exclusion criteria and 
standardised assessment ensured that the included participants were representative of 
female patients with different types of NS-NP (e.g. acute, subacute and chronic) and the 
degrees of symptom severity experienced. Reliable, valid and responsive scales, 
including the VAS scale (0-10) and Likert scale (1-9), were used to assess the neck and 
UL symptoms severity before testing, immediately after testing, and 24 hours after 
testing, and to evaluate the acceptability and feasibility of the SAMP testing procedure 
to both patients and clinicians (Donovan et al. 1993, Fitzpatrick et al. 1998, Hasson and 
Arnetz 2005, Brokelman and Haverkamp 2012). The use of a stratified randomisation 
strategy to allocate participants led to three broadly similar testing groups.   
 
5.4.3 Limitations of the study   
This study was conducted on female patients and this may prevent the generalisability 
of the findings to male patients with NS-NP. It is well known that, on average, males 
are stronger than females but most of the difference in strength is based on body size 
and muscle cross-sectional area only (Hunter 2010). Consequently, the 1-kg hand 
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weight may be too light and therefore not suitable for male patients with NS-NP. 
However, the SAMP test is a performance-based and include tasks to evaluate the 
strength and endurance of the UL and women tend to have better muscle endurance than 
men since they generally take longer to fatigue (Cheng et al. 2003). In addition, the 
findings of other studies which have used a1-kg weight when examining the functional 
capacity of the UL in patients with shoulder pathology or NS-NP indicate that a 1-kg 
hand weight was suitable for female as well as male patients with shoulder pathology or 
NS-NP (MacDermid et al. 2007, Kumta et al. 2012, Constand and MacDermid 2013).    
 
This study focused on participants with NS-NP which limits the generalisability to other 
forms of NP, such as cervical radiculopathy and Whiplash Associated Disorders 
(WAD). It is likely that patients with cervical radiculopathy and WAD may have more 
severe neck problems and greater levels of central sensitisation, and consequently may 
experience greater levels of ULD. Using the 1-kg SAMP test may be too difficult for 
these groups. Therefore, the suitability of the 1-kg SAMP test would need to be 
established in a separate study.  
 
5.4.4 Clinical implications   
This study established the acceptability and feasibility of the SAMP test. From the 
patient perspective, the SAMP test is extremely easy regarding instruction and 
performance; time and effort required; and physical ability and willingness. Therefore, 
the SAMP test is suitable for use in practice. From the clinicians’ perspective, the 
SAMP test is advantageous in relation to qualities such as demonstration, instruction, 
score, interpretation of score and overall administration and completion. No additional 
training, staff or technological support are required to facilitate the application 
(administration and completion) of the SAMP test. Incorporating a 1-kg hand weight in 
the practical application of the SAMP test was most appropriate for female patients with 
NS-NP regardless of the severity of their symptoms. The test is likely to elevate the 
neck and UL symptoms severity slightly but they return to normal or possibly reduce 
slightly after 24 hours, and this indicates that Delayed Onset Muscle Soreness following 
testing is likely to be minimal. Consequently, the SAMP test can be recommended as a 
suitable test for use in clinical practice. However, this test has not yet been shown to be 
a reliable or valid measure of UL capacity in patients with NP, and therefore cannot at 
this stage be recommended as a measure of UL functional capacity in female patients 
with NS-NP.      
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5.4.5 Research implications  
Although the findings of this chapter have demonstrated that the SAMP test is a highly 
acceptable and feasible measure of UL functional capacity in female patients with NS-
NP; further research is required to investigate important measurement properties such as 
reliability and validity. In addition, future testing should be done to establish its 
feasibility, reliability and validity in male patients and patients with other NP disorders, 
including cervical radiculopathy and WAD.  
 
5.5 Conclusion  
The 1-kg SAMP test was found to be an acceptable and feasible weight for use with 
female patients with NS-NP and therefore has demonstrated its potential for use in 
clinical practice. The measurement and practical properties of the SAMP test should be 
confirmed and further tested in other female populations, male populations and in 
different types of NP.  
 
The next chapter is a validity study which addresses the final research question (see 
Section 1.5) and describes the evaluation of the reliability and validity of the SAMP test 
in a second cohort of Egyptian female patients with NS-NP and healthy subjects.   
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Chapter 6: Measuring upper limb disability in female patients with 
non-specific neck pain: Evaluation of the reliability and validity of the 
Single Arm Military Press (SAMP) test. 
 
6.1 Introduction 
This chapter describes the methodology, and presents and discusses the results, of a 
study that was conducted to establish the reliability and validity of the 1-kg SAMP test 
in Egyptian female patients with NS-NP and healthy subjects.  
 
Chapter five of this thesis has successfully established the acceptability, feasibility and 
therefore the suitability of the SAMP test for clinical practice as a measure of UL 
functional capacity for female patients with NS-NP. However, this chapter also 
concluded that further testing for reliability and validity would be required before the 
SAMP test can be formally recommended for use in clinical practice.  
 
6.1.1 Aim  
The main aim of this study was to investigate the reliability and validity of the SAMP 
test as a measure of ULD Egyptian female patients with NS-NP alongside healthy 
subjects. 
 
6.1.2 Hypotheses (reliability)  
1. The inter- and intra-rater reliability of the SAMP test will be high (ICCs ≥ 0.90) 
2. The agreement in the repeated measurement will be very high and the SEM will 
be very low (SEM ≤ 1) and smaller than the smallest detectable change (SDC). 
 
6.1.3 Hypotheses (validity)  
1. The SAMP test performance has highly significant (p < 0.05) and substantial 
negative correlation (r > -0.70) with the DASH score (convergent validity). 
2. The SAMP test has the capacity to discriminate between healthy subjects and a 
patient group. 
3. The SAMP test has the capacity to discriminate between patient groups of 
different severity of NS-NP. 
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6.1.4 Reliability and validity: Concepts  
6.1.4.1 Reliability  
Reliability is an essential requirement of all outcome measures; poor reliability 
alongside a high level of measurement error would limit the extent to which the findings 
of an instrument can be generalised. Consequently, this would reduce the usefulness as 
well as the clinical utility of the instrument (de Vet et al. 2006). Reliability concerns the 
extent to which the measurement of stable patients can be reproduced when the same 
instrument is used at different moments, in different conditions, by different examiners 
or by the same examiner at different times (Streiner and Norman 2003). Reliability as a 
domain reflects the extent of correlation as well as the agreement in repeated 
measurements and comprises three measurement properties: internal consistency, 
reliability and measurement error (Mokkink et al. 2010b). Internal consistency is 
assessed only for PROMs and is defined as the extent to which items in a questionnaire 
are interrelated (Mokkink et al. 2010b). It concerns the extent to which items assess the 
same construct in a unidimensional scale of a multi-item instrument (de Vet et al. 2011). 
Given that the SAMP test is a physical performance test, internal consistency is not 
relevant and therefore redundant in this study. Reliability as a measurement property is 
described as the proportion of the total variance in the measurement resulting in the 
consistency of the scores as well as the error which is not attributed to true changes but 
resulting in the systematic and random error of a patient’s scores (Mokkink et al. 
2010b). It includes test-retest, inter-rater and intra-rater reliability which are illustrated 
in Table 6.1. Reliability examines the ability of an instrument to distinguish between 
patients despite the measurement errors that are related to the variability between the 
study objects “participants” and is expressed in correlations using the Interclass 
Correlation Coefficient (ICC) (de Vet et al. 2006). The ICC uses a typical basic 
formula:  
 
 
Table 6.1: Reliability types (de Vet et al. 2011) 
Inter-rater 
Reliability  
Examines the variation between multiple examiners (2 examiners or more) who 
measure the same patients/subjects using the same instrument in the same 
occasion/session.  
Intra-rater 
Reliability  
Examines the variation in repeated measurements by the same examiner on stable 
patients/subjects using the same instrument under the same condition in different 
occasions/sessions.     
Test-retest 
Reliability 
Examines the variation in repeated measurements on stable patients/subjects under 
the same condition using the same instrument, but the examiner is neglected/not 
involved (e.g. self-reported survey instrument).    
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The reliability parameter ICC ranges between 0.0 to 1.0, where values close to 0.0 
indicate poor reliability and ICC values close to 1.0 suggest high reliability (Portney 
and Watkins 2009). An interpretation of the ICC values is illustrated in Table 6.2.  
 
Table 6.2: ICC values interpretation (Landis and Koch 1977 
ICC Value Interpretation of Strength 
< 0.000 Poor 
0.00-0.20 Slight 
0.21-0.40 Fair 
0.41-0.59 Moderate  
0.60-0.79 Substantial (High) 
0.80-1.00 Almost Perfect (Very High) 
ICC: Interclass Correlation Coefficient  
 
Measurement error is a measurement property of the reliability domain which represents 
the systematic and random error of a patient’s score that is not attributed to true changes 
in the construct being measured (Mokkink et al. 2010b). Measurement error quantifies 
the extent to which an OM provides accurate scores, independent from the population 
and reflects the agreement in repeated measurements (de Vet et al. 2011). It is the 
absolute measurement error over repeated measurements of the test when the patients 
are stable between measurements. Measurement error is expressed by the Standard 
Error of Measurement (SEM), which estimates how the repeated measurement of a 
patient on the same instrument tends to be distributed around their “true” score. SEM is 
the standard deviation of the errors of measurement that are associated with an 
instrument’s scores and is equal to the square root of the error variance (Ö σ2 error) (de 
Vet et al. 2006). Low levels of SEM indicate high levels of score accuracy and high 
levels of SEM indicate low levels of score accuracy (Vincent and Weir 2012). SEM 
should be smaller than the Smallest Detectable Change (SDC), which represents the 
minimal change that a patient must show on an OM to ensure that the observed change 
is real and not just measurement error (Bland and Altman 1996). The ICC and SEM 
formulas and variance are illustrated in Table 6.3. 
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Table 6.3: ICCs, SEM and SDC formulas and variances (de Vet et al., 2011) 
ICC Interclass Correlation Coefficient  
SEM Standard Error of Measurement  
SDC Smallest Detectable Change  
σ2 Variance: The statistical term that is used to represent the variability in 
the measurement scores  
σ2 p Variance due to differences in the study objects (participants) 
σ2 pt. Variance due to systematic differences between 
examiners/physiotherapists (i.e. pt. ‘A’ and pt. ‘B’). 
σ2 error (residual) Variance due to differences in the interaction between participants and 
examiners.  
ICC agreement = σ2 p ÷ σ2 p + σ2 pt. + σ2 residual 
ICC consistency = σ2 p ÷ σ2 p + σ2 residual 
SEM agreement = Ö σ2 pt. + σ2 residual 
SEM consistency = Ö σ2 residual 
SDC = 1.96 C Ö2 C SEM 
σ2: Variance, pt.: Physiotherapist 
 
6.1.4.2 Validity  
Validity as a domain concerns the degree to which an instrument truly measures the 
construct for which it was developed and validated to measure and comprises three 
measurement properties: content, criterion, and construct validity (Mokkink et al. 
2010b). Content validity, concerns the adequacy between the content of an instrument 
and the construct being measured and is not relevant in this study since it is usually an 
aspect of OMs development (Mokkink et al. 2010b). Criterion validity describes the 
degree to which the scores of an instrument adequately reflects the scores of a gold 
standard (that is, a perfectly valid assessment/OM that is considered to represent the 
true state of the construct being measured) (Mokkink et al. 2010b). Criterion validity is 
used to provide evidence of an OMs validity only when a gold standard is available (de 
Vet et al. 2011). Given that there is currently no gold standard for measuring UL 
functional capacity in patients with NS-NP, criterion validity is redundant in this study. 
Construct validity is the other measurement property which should be assessed to 
provide evidence of the validity of an instrument when a gold standard of the construct 
being measured is not available. It concerns the degree to which the scores of the 
instrument under study are consistent with clearly and a priori formulated hypotheses 
regarding the relationship with the scores of other instruments that should be measuring 
the same construct (Mokkink et al. 2010b). Construct validity is frequently investigated 
using analyses that test for statistical differences (de Vet et al. 2011). Construct validity 
types and definitions are presented in Table 6.4, and the Pearson correlation values and 
interpretation are presented in Table 6.5. 
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Table 6.4: Construct validity types and definitions (Mokkink et al. 2010b)   
Construct 
Validity  
The extent to which the scores of an instrument are consistent with clearly a 
priori formulated hypotheses.  
Convergent 
Validity   
The extent to which an instrument scores are correlated with the scores of 
other instruments that measure the same construct based on a priori 
formulated hypotheses 
Discriminate 
Validity  
The extent to which an instrument has the capacity to discriminate between 
groups that are known to be clinically different.  
 
Table 6.5: Pearson correlation values and interpretation (Domholdt 2000) 
Pearson value Interpretation of strength 
r = < 0.40 Low 
r = 0.40 to 0.70  Moderate  
r = > 0.70 High 
r: Pearson Correlation Coefficient 
 
6.2 Methods  
6.2.1 Study design  
A large-scale validation study was designed to investigate the reliability and validity of 
the SAMP test in female Egyptian patients with NS-NP and healthy subjects in 
accordance with the “COnsensus-based Standards for the selection of health 
Measurement INstruments” (COSMIN) checklist recommendations (Mokkink et a. 
2010a, Terwee et al. 2012). Patients participants were recruited from the Rheumatology 
and Physical Therapy Department at Tanta Universal Teaching Hospital in Egypt, while 
matched healthy subjects were recruited from the general population living in Egypt. 
Participants (patients and healthy subjects) were tested using the 1-kg SAMP test since 
it was found to be acceptable and feasible for use in patients with NS-NP (explored in 
chapter 5, sections 5.3 and 5.4). This study was conducted from March 2016 to April 
2016 in the Rheumatology and Physical Therapy Department at Tanta Universal 
Teaching Hospital (Egypt).  
 
6.2.2 Ethical approval  
This study was approved by Tanta Universal Teaching Hospital (Rheumatology and 
Physical Therapy Department) (see Appendix 7). Subsequently, approval was sought 
and gained from the Health & Wellbeing Faculty Ethics Committee at Sheffield Hallam 
University to conduct this study in Egypt (SHUREC) (see Appendix 8).  
 
6.2.3 Study setting  
This study, similar to the acceptability and feasibility study in chapter 5, took place in 
the Rheumatology and Physical Therapy Department at Tanta Universal Teaching 
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Hospital in El-Gharbia province, Egypt. Further details about the setting can be found in 
(chapter 5, section 5.2.3). 
 
6.2.4 Study sample  
Female patients who had visited the Rheumatology and Physical Therapy Department at 
Tanta Universal Teaching Hospital or were on the waiting list with a diagnosis 
indicating NS-NP were recruited to this study alongside frequency matching of healthy 
subjects. Participants in this study were different from those who participated in the 
validation (SAMP acceptability and feasibility) study that is reported in chapter 5. 
 
6.2.5 Inclusion and exclusion criteria  
6.2.5.1 Patient participants  
The inclusion and exclusion criteria for patient participants in this study were identical 
to the validation study (SAMP acceptability and feasibility) described in chapter 5 and 
are described in detail in sections 5.2.5.1 and 5.2.5.2.   
 
6.2.5.2 Healthy subjects  
Healthy subjects were considered for inclusion in this study if they were a female adult 
aged ≥ 18-years, with no history of head/neck/UL trauma and no current or recent neck 
or UL problems (within the last three months). Eligible participants were frequency 
matched with prospective patient participants regarding gender, age, occupation, weight 
and height.  
 
6.2.6 Recruitment of study sample  
Similar to the validation study described in chapter 5, a list of 300 female patients with 
NS-NP was obtained from the Rheumatology and Physical Therapy Medicine 
Department at Tanta Universal Teaching Hospital. Healthy female subjects were 
recruited from the general population by announcement via social network sites (e.g. 
Facebook and Twitter), personal networking and posters/flyers within Tanta University 
and Tanta city centre. Willing and potentially eligible participants were asked to contact 
the researcher (ASEA) using the research hotline number. This resulted in 100 healthy 
subjects contacting the study hotline after which the line was closed and the process was 
stopped.   
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Potentially eligible patients and healthy subjects were telephoned by the researcher 
(ASEA) or another member of the research team who explained the study and 
conducted a phone screening to confirm their provisional eligibility and gain verbal 
consent. In the phone screening, patients and healthy subjects were checked against the 
inclusion and exclusion criteria. A telephone checklist of clinical and demographic 
questions was completed for each patient and healthy subject to ensure standardisation 
of the information given and to cover the inclusion and exclusion criteria (see Appendix 
21). If provisional eligibility was confirmed and verbal consent was obtained, an 
appointment for a face-to-face assessment followed by the first testing session was 
organised. The company that was used in the validation study in chapter 5 was 
commissioned again in this study to deliver the study information sheet (see Appendix 
22) to each verbally consented participant at least 48 hours before their first assessment 
and testing session. Participants were requested to carefully read the study information 
sheet and discuss their potential participation with their family and friends.  
 
Participants (patients and healthy subjects) who were found provisionally eligible and 
verbally consented to take part in this study were booked for a face-to-face assessment 
at Tanta Universal Teaching Hospital (Egypt). Participants were given the opportunity 
to ask questions, the researcher checked eligibility against the inclusion/exclusion 
criteria prior to gaining written consent from willing participants. Participants were 
informed that taking part in this study was entirely voluntary and that they could 
withdraw from the study at any time without reprisal. 
 
6.2.7 Sample size  
Sample size estimates in this study were based on the COSMIN checklist 
recommendations, which suggest that at least 50 patients are required for a reliability 
study in order to achieve a reasonable number of dots on the Bland and Altman plot 
which estimates the limits of agreement in the repeated measurements (de Vet et al., 
2011). COSMIN also suggests that a larger sample size (≥100) is better when evaluating 
the inter-rater and intra-rater reliability of an instrument in order to obtain a Confidence 
Interval (CI) > 0.90 around Interclass Correlation Coefficient (ICC) of 0.90 – 0.95 
(Giraudeau and Mary 2001). However, given that the validity (convergent and 
discriminant) of the SAMP test are statistically investigated in this study using a group 
of healthy subjects and four sub-groups of patients with different severity level of NS-
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NP, it was proposed to recruit ≥ 200 patients and 50-100 healthy subjects (de Vet et al., 
2011).       
 
6.2.8 Clinical staff involved in the SAMP testing  
A total of four female examiners who were all physicians and employed at the 
Rheumatology and Physical Therapy Medicine Department at Tanta Universal Teaching 
Hospital, with at least 3-years of experience in working with musculoskeletal patients 
were involved in the recruitment as well as the data collection in this study.  
 
6.2.9 Training and information delivered to staff 
The three examiners involved in the data collection of the validation study described in 
chapter 5, plus one additional examiner (four examiners in total) were involved in the 
data collection in this study. Twenty-four hours prior to the face-to-face assessment and 
the first testing session, the four examiners attended a 45-minute practical training and 
information giving session at the Rheumatology and Physical Therapy Department at 
Tanta Universal Teaching Hospital (Egypt). The session was delivered by the PhD 
researcher (ASEA) who discussed the purpose of this reliability and validity study, 
provided a brief outline of the SAMP test description and the practical application; 
demonstrated the warm-up; standard utilisation of the SAMP technique; and recognition 
of compensatory strategies and/or ineligible lift, and the scoring system. Examiners 
were paired for simultaneous SAMP testing of patient participants (inter-rater 
reliability). The first pair, a member of staff (GE) was the rater who administered the 
SAMP test, while a second member of staff (HA) was the co-assessor who only 
recorded the SAMP test score independently but simultaneously in the first testing 
session. The second pair, a member of staff (BH) was the rater, while the fourth 
member of staff (AH) was the co-assessor in the first testing session. The role of the 
rater and co-assessor were shifted in the second testing session for the two pairs to 
examine whether a switch between the rater and co-assessor (interaction with patients 
during the administration) could present another variance and influence the performance 
of patients (de Vet et al. 2006). Data regarding the SAMP testing were collected and 
analysed for the two pairs of examiners.   
 
6.2.10 Outcome measures  
The SAMP test and two PROMs (NDI and DASH) were used in this study. A brief 
description of each instrument used are given below.  
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6.2.10.1 The SAMP tests 
The SAMP test performance consists of tasks that simulate daily activities of carrying, 
lifting and using the UL in overhead function. The attribute of interest in this instrument 
related to the sustained work that involves repetitive overhead activity. The SAMP test 
procedure was conducted as described in chapter 5 (see Section 5.2.7). First, 
participants were asked to stand with their feet positioned at shoulder width and lift a 1-
kg dumbbell, using their dominant hand, to shoulder level (see Figure 6.1A). Second, 
participants were asked to raise their hand with the dumbbell directly overhead by 
extending through the elbow (see Figure 6.1B). Finally, participants were asked to 
repeat this process as fast and as frequently as possible for 30 seconds but to take their 
pain and fatigue into account. It was emphasised that they could stop at any time during 
the 30 seconds testing. The test was stopped if a participant reported extreme pain or 
fatigue. The scoring system of the SAMP test is a repetition count (number of 
repetitions) within 30 seconds, in which higher values represent batter performance and 
a lower level of ULD.   
 
6.2.10.2 The Neck and Disability Index (NDI) 
The NDI is a standard PROM for measuring a patient’s disability due to neck pain and 
is the most commonly used instrument in clinical practice and research (MacDermid et 
al. 2009, MacDermid et al. 2013). The NDI has 10 items, in which 7 items are related to 
activities of daily living, 2 items related to pain, and 1 item related to concentration 
 144 
(Vernon and Mior 1991). Each item is scored from 0-5 and the total score is expressed 
as a percentage score, with higher scores indicating greater disability. The NDI is 
supported by the largest volume of neck related clinical measurement evidence and 
demonstrates excellent measurement properties across multiple studies (MacDermid et 
al. 2009). In addition, the NDI is the most commonly used patient-reported outcome 
measure for patients with neck pain and/or disability in clinical practice and research 
practice (Linton 2000, Sterling et al. 2003, Dunckley et al. 2005, Abrams et al. 2006, 
Bot et al. 2007, Cote et al. 2008, de Koning et al. 2008, Nordin et al. 2008, Skeat and 
Perry 2008). The NDI was translated and culturally-adapted to the Arabic language and 
its reliability and validity were determined in Arabic-speaking patients with NP 
(Shaheen et al. 2013). The NDI scoring intervals for interpretation, which was used to 
create the 4-subgroups of patients in this study, are shown in Table 6.6.  
 
 Table 6.6: NDI score and interpretation (Vernon and Mior 1991 
NDI Score Interpretation 
0-8 No Disability 
10-28 Mild Disability 
30-48 Moderate Disability 
50-68 Severe Disability 
69-100 Extremely severe Disability 
 
6.2.10.3 The Disability of the Arm, Shoulder and Hand (DASH) 
The DASH is a multidimensional PROM developed primarily to evaluate the upper 
limb disability and/or symptoms as a single functional unit (Hudak et al. 1996). The 
DASH uses 30-items related to difficulty when performing activities which use the 
upper limb. The dimension physical function comprised 21-items, pain 5-items and 
emotional/social function comprised 4-items. Each item is scored on a 1-5 scale. A total 
score is calculated by summing item scores and transforming them into a score from 0-
100 where 0 equals no disability and 100 equals the most severe disability (Hudak et al. 
1996). Since its development, the measurement properties of the DASH questionnaire 
have been extensively and successfully evaluated for a variety of upper limb conditions 
and translated and cross-culturally adapted into over 40 different languages, including 
Arabic (Hudak et al. 1996, Turchin et al. 1998, Beaton et al. 2001, Westphal et al. 2002, 
Veehof et al. 2002, Soohoo et al. 2002, Offenbacher et al. 2003, Greenslade et al. 2004, 
Liang et al. 2004, Raven et al. 2008). The DASH was also validated to measure ULD in 
patients with NS-NP (Huisstede et al. 2009, Mehta et al. 2010). Further details about the 
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DASH and its validation for patients with NS-NP can be found in chapter 2 (see Section 
2.3.4).   
 
6.2.11 Testing procedure 
Participants who were found to be provisionally eligible and verbally consented to take 
part in this study were booked for a face-to-face assessment and SAMP testing at Tanta 
Universal Teaching Hospital (Egypt). The testing procedure, including phone screening 
is detailed in Table 6.7. In the first assessment and testing session, participants were 
requested to complete the NDI and the DASH questionnaires (Arabic versions) on their 
arrival (see Appendices 11and 24), since they were used to confirm a patient’s 
eligibility and facilitate allocation to subgroups. This was followed by a face-to-face 
assessment with the researcher (ASEA) in a designated room where their weight and 
height as well as their neck and upper limb symptoms severity were measured alongside 
subjective examination using standardised clinical questions (see Appendix 25). 
Participants were then requested to meet immediately with the relevant examiners, as 
appropriate, for the first SAMP testing, if they were found eligible and consented in 
writing (see Appendix 26). The SAMP testing was conducted by two examiners 
independently but simultaneously for each patient participant, meanwhile healthy 
subjects were tested by one examiner only. Each examiner completed the data collection 
sheet (see Appendix 27) for each participant regarding the SAMP score (i.e. the number 
of valid SAMP repetitions within 30 seconds) and the administration time (that is, the 
time taken for the examiner to describe and demonstrate the SAMP test as well as 
instruction and performance of the SAMP test by the patient). Two pairs of examiners 
“GE and HA” and “BH and AH” were used in this study.  The first session, including 
the face-to-face assessment and testing procedure, took up to 60 minutes, after which 
participants were booked for the second session within 7 days (minimum of 4 days) 
after the first session as appropriate and convenient to participants. 
 
Participants in this study were stable in the time interval between sessions. During the 
second session, participants were requested to complete the NDI and the DASH 
questionnaires (Arabic versions) upon their arrival. The neck and upper limb symptoms 
severity were measured as per the first session, using the VAS scale 0-10 where 0 
indicates no pain/symptoms and 10 indicates the worst possible pain/symptoms. 
Participants were requested to meet immediately with the relevant examiners for the 
second SAMP testing. Patients were SAMP tested in the second session by the same 
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pair of examiners who tested them in the first session, though they had swapped their 
rater/co-assessor roles. Similar to the first session, healthy subjects were tested by one 
examiner only that had tested them in the first session. The second session took up to 45 
minutes, after which participants were discharged.  
 
Table 6.7: Testing procedure  
 What When 
Telephone Call  
(Preliminary 
Assessment) 
Explanation of the study protocol  
Phone screening  
Verbal consent  
Provision of information sheet 
Immediately after the 
patients were identified by 
obtaining the patients’ list 
or after the healthy 
subjects were identified by 
contacting the research 
hotline number.  
Face-to Face 
Assessment and 
First Testing 
Session  
Outcome measures (NDI and DASH) 
Face-to-Face Assessment  
Written consent  
SAMP testing 
Arranged to suit 
participant (patient or 
healthy subject) 
Second Testing 
Session 
Repeat outcome measures (NDI and DASH) 
N/UP symptoms severity (patient only) 
Repeat SAMP testing   
Within 7 days (minimum 4 
days) after the first 
session.  
NDI: Neck and Disability Index, DASH: Disability of Arm, Shoulder and Hand, SAMP: 
Single Arm Military Press Test, N: Neck, UL: Upper Limb.     
 
6.2.12 Data analysis  
Data were transferred into Excel and then to SPSS (IBM SPSS Statistical Software, 
version 24.0) for further analysis. Descriptive statistics (mean, standard deviation, 
standard error of mean, and 95% confidence interval) were computed for the SAMP 
test, the DASH and the NDI for patient participants and healthy subjects.  
 
Inter-rater reliability, which compares the scores of the two independent but 
simultaneous examiners, was calculated for the two pairs of examiners (see Table 6.8) 
across the two testing sessions. Intra-rater reliability, which compares the score of a 
single examiner across two sessions was calculated for the two examiners (GE and BH) 
across the two testing sessions. Given that the objective was to examine the reliability of 
the SAMP test and the type of data are continuous, the ICC 2,1 (Modal: Two-Way 
Random, and Type: Absolute Agreement, and Single Measure) value with 95% 
Confidence Interval (CI) is recommended for calculating the reliability parameters as it 
considers both systematic and random errors (Shavelson 1991, de Vet et al. 2011). For 
inter- and intra-rater reliability, the ICC was anticipated to be (≥ 0.90) (see hypothesis 1 
in section 6.1.2). Measurement error was calculated by estimating the SEM which was 
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derived using a two-way analysis of variance (ANOVA) ICC 2,1 (McGraw and Wong 
1996). The SDC was then calculated using the formula: (SDC = 1.96 C Ö2 C SEM). For 
measurement error, the SEM was anticipated to be (≤ 1) and smaller than the SDC (see 
hypothesis 2 in section 6.1.2).  
 
Table 6.8: Examiners and testing sessions  
Examiners Session 1 Session 2 
First Pair:  
Examiner GE 
Rater (Administrating the SAMP test)   Co-assessor (counting SAMP score only)  
First Pair:  
Examiner HA 
Co-assessor Rater 
Second Pair: 
Examiner BH 
Rater  Co-assessor 
Second Pair: 
Examiner AH 
Co-assessor Rater 
GH: Dr Ghada Eid, HA: Dr Heba Abdo, BH: Dr Basma Hassan, AH: Dr Asmaa 
Hamdy   
 
Since there is no gold standard OM available in relation to measuring UL functional 
capacity in patients with NS-NP, construct validity (convergent and discriminant) was 
assessed in this study to provide evidence for the validity of the SAMP test as a measure 
of UL functional capacity in patients with NS-NP. The construct validity (convergent) 
for the SAMP test was assessed in terms of the level of association between the SAMP 
test scores and standardised instrument UL PROM (DASH) that measures the same 
constructs (physical function). Convergent validity of the SAMP test was elucidated by 
use of Pearson correlation coefficient (r) (de Vet et al. 2011). Significant and high 
negative correlation between the SAMP score and the DASH score was anticipated (see 
hypotheses 1 in section 6.1.3).  
 
Discriminant validity (known group) was evaluated by assessing the difference in the 
SAMP scores between patient participants and healthy subjects. The differences in the 
SAMP scores for the patient group and healthy subject group was calculated using the 
independent sample t-test. It was anticipated that the patient group would have a 
statistically significant (p < 0.05) and substantially poorer SAMP score compared to the 
healthy subject group with a large magnitude of difference in the mean (Effect Size = > 
0.8) (Cohen 1988).  
 
Discriminant validity between patient sub-groups was also examined by comparing 
SAMP test scores obtained during the first session by examiner GE using the 
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independent sample t-test and an analysis of variance. Four sub-groups of patients were 
formulated based on the NDI scores as illustrated in Table 6.9. It was anticipated that 
patients in the extremely severe NS-NP sub-group would have a statistically significant 
(p < 0.05) and substantially poorer SAMP score as compared to the patients in the other 
3 sub-groups with mild, moderate or severe NS-NP with a large magnitude of difference 
in the mean (Effect Size = > 0.8) (Cohen 1988). The effect size was calculated in this 
study in accordance with Cohen (1988) recommendations using the formula: (Effect 
Size = t2 ÷ t2 + (n1 + n2 – 2), in which t donated to t-test score, n 1 donated to sample 1 
and n 2 donated to sample 2. The effect was considered small when the effect size 
ranged between 0.0 – 0.4, medium 0.5 – 0.7 and large 0.8+ (Cohen 1988).   
 
Table 6.9: Patient sub-groups 
Sub-Groups Description 
Sub-Group 1  Patients with mild NS-NP who scored between 10-29 in the NDI 
Sub-Group 2 Patients with moderate NS-NP who scored between 30-49 in the NDI 
Sub-Group 3 Patients with severe NS-NP who scores between 50-68 in the NDI 
Sub-Group 4 Patients with extremely severe NS-NP who scored between 69-100 in the NDI 
NDI: Neck Disability Index 
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6.3 Results  
The flow of patient participants and healthy subjects through each stage is presented in 
Figure 6.2 below. A list of 300 patients was obtained from the Rheumatology and 
physical Therapy Department at Tanta Universal Teaching Hospital. Following the 
phone screening, 250 patients were eligible and willing to voluntarily participate in the 
study. Thirty patients were ineligible, 20 patients declined and 40 patients did not turn-
up for their first assessment and testing session. Following the face-to-face assessment 
in the first session, 210 patient participants and 81 healthy subjects were found eligible 
for SAMP testing, interested to participate in the study, consented in writing and 
participated in session 1 testing. All the participants from session 1 testing participated 
in session 2 testing (no drop-out).  
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6.3.1 Participants characteristics and baseline data  
The demographic characteristics of participants in this study alongside the baseline data 
are summarised in Table 6.10. The mean age of the recruited 210 patient participants 
was 40.41 ± 4.938 years. Further, 81 healthy subjects were recruited in the control 
group (36.54 ± 4.917 years). There were no significant differences between patients and 
healthy subjects on age, occupation, weight or height, and this indicates that these 
groups were well frequency matching in demographics. However, as expected, there 
were clear and substantial differences between these groups regarding the severity of 
NS-NP and UL functional capacity in all measures. In the second testing session, 
patients reported slight, but non-significant, improvements on their neck symptoms 
severity (NSS) and UL symptoms severity (ULSS) scores, indicating that these groups 
were stable between testing sessions.  
  
Table 6.10: Participants characteristics at baseline stratified by the NDI 
Variables  Healthy 
Subjects 
N=81 
All Patients 
with NS-NP 
N=210 
Patients with 
Mild NS-NP:  
N=23 
Patients with 
Moderate NS-
NP: N=120 
Patients with 
Severe NS-
NP:  N=46 
 Patient with 
E Severe NS-
NP: N=21 
Age in years 
Mean 
SD 
 Minimum 
Maximum 
 
36.54 
4.917 
30 
50 
 
40.41 
4.938 
30 
53 
 
34.43 
2.609 
30 
39 
 
38.50 
2.834 
32 
46 
 
44.72 
3.053 
41 
53 
 
48.43 
2.336 
41 
52 
Occupation: frequencies 
(%) 
Office Clark 
Teacher 
House Wife 
 
 
77 (95.1) 
3 (3.7) 
1 (1.2) 
 
 
200 (95.2) 
8 (3.8) 
2 (1.0) 
 
 
17 (73.9) 
6 (26.1) 
0 (0.0) 
 
 
118 (98.3) 
1 (0.8) 
1 (0.8) 
 
 
45 (97.8) 
0 (0.0) 
1 (2.2) 
 
 
20 (95.2) 
1 (4.8) 
0 (0.0) 
Weight (kg): 
Frequencies (%)  
75-80 
81-85 
86-90 
91+ 
 
 
4 (5) 
4 (5) 
23 (28.3) 
50 (61.7) 
 
 
10 (4.8) 
11 (5) 
60 (28.6) 
129 (61.4) 
 
 
1 (4.4) 
1 (4.4) 
7 (30.4) 
14 (60.8) 
 
 
5 (4.2) 
6 (5) 
33 (27.5) 
76 (63.3) 
 
 
3 (6.5) 
2 (4.4) 
10 (21.8) 
31 (67.3) 
 
 
1 (4.8) 
2 (9.6) 
9 (42.8) 
9 (42.8) 
Height (cm): 
Frequencies (%) 
155-160 
161-165 
166+ 
 
 
25 (30.8) 
51 (63) 
5 (6.2) 
 
 
65 (31) 
130 (62) 
15 (7) 
 
 
8 (34.7) 
14 (60.9) 
1 (4.4) 
 
 
36 (30) 
76 (63.4) 
8 (6.6) 
 
 
15 (32.6) 
27 (58.6) 
4 (8.8) 
 
 
6 (28.6) 
13 (61.8) 
2 (9.6) 
NSS: Sessions 1 and 2 
Mean 
SD 
Minimum 
Maximum  
0 
 
4.40 – 4.04 
1.475–1.452 
2 - 2 
8 - 7 
 
2.57 – 2.43 
0.507 - 0.507 
2 - 2 
3 – 3 
 
3.74 – 3.36 
0.642 - 0.754 
3 - 2 
5 - 5 
 
5.78 – 5.50 
0.593 - 0.658 
5 – 4 
7 - 7 
 
7.19 – 6.52 
0.402 - 0.512 
7 - 6 
8 – 7  
ULSS: Sessions 1 and 2 
Mean 
SD 
Minimum 
Maximum 
0 
 
2.45 – 2.28 
1.414-1.295 
1 - 1 
6 - 5 
 
1.00-1.00 
0.000 - 0.000 
1 - 1 
1 – 1 
 
1.73 - 1.61 
0.645 - 0.677 
1 – 1 
3 - 3 
 
3.78 – 3.70 
0.593 - 0.465 
3 – 3 
5 – 4  
 
5.19 – 4.43 
0.402 - 0.507 
5 – 4  
6 - 5 
NDI Scores: (Session1) 
Mean 
SD 
Minimum 
Maximum 
 
4.63 
0.798 
4 
6 
 
43.38 
14.474 
20 
80 
 
25 
3.275 
20 
29 
 
36.85 
5.291 
30 
49 
 
55.98 
5.053 
50 
67 
 
73.19 
3.326 
69 
80 
NSS: Neck Symptoms Severity, ULSS: Upper Limb Symptoms Severity, SD: Standard 
Deviation, NDI: Neck Disability Index, E: Extremely, NS-NP: Non-Specific Neck Pain  
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6.3.2 Descriptive statistics of the SAMP test 
Participants in the study were SAMP tested in two sessions approximately 1 week apart. 
Descriptive statistics of the SAMP test scores for the healthy subject group, all patient 
groups, and the four sub-groups of patients are summarised in Table 6.11. There were 
significant differences between the healthy subject group and the all patients group, of 
which the healthy subjects group scored substantially higher in the SAMP performance 
in the two testing sessions. In addition, the sub-group of patients with extremely severe 
NS-NP demonstrated the poorest SAMP performance across the two testing sessions.       
  
Table 6.11: Descriptive statistics of the SAMP test 
 
Healthy 
Subjects 
N=81 
All Patient 
NS-NP 
N=210 
Mild NS-
NP 
N=23 
Moderate 
NS-NP 
N=120 
Severe 
NS-NP 
N=46 
Extremely 
Severe NS-NP 
N=21 
Session 1 
 
Mean 
SD 
Std. Error of Mean 
Minimum 
Maximum 
 
 
35.23 
3.348 
0.372 
28 
39 
 
 
17.90 
6.167 
0.426 
3 
30 
 
 
24.17 
2.588 
0.540 
19 
28 
 
 
20.48 
4.048 
0.370 
12 
30 
 
 
13.15 
2.996 
0.442 
7 
20 
 
 
6.67 
1.713 
0.374 
3 
9 
Session 2 
 
Mean 
SD 
Std. Error of Mean 
Maximum 
Maximum 
 
 
35.07 
2.692 
0.299 
29 
40 
 
 
17.99 
6.140 
0.424 
3 
30 
 
 
24.04 
2.549 
0.532 
20 
28 
 
 
20.60 
4.123 
0.376 
12 
30 
 
 
13.17 
2.961 
0.437 
7 
20 
 
 
7.00 
1.673 
0.365 
3 
9 
NS-NP: Non-Specific Neck Pain, SD: Standard Deviation, Std. Error of Mean: 
Standard Error of Mean. 
 
6.3.3 Descriptive statistics of the DASH and the NDI questionnaires  
Participants in this study completed the NDI and the DASH questionnaire before SAMP 
testing in each session. The DASH and the NDI scores for all participants are presented 
in Table 6.12. The DASH and the NDI scores for the all patients group were 
significantly higher compared to those in the healthy subject group in the two testing 
sessions. Furthermore, the DASH and NDI scores across the two sessions for the patient 
sub-group with extremely severe NS-NP were also significantly higher compared to 
those in the sub-groups with mild, moderate or severe NS-NP, indicating the strong 
relationship between NS-NP and ULD.  
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Table 6.12: Descriptive statistics of the DASH and NDI questionnaires 
Variable 
Healthy 
Subjects 
N=81 
All 
Patient 
N=210 
Mild NS-
NP  
N=23 
Moderate 
NS-NP  
N=120 
Severe 
NS-NP 
N=46 
Extremely 
Severe NS-NP 
N=21 
DASH: Session 1 
Mean 
SD 
Std. Error of Mean 
Minimum 
Maximum 
 
4.04 
1.167 
0.130 
3 
6 
 
31.66 
16.420 
1.133 
15 
75 
 
16.87 
1.632 
.340 
15 
20 
 
23.11 
7.346 
0.671 
15 
47 
 
45.54 
5.648 
0.833 
40 
62 
 
66.33 
5.083 
1.109 
57 
75 
DASH: Session 2 
Mean 
SD 
Std. Error of Mean 
Minimum 
Maximum 
 
4.10 
0.682 
0.076 
3 
6 
 
30.56 
15.810 
1.091 
14 
74 
 
16.74 
1.514 
0.316 
15 
19 
 
22.22 
6.988 
0.638 
14 
45 
 
43.98 
5.467 
0.806 
38 
60 
 
64.00 
5.099 
1.113 
55 
74 
NDI: Session 1 
Mean 
SD 
Std. Error of Mean 
Minimum 
Maximum 
 
4.63 
0.798 
0.089 
4 
6 
 
43.38 
14.474 
0.999 
20 
80 
 
25.00 
3.275 
0.683 
20 
29 
 
36.85 
5.291 
0.483 
30 
49 
 
55.98 
5.053 
0.745 
50 
67 
 
73.19 
3.326 
0.726 
69 
80 
NDI: Session 2 
Mean 
SD 
Std. Error of Mean 
Minimum 
Maximum 
 
4.48 
0.550 
0.061 
4 
6 
 
38.61 
14.934 
1.031 
18 
78 
 
21.57 
2.501 
0.522 
18 
26 
 
31.48 
5.689 
0.519 
22 
45 
 
51.67 
6.332 
0.934 
42 
65 
 
69.38 
3.930 
0.858 
64 
78 
NS-NP: Non-Specific Neck Pain, SD: Standard Deviation, Std. Error of Mean: 
Standard Error of Mean. 
 
6.3.4 Inter-and intra-rater reliability  
The ICC, SEM and SDC with 95% Confidence Interval (CI) for the patient group were 
calculated for the two pairs of examiners across the two testing sessions to assess the 
inter-rater reliability and agreement for the SAMP scores for all patient group and the 
four sub-groups of patients. Meanwhile, the ICC, SEM and SDC with 95% CI, patient 
group, were calculated for examiners A (GE) and B (BH) across the two sessions to 
assess the intra-rater reliability and agreement for the SAMP scores for all patient group 
and the four sub-groups of patients. The ICC 2,1, SEM and SDC statistics with 95% CI 
(lower bound and upper bound) for inter-and intra-rater reliability are presented in 
Tables 6.13 and 6.14 respectively. The ICCs exceeded 0.90 for all patients group and 
the four sub-groups with NS-NP (see hypothesis 1, section 6.1.2) and therefore the 
SAMP test demonstrated almost perfect reliability (Landis and Koch 1977). The SEM 
was ≤ 1 and smaller than the SDC for inter- and intra-rater reliability (see hypothesis 2, 
section 6.1.2) indicating that the SAMP performance demonstrated high levels of score 
accuracy and agreement (de Vet et al. 2011, Vincent and Weir 2012). 
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Table 6.13: Inter-rater Reliability Coefficient, SEM and SDC with 95% CI for the SAMP test   
Variables 
All Patient 
with NS-NP 
N=210 
Patients with 
Mild NS-NP 
N=23 
Patients with 
Moderate NS-
NP: N=120 
Patients with 
Severe NS-
NP: N=46 
Patients with 
E Severe NS-
NP: N=21 
Session: (1)  
ICC 2,1  
95% CI (LB – UB) 
SEM 
SDC 
 
0.995 
0.993 - 0.996 
0.42 
1.2 
 
0.951 
0.884 - 0.980 
0.54 
1.5 
 
0.983 
0.972 - .990 
0.48 
1.3 
 
0.999 
0.998 - .999 
0.10 
0.28 
 
0.999 
0.998 - .999 
0.10 
0.28 
Session: (2) 
ICC 2,1  
95% CI (LB – UB) 
SEM 
SDC 
 
0.997 
0.996 - 0.998 
0.35 
1.0 
 
0.950 
0.888 - 0.978 
0.58 
1.6 
 
0.992 
0.998 - 0.994 
0.37 
1.0 
 
0.999 
0.998 - 0.999 
0.10 
0.28 
 
0.983 
0.958 - 0.993 
0.21 
0.58 
ICC: Interclass Correlation Coefficient, NS-NP: Non-Specific Neck Pain, E: Extremely, CI: Confidence 
Interval, LB: Lower Bound, UB: Upper Bound 
 
Table 6.14: Intra-rater Reliability Coefficient, SEM and SDC with 95% CI for the SAMP test   
Variables All Patient with NS-NP: N=210 
Patients with 
Mild NS-NP 
N=23 
Patients with 
Moderate NS-
NP: N=120 
Patients with 
Severe NS-
NP: N=46 
Patients with 
E Severe NS-
NP: N=21 
Examiner: A   
ICC 2,1  
95% CI (LB – UB) 
SEM 
SDC 
 
0.997 
0.996 - 0.998 
0.35 
1.0 
 
0.964 
0.918 - 0.984 
0.49 
1.2 
 
0.992 
0.989 - 0.995 
0.35 
1.0 
 
0.999 
0.998 - 0.999 
0.10 
0.28 
 
0.926 
0.784 - 0.972 
0.41 
1.1 
Examiner: B   
ICC 2,1  
95% CI (LB – UB) 
SEM 
SDC 
 
0.994 
0.998 - 0.996 
0.44 
1.2 
 
0.938 
0.858 - 0.973 
0.62 
1.7 
 
0.983 
.0 956 - 0.991 
0.45 
1.2 
 
0.999 
0.998 – 0.999 
0.10 
0.28 
 
0.893 
0.675 – 0.960 
0.48 
1.3 
ICC: Interclass Correlation Coefficient, NS-NP: Non-Specific Neck Pain, E: Extremely, CI: Confidence 
Interval, LB: Lower Bound, UB: Upper Bound. 
 
 
6.3.5 Construct validity (convergent) 
The SAMP test score for examiner (A) in the first testing session was used in assessing 
construct validity. To test the a priori formulated hypotheses regarding the convergent 
validity of the SAMP test, the relationship between the SAMP test and other extensively 
validated and commonly used OMs that measure the same construct (physical function) 
for the UL, namely DASH, was investigated using Pearson correlation (r). Pearson 
correlation and the p values are summarised in Table 6.15. Highly significant negative 
correlations, exceeding -0.70 were observed between the SAMP performance and the 
DASH scores in the expected direction. This indicates that the SAMP test and the 
DASH are closely related instruments and measure the same construct, which support 
the hypothesis (see hypothesis 1 in section 6.1.3) and established the SAMP test’s 
convergent validity (Domholdt 2000). 
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Table 6.15: Correlation between the scores on the SAMP and the PROM (DASH) 
Measurements  Healthy Subjects: N=81 
Patients with NS-NP: 
N=210 
DASH v SAMP 
r 
p 
 
-0.870 
< 0.001 
 
-0.911 
< 0.001 
DASH: Disability of the Arm, Shoulder and Hand, SAMP: Single Arm Military Press, r: 
Pearson Correlation, p: p value. 
 
6.3.6 Construct validity (discriminant) 
The SAMP test scores for examiner (A) in the first testing session was used in assessing 
discriminant validity. To test the a priori formulated hypotheses regarding discriminant 
validity of the SAMP test, an independent t-test was conducted to compare the SAMP 
scores between the healthy subject group and the all patient group; the patient sub-
groups one (mild NS-NP) and two (moderate NS-NP); subgroups two and three (severe 
NS-NP); and sub-groups three and four (extremely severe NS-NP). Meanwhile, an 
analysis of variance (ANOVA) was used to compare the SAMP scores between the four 
patient sub-groups. The mean, standard deviation, mean difference, t-test (t), ANOVA 
(F), effect size and p value with 95% confidence interval (lower bound – upper bound) 
between the groups are presented in Table 6.16. The healthy subjects had statistically 
significant higher mean SAMP score than those subjects with NS-NP (p < 0.001) with a 
large magnitude of difference in the mean, exceeding 0.8 in the anticipated direction.  
This support the hypothesis (see hypothesis 2, section 6.1.2) and indicates that the 
SAMP test has the capability to discriminate between healthy subjects and patients with 
NS-NP. Patients with extremely severe NS-NP had statistically significant lower SAMP 
scores than those with severe, moderate or mild NS-NP (p < 0.001) with a large 
magnitude of difference in the mean, exceeding 0.8 in the anticipated direction. This 
support the hypothesis (see hypothesis 3, section 6.1.3) and indicates that the SAMP test 
has the capacity to discriminate between patient sub-groups with different symptoms 
severity levels.     
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Table 6.16: Differences in the SAMP scores for patients/healthy subjects and patient sub-groups  
Group Mean (SD) Mean Difference t f p ES 
95% CI 
(LB – UB) 
Patients (N=210) 
Controls (N=81) 
17.90 (6.167) 
35.23 (3.348) -17.339 -23.964 
 < 0.001 0.67 (-18.763 – -15.915) 
Mild (N=23) 
Moderate (N=120) 
24.17 (2.588) 
20.48 (4.048) 3.699 4.214 
20.857 
< 0.001 0.11 (2.382 – 5.016) 
Moderate (N=120) 
Severe (N=46) 
20.48 (4.048) 
13.15 (2.996) 7.323 12.715 < 0.001 0.50 
(6.181 – 
8.464) 
Severe (N=46) 
E. Severe (N=21) 
13.15 (2.996) 
6.67 (1.713) 6.486 11.208 < 0.001 0.66 
(5.329 – 
7.642) 
SD: Standard Deviation, t: Independent Sample T-Test, f: ANOVA, p: p value, CI: 
Confidence Interval, LB: Lower Bound, UB: Upper Bound, ES: Effect Size, E: 
Extremely. 
 
6.4 Discussion  
6.4.1 Summary and discussion of the main findings  
This chapter reports the findings of a validation study and has captured information 
regarding the reliability (inter- and intra-rater), agreement (measurement error) and 
construct validity (convergent and discriminant). The findings demonstrate that the 
SAMP test is a reliable and valid measure of UL functional capacity for female patients 
with NS-NP, hence meeting the aim set out in section 6.1.1.  
 
6.4.1.1 Reliability  
The SAMP test in this study demonstrated almost perfect levels of reliability. 
Interpretation of the 95% Confidence Intervals around the Interclass correlation 
coefficient (ICC2,1) values suggest that the ‘true’ estimate of inter-rater and intra-rater 
reliability of the SAMP test ranges between ICCs of 0.993 and 0.996, indicating a very 
high degree of stability of the SAMP scores over time and agreement between 
examiners. This exceeds the ICC ≥0.90 set out in hypothesis 1 of (section 6.1.2). Given 
that an ICC of at least 0.70 is considered to be satisfactory for an instrument to detect 
differences in severity between groups in research practice and an ICC value of 0.90-
0.95 is required to enable this instrument to detect differences in severity between 
individual patients in clinical practice (de Vet et al. 2011). This indicates that the SAMP 
test can be consistently well used by different examiners or the same examiner in 
different occasions to measure the UL functional capacity in female patients with NS-
NP in clinical practice and research practice. The reliability results of this study have 
confirmed previous results reported for the SAMP test. McLean et al. (2010a) 
investigated the reliability (inter- and intra-rater) of the SAMP test in a series of 
preliminary studies on a symptomatic and asymptomatic non-patient population 
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(n=265) and reported an ICC of 0.94 and 0.99, indicating almost perfect reliability. The 
reason for this high level of reliability may be due to the simplicity, efficiency and 
standardisation of the SAMP test procedure. The SAMP test requires simple 
instructions and minimal training for observers who are required to only count the valid 
repetitions within 30 second in order to complete the administration of the test.   
 
The SAMP test also demonstrated very low levels of measurement error. The Standard 
Error of Measurement (SEM) was very low, smaller than the Smallest Detectable 
Change (SDC), as expected and ranged between 0.10 and 0.58 for inter-rater reliability 
and 0.10 and 0.62 for intra-rater reliability, indicating a very high level of precision in 
the patients’ scores. This is smaller than the SEM ≤ 1 and smaller than the SDC set out 
in hypothesis 2 of (section 6.1.2). In conclusion, these results support the hypotheses of 
this study in terms of reliability and suggests that the SAMP test can be considered a 
reliable instrument for use in clinical practice as well as research practice to evaluate the 
UL functional capacity in female patients with NS-NP. The hypotheses regarding 
reliability and agreement have been confirmed (see Section 6.1.2).  
 
6.4.1.2 Validity  
Construct validity was used in this study to determine the validity of the SAMP test 
since there is no gold standard available in relation to measuring UL functional capacity 
in patients with NS-NP. The SAMP test demonstrated very high level of convergent 
validity. The Pearson correlation analysis revealed a significant (p < 0.001) and 
substantial negative correlation (r = 0.911) between the SAMP score and the DASH 
score in the patient group. The correlation and significance levels were in the 
anticipated direction stated in hypothesis 3 (section 6.1.3), indicating that the SAMP 
test and the DASH are measuring a related construct and thus providing evidence of 
convergent validity for the SAMP test. The results of this study in terms of convergent 
validity confirmed the previous results reported for the SAMP test. McLean et al. 
(2010a) investigated convergent validity of the 3-kg SAMP test in a series of 
preliminary studies on a symptomatic and asymptomatic non-patient population and 
reported a highly significant negative correlation between the SAMP test scores and the 
DASH scores (r = 0.814, p < 0.001, n=190), indicating a high level of convergent 
validity.   
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The SAMP test also demonstrated very high level of discriminant validity. The 
independent t-test analysis revealed substantial differences in scores between patient 
participants (mean SAMP score = approximately 18 repetitions) and healthy subjects 
(mean SAMP score = approximately 35 repetitions). The magnitude of the difference in 
the mean (mean difference = -17.339, 95% CI: -18.763 to -15.915) with large effect 
(Effect Size = 0.67), indicates that the SAMP test can consistently distinguish well 
between patients with NS-NP and healthy subjects (see hypothesis 3, section 6.1.3). In 
addition, substantial significant differences were observed between the four sub-groups 
of patients, depending on the severity of their NS-NP (mild, moderate, severe and 
extremely severe) as the mean SAMP scores were approximately 24, 20, 13 and 7 
repetitions respectively. This indicates that the SAMP test can consistently discriminate 
well between groups of patients with different severity levels (see hypothesis 4, section 
6.1.3). In conclusion, these results support the hypotheses of this study in terms of 
construct validity (convergent and discriminant) and suggest that the SAMP test is a 
valid measure of UL functional capacity for female patients with NS-NP. The 
hypotheses about convergent and discriminant validity which are set out in section 6.1.3 
have been confirmed.  
 
6.4.2 Strengths of the study  
This study was conducted, analysed and interpreted in accordance with the COSMIN 
recommendations for developing health-related OMs (Mokkink et al. 2010a, Terwee et 
al. 2012). Independent but simultaneous examiners were used when assessing the inter-
rater reliability in order to reduce or possibly prevent the risk of fatigue or soreness to 
patients, which could lead to drop-out and also to avoid the Hawthorne effect (de Vet et 
al. 2011). The large sample size achieved (n=290), which was significantly higher than 
the recommended sample size by the COSMIN checklist (n=100), increased the 
statistical power of the test of mean differences, prevented potential masking of 
systematic error and enabled appropriate quantification of the SAMP test reliability and 
agreement (de Vet et al. 2006). The use of broad inclusion and exclusion criteria and 
standardised assessments which ensured that the included participants were 
representative of typical healthy subjects from the general population and patients with 
a variety of NS-NP severity levels. All patients and healthy subjects who attended the 
first assessment and testing session were retrained for the second testing session (no 
drop-out), The reasons for this may be due to the strategies used during the recruitment 
and data collection stages to ensure participation adherence to the testing protocol, such 
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as establishing tracking system to locate participants, creating a welcoming environment 
that made the assessment and testing as smooth and enjoyable as possible, educating 
patients regarding the importance and the benefits of this testing which may have 
enhanced their ability and encouraged their adherence, maintaining flexibility when 
scheduling appointments and using reminder phone calls about appointments. To ensure 
robust methodology, the DASH questionnaire, which is relevant, standardised and 
extensively validated UL PROM, was used as comparator when evaluating the 
convergent validity of the SAMP test.      
 
6.4.3 Limitations of the study  
The limitations of this study are very similar to those of the acceptability and feasibility 
study outlined in chapter 5 and relate to poor generalisability to the male population as 
well as those patients with other types of neck disorders. This study also involved 
female participants in the age group (30-50-year) only, which may limit generalisability 
of the findings to other younger and older patients age groups. In addition, a small 
number of raters were used when investigating the inter-and intra-rater reliability, which 
may limit the generalisability of the findings. These limitations point to the requirement 
for further validation studies in these populations and additional raters.    
 
6.4.4 Clinical implications  
The findings of this study provide preliminary evidence that the SAMP test is a reliable 
and valid measure of UL functional capacity in a female patient with NS-NP. The study 
also provides normative data for the SAMP performance in healthy subjects which can 
provide a possible target for rehabilitation. This study also demonstrated that there are 
significant and substantial differences in the SAMP performance depending on the NS-
NP severity level.  Healthy subjects had an average SAMP performance of 36, patients 
with mild NS-NP had an average of 25, patients with moderate NS-NP had an average 
of 20, patients with severe NS-NP had an average of 14, whereas those with extremely 
severe NS-NP had an average of 7 repetitions within the 30 seconds. This indicates that 
the SAMP performance is poorer when the severity increases. Clinicians can use the 
SAMP test in clinical and research practice to evaluate the UL functional capacity in 
female patients with NS-NP.      
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6.4.5 Research implications  
In this study, the SAMP test has been subject to only reliability and validity testing in 
female patients with NS-NP but provides preliminary evidence that the 1-kg SAMP test 
is a potentially suitable measure for use in clinical practice and research. Further 
research is required to investigate the measurement and practical properties of the 
SAMP test in younger and older female patients, male populations and those with other 
neck disorders such as Whiplash Associated Disorder (WAD), cervical radiculopathy 
and post-surgical neck disorders. In addition, longitudinal studies to explore the 
responsiveness of the SAMP test are also warranted.      
 
6.5 Conclusion  
This validation study established that the SAMP test has adequate reliability and 
agreement levels in a female patient population with NS-NP to be used in clinical 
practice and research practice. The study provides preliminary evidence regarding the 
expected relationships and convergent validity of the SAMP test with selected 
standardised instruments measuring the same construct (DASH). The SAMP test was 
able to discriminate between patients and healthy subjects as well as between NS-NP 
patient sub-groups with different levels of NS-NP severity.    
    
The next chapter is the concluding chapter to the thesis and aims to bring together the 
findings of the thesis to show that the overall aim and objectives of the PhD programme 
have been met and to make recommendations regarding the assessment and 
management of ULD in patient populations with NS-NP.  
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Chapter 7: Summary, discussion and conclusion  
 
7.1 Introduction  
This chapter summarises and discusses the key findings of the thesis, provides 
reflection on the main strengths and limitations of the programme of research and 
explores the implications for clinical practice and future research, before drawing final 
conclusions.  
 
This thesis was concerned with the clinical measurement and management of ULD in 
female patient populations with NS-NP. Although ULD is known to be present in 
people with NS-NP, little was known about the extent to which physiotherapists might 
measure or manage ULD in this patient group. However, one of the key challenges to 
optimising the management of this group of patients was the lack of guidance around 
available measures of ULD which were suitable for use in this population. 
Consequently, the current programme of research was designed and conducted in order 
to better understand the challenges of measuring and managing ULD in patients with 
NS-NP and provide guidance and possible solutions to overcome the challenges.  
 
The aims of this programme of research were to: 
1. Investigate the measurement and practical properties of all available ULD OMs 
that have been developed or validated for patients with NS-NP and identify 
those that are suitable for use in research and clinical practice.  
2. Investigate the measurement and management strategies used by UK 
physiotherapists for patients with NS-NP, particularly those related to measuring 
and managing ULD. 
3. Identify an acceptable and feasible SAMP test weight for use in female patents 
with NS-NP.  
4. Investigate the measurement properties of the SAMP test in female patients with 
NS-NP.  
 
7.2 Summary of the thesis methodology  
The findings and conclusions reached in this thesis were reported through four research 
studies. First, a systematic review identified, summarised and critically examined all 
available studies on the measurement and practical properties of OMs that had been 
developed or validated to measure ULD in patients with NS-NP (Aim 1). Second, a 
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literature review investigated current evidence-based management practices 
recommended for the management of patients with NS-NP. The findings from this 
review were used to inform the development of the subsequent UK national survey of 
neck pain, which established current UK physiotherapy about the measurement and 
management of NS-NP and ULD (Aim 2). Third, a validation study explored the 
acceptability and feasibility of the SAMP test in female patients with NS-NP (Aim 3). 
Finally, a validation study investigated the reliability and validity of the SAMP test in 
female patients with NS-NP and healthy subjects (Aim 4). A summary and discussion 
of the key findings are presented in the next two sections. 
 
7.3 Summary of the thesis findings  
In chapter two, the systematic review identified five clearly defined and reproducible 
OMs which were supported by 11 developmental and/or evaluative studies. Evidence 
for the five identified and reviewed OMs in this systematic review was either limited, 
unknown or unavailable, and this prevented a clear recommendation for any of the 
identified instruments. However, since brevity of an OM is essential for busy clinical 
practice, the QuickDASH, NULI and the SAMP test were considered promising ULD 
OMs for patients with NS-NP, if adequately validated.  
 
Chapter three reported the findings from a literature review that explored current 
evidence-based management practices within the scope of physiotherapy for patients 
with NS-NP. A wide range of treatment approaches are currently recommended for the 
management of patients with NS-NP. Evidence for the effectiveness of these 
approaches were mostly limited, inconclusive or does not exist when used in isolation. 
However, evolving evidence suggests the benefits and clinical usefulness of 
incorporating a multimodal approach to management. Strong evidence of effectiveness 
was only found for the multimodal management approach that includes exercise and 
manual therapy with/without patient education programme (Gross et al. 2007, Hurwitz 
et al. 2008, Kay et al, 2012). The findings of this literature review were subsequently 
used to inform the development of the UK national survey of neck pain (see chapter 4). 
 
Chapter four reported the findings from the UK national survey that explored 
musculoskeletal physiotherapists’ use of treatment approaches and OMs in the 
management of patients with NS-NP. The primary findings relating to utilisation of 
OMs revealed that over one-third of the survey respondents did not utilise any OMs in 
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the management of their patients with NS-NP. The most commonly reported reasons for 
this were a lack of clear guidance about the suitability of the available OMs and a lack 
of time. Further, of the two-thirds of the survey respondents who reported utilising 
OMs, the majority were consistently using single-dimensional numeric pain and range 
of motion rating scales (e.g. the Visual Analogue Scale and the Goniometric Measure of 
Neck Motion). Pain and range of motion do not adequately reflect the construct of NP 
and therefore indicates an inadequate level of measurement activity within 
physiotherapists who manage patients with NS-NP. Physical and functional limitations, 
psychological distress and reduced quality of life constructs that are relevant and 
frequently associated with NS-NP were rarely, if ever, measured. Moreover, the 
majority of the physiotherapists in this national survey reported that they would not 
consider using ULD rehabilitation strategies while managing their patients with NS-NP. 
This survey suggests that physiotherapists in the UK have a long distance to go 
regarding implementing evidence-based practice when measuring their patients with 
NS-NP as well as measuring and managing ULD in patients with NS-NP. These 
findings were consistent with the findings of comparative surveys (Jette et al. 2009, 
MacDermid et al. 2013). 
 
Chapter five reported the findings from a pragmatic randomised controlled study that 
explored the acceptability and feasibility of the SAMP test from both the patients and 
clinicians’ perspective. Following comparison of the ½-kg, 1-kg, 1½-kg weights, the 
1kg SAMP test was identified, from both the patient and clinician perspective, as being 
the most suitable weight for use with female patients with NS-NP. The feasibility of the 
SAMP test was also demonstrated regarding the time and resources required. This study 
established that the 1-kg SAMP test is an acceptable and feasible measure of ULD for 
female patients with NS-NP. 
 
Chapter six reported the findings from the validation study that further investigated the 
reliability and validity of the SAMP test. The study revealed that the SAMP test had 
adequate levels of inter-rater and intra-rater reliability, and very low error, which 
indicates high level of agreement and score accuracy. A high level of correlation 
between the SAMP test and DASH scores of the patient population confirmed the 
convergent validity of the 1-kg SAMP test. Substantial significant differences between 
the SAMP scores of healthy controls compared to the population with NS-NP, coupled 
with further analysis which demonstrated substantial significant differences between the 
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SAMP scores of four clinically known groups (mild, moderate, severe and extremely 
severe NS-NP groups) confirmed the discriminant validity of the SAMP test. All a 
priori formulated hypotheses (see sections 6.1.2 and 6.1.3) regarding convergent 
validity and discriminant validity were confirmed. This study established that the 1-kg 
SAMP test is a reliable and valid measure of ULD for female patients with NS-NP. 
 
7.4 Discussion of key findings  
This thesis identified the 1kg SAMP test as a reliable and valid performance-based 
instrument for measuring ULD in patients with NS-NP. The findings of the systematic 
review in chapter two highlighted that the QuickDASH, NULI and the SAMP test were 
promising UL measures for patients with NP. The QuickDASH and NULI are PROMs 
which have the advantages that they are short and can be completed quickly at the clinic 
or from home; and they enable patients to report their own pain and functional ability 
alongside the effects of pain and disability on their psychological, psychosocial and 
quality of life constructs (Bellamy et al., 1997; Lee et al., 2000; Reneman et al., 2002). 
However, the main disadvantage is that they are subjective and likely to be biased based 
on a patient’s sex, age, race and perception of pain and/or functional limitations 
(McDowell, 2006). The sources of bias frequently related to the patients over-or under 
estimation of their physical and functional ability (Rose et al., 2008; Terwee et al., 
2006; Stratford et al., 2006; Stratford et al., 2010). Evidence from the literature suggests 
that patients often have difficulties estimating their ability to perform activities that they 
did not undertake during the last week because of pain and/or disability, and that their 
estimates of their performance often exceeded their actual ability (Youn et al. 1996). 
Other patients perform their daily activities using compensatory mechanisms and this is 
likely to influence the magnitude of their disability and thus the patient-reported OM 
score (Heaton and Bamford, 2001; Bialocerkowski, 2002). 
 
The SAMP test was the only identified performance-based OM that was developed 
specifically to identify and quantify ULD in the assessment of patients with NP and to 
monitor its progress during rehabilitation (McLean et al. 2010a). Since it is a physical 
performance test that requires the patient to use multiple joints to physically perform a 
task that represents some construct of function including endurance and strength, it has 
a greater likelihood of accurately capturing the presence of any level of disability (e.g. 
subtle, mild, moderate, severe or extremely severe) (Curb et al. 2006, Pinheiro et al. 
2016). The SAMP test is also advantageous because it can be efficiently administered 
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by clinicians of varying experience, in any setting, using minimal equipment and within 
less than 2-minutes. The SAMP test is convenient, efficient and inexpensive and 
therefore has the characteristics to be very useful in clinical practice and research. The 
only disadvantage is that the SAMP test does not capture information about patients’ 
psychological, psychosocial or quality of life constructs. However, this information can 
be acquired by using any standardised generic PROM alongside the SAMP test. 
Therefore, the SAMP test was taken forward for further testing (see Chapters 5 and 6).  
 
The findings from the UK national survey of neck pain highlighted gaps between 
evidence-based practice and current UK physiotherapy practice regarding the utilisation 
of OMs in the assessment and during the management of patients with NS-NP. A lack 
of clear guidance regarding the suitability of available OMs and a lack of time were 
found to be the main barriers to utilisation. Routine utilisation of standardised OMs is 
considered to be a fundamental part of physiotherapy rehabilitation and frequently 
advocated by clinical guidelines and professional bodies as the optimal way for 
implementing evidence-based practice (Hammond 2000, Rudd et al. 2000, CSP 2005, 
College of Occupational Therapists 2007, American Occupational Therapy Association 
2010). Further, UK organisations such as the HCPC, CSP and the NHS explicitly 
recommend the routine utilisation of 
standardised OMs wherever practicable (NHS, 2010; CSP, 2012; HCPC, 2013). 
Meanwhile, in standard 12 of the Standards of Proficiency for Physiotherapists (HCPC, 
2013), the HCPC suggests that physiotherapists must be able to collect and document 
qualitative and quantitative data regarding their patient’s condition by using 
standardised OMs. This is to assure the quality of clinical practice by meeting the 
patient’s needs and changes in health, demonstrating the significance of physiotherapy 
by enabling physiotherapists to prove their impact and cost-effectiveness (HCPC, 
2013). 
 
The findings of the survey also highlighted the gap between evidence-based practice 
and current UK physiotherapy practice in relation to measuring and rehabilitating ULD 
in patients with NS-NP. There is strong evidence that patients with NS-NP frequently 
reported ULD and the presence of NS-NP may be a risk factor for the development and 
progression of ULD (Walker-Bone et al. 2004, Frank et al. 2005, Bot et al. 2005, 
Huisstede et al. 2006, Rasmussen et al. 2008, Feleus et al. 2008). Further, ULD may 
lead to NS-NP becoming recurrent, persistent or disabling (Eriksen et al. 1999, Bot et 
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al. 2005, McLean et al. 2011). Consequently, routine utilisation of suitable ULD OMs 
in the assessment and during the management of patients with NS-NP is essential since 
it enables clinicians to quantify the presence of any ULD and include ULD 
rehabilitation in the management plan, if indicated (McLean et al. 2011, Osborn and Jull 
2013). 
 
The findings of the validation studies (chapters 5 and 6) established the acceptability, 
feasibility, reliability and validity of the 1-kg SAMP test which is quick, easy, 
inexpensive and efficient. The SAMP test provides both clinicians and patients alike a 
quick, easy and intuitive way to understand the extent of ULD and the direction of 
travel towards incorporating ULD rehabilitation as part of the individualised patient-
centred approach to management. The SAMP test has the advantage that it may identify 
a deficit in UL capacity before a patient is aware themselves that they have a deficit and 
prevent the progression of ULD by undertaking early UL rehabilitation. This will 
reduce or possibly eliminate the potential of ULD to have a detrimental cyclical effect 
on the neck and UL, which may then contribute to chronic, persistent NS-NP and ULD 
(McLean et al. 2010b). The SAMP test, however still has some limitations as an OM 
since it has been tested only on female patients with NS-NP in the 30-50-year age group 
using low number of raters. In addition, the SAMP test has not been tested for 
responsiveness.  
 
7.5 Contribution to knowledge  
This thesis has made a significant contribution to the field of ULD in patients with NS-
NP. First, through successfully identifying and critically examining all available OMs, 
this programme has identified a lack of high-quality UL OMs that are suitable for use in 
patients with NS-NP. However, promising measures were identified that would be 
clinically useful if supported by further high-quality validation studies, these include the 
QuickDASH, NULI and the SAMP test (see section 2.4). 
 
Second, the national survey provided empirical evidence regarding the relatively poor 
utilisation of multimodal measurement and management approaches in patients with 
NS-NP. This indicates that many physiotherapists are not adhering to high quality 
research recommendations or evidence-based guidelines for the measurement and 
management of patients with NS-NP. Also, there is a relative absence of management, 
and a lack of measurement of ULD by physiotherapists for patients with NS-NP. 
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Third, the results of the survey have also provided an extensive and innovative online 
methodology that incorporated popular Social Networking Sites (e.g. Twitter, 
Facebook, and LinkedIn) and could be used in future web-based surveys. This online 
methodology, which does not need any organisational permissions, can provide instant 
access to a national and/or international population of interest and achieve a large 
sample size at a very low cost.  
 
Fourth, this programme of research has led to the validation of the 1-kg SAMP test as a 
valid and reliable measure of ULD for patients with NS-NP. It is also acceptable, 
feasible and therefore suitable for use in clinical practice and research. It is a quick, 
easy, intuitive measure which requires minimal equipment, training or resources and 
may therefore have cross-cultural validity. 
 
7.6 Strengths of the programme of research  
The main strength of this thesis is related to the investigation of clinical measurement 
and management of ULD in patients with NS-NP using robust methodological 
approaches. A wide range of high-quality strategies were used to address the research 
aim and objectives including a systematic review in chapter 2, a national survey in 
chapter 4, a validation (acceptability and feasibility) study in chapter 5 and another 
validation (reliability and validity) study in chapter 6. Theses research strategies were 
designed and conducted according to standardised and established guidelines and 
recommendations such as COSMIN, PRISMA, Web-Based Survey Design Standard 
and ISOQOL. This programme of research as a whole has been carefully developed to 
ensure that each of the stages conducted supported the development and conduct of the 
subsequent stages, which helps to ensure rigour of each of the research studies and 
therefore the overall validity of the findings at each stage. The data collection phase of 
the UK national survey of neck pain (chapter 4) used a novel, extensive and innovative 
online methodology incorporating social networking sites such as Twitter, Facebook 
and LinkedIn to facilitate the recruitment of a large sample size at a very low cost 
without permission for access. 
 
7.7 Limitations of the programme of research 
The specific limitations to each part of the PhD project have been discussed within 
individual chapters of the thesis. Overall, the primary limitations of the programme of 
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research relate to generalisability of the findings due to the use of sample of Egyptian 
female patients with NS-NP who are in the 30-50-year age group alongside the low 
number of raters in the validation studies of the SAMP test in chapters 5 and 6. 
However, there were many good reasons for starting with this population. First, NS-NP 
is the most common form of NP with approximately 80% of patients experiencing this 
form (Binder 2007, Jull et al. 2008). Second, given that there are differences between 
the strength of men and women, it was not feasible to use a mixed population, and so 
acceptability testing and validation testing need to be conducted in either male or female 
populations. Third, the most recent and well-designed epidemiological studies found 
that the incidence of NP is higher among females with an increased risk of developing 
NP until the 35-49-year age group (Freburger et al. 2005, Cote et al. 2008, Sahin et al. 
2008, Hog-Jonson et al. 2008, Hoy et al. 2010, Hoy et al. 2014). Fourth, the Egyptian 
population was chosen because it was easy to access by the lead researcher (ASEA) and 
cost-effective. Nevertheless, the transferability of the SAMP test to men and patients 
with potentially more severe forms of NP such as Whiplash Associated Disorder 
(WAD) or cervical radiculopathy is not possible. Although the SAMP test has a lot of 
characteristics which suggest that it has cross-cultural validity, the extent of 
transferability of the 1-kg SAMP test to other female populations needs to be assessed.  
 
Given the constraints of this programme of research, limited investigation into the 
measurement properties was conducted, which included acceptability and feasibility 
testing as well as reliability and validity testing using specific age group and low 
number of raters. The responsiveness which is validity over time was not investigated in 
this thesis, and therefore the SAMP test’s use as a measure of treatment outcome is not 
yet established.  
 
7.8 Clinical implications  
The key emergent findings of this programme of research is that the 1-kg SAMP test is 
an acceptable and feasible measure of ULD in female patients with NS-NP. The 
findings from chapter five of this thesis provided evidence for the practical properties, 
acceptability and feasibility of the SAMP test when using the 1-kg weight in its 
practical application, and this in turn established its relevance and clinical utility. In 
addition, the study in chapter six provided preliminary evidence for the reliability and 
validity of the SAMP test, and therefore the SAMP test can be recommended for use in 
clinical practice and research to measure ULD in female patients with NS-NP. The 
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SAMP test is advantageous because it is easy, simple, quick, inexpensive and can be 
efficiently administered by physiotherapists or clinicians with varying experience in any 
setting with the minimum of equipment (one hand-weight) in less than 2 minutes. 
 
The majority (80%) of patients with NS-NP report UL functional limitations. Routine 
utilisation of a suitable UL OM in the assessment is necessary to quantify the presence 
of any ULD and provide a rational and a target for UL rehabilitation in the management 
plan (McLean et al. 2011, Osborn and Jull 2013). However, in this thesis (chapter 4), 
the UK physiotherapists reported inadequate utilisation of OMs in the assessment of 
their patients with NS-NP. In particular, physiotherapists rarely, if ever, used an UL 
OM. This insufficient evaluation of patients may contribute to overall inadequate 
management as more than half of physiotherapists failed to utilise recommended 
multimodal management approach, and nearly all UK physiotherapists reported not 
including UL rehabilitation in the management of their patients with NS-NP. They 
reported a lack of clear guidance regarding the availability of suitable measures and a 
lack of time to be the main barriers to their utilisation of OMs. However, this 
programme of work provided the 1-kg SAMP test that can be used quickly and easily 
by physiotherapists to partially support the management of patients with NS-NP. 
However, the SAMP test, as a PBOM, does not have some of the advantages which 
PROMs possess such as measuring patient’s psychological, psychosocial and quality of 
life constructs and to overcome this, it is possible that the SAMP test can be used to 
measure the physical/function construct of the UL in patients with NS-NP alongside a 
standardised generic PROM to measure those other relevant constructs. 
 
7.9 Research implications  
The findings from this thesis have provided evidence of the acceptability, feasibility, 
reliability and validity of the SAMP test, which has the capacity to accurately measure 
the ULD in patients with NS-NP. However, further research into the validation of the 
SAMP test is warranted. This includes investigating the measurement and practical 
properties of the SAMP test in younger and older female patients with NS-NP, male 
populations and those with other neck disorders such as Whiplash Associated Disorder 
(WAD), cervical radiculopathy and post-surgical neck disorders. In addition, 
longitudinal studies to explore the responsiveness of the SAMP test are also warranted.          
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7.10 Conclusion  
This programme of research used a variety of research methodologies to identify and 
critically examine all available UL OMs for patients with NS-NP. Subsequently, this 
research described substantial gaps in current evidence-based practice of UK 
physiotherapists regarding the measurement of patients with NS-NP and associated 
deficits in the measurement and management of ULD in this patient population. 
Additional research led to the development of a valid and reliable 1-kg SAMP test 
which is a measure of UL functional capacity for female patients with NS-NP. The 1-kg 
SAMP test is acceptable, feasible and therefore suitable for use in clinical practice and 
research. Furthermore, it is quick to administer (less than two minutes), easy to use, 
interpret, and can be used in any situation where resources are limited. Further research 
regarding the validation of the SAMP test is still required to investigate its measurement 
and practical properties in other populations with NP. Following the findings of this 
thesis, the SAMP test may go some way towards facilitating improved measurement 
and management by physiotherapists of female patients with NS-NP. 
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Appendix 1  
Data Extraction Form - Systematic Review  
PUBLICATION DETAILS 
• Author:  
• Title:  
• Journal/source:  
• Origin:  
 
Note:  
…………………………….......................................................……………………………................................................................... 
…………………………….......................................................……………………………................................................................... 
 
STUDY POPULATION & SAMPLING PROCEDURES  
 
Was the sample in which the measure was validated adequately described? 
1- Study (sample) size?  
2- Median or mean age? (With SD or range)  
3- Distribution of gender?  
4- Setting(s) in which the study was conducted (e.g. general population, primary care, hospital, rehab centred)?  
5- Countries in which the study was conducted?   
6- Language in which the measure was evaluated?  
7- was the method used to select patients adequately described? (e.g. convenience, constructed, random?)   
8- Was the percentage of missing responses (response rate) acceptable? (Report rate)  
9- Important disease characteristics (e.g. diagnosis, severity, status, duration etc.)  
10- Description of treatment?  
11- Additional information of relevance to study population?  
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CHARACTERISTIC OF MEASURES INCLUDED IN THE STUDY 
 
Table 1 - Please list all measure included in the study (number of measures will link to table 2) 
Footnote: Response options: 
 
Name of the measure: please enter the name as reported by the study author. Full name and acronym.  
Original ref: does the author provide the original reference for the measure?  Please indicate if original version (O) or modification (M). if modification – please detail in 
item 2 
Contact details: does the author provide contact details for the developer? Yes (√), No (x), or Not clear? If Yes = please note author and year  
Repro: is sufficient information provided to support reproduction? Yes (√), No (x), or Not clear?   
How was the measure completed? Pt=patient; C=clinician; int=interview; Px=proxy (detail); O=other (detail); NC=not clear 
Mode of completion? Pen and paper; Computer; Web-based; Other 
Type of measure? 
 
 
 
 
 
 
 
 
G- generic; HU-health utility; CS-condition-specific; DS-domain-specific; PS-population 
specific 
 PROM-specific Information 
Name of the measure 
(Original / modification? - please detail M in text) 
Original ref? Contact details? Repro? Self-completion? Mode of 
completion  
Type 
1-       
2-       
3-       
4-       
5-       
6-        
7-        
8-        
9-       
10-       
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Table 2 - which measurement and/or practical properties are evaluated in this study? 
 O Reliability Validity (I) 
Responsiveness 
Measure 
(Table 3.1) 
 (A) Internal 
consistency 
(B) Test-
retest 
Reliabilit
y 
Inter/intr
a-rater 
reliability 
(C) 
Measureme
nt error 
(D) 
Content 
validity 
Construct validity (H) Criterion validity  
     (E) 
Structural 
(F) Hypothesis 
Testing 
 
(G) Cross-cultural 
Validity 
Concurrent Predictive  
1-             
2-            
3-            
4-            
5-            
6-            
7-            
8-            
9-            
10-            
 
O. Does the study describe original development of the measure? Yes √ No x 
 
Reliability – Does the study report evidence of reliability? Yes √ No x 
(A) Internal Consistency  
(B) Test-retest / Inter / Intra-rater reliability 
(C) Evidence of measurement error 
 
Validity – Does the study report evidence of validity? Yes √ No x 
(D) Content validity 
(E) Construct validity – Structural 
(F) Construct validity – Hypothesis testing 
 4 
• Convergent or divergent 
• Known group 
(G) Construct validity - Cross-cultural validity  
(H) Criterion validity  
• Concurrent validity  
• Predictive validity 
Responsiveness – Does the study report evidence of responsiveness? Yes √ No x 
(I) Responsiveness 
 
Practical properties: 
Evidence of practical properties such as precision, acceptability, and feasibility will be acquired or deduced for all relevant outcome measures. 
 
Precision – Does the study provide any evidence of data quality for the measure? (e.g. end effects, missing value etc.)  Yes √ No x 
 
Acceptability – Does the study report evidence of acceptability? (e.g. completion rate, completion time, missing value at item level etc.) Yes √ No x 
 
Feasibility – does the study report evidence of feasibility? (e.g. time taken to complete/administer the measure reported, cost of using the measure etc.) Yes √ No x 
  
 
3.3 Additional information relevant to measures listed above (e.g. modification, contact details etc.): 
…………………………….......................................................……………………………................................................................... 
 
 
3.4 Other factors relevant to measurement application: 
…………………………….......................................................……………………………................................................................... 
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MEASUREMENT AND PRACTICAL PROPERTIES 
1. RELIABILITY 
1.1 Internal consistency   
Is there evidence of internal consistency reliability? 
Yes – Please complete table 1.1.1 (A) and 1.1.2 
No 
Not clear 
Not applicable 
 
Is there evidence of Item-total correlation? 
Yes   
No 
Not clear 
Not applicable 
 
TABLE 1.1.1 - (A) COSMIN Checklist INTERNAL CONSISTENCY  
Box A. Internal consistency 
1- Does the scale consist of effect indicators, i.e. is it based on reflective 
model? 
Excellent  Good  Fair Poor 
    
2- Was the percentage of missing items given? Percentage of missing 
items described 
Percentage of missing 
items not described 
  
3- Was there a description of how missing items were handled?   Described how 
missing items were 
handled 
Not described but it 
can be deduced how 
missing items were 
handled 
No clear how missing 
items were handled  
 
4- Was the sample size included in the internal consistency analysis 
adequate?  
Adequate sample size 
(≥100) 
 
Good sample size (50-
99) 
Moderate sample size (30-
49) 
Small sample size 
(<30) 
5- Was the unidimensionality of the scale checked? i.e. was factor 
analysis or IRT model applied? 
Factor analysis 
performed in the 
study population  
Authors refer to 
another study in which 
factor analysis was 
performed in a similar 
study population  
Authors refer to another study in 
which factor analysis was 
performed, but not in a similar 
study population 
Factor analysis not 
performed and no 
reference to another 
study 
 6 
6- Was the sample size included in the unidimensionality analysis 
adequate?  
7* #items and ≥100 
 
5* #items and ≥100 OR 
6-7* #items but <100 
 
5* #items but <100 
 
<5* #items 
 
7- Was an internal consistency statistic calculated for each 
(unidimensional) (sub) scale separately?   
Internal consistency 
statistics calculated 
for each subscale 
separately  
  Internal consistency 
statistics not calculated 
for each subscale 
separately 
8- Were there any important flaws in the design or methods of the study? No other important 
methodological flaws In 
the design or execution of 
the study 
 Other minor methodological 
flaws in the design or execution 
of the study 
Other important 
methodological flaws in 
the design or execution 
of the study 
Statistical methods 
9- for classical Test Theory (CTT), continuous scores: was Cronbach’s alpha calculated?  
 
Cronbach’s alpha 
calculated 
 Only item-total correlations 
calculated  
No Cronbach’s alpha 
and no item-total 
correlation calculated 
10- for CTT, dichotomous scores: was Cronbach’s alpha or KR-20 calculated? Cronbach’s alpha or KR-
20 calculated  
 Only item-total correlations 
calculated  
No cronbach’s alpha or 
KR-20 and no item-total 
correlations calculated 
11-for IRT: was a goodness of fit statistics at a global level calculated? E.g. X2, reliability 
coefficient of estimated latent trait value (index of (subject or item) separation)  
 
Goodness of fit statistics at 
a global level calculated.   
  Goodness of fit statistics 
at a global level NOT 
calculated.   
TOTAL SCORE: ………………………………………………    
NB. Item 1 is used to determine whether internal consistency is relevant for the instrument under study. It is not used to rate the quality of the study. 
 
TABLE 1.1.2 Evidence of INTERNAL CONSISTENCY - RESULTS 
Name of the measure: 
 
Index Score and/or Domains  
Internal Consistency Reliability 
Population 
(n) 
Unidimensionality of scale confirmed? (i.e 
in this study or by reference to other study) 
Statistical analysis (e.g. alpha) and 
results 
Item-total Correlation 
     
     
     
     
     
Other comments specific to reliability: 
…………………………………………………………………………………………………………………………………………………… 
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Table 1.1.2 Guide for data extraction: Internal Consistency reliability 
Index score and/or Domains: please list name of measure / index score and/or separate domains of which evidence is reported 
Population and size: is evidence reported in the study population or other?   
Adequacy of sample size  
SP - Study Population  
O - Other please summarize (plus n=) 
 
Statistical analysis and result: 
For Classic Test Theory (CTT) – Was Cronbach’s alpha calculated? Indicate if different analysis. Report statistical value (and confidence intervals if reported).  
For dichotomous scores – Was Cronbach’s alpha or KR-20 calculated? Indicate if different analysis. Report statistical value (and confidence interval if reported).  
For Item Response Theory (IRT) - Was goodness of fit statistic at a global level calculated? E.g. x2, reliability Coefficient of estimated latent trait value (index of (subject or 
item (separation). 
Item-total correlation: please report statistical value. If reported for each item. 
Please report the range of values. If values less than 0.4 are reported highlight these specific items   
 
1.2 Test-retest / Intra-tester / Inter-tester reliability 
Is there evidence of test-retest / Intra / Inter-tester reliability? 
Yes – pleas complete table 1.2.1 (B) and 1.2.2 
No 
Not clear 
Not applicable 
 
TABLE 1.2.1 - (B) COSMIN Checklist RELIABILITY  
Box (B) Reliability: relative measures (including test-retest reliability, inter-rater reliability and intra-rater reliability) 
Design requirements 
1- Was the percentage of missing items given? 
 
Excellent  Good  Fair Poor 
Percentage of missing items 
described 
Percentage of missing 
items not described 
  
2- Was there a description of how missing items were handled? Described how missing items 
were handled 
Not described but it can be 
deduced how missing 
items were handled 
No clear how 
missing items 
were handled 
 
3- Was the sample size included in the analysis adequate? Adequate sample size (≥100) Good sample size (50-99) Moderate sample 
size (30-49) 
Small sample 
size (<30) 
4- Were at least two measurements available?  At least two measurements   Only one 
measurement 
 8 
available 
5- Were the administrations independent? Independent measurements  Assumable that the 
measurements were 
independent 
Doubtful whether the 
measurements were 
independent 
Measurements 
NOT 
independent 
6- Was the time interval stated? Time interval stated  Time interval not 
stated 
 
7- Was patients stable in the interim period on the construct to be 
measured? 
Patients were stable (evidence 
provided) 
Assumable that patients 
were stable 
Unclear if patients 
were stable  
Patients were 
NOT stable 
8- Was the time interval appropriate?  Time interval appropriate   Doubtful whether time 
interval was 
appropriate 
Time interval 
NOT appropriate 
9- Were the test condition similar for both measurement? e.g. type of 
administration, environment, instructions 
Test conditions were similar 
(evidence provided) 
Assumable that test 
conditions were similar 
Unclear if test 
conditions were 
similar  
Test conditions 
were NOT similar 
10- Were any important flaws in the design or methods of the study?  No other methodological flaws in the 
design or execution of the study 
 Other minor 
methodological flaws 
in the design or 
execution of the study 
Other important 
methodological 
flaws in the 
design or 
execution of the 
study 
Statistical methods 
 
11- for continuous scores: was an interclass correlation coefficient (ICC) 
calculated?   
ICC calculated and model or 
formula of the ICC is described  
ICC calculated and model 
or formula not described or 
not optimal. Pearson or 
Spearman correlation 
coefficient calculated with 
evidence provided that no 
systematic change has 
occurred  
Pearson or 
Spearman 
correlation 
coefficient 
calculated 
WITHOUT 
evidence provided 
that no systematic 
change has 
occurred or with 
evidence that 
systematic change 
has occurred 
No ICC or 
Pearson or 
Spearman 
correlation 
calculated 
12- for dichotomous/nominal/ordinal scores: was Kappa calculated? Kappa calculated   Only 
percentage 
 9 
agreement 
calculated 
13- for ordinal scores: was a weighted Kappa calculated? Weighted Kappa calculated  Unweighted 
Kappa calculated  
Only percentage 
agreement 
calculated  
14- for ordinal scores: was the weighting scheme described? e.g. linear, 
quadratic 
Weighting scheme described  Weighting scheme NOT 
described 
  
TOTAL SCORE: ……………………………………………… 
 
TABLE 1.2.2 Evidence of RELIABILITY - RESULTS 
Name of measure:  
Index score and/or domains 
Test-retest / inter/intra-tester reliability 
Population (n) Number of measurement/independence of administration/retest period/raters Stability / similarity of test conditions Statistical analysis and result 
     
     
     
     
     
     
 
1.3 Measurement error (absolute measures) 
Is there evidence of measurement error? 
 
Yes – Name of the measure: …………………………………………………………………… 
 
Statistical analysis and result: ………………………………………………………………… 
 
Evidence of Smallest Detectable Difference: ………………………………………… 
 
Evidence of Minimal Important Change: ……………………………………………… 
 
No 
Not clear 
Not applicable 
 
Other comments specific to measurement error:  
……………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………… 
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TABLE 1.3 - (C) COSMIN Checklist MEASUREMENT ERROR  
Box (C) Measurement error: absolute measures 
Design requirement 
 
1- was the percentage of missing items given?  
Excellent  Good  Fair Poor 
Percentage of missing items 
described 
Percentage of missing 
items NOT described 
  
2- was there a description of how missing items were handled? Described how missing items 
were handled 
NOT described it can be 
deduced how missing 
items were handled 
NOT clear how 
missing items 
were handled 
 
3- as the sample size included in the analysis adequate? Adequate sample size (≥100) Good sample size (50-
99) 
Moderate 
sample size (30-
49) 
Small sample size 
(<30) 
4- were at least two measurements available?  At least two measurements   Only one 
measurement 
5- were the administrations independent?  Independent measurements Assumable that the 
measurement were 
independent 
Doubtful 
whether the 
measurements 
were 
independent 
Measurements 
NOT independent 
6- was the time interval stated? Time interval stated   Time interval 
NOT stated 
 
7- were patients stable in the interim period on the construct to be 
measured?   
Patients were stable (evidence 
provided) 
Assumable patients were 
stable  
Unclear if 
patients were 
stable 
Patients were not 
stable 
8- Was the time interval appropriate? Time interval appropriate  Doubtful 
whether time 
interval was 
appropriate 
Time interval 
NOT appropriate 
9- were the least conditions similar for both measurements? e.g. type of 
administration, environment, instructions 
Test conditions were similar 
(evidence provided) 
Assumable that test 
conditions were similar 
Unclear if test 
conditions were 
similar 
Test conditions 
were NOT similar 
10- were there any important flaws in the design or methods of the study? No other important 
methodological flaws in the 
design or the execution of the 
study 
 Other minor 
methodological 
flaws in the 
design or 
Other important 
methodological 
flews in the design 
or execution of the 
study 
 11 
execution of the 
study 
Statistical methods 
11- for CTT: was the standard Error of Measurement (SEM), Smallest Detectable Change 
(SDC) or Limits of Agreement (LoA) calculated  
SEM, SDC, or LoA calculated Possible to calculate LoA from 
the data presented  
 SEM calculated based 
on Cronbach’s alpha, 
or on SD from another 
population 
TOTAL SCORE: ……………………………………………… 
 
2. VALIDITY 
 
2.1 Content validity (face validity) 
Is there evidence of the evaluation of content or face validity? (Please tick one box) 
Yes – please complete Table 2.1.1 (D)  
No  
Not clear 
Not applicable    
 
2.1.1 Name of the measure: …………………………………………………………………………………………………………………………………………………… 
a. Development paper: YES / NO 
• Measurement aim clear: YES / NO 
• Conceptual basis / construct clear: YES / NO 
• Purpose of the measure defined: YES / NO 
• Target population defined: YES / NO  
• Qualitative evidence from pre-testing with ‘experts’  - comprehensiveness confirmed: YES / NO  
 
b. Application of measure in population for which it was not originally developed: YES / NO 
• Measurement aim clear: YES / NO 
• Conceptual basis / construct clear: YES / NO 
• Purpose of the measure defined: YES / NO 
• Target population defined: YES / NO  
• Qualitative evidence from pre-testing with ‘experts’  - comprehensiveness confirmed: YES / NO  
 
c. Application of measure for PURPOSE for which it was NOT originally developed: YES / NO 
• Measurement aim clear: YES / NO 
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• Conceptual basis / construct clear: YES / NO 
• Purpose of the measure defined: YES / NO 
• Target population defined: YES / NO  
• Qualitative evidence from pre-testing with ‘experts’ - comprehensiveness confirmed: YES / NO  
 
TABLE 2.1.1 - (D) COSMIN Checklist - CONTENT VALIDITY  
Box (D) Content Validity (Including face validity) 
General requirement  
1- was there an assessment of whether all items refer to relevant 
aspects of the construct to be measured?  
Excellent  Good  Fair Poor 
Assessed if all items refer to 
relevant aspects of the construct 
to be measured  
 Aspects of construct to 
be measured poorly 
described AND this was 
not taken into 
consideration  
NOT assessed if all 
items refer to relevant 
aspects of the 
construct to be 
measured  
2- was there an assessment of whether all items are relevant for 
the study population? (e.g. age, gender, disease characteristics, 
country, setting) 
Assessed if all items are relevant 
for the study population in 
adequate sample size (≥10) 
  
Assessed if all 
items are relevant 
for the study 
population in 
moderate sample 
size (5-9) 
Assessed if all items are 
relevant for the study 
population in small 
sample size (<5) 
NOT assessed if all 
items are relevant for 
the study population 
OR target population 
not involved 
3- was there an assessment of whether all items are relevant for 
the purpose of the measurement instrument? (Discriminative, 
evaluative, and/or predictive) 
Assessed if all items are relevant 
for the purpose of the application  
Purpose of the 
instrument was 
not described but 
assumed 
NOT assessed if all items 
are relevant for the 
purpose of the 
application 
 
4- was there an assessment of whether all items together 
comprehensively reflect the construct to be measured?   
Assessed if all items together 
comprehensively reflect the 
construct to be measured 
 No theoretical 
foundation of the 
construct and this was 
not taken into 
consideration  
NOT assessed if all 
items together 
comprehensively 
reflect the construct 
to be measured  
5- were there any important flaws in the design or methods of the 
study 
No other important 
methodological flaws in the 
design or execution of the study  
 Other minor 
methodological flaws in 
the design or execution 
of the study 
Other important 
methodological flaws 
in the design or 
execution of the 
study 
TOTAL SCORE: ……………………………………………… 
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2.2 CONSTRUCT validity 
  
2.2.1 STRUCTURAL validity   
 Is there evidence of structural (Internal construct) validity? E.g. principle component analysis; factor analysis 
Yes – please complete Table 2.2.1 (E) and results 
No 
Not clear 
TABLE 2.2.1 - (E) COSMIN Checklist STRUCTURAL validity  
Box (E) Structural validity 
1- does the scale consists of effect indicators, i.e. it 
based on a reflective model?  
Excellent  Good  Fair Poor 
    
Design requirement  
2- was the percentage of missing items given? 
Percentage of missing items 
described  
Percentage of missing 
items NOT described  
  
3- was there a description of how missing items 
were handled? 
Described how missing items were 
handled 
Not described how missing 
items were handled 
Not clear how 
missing items were 
handled 
 
4- was the sample size included in the analysis 
adequate? 
7* #items and ≥100 5* #items and ≥100 OR 5-
7* #items but <100 
5* #items but <100 <5* #items 
5- were there any important flaws in the design or 
methods of the study? 
No other important methodological 
flaws in the design or execution of 
the study  
 Other minor 
methodological 
flaws in the design 
or execution of the 
study (e.g. rotation 
methods not 
described) 
Other important 
methodological flaws in 
the design or execution 
of the study (e.g. 
inappropriate rotation 
method) 
Statistical methods 
6- for CTT: was exploratory or confirmatory factor 
analysis performed? 
Exploratory or confirmatory factor 
analysis performed and type of factor 
analysis appropriate in view of 
existing information  
Exploratory factor analysis 
performed while 
confirmatory would have 
been more appropriate 
 No exploratory or 
confirmatory factor 
analysis performed 
7- for IRT: were IRT tests for determining the (uni-
) dimensionality of the items performed?   
IRT test for determining (uni) 
dimensionality performed  
  IRT test determining 
(uni) dimensionality 
NOT Performed 
TOTAL SCORE: ……………………………………………… 
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Structural validity – Results 
a. Name of measure:………………………………………………………………………………………………………………………… 
Statistical analysis and result (include population and n=):……………………………………………………………………………… 
………………………………………………………………………………………………………………………… 
………………………………………………………………………………………………………………………… 
………………………………………………………………………………………………………………………… 
………………………………………………………………………………………………………………………… 
b. Name of measure:………………………………………………………………………………………………………………………… 
Statistical analysis and result (include population and n=):……………………………………………………………………………… 
………………………………………………………………………………………………………………………… 
………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
 
2.2.2 CROSS-CULTURAL validity (Translated Questionnaire Only) 
 
Table 2.2.2 - (G) COSMIN checklist CROSS-CULTURAL Validity 
Box (G) Cross-cultural validity  
Design requirements 
1- Was the percentage of missing items given? 
 
Excellent  Good  Fair Poor 
Percentage of 
missing items 
described 
Percentage of missing 
items not described 
  
2- Was there a description of how missing items were 
handled? 
Described how 
missing items 
were handled 
Not described but it can be 
deduced how missing 
items were handled 
No clear how 
missing items 
were handled 
 
3- Was the sample size included in the analysis adequate? CTT: 7* #items 
and ≥100IRT: 
≥200 per group 
CTT: 5* #items and ≥100 
OR 5-7* #items but <100 
IRT: ≥200 in 1 group and 
100- 199 in 1 group 
CTT: 5* #items 
but <100IRT: 
100-199 per 
group 
CTT: <5* #items IRT: 
(<100 in 1 or both groups 
4- where both the original language in which the HR-PRO 
instrument was developed, and the language in which the 
HR-PRO instrument was translated described? 
Both source 
language and 
target language 
described 
  Source language not 
known 
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5 Was the expertise of the people involved in the translation 
process adequately described? e.g. expertise in the construct 
to be measured, expertise in both languages 
Expertise of the 
translators 
described with 
respect to disease, 
construct, and 
language 
Expertise of the translators 
with respect to disease or 
construct poor or not 
described 
Expertise of the 
translators with 
respect to 
language not 
described 
 
6- Did the translators work independently from each other? Translators 
worked 
independent 
Assumable that the 
translators worked 
independent 
Unclear whether 
translators worked 
independent 
Translators worked NOT 
independent 
7- Were items translated forward and backward? Multiple forward 
and multiple 
backward 
translations 
Multiple forward 
translation but one 
backward translation 
One forward and 
one backward 
translation 
Only a forward translation 
8- Was there an adequate description of how differences 
between the original and translated version were resolved? 
Adequate 
description of 
how differences 
between 
translators were 
resolved  
Poorly or NOT described 
how differences between 
translators were resolved 
  
9. Was the translation reviewed by committee (e.g. original 
developers)? 
Translation 
reviewed by a 
committee 
(involving other 
people than the 
translators, e.g. 
the original 
developers) 
Translation NOT reviewed 
by (such) a committee 
  
10. Was the HR-PRO instrument pre-tested (e.g. cognitive 
interviews) to check interpretation, cultural relevance of the 
translation, and ease of comprehension? 
Translated 
instrument pre-
tested, in the 
Translated instrument pre-
tested, but unclear if this 
was done in the target 
population 
Translated 
instrument pre-
tested, but NOT 
Translated instrument 
NOT pre-tested 
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2.2.3 HYPOTHESES TESTING COSMIN Checklist (F) 
 
 Is there evidence of construct (Convergent / divergent) validity? Please tick one box 
target population in the target 
population 
11. Was the sample used in the pre-test adequately 
described? 
Sample used in 
the pre-test 
adequately 
described 
 Sample used in 
the pre- test NOT 
(adequately) 
described 
 
12. Were the samples similar for all characteristics except 
language and/or cultural background? 
Shown that 
samples were 
similar for all 
characteristics 
except 
language/culture 
Stated (but not shown) that 
samples were similar for 
all characteristics except 
language/culture 
Unclear whether 
samples were 
similar for all 
characteristics 
except 
language/culture 
Samples were NOT similar 
for all characteristics 
except language/culture 
13. Were there any important flaws in the design or methods 
of the study? 
No other 
methodological 
flaws in the 
design or 
execution of the 
study 
 Other minor 
methodological 
flaws in the 
design or 
execution of the 
study 
Other important 
methodological flaws in 
the design or execution of 
the study 
Statistical methods  
14- for CTT: was confirmatory factor analysis performed? 
Multiple-group 
confirmatory 
factor analysis 
performed 
  Multiple-group 
confirmatory factor 
analysis NOT performed 
15- for IRT: was differential item function (DIF) between 
language groups assessed? 
DIF between 
language groups 
assessed 
  DIF between language 
groups NOT assessed. 
TOTAL SCORE: ……………………………………………… 
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Yes – please complete Table 2.2.3.1 (F) and 2.2.3.2 
No  
Not clear  
 
Is there evidence of known groups validity? Please tick one box 
 
Yes – please complete Table 2.2.3.1 (F) and 2.2.3.2  
No  
Not clear  
 
Was a hypothesis to be tested stated priori? 
Yes – please complete Table 2.2.3.1 (F) and 2.2.3.2 
No  
Not clear  
 
TABLE 2.2.3.1 - (F) COSMIN checklist - HYPOTHESIS TESTING  
Box (F) Hypothesis Testing 
Design requirements 
1- Was the percentage of missing items given? 
 
Excellent  Good  Fair Poor 
Percentage of missing 
items described 
Percentage of missing 
items not described 
  
2- Was there a description of how missing items were handled? Described how missing 
items were handled 
Not described but it can 
be deduced how missing 
items were handled 
No clear how missing 
items were handled 
 
3- Was the sample size included in the analysis adequate? Adequate sample size 
(≥100) 
Good sample size (50-
99) 
Moderate sample size 
(30-49) 
Small sample size 
(<30) 
4- Were hypotheses regarding correlation or mean differences 
formulated a priori (i.e. before data collection)? 
Multiple hypotheses 
formulated a priori  
Minimal number of 
hypotheses formulated a 
priori 
Hypotheses vague or 
not formulated but 
possible to deduce 
what was expected  
Unclear what was 
expected 
5- was the expected direction of correlation or mean differences 
included in the hypotheses?  
Expected direction of the 
correlation or differences 
Expected direction of the 
correlation or differences 
NOT stated  
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stated  
6- Was the expected absolute or relative magnitude of correlation or 
mean differences included in the hypotheses?  
Expected magnitude of the 
correlation or differences 
stated  
Expected magnitude of 
the correlation or 
differences NOT stated  
  
7- for convergent validity: was an adequate description provided of 
the comparator instrument(s)?  
Adequate description of 
the construct measured by 
the comparator 
instrument(s) 
Adequate description of 
most of the constructs 
measured by the 
comparator instrument(s) 
Poor description of 
the constructs 
measured by the 
comparator 
instrument(s) 
No description of the 
constructs measured 
by the comparator 
instrument(s) 
8- for convergent validity: were the measurement properties of the 
comparator instrument(s) adequately described? 
Adequate measurement 
properties of the 
comparator instrument(s) 
in a population similar to 
the study population 
Adequate measurement 
properties of the 
comparator instrument(s) 
but not sure if these 
apply to the study 
population  
Some information on 
the measurement 
properties (or a 
reference to a study 
on measurement 
properties) of the 
comparator 
instrument(s) in any 
study population 
No information on 
the measurement 
properties of the 
comparator 
instrument(s) 
9- were there any important flaws in the design or methods of the 
study?  
No other important 
methodological flaws in 
the design or execution of 
the study 
 Other minor 
methodological flaws 
in the design or 
execution of the 
study (e.g. only data 
presented on a 
comparison with an 
instrument that 
measure another 
construct) 
Other important 
methodological flaws 
in the design or 
execution of the 
study 
Statistical methods 
10- were design and statistical methods adequate for the hypotheses 
to be tested? 
Statistical methods applied 
appropriate  
Assumable that statistical 
methods were 
appropriate, e.g. Pearson 
correlation applied, but 
distribution of the score 
Statistical methods 
applied NOT optimal 
Statistical methods 
applied NOT 
appropriate 
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TABLE 2.2.3.2a: evidence of CONSTRUCT VALIDITY: Name of the measure: …………… 
Name of the test / measure / known groups:   Hypothesised relationship  
 Domain measured  Stated priori? Confirmed? Result  
     
     
     
     
 
TABLE 2.2.3.2b: evidence of CONSTRUCT VALIDITY: name of measure: …………… 
Name of the test / measure / known groups:   Hypothesised relationship  
 Domain measured  Stated priori? Confirmed? Result  
     
     
     
     
 
TABLE 2.2.3.2c: evidence of CONSTRUCT VALIDITY: name of measure: …………… 
Name of the test / measure / known groups:   Hypothesised relationship  
 Domain measured  Stated priori? Confirmed? Result  
     
     
     
     
 
Table 2.2.3.2 a, b, and c: Guide for data extraction  
 
Name of test / measure: Please list 
 
Domain: Please list 
 
Was a hypothesised relationship between measures / domains proposed a priori?  
or mean (SD) not 
presented 
TOTAL SCORE: ……………………………………………… 
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YES 
NO 
NOT CLEAR 
 
Was a hypothesised relationship between measures / domains confirmed?  
YES 
NO 
NOT CLEAR 
 
Result of correlation: please report: …………… 
 
2.3 CRITERION validity (Concurrent and Predictive)   
 
TABLE 2.3 - (H) COSMIN checklist CRITERION VALIDITY  
Box (H) Criterion validity including concurrent and predictive  
Design requirements 
1. Was the percentage of 
missing items given? 
 
Excellent  Good  Fair Poor 
Percentage of missing items 
described 
Percentage of missing items 
not described 
  
2. Was there a description 
of how missing items were 
handled? 
Described how missing 
items were handled 
Not described but it can be 
deduced how missing items 
were handled 
No clear how missing items were 
handled 
 
3. Was the sample size 
included in the analysis 
adequate? 
Adequate sample size 
(≥100) 
Good sample size (50-99) Moderate sample size (30-49) Small sample size (<30) 
4. Can the criterion used 
or employed be considered 
as a reasonable ‘gold 
standard’? 
Criterion used can be 
considered an adequate 
‘gold standard’ (evidence 
provided) 
No evidence provided, but 
assumable that the criterion 
used can be considered an 
adequate ‘gold standard’ 
Unclear whether the criterion used 
can be considered an adequate ‘gold 
standard’ 
Criterion used can NOT be 
considered an adequate 
‘gold standard’ 
5. Were there any 
important flaws in the 
design or methods of the 
study? 
No other important 
methodological flaws in the 
design or execution of the 
 Other minor methodological flaws in 
the design or execution of the study 
Other important 
methodological flaws in 
the design or execution of 
the study 
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3. RESPONSIVENESS 
 
Is there evidence of responsiveness?  
YES (Please complete table 3.1 (I) and 3.2 
NO 
NOT CLEAR 
 
Was a hypothesis to be tested stated a priori? 
YES (please briefly state) 
NO 
NOT CLEAR 
 
TABLE 3.1 - (I) COSMIN Checklist RESPONSIVENESS   
study 
Statistical methods 
6. For continuous scores: 
were correlation, or the 
area under the receiver-
operating curve 
calculated? 
Correlation or AUC 
calculated 
  Correlation or AUC NOT 
calculated 
7. For dichotomous 
scores: were sensitivity 
and specificity 
determined? 
Sensitivity and specificity 
calculated 
  Sensitivity and specificity 
NOT calculated 
TOTAL SCORE: ……………………………………………… 
Box (I) Responsiveness     
Design requirements 
1- Was the percentage of missing items given? 
 
Excellent  Good  Fair Poor 
Percentage of missing items 
described 
Percentage of missing 
items not described 
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2- Was there a description of how missing items were handled? Described how missing 
items were handled 
Not described but it can be 
deduced how missing 
items were handled 
No clear how missing 
items were handled 
 
3- Was the sample size included in the analysis adequate? Adequate sample size 
(≥100) 
Good sample size (50-99) Moderate sample size 
(30-49) 
Small sample size 
(<30) 
4- was the longitudinal design with at least two measurement used?  Longitudinal design used    No longitudinal 
design used 
5- was the time interval stated?  Time interval adequately 
described  
  Time interval NOT 
described 
6- if anything occurred in the interim period (e.g. intervention, 
other relevant event), was it adequately described? 
Anything that occurred 
during the interim period 
(e.g. treatment) adequately 
described 
Assumable what occurred 
during the interim period 
Unclear or NOT 
described what 
occurred during the 
interim period 
 
7-was the proportion of the patients changed (i.e. improvement or 
deterioration) ?  
Part of the patients were 
changed (evidence provided) 
No evidence provided, but 
assumable that part of the 
patients were changed  
Unclear if part of the 
patients were 
changed  
Patients were NOT 
changed 
Design requirement for hypotheses testing 
For construct for which a gold standard was not available: 
8- were hypotheses about changes in scores formulated a priori (i.e. 
before data collection)?  
Hypotheses formulated a 
priori 
 Hypotheses vague or 
not formulated but 
possible to deduce 
what was expected 
Unclear what was 
expected 
9- was the expected direction or correlation or mean differences of 
the change scores of HR-PRO instruments included in these 
hypotheses?   
Expected direction of the 
correlations or differences 
stated  
Expected direction of the 
correlation or differences 
NOT stated 
  
10- Were the expected absolute or relative magnitude of correlation 
or mean differences of the change scores of HR-PRO instruments 
included in these hypotheses?  
Expected magnitude of the 
correlations or differences 
stated  
Expected magnitude of the 
correlations or differences 
NOT stated  
  
11- was an adequate description provided of the comparator 
instrument(s)?  
Adequate description of the 
constructs measured by the 
comparator instrument(s)  
 Poor description of 
the construct 
measured by the 
comparator 
instrument(s) 
No description of 
the constructs 
measured by the 
comparator 
instrument(s) 
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12- Were the measurement properties of the comparator 
instrument(s) adequately described? 
Adequate measurement 
properties of the comparator 
instrument(s) in a population 
similar to the study 
population 
Adequate measurement 
properties of the 
comparator instrument(s) 
but not sure if these apply 
to the study population 
Some information on 
the measurement 
properties (or a 
reference to a study 
on measurement 
properties) of the 
comparator 
instrument(s) in any 
study population 
No information on 
the measurement 
properties of the 
comparator 
instrument(s) 
13- were any important flaws in the design or methods of the 
study?  
No other important 
methodological flaws in the 
design or execution of the 
study 
 Other minor 
methodological flaws 
in the design or 
execution of the 
study (e.g. only data 
presented on a 
comparison with an 
instrument that 
measure another 
construct) 
Other important 
methodological 
flaws in the design 
or execution of the 
study 
Statistical methods 
14- were design and statistical methods adequate for the hypotheses 
to be tested? 
Statistical methods applied 
appropriate 
 Statistical methods 
applied NOT optimal 
Statistical methods 
applied NOT 
appropriate 
Design requirement for comparison to a gold standard  
For construct for which a gold standard was available: 
15- can the criterion for change be considered as a reasonable gold 
standard? 
Criterion used can be 
considered an adequate 
‘gold standard’ (evidence 
provided) 
No evidence provided, but 
assumable that the 
criterion used can be 
considered an adequate 
‘gold standard’ 
Unclear whether the 
criterion used can be 
considered an 
adequate ‘gold 
standard’ 
Criterion used can 
NOT be considered 
an adequate ‘gold 
standard’ 
16- were there any important flaws in the design or methods of the 
study? 
No other important 
methodological flaws in the 
design or execution of the 
study  
 Other minor 
methodological flaws 
in the design or 
execution of the 
study 
Other important 
methodological 
flaws in the design 
or execution of the 
study 
Statistical methods 
17- for continuous scores: were correlations between change scores, 
or the area under the Receiver Operator Curve (ROC) curve 
calculated?  
Correlations or Area under 
the ROC Curve (AUC) 
calculated 
  Correlations or 
AUC NOT 
calculated 
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TABLE 3.2: evidence of RESPONSIVENESS (please complete table for each measure with evidence of responsiveness. (Additional details in following text) 
Name of the 
measure 
Condition/Intervention/Criterion 
for change 
N Follow-
up 
Baseline 
mean (SD) 
Follow-
up mean 
(SD) 
Mean change 
in score (p 
value) 
Reported evidence of responsiveness 
       Distribution-
based (ES) 
Anchor-based 
(external criterion: 
p value) 
Correlation of change 
score (p value) 
          
         
         
         
         
Guide for data extraction  
Name of the measure:  
Condition / intervention / criterion for change Type of intervention and study (e.g.RCT) / health transition question etc.  
Period of follow-up As reported by author 
Type of evidence reported Please inter results OR indicate if not reported (NR) or not clear (NC) etc.  
 
RESPONSIVENESS Where appropriate please complete detail for each measure: 
  
3.2.1 Detail re intervention and/or Criterion change in health: 
• Intervention (known efficacy?): …………………………………………………………………………………………………………… 
• Criterion for change in health: ……………………………………………………………………………………………………………… 
• Health transition questions: ………………………………………………………………………………………………………………… 
• Hypothesised association between intervention and outcome stated a priori: …………………………………………………… 
3.2.2 Evidence of distribution-based assessment: 
NOT CLEAR 
NO 
YES (please detail below and complete Table 3.2): duration of follow-up: ……………………………………………………………………………  
 
18- for dichotomous scales: were sensitivity and specificity 
(changed versus not changed) determined? 
Sensitivity and specificity 
calculated 
  Sensitivity and 
specificity NOT 
calculated 
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Effect size: Value: ……………………………………  
Standardised response mean: Value: …………………………………… 
Modified standardised response mean: Value: …………………………………… 
Other: Value: …………………………………… 
  
3.2.3 Evidence of Anchor-based assessment: 
NOT CLEAR 
NO 
YES (please detail below and complete table 3.2): duration of follow-up: ……………………………………  
• External anchor – e.g. external measure of change in health: …………………………………… 
• Statistical analysis and result: …………………………………… 
 
3.2.4 Correlation of change scores 
NOT CLEAR 
NO 
YES ((please detail below and complete table 3.2): duration follow-up: …………………………………… 
• Correlation between change scores in which measures: …………………………………… 
• Statistical analysis and result: ……………………………………  
 
3.2.5 Does the study report mean change in score? 
NOT CLEAR 
NO 
YES (please detail below and complete table 3.2): duration of follow-up: …………………………………… 
• Statistical analysis and results: …………………………………… 
 
3.2.6 Is other evidence of measurement responsiveness reported? For example ROC analysis 
NOT CLEAR 
NO 
YES (please detail below and complete table 3.2): duration of follow-up: …………………………………… 
• Statistical analysis and results: …………………………………… 
3.2.7 Other comments specific to responsiveness: …………………………………… 
……………………… 
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3. PRACTICAL PROPERTIES 
  
4.1 PRECISION 
 
4.1.1 Does the study describe measurement end effects? 
Not reported  
Yes (please give detail) 
 
Name of the measure:  
No evidence of end effects 
Floor effects: % floor: …………………………………… 
Ceiling effects: % ceiling: …………………………………… 
 
Other comment specific to precision: ……………………………………  
 
4.2 ACCEPTABILITY 
 
Name of the measure(s): …………………………………… 
4.2.1 Are measurement completion rates (response rate) reported? 
NO  
NOT CLEAR 
YES (please detail): ………………… 
  
4.2.2 Are missing values reported at item level (i.e. items omitted more frequently than other items):  
No  
NOT CLEAR 
YES (please detail): ……………………………………  
 
 
 
4.2.3 Is completion time reported? 
NO  
NOT CLEAR 
YES (please detail): …………………………………… 
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4.2.4 Is the reading / comprehension level reported? 
NO  
NOT CLEAR 
YES (please detail): ……………………………………  
 
4.2.5 Are any special requirements placed on respondents? 
NO 
NOT CLEAR 
YES (please detail): ……………………………………   
 
4.2.6 Were the views of patients explicitly explored with regard to the measure?  
NO 
NOT CLEAR 
YES (please detail – include population details if different from main study): ……………………………………  
 
4.2.7 Other comments specific to acceptability (complete as necessary): …………………………………… 
 
4.3 FEASIBILTY  
 
Name of the measure(s): ……………………………………  
 
4.3.1 Was the time taken to administer / complete the measure reported? 
NO  
NOT CLEAR 
YES (please detail): …………………………………… 
 
4.3.2 Was the time taken to score the measure reported? 
NO  
NOT CLEAR 
YES (please detail): ……………………………………  
 
4.3.3 Is the cost of using the measure reported? For example, purchasing the license? 
NO  
NOT CLEAR 
YES (please detail): …………………………………… 
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4.3.4 Is there a need for technological or instruction support when using the measure? 
NO  
NOT CLEAR 
YES (please detail): ……………………………………  
 
4.3.5 Is there a need for staff training to support application of the measure? 
NO  
NOT CLEAR 
YES (please detail): ……………………………………  
 
4.3.6 Other comments specific to feasibility: ……………………………………  
 
5. INTERPRETABILITY (J) 
 
Interpretability box is used to extract all information on the interpretability issues described in this box of the instrument under study from included articles. INTERPRETABILITY 
IS NOT A MEASUREMENT PROPERTY TO BE RATED/ASSESSED. 
 
TABLE 5 (J) (COSMIN Checklist) – INTERPRETABILITY 
 
5.1 Interpretability – the author reports evidence in support of: (please tick all that apply and provide detail if possible) 
 
5.1.1 Name of the measure: …………………………………… 
• Minimal important change (MIC): …………………………………… 
• Minimal clinically important change (MCIC): …………………………………… 
Box (J) Interpretability 
1. Percentage of missing items  
2. Description of how missing items were handled   
3. Distribution of the (total) score   
4. Percentage of the respondents who had the lowest possible (total) score  
5. Percentage of respondents who had the highest (total) score  
6. Scores and change scores (i.e. mean and SD) for relevant (sub) groups e.g. for normative 
groups, subgroups of patients, or general population  
 
7. Minimal important change (MIC) or minimal important differences (MID)  
 29 
• Smallest detectable change (SDC): ……………………………………  
• Patient acceptable symptom state (PASS): ……………………………………  
• Other: please describe: …………………………………… 
 
5.1.2 Name of the measure: 
• Minimal important change (MIC): ……………………………………  
• Minimal clinically important Change (MCIC): …………………………………… 
• Smallest detectable Change (SDC): ……………………………………  
• Patient acceptable symptom state (PASS): …………………………………… 
• Other: please describe: ……………………………………  
 
5.1.3 Other comments specific to interpretability: (population groups / external criterion / intervention of known efficacy etc 
………………………………………………………………………………………………………………… 
………………………………………………………………………………………………………………… 
 
6. ADDITIONAL COMMENTS 
 
Please list any references from the article, which should be obtained for future review (please list ref number, author, and journal details):   
………………………………………………………………………………………………………………… 
………………………………………………………………………………………………………………… 
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Appendix 2  
 
COSMIN Checklist with 4-Point Scale 
 
Contact  
CB Terwee, PhD  
VU University Medical Center  
Department of Epidemiology and Biostatistics  
EMGO Institute for Health and Care Research  
1081 BT Amsterdam  
The Netherlands  
Website: www.cosmin.nl, www.emgo.nl  
E-mail: cb.terwee@vumc.nl  
 
Instructions  
This version of the COSMIN checklist is recommended for use in systematic reviews of 
measurement properties. With this version it is possible to calculate overall 
methodological quality scores per study on a measurement property. A methodological 
quality score per box is obtained by taking the lowest rating of any item in a box 
(‘worse score counts’). For example, if for a reliability study one item in the box 
‘Reliability’ is scored poor, the methodological quality of that reliability study is rated 
as poor. The Interpretability box and the Generalizability box are mainly used as data 
extraction forms. We recommend to use the Interpretability box to extract all 
information on the interpretability issues described in this box (e.g. norm scores, floor-
ceiling effects, minimal important change) of the instruments under study from the 
included articles. Similar, we recommend to use the Generalizability box to extract data 
on the characteristics of the study population and sampling procedure. Therefore, no 
scoring system was developed for these boxes.  
 
This scoring system is described in this paper:  
 
Terwee CB, Mokkink LB, Knol DL, Ostelo RWJG, Bouter LM, de Vet HCW. Rating 
the methodological quality in systematic reviews of studies on measurement properties: 
a scoring system for the COSMIN checklist. Quality of Life Research 2011, July 6.  
 
Step 1. Evaluated measurement properties in the article 
 Internal Consistency  Box A 
 Reliability  Box B 
 Measurement Error Box C 
 Content Validity  Box D 
 Structural Validity  Box E 
 Hypothesis Testing  Box F 
 Cross-cultural Validity Box G 
 Criterion Validity Box H 
 Responsiveness Box I 
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Step 2. Determining if the statistical method used in the article are based on CTT 
or IRT 
 
1- Was the IRT model used 
adequately described? e.g. one 
Parameter Logistic Model (OPLM), 
Partial Credit Model (PCM), Graded 
Response Model (GRM)    
Excellent  Good  Fair Poor 
IRT model adequately 
described 
IRT model not 
adequately 
described  
  
2- Was the computer software 
package used adequately described? 
e.g. RUMM 2020, WINSTEPS, 
OPLM, MULTILOG, PARSCALE, 
BILOG, NLMIXED 
Software package 
adequately described  
Software 
package not 
adequately 
described 
  
3- Was the method of estimation 
used adequately described? e.g. 
conditional maximum likelihood 
(CML), marginal maximum 
likelihood (MML)  
Method of estimation 
adequately described  
Method of 
estimation not 
adequately 
described 
  
4- Were the assumptions for 
estimating parameters of the IRT 
model checked? E.g. 
unidimensionality, local 
independence, and item fit (e.g. 
differential item functioning (DIF))  
Assumption of the IRT 
model checked 
Assumption of 
the IRT model 
party checked  
Assumption of 
the IRT model 
not checked or 
unknown  
 
 
To obtain a total score for the methodological quality of studies that use IRT methods, 
the ‘worse score count’ algorithm should be applied to the IRT box in combination with 
the box of the measurement property that was evaluated in the IRT study. For example, 
if IRT methods are used to study internal consistency and item 4 in the IRT box is 
scored fair, while the items in the internal consistency box (box A) are all scored as 
good or excellent, the methodological quality score for internal consistency will be fair. 
However, if any of the items in box A is scored poor, the methodological quality score 
for internal consistency will be poor.  
 
Step 3. Determining if a study meets the standards for good methodological quality 
 
Box A. Internal consistency  
 
1- Does the scale consist of effect indicators, 
i.e. is it based on reflective model? 
Excellent  Good  Fair Poor 
    
2- Was the percentage of missing items given? Percentage of 
missing items 
described 
Percentage of 
missing items not 
described 
  
3- Was there a description of how missing 
items were handled?   
Described how 
missing items 
were handled 
Not described but it 
can be deduced 
how missing items 
were handled 
No clear 
how 
missing 
items 
were 
handled  
 
4- Was the sample size included in the internal 
consistency analysis adequate?  
Adequate 
sample size 
(≥100) 
 
Good sample size 
(50-99) 
Moderate 
sample 
size (30-
49) 
Small 
sample 
size (<30) 
5- Was the unidimensionality of the scale 
checked? i.e. was factor analysis or IRT 
model applied? 
Factor analysis 
performed in the 
study population  
Authors refer to 
another study in 
which factor 
analysis was 
Authors 
refer to 
another 
study in 
which 
factor 
Factor 
analysis 
not 
performed 
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performed in a 
similar study 
population  
analysis 
was 
performed, 
but not in a 
similar 
study 
population 
and no 
reference 
to another 
study 
6- Was the sample size included in the 
unidimensionality analysis adequate?  
7* #items and 
≥100 
 
5* #items and ≥100 
OR 6-7* #items but 
<100 
 
5* 
#items 
but <100 
 
<5* #items 
 
7- Was an internal consistency statistic 
calculated for each (unidimensional) (sub) 
scale separately?   
Internal 
consistency 
statistics 
calculated for 
each subscale 
separately  
  Internal 
consistency 
statistics not 
calculated for 
each subscale 
separately 
8- Were there any important flaws in the 
design or methods of the study? 
No other important 
methodological 
flaws In the design 
or execution of the 
study 
 Other 
minor 
methodolog
ical flaws 
in the 
design or 
execution 
of the study 
Other 
important 
methodologic
al flaws in the 
design or 
execution of 
the study 
Statistical methods 
9- for classical Test Theory (CTT), continuous scores: 
was Cronbach’s alpha calculated?  
 
Cronbach’s 
alpha calculated 
 Only item-
total 
correlations 
calculated  
No 
Cronbach’s 
alpha and no 
item-total 
correlation 
calculated 
10- for CTT, dichotomous scores: was Cronbach’s alpha 
or KR-20 calculated? 
Cronbach’s alpha or 
KR-20 calculated  
 Only item-
total 
correlations 
calculated  
No 
cronbach’s 
alpha or KR-
20 and no 
item-total 
correlations 
calculated 
11-for IRT: was a goodness of fit statistics at a global 
level calculated? E.g. X2, reliability coefficient of 
estimated latent trait value (index of (subject or item) 
separation)  
  
Goodness of fit 
statistics at a global 
level calculated.   
  Goodness of 
fit statistics at 
a global level 
NOT 
calculated.   
NB. Item 1 is used to determine whether internal consistency is relevant for the 
instrument under study. It is not used to rate the quality of the study. 
 
Box B. Reliability: relative measures (including test-retest, inter- and intra-rater 
reliability). 
Design requirements 
1- Was the percentage of missing 
items given? 
 
Excellent  Good  Fair Poor 
Percentage of 
missing items 
described 
Percentage of missing 
items not described 
  
2- Was there a description of how 
missing items were handled? 
Described how 
missing items 
were handled 
Not described but it 
can be deduced how 
missing items were 
handled 
No clear how 
missing items 
were handled 
 
3- Was the sample size included in 
the analysis adequate? 
Adequate sample 
size (≥100) 
Good sample size 
(50-99) 
Moderate 
sample size (30-
49) 
Small 
sample 
size (<30) 
4- Were at least two measurements 
available?  
At least two 
measurements 
available 
  Only one 
measureme
nt 
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5- Were the administrations 
independent? 
Independent 
measurements  
Assumable that the 
measurements were 
independent 
Doubtful whether 
the measurements 
were independent 
Measurem
ents NOT 
independe
nt 
6- Was the time interval stated? Time interval 
stated 
 Time interval 
not stated 
 
7- Was patients stable in the interim 
period on the construct to be 
measured? 
Patients were 
stable (evidence 
provided) 
Assumable that 
patients were stable 
Unclear if 
patients were 
stable  
Patients were 
NOT stable 
8- Was the time interval 
appropriate?  
Time interval 
appropriate  
 Doubtful whether 
time interval was 
appropriate 
Time interval 
NOT 
appropriate 
9- Were the test condition similar 
for both measurement? e.g. type of 
administration, environment, 
instructions 
Test conditions 
were similar 
(evidence 
provided) 
Assumable that test 
conditions were 
similar 
Unclear if test 
conditions were 
similar  
Test 
conditions 
were NOT 
similar 
10- Were any important flaws in 
the design or methods of the study?  
No other 
methodological flaws 
in the design or 
execution of the study 
 Other minor 
methodological 
flaws in the design 
or execution of the 
study 
Other 
important 
methodologic
al flaws in the 
design or 
execution of 
the study 
Statistical methods 
 
11- for continuous scores: was an 
interclass correlation coefficient 
(ICC) calculated?   
ICC calculated 
and model or 
formula of the 
ICC is described  
ICC calculated and 
model or formula not 
described or not 
optimal. Pearson or 
Spearman correlation 
coefficient calculated 
with evidence 
provided that no 
systematic change 
has occurred  
Pearson or 
Spearman 
correlation 
coefficient 
calculated 
WITHOUT 
evidence 
provided that no 
systematic 
change has 
occurred or with 
evidence that 
systematic 
change has 
occurred 
No ICC or 
Pearson or 
Spearman 
correlation 
calculated 
12- for 
dichotomous/nominal/ordinal 
scores: was Kappa calculated? 
Kappa calculated   Only 
percentage 
agreement 
calculated 
13- for ordinal scores: was a 
weighted Kappa calculated? 
Weighted Kappa 
calculated 
 Unweighted 
Kappa 
calculated  
Only 
percentage 
agreement 
calculated  
14- for ordinal scores: was the 
weighting scheme described? e.g. 
linear, quadratic 
Weighting 
scheme described  
Weighting scheme 
NOT described 
  
 
Box C. Measurement error: absolute measures  
Design requirement 
 
1- was the percentage of missing items 
given?  
Excellent  Good  Fair Poor 
Percentage of missing 
items described 
Percentage of 
missing items 
NOT 
described 
  
2- was there a description of how missing 
items were handled? 
Described how missing 
items were handled 
NOT 
described it 
can be 
deduced how 
missing items 
were handled 
NOT clear 
how 
missing 
items were 
handled 
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3- as the sample size included in the 
analysis adequate? 
Adequate sample size 
(≥100) 
Good sample 
size (50-99) 
Moderate 
sample size 
(30-49) 
Small 
sample 
size 
(<30) 
4- were at least two measurements 
available?  
At least two 
measurements 
  Only one 
measure
ment 
5- were the administrations independent?  Independent 
measurements 
Assumable 
that the 
measurement 
were 
independent 
Doubtful 
whether the 
measuremen
ts were 
independen
t 
Measurem
ents NOT 
independ
ent 
6- was the time interval stated? Time interval stated   Time 
interval 
NOT stated 
 
7- were patients stable in the interim 
period on the construct to be measured?   
Patients were stable 
(evidence provided) 
Assumable 
patients were 
stable  
Unclear if 
patients 
were stable 
Patients 
were not 
stable 
8- Was the time interval appropriate? Time interval appropriate  Doubtful 
whether 
time 
interval 
was 
appropriate 
Time 
interval 
NOT 
appropria
te 
9- were the least conditions similar for 
both measurements? e.g. type of 
administration, environment, instructions 
Test conditions were 
similar (evidence 
provided) 
Assumable 
that test 
conditions 
were similar 
Unclear if 
test 
conditions 
were 
similar 
Test 
condition
s were 
NOT 
similar 
10- were there any important flaws in the 
design or methods of the study? 
No other important 
methodological flaws in the 
design or the execution of 
the study 
 Other 
minor 
methodolo
gical flaws 
in the 
design or 
execution 
of the study 
Other 
important 
methodolo
gical 
flews in 
the design 
or 
execution 
of the 
study 
Statistical methods 
11- for CTT: was the standard Error of 
Measurement (SEM), Smallest Detectable 
Change (SDC) or Limits of Agreement 
(LoA) calculated  
SEM, SDC, or LoA 
calculated 
Possible to 
calculate LoA 
from the data 
presented  
 SEM 
calculate
d based 
on 
Cronbac
h’s 
alpha, or 
on SD 
from 
another 
populatio
n 
 
Box D. Content validity (including face validity)  
General requirement  
1- was there an assessment of 
whether all items refer to relevant 
aspects of the construct to be 
measured?  
Excellent  Good  Fair Poor 
Assessed if all 
items refer to 
relevant aspects of 
the construct to be 
measured  
 Aspects of 
construct to be 
measured poorly 
described AND 
this was not 
taken into 
consideration  
NOT assessed 
if all items 
refer to 
relevant 
aspects of the 
construct to be 
measured  
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2- was there an assessment of 
whether all items are relevant for 
the study population? (e.g. age, 
gender, disease characteristics, 
country, setting) 
Assessed if all 
items are relevant 
for the study 
population in 
adequate sample 
size (≥10) 
  
Assessed if all 
items are relevant 
for the study 
population in 
moderate sample 
size (5-9) 
Assessed if all 
items are 
relevant for the 
study population 
in small sample 
size (<5) 
NOT assessed 
if all items are 
relevant for 
the study 
population OR 
target 
population not 
involved 
3- was there an assessment of 
whether all items are relevant for 
the purpose of the measurement 
instrument? (Discriminative, 
evaluative, and/or predictive) 
Assessed if all 
items are relevant 
for the purpose of 
the application  
Purpose of the 
instrument was 
not described but 
assumed 
NOT assessed if 
all items are 
relevant for the 
purpose of the 
application 
 
4- was there an assessment of 
whether all items together 
comprehensively reflect the 
construct to be measured?   
Assessed if all 
items together 
comprehensively 
reflect the 
construct to be 
measured 
 No theoretical 
foundation of 
the construct 
and this was not 
taken into 
consideration  
NOT assessed 
if all items 
together 
comprehensiv
ely reflect the 
construct to be 
measured  
5- were there any important flaws 
in the design or methods of the 
study 
No other 
important 
methodological 
flaws in the design 
or execution of the 
study  
 Other minor 
methodological 
flaws in the 
design or 
execution of the 
study 
Other 
important 
methodologica
l flaws in the 
design or 
execution of 
the study 
 
Box E. Structural validity  
1- does the scale consists of effect 
indicators, i.e. it based on a 
reflective model?  
Excellent  Good  Fair Poor 
    
Design requirement  
2- was the percentage of missing 
items given? 
Percentage of missing 
items described  
Percentage of 
missing items 
NOT described  
  
3- was there a description of how 
missing items were handled? 
Described how missing 
items were handled 
Not described 
how missing 
items were 
handled 
Not clear how 
missing items 
were handled 
 
4- was the sample size included in 
the analysis adequate? 
7* #items and ≥100 5* #items and 
≥100 OR 5-7* 
#items but <100 
5* #items but 
<100 
<5* #items 
5- were there any important flaws 
in the design or methods of the 
study? 
No other important 
methodological flaws in 
the design or execution 
of the study  
 Other minor 
methodologica
l flaws in the 
design or 
execution of 
the study (e.g. 
rotation 
methods not 
described) 
Other 
important 
methodologi
cal flaws in 
the design or 
execution of 
the study 
(e.g. 
inappropriat
e rotation 
method) 
Statistical methods 
6- for CTT: was exploratory or 
confirmatory factor analysis 
performed? 
Exploratory or 
confirmatory factor 
analysis performed and 
type of factor analysis 
appropriate in view of 
existing information  
Exploratory 
factor analysis 
performed while 
confirmatory 
would have 
been more 
appropriate 
 No 
exploratory 
or 
confirmatory 
factor 
analysis 
performed 
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7- for IRT: were IRT tests for 
determining the (uni-) 
dimensionality of the items 
performed?   
IRT test for 
determining (uni) 
dimensionality 
performed  
  IRT test 
determining 
(uni) 
dimensionali
ty NOT 
Performed 
 
Box F. Hypotheses testing  
Design requirements 
1- Was the percentage of missing 
items given? 
 
Excellent  Good  Fair Poor 
Percentage of 
missing items 
described 
Percentage of 
missing items not 
described 
  
2- Was there a description of how 
missing items were handled? 
Described how 
missing items were 
handled 
Not described but it 
can be deduced 
how missing items 
were handled 
No clear how 
missing items 
were handled 
 
3- Was the sample size included in 
the analysis adequate? 
Adequate sample 
size (≥100) 
Good sample size 
(50-99) 
Moderate 
sample size (30-
49) 
Small 
sample 
size (<30) 
4- Were hypotheses regarding 
correlation or mean differences 
formulated a priori (i.e. before data 
collection)? 
Multiple hypotheses 
formulated a priori  
Minimal number of 
hypotheses 
formulated a priori 
Hypotheses 
vague or not 
formulated but 
possible to 
deduce what 
was expected  
Unclear 
what was 
expected 
5- was the expected direction of 
correlation or mean differences 
included in the hypotheses?  
Expected direction 
of the correlation or 
differences stated  
Expected direction 
of the correlation or 
differences NOT 
stated  
  
6- Was the expected absolute or 
relative magnitude of correlation or 
mean differences included in the 
hypotheses?  
Expected magnitude 
of the correlation or 
differences stated  
Expected 
magnitude of the 
correlation or 
differences NOT 
stated  
  
7- for convergent validity: was an 
adequate description provided of 
the comparator instrument(s)?  
Adequate 
description of the 
construct measured 
by the comparator 
instrument(s) 
Adequate 
description of most 
of the constructs 
measured by the 
comparator 
instrument(s) 
Poor description 
of the constructs 
measured by the 
comparator 
instrument(s) 
No 
description 
of the 
constructs 
measured 
by the 
comparator 
instrument
(s) 
8- for convergent validity: were the 
measurement properties of the 
comparator instrument(s) 
adequately described? 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) in a 
population similar 
to the study 
population 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) but 
not sure if these 
apply to the study 
population  
Some 
information on 
the 
measurement 
properties (or a 
reference to a 
study on 
measurement 
properties) of 
the comparator 
instrument(s) in 
any study 
population 
No 
informatio
n on the 
measureme
nt 
properties 
of the 
comparator 
instrument
(s) 
9- were there any important flaws 
in the design or methods of the 
study?  
No other important 
methodological 
flaws in the design 
or execution of the 
study 
 Other minor 
methodological 
flaws in the 
design or 
execution of the 
study (e.g. only 
Other 
important 
methodolo
gical flaws 
in the 
design or 
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data presented 
on a comparison 
with an 
instrument that 
measure another 
construct) 
execution 
of the 
study 
Statistical methods 
10- were design and statistical 
methods adequate for the 
hypotheses to be tested? 
Statistical methods 
applied appropriate  
Assumable that 
statistical methods 
were appropriate, 
e.g. Pearson 
correlation applied, 
but distribution of 
the score or mean 
(SD) not presented 
Statistical 
methods applied 
NOT optimal 
Statistical 
methods 
applied 
NOT 
appropriate 
 
Box G. Cross-cultural validity  
Design requirements 
1- Was the percentage of missing 
items given? 
 
Excellent  Good  Fair Poor 
Percentage of missing 
items described 
Percentage of 
missing items 
not described 
  
2- Was there a description of how 
missing items were handled? 
Described how missing 
items were handled 
Not described 
but it can be 
deduced how 
missing items 
were handled 
Not clear how 
missing items 
were handled 
 
3- Was the sample size included in 
the analysis adequate? 
CTT: 7* #items and 
≥100IRT: ≥200 per 
group 
CTT: 5* #items 
and ≥100 OR 5-
7* #items but 
<100 IRT: ≥200 
in 1 group and 
100- 199 in 1 
group 
CTT: 5* #items 
but <100IRT: 
100-199 per 
group 
 
CTT: <5* 
#items 
IRT: (<100 
in 1 or 
both 
groups 
 
4- where both the original language 
in which the HR-PRO instrument 
was developed, and the language in 
which the HR-PRO instrument was 
translated described?  
Both source language 
and target language 
described  
  Source 
language 
not known 
5- was the expertise of the people 
involved in the translation process 
adequately described? e.g. 
expertise in the construct to be 
measured, expertise in both 
languages  
Expertise of the 
translators described 
with respect to disease, 
construct, and language  
Expertise of the 
translators with 
respect to 
disease or 
construct poor 
or not described 
Expertise of the 
translators with 
respect to 
language not 
described  
 
6- did the translators work 
independently from each other?  
Translators worked 
independent 
Assumable that 
the translators 
worked 
independent  
Unclear whether 
translators 
worked 
independent 
Translators 
worked 
NOT 
independe
nt  
7- Were items translated forward 
and backward? 
Multiple forward and 
multiple backward 
translations  
Multiple 
forward 
translation but 
one backward 
translation 
One forward 
and one 
backward 
translation 
Only a 
forward 
translation 
8- was there an adequate 
description of how differences 
between the original and translated 
version were resolved? 
Adequate description of 
how differences 
between translators 
were resolved  
Poorly or NOT 
described how 
differences 
between 
translators were 
resolved 
  
 38 
9- Was the translation reviewed by 
committee (e.g. original 
developers)? 
Translation reviewed 
by a committee 
(involving other people 
than the translators, e.g. 
the original developers) 
Translation 
NOT reviewed 
by (such) a 
committee 
  
10- Was the HR-PRO instrument 
pre-tested (e.g. cognitive 
interviews) to check interpretation, 
cultural relevance of the 
translation, and ease of 
comprehension?  
Translated instrument 
pre-tested, in the target 
population 
Translated 
instrument pre-
tested, but 
unclear if this 
was done in the 
target 
population 
Translated 
instrument pre-
tested, but NOT 
in the target 
population 
Translated 
instrument 
NOT pre-
tested 
11- Was the sample used in the 
pre-test adequately described? 
Sample used in the pre-
test adequately 
described  
 Sample used in 
the pre-test 
NOT 
(adequately) 
described 
 
12- Were the samples similar for 
all characteristics except language 
and/or cultural background? 
Shown that samples 
were similar for all 
characteristics except 
language/culture  
Stated (but not 
shown) that 
samples were 
similar for all 
characteristics 
except 
language/culture 
Unclear whether 
samples were 
similar for all 
characteristics 
except 
language/culture 
Samples 
were NOT 
similar for 
all 
characteris
tics except 
language/c
ulture 
13- Were there any important flaws 
in the design or methods of the 
study? 
No other 
methodological flaws in 
the design or execution 
of the study 
 Other minor 
methodological 
flaws in the 
design or 
execution of the 
study 
Other 
important 
methodolo
gical flaws 
in the 
design or 
execution 
of the 
study 
Statistical methods  
14- for CTT: was confirmatory 
factor analysis performed?  
Multiple-group 
confirmatory factor 
analysis performed  
  Multiple-
group 
confirmato
ry factor 
analysis 
NOT 
performed 
15- for IRT: was differential item 
function (DIF) between language 
groups assessed? 
DIF between language 
groups assessed  
  DIF 
between 
language 
groups 
NOT 
assessed. 
 
Box H. Criterion validity  
Design requirements 
1- Was the percentage of missing 
items given? 
 
Excellent  Good  Fair Poor 
Percentage of missing items 
described 
Percentage of 
missing items 
not described 
  
2- Was there a description of how 
missing items were handled? 
Described how missing items 
were handled 
Not described 
but it can be 
deduced how 
missing items 
were handled 
No clear 
how 
missing 
items were 
handled 
 
3- Was the sample size included in 
the analysis adequate? 
Adequate sample size (≥100) Good sample 
size (50-99) 
Moderate 
sample 
Small 
sample 
size (<30) 
 39 
size (30-
49) 
4- can the criterion used or 
employed be considered as a 
reasonable ‘gold standard’?  
Criterion used can be 
considered an adequate ‘gold 
standard’ (evidence provided) 
No evidence 
provided, but 
assumable that 
the criterion 
used can be 
considered an 
adequate ‘gold 
standard’  
Unclear 
whether 
the 
criterion 
used can 
be 
considered 
an 
adequate 
‘gold 
standard’ 
Criterion 
used can 
NOT be 
considered 
an 
adequate 
‘gold 
standard’ 
5- were there any important flaws 
in the design or methods of the 
study? 
No other important 
methodological flaws in the 
design or execution of the 
study  
 Other 
minor 
methodolo
gical flaws 
in the 
design or 
execution 
of the 
study 
Other 
important 
methodolo
gical flaws 
in the 
design or 
execution 
of the 
study 
Statistical methods 
6- for continuous scores: were 
correlation, or the area under the 
receiver-operating curve 
calculated?  
Correlation or AUC calculated   Correlation 
or AUC 
NOT 
calculated 
7- for dichotomous scores: were 
sensitivity and specificity 
determined?  
Sensitivity and specificity 
calculated 
  Sensitivity 
and 
specificity 
NOT 
calculated 
 
Box I. Responsiveness  
Design requirements 
1- Was the percentage of missing 
items given? 
 
Excellent  Good  Fair Poor 
Percentage of missing 
items described 
Percentage of 
missing items not 
described 
  
2- Was there a description of how 
missing items were handled? 
Described how missing 
items were handled 
Not described but 
it can be deduced 
how missing 
items were 
handled 
No clear 
how 
missing 
items were 
handled 
 
3- Was the sample size included in 
the analysis adequate? 
Adequate sample size 
(≥100) 
Good sample size 
(50-99) 
Moderate 
sample 
size (30-
49) 
Small 
sample 
size (<30) 
4- was the longitudinal design with 
at least two measurements used?  
Longitudinal design used    No 
longitudina
l design 
used 
5- was the time interval stated?  Time interval adequately 
described  
  Time 
interval 
NOT 
described 
6- if anything occurred in the 
interim period (e.g. intervention, 
other relevant event), was it 
adequately described? 
Anything that occurred 
during the interim period 
(e.g. treatment) adequately 
described 
Assumable what 
occurred during 
the interim period 
Unclear or 
NOT 
described 
what 
occurred 
during the 
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interim 
period 
7-was the proportion of the patients 
changed (i.e. improvement or 
deterioration)?  
Part of the patients were 
changed (evidence 
provided) 
No evidence 
provided, but 
assumable that 
part of the 
patients were 
changed  
Unclear if 
part of the 
patients 
were 
changed  
Patients 
were NOT 
changed 
Design requirement for 
hypotheses testing 
For construct for which a gold 
standard was not available: 
8- were hypotheses about changes 
in scores formulated a priori (i.e. 
before data collection)?  
Hypotheses formulated a 
priori 
 Hypothese
s vague or 
not 
formulated 
but 
possible to 
deduce 
what was 
expected 
Unclear 
what was 
expected 
9- was the expected direction or 
correlation or mean differences of 
the change scores of HR-PRO 
instruments included in these 
hypotheses?   
Expected direction of the 
correlations or differences 
stated  
Expected 
direction of the 
correlation or 
differences NOT 
stated 
  
10- Were the expected absolute or 
relative magnitude of correlation or 
mean differences of the change 
scores of HR-PRO instruments 
included in these hypotheses?  
Expected magnitude of the 
correlations or differences 
stated  
Expected 
magnitude of the 
correlations or 
differences NOT 
stated  
  
11- was an adequate description 
provided of the comparator 
instrument(s)?  
Adequate description of the 
constructs measured by the 
comparator instrument(s)  
 Poor 
description 
of the 
construct 
measured 
by the 
comparator 
instrument
(s) 
No 
description 
of the 
constructs 
measured 
by the 
comparator 
instrument
(s) 
12- Were the measurement 
properties of the comparator 
instrument(s) adequately 
described? 
Adequate measurement 
properties of the 
comparator instrument(s) 
in a population similar to 
the study population 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) but 
not sure if these 
apply to the study 
population 
Some 
informatio
n on the 
measureme
nt 
properties 
(or a 
reference 
to a study 
on 
measureme
nt 
properties) 
of the 
comparator 
instrument
(s) in any 
study 
population 
No 
informatio
n on the 
measureme
nt 
properties 
of the 
comparator 
instrument
(s) 
13- were any important flaws in the 
design or methods of the study?  
No other important 
methodological flaws in 
the design or execution of 
the study 
 Other 
minor 
methodolo
gical flaws 
in the 
design or 
execution 
Other 
important 
methodolo
gical flaws 
in the 
design or 
execution 
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of the 
study (e.g. 
only data 
presented 
on a 
compariso
n with an 
instrument 
that 
measure 
another 
construct) 
of the 
study 
Statistical methods 
14- were design and statistical 
methods adequate for the 
hypotheses to be tested? 
Statistical methods applied 
appropriate 
 Statistical 
methods 
applied 
NOT 
optimal 
Statistical 
methods 
applied 
NOT 
appropriate 
Design requirement for 
comparison to a gold standard  
For construct for which a gold 
standard was available: 
15- can the criterion for change be 
considered as a reasonable gold 
standard? 
Criterion used can be 
considered an adequate 
‘gold standard’ (evidence 
provided) 
No evidence 
provided, but 
assumable that the 
criterion used can 
be considered an 
adequate ‘gold 
standard’ 
Unclear 
whether 
the 
criterion 
used can 
be 
considered 
an 
adequate 
‘gold 
standard’ 
Criterion 
used can 
NOT be 
considered 
an 
adequate 
‘gold 
standard’ 
16- were there any important flaws 
in the design or methods of the 
study? 
No other important 
methodological flaws in 
the design or execution of 
the study  
 Other 
minor 
methodolo
gical flaws 
in the 
design or 
execution 
of the 
study 
Other 
important 
methodolo
gical flaws 
in the 
design or 
execution 
of the 
study 
Statistical methods 
17- for continuous scores: were 
correlations between change 
scores, or the area under the 
Receiver Operator Curve (ROC) 
curve calculated?  
Correlations or Area under 
the ROC Curve (AUC) 
calculated 
  Correlation
s or AUC 
NOT 
calculated 
18- for dichotomous scales: were 
sensitivity and specificity (changed 
versus not changed) determined? 
Sensitivity and specificity 
calculated 
  Sensitivity 
and 
specificity 
NOT 
calculated 
 
Interpretability 
We recommend to use the Interpretability box to extract all information on the 
interpretability issues described in this box of the instruments under study from the 
included articles. 
 
1- Percentage of missing items   
2- Description of how missing items were handled   
3- Distribution of the (total) score   
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4- Percentage of the respondents who had the 
lowest possible (total) score  
 
5- Percentage of the respondents who had the 
highest possible (total) score 
 
6- Scores and change scores (i.e. mean and SD) 
for relevant (sub) groups, e.g. for normative 
groups, subgroups of patients, or general 
population 
 
7- Minimal important change (MIC) or minimal 
important differences (MID) 
 
 
Generalizability 
We recommend to use the Generalizability box to extract data on the characteristics of 
the study populations and sampling procedures of the included studies. 
 
1- Median or mean age (with standard deviation or 
range) 
 
2- Distribution of sex  
3- Important disease characteristics (e.g. severity, 
status, duration) and description of treatment 
 
4- Setting(s) in which the study was conducted (e.g. 
general population, primary care or 
hospital/rehabilitation care) 
 
5- Countries in which the study was conducted  
6- Language in which the HR-PRO instrument was 
evaluated 
 
7- Methods used to select patients (e.g. convenience, 
consecutive, or random) 
 
8- Percentage of missing responses (response rate)  
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Appendix 3  
 
Summary of Quality of the Measurement Properties (Systematic 
Review) 
Measurement properties that were tested in each study are reported below. 
Items with the worst rating only are reported for each measurement property.  
Yellow highlight indicates the rating assigned to each measurement property.  
 
Study 1: 
Author: Huisstede et al. (2009) 
Title: Is the Disability of Arm, Shoulder, and Hand Questionnaire (DASH) Also Valid 
and Responsive in patients with Neck Complaints.   
Journal/Source: Spine Volume 34, pp E130 – E138 
Origin: Netherland  
Tested Properties: Hypothesis testing and Responsiveness 
 
Table 1: Quality Rating 
Measurement 
Property 
Excellent Good  Fair Poor  
Construct Validity 
(Hypothesis Testing) 
 
Item 8 
 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) in a 
population similar 
to the study 
population 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) but 
not sure if these 
apply to the study 
population 
Some information on 
the measurement 
properties (or a 
reference to a study on 
measurement 
properties) of the 
comparator 
instrument(s) in any 
study population 
No information on 
the measurement 
properties of the 
comparator 
instrument(s) 
Responsiveness  
 
Item 12 
 
 
 
 
 
 
Item 13 
 
 
 
 
 
 
 
Item 14 
 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) in a 
population similar 
to the study 
population 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) 
but not sure if 
these apply to 
the study 
population 
Some information on 
the measurement 
properties (or a 
reference to a study 
on measurement 
properties) of the 
comparator 
instrument(s) in any 
study population 
No information on 
the measurement 
properties of the 
comparator 
instrument(s) 
No other 
important 
methodological 
flaws in the 
design or 
execution of the 
study 
 Other minor 
methodological flaws 
in the design or 
execution of the 
study (e.g. only data 
presented on a 
comparison with an 
instrument that 
measure another 
construct) 
Other important 
methodological 
flaws in the design 
or execution of the 
study 
Statistical 
methods applied 
appropriate 
 
 
 
Statistical methods 
applied NOT optimal 
 
Statistical methods 
applied NOT 
appropriate 
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Study 2: 
Author: Mehta et al. (2010)  
Title: Concurrent validation of the DASH and the QDASH in comparison to neck-
specific scales in patients with neck pain 
Journal/source: Spine  
Origin: Canada  
Tested Properties: Hypothesis testing and Criterion validity  
  
Table 2: Quality Rating 
Measurement Property Excellent Good  Fair Poor  
Construct Validity  
(Hypothesis Testing) 
 
Item 8 
 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) in a 
population similar 
to the study 
population 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) but not 
sure if these apply to 
the study population 
Some information 
on the measurement 
properties (or a 
reference to a study 
on measurement 
properties) of the 
comparator 
instrument(s) in any 
study population 
No information on 
the measurement 
properties of the 
comparator 
instrument(s) 
Criterion Validity 
Item 3 
 
Adequate sample 
size (≥100) 
Good sample size 
(50-99) 
Moderate sample 
size (30-49) 
Small sample size 
(<30) 
 
Study 3: 
Author: Fan et al. (2008)   
Title: Assessing validity of the QuickDASH and SF-12 as surveillance tools among 
workers with neck or upper extremity musculoskeletal disorders 
Journal/source: Journal Hand Therapy 
Origin: USA  
Tested Properties: Hypothesis testing and Criterion validity 
   
Table 3: Quality Rating  
Measurement 
Property 
Excellent Good  Fair Poor  
Construct Vallidity 
(Hypothesis Testing) 
Item 4 
 
 
 
 
Item 9 
 
 
 
 
 
 
 
 
Item 10 
Multiple 
hypotheses 
formulated a 
priori 
 
Minimal number 
of hypotheses 
formulated a 
priori 
Hypotheses vague 
or not formulated 
but possible to 
deduce what was 
expected 
Unclear what was 
expected 
No other 
important 
methodological 
flaws in the 
design or 
execution of the 
study 
 Other minor 
methodological 
flaws in the design 
or execution of the 
study (e.g. only 
data presented on 
a comparison with 
an instrument that 
measure another 
construct) 
Other important 
methodological 
flaws in the design 
or execution of the 
study 
Statistical 
methods applied 
appropriate 
Assumable that 
statistical 
methods were 
appropriate, e.g. 
Pearson 
correlation 
applied, but 
distribution of the 
score or mean 
Statistical methods 
applied NOT 
optimal 
Statistical methods 
applied NOT 
appropriate 
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(SD) not 
presented 
Criterion Validity 
 
Item 4 
Criterion used 
can be 
considered an 
adequate ‘gold 
standard’ 
(evidence 
provided) 
No evidence 
provided, but 
assumable that 
the criterion used 
can be considered 
an adequate ‘gold 
standard’ 
Unclear whether 
the criterion used 
can be considered 
an adequate ‘gold 
standard’ 
Criterion used can 
NOT be considered 
an adequate ‘gold 
standard’ 
 
Study 4: 
Author: Fan et al. (2011)   
Title: Responsiveness of the QuickDASH and SF-12 in workers with neck or upper 
extremity musculoskeletal disorders: one-year follow-up. 
Journal/source: J Occup Rehabil   
Origin: USA  
Tested Properties: Responsiveness 
 
Table 4: Quality Rating  
Measurement Property Excellent Good  Fair Poor  
Responsiveness  
 
1tem 14 
 
 
 
Statistical 
methods applied 
appropriate 
 
 
 
 
 
Statistical methods 
applied NOT optimal 
 
 
Statistical 
methods applied 
NOT appropriate 
 
Study 5: 
Author: Stock et al., 2003 
Title: The impact of neck and upper limb musculoskeletal disorders on the lives of 
affected workers: development of a new functional status index.  
Journal/source: Qual Life Res  
Origin: Canada 
Tested Properties: Reliability (Internal consistency), (test-retest, inter-rater), content 
validity and construct validity (structural, hypothesis testing). 
 
Table 5: Quality Rating 
Measurement 
Property 
Excellent  Good  Fair Poor 
Reliability: (internal 
consistency) 
Item 3 
Described how 
missing items 
were handled 
Not described 
but it can be 
deduced how 
missing items 
were handled 
No clear how 
missing items 
were handled 
 
Reliability: Test-
retest/interrater  
Item 2 
 
 
Item 7  
Described how 
missing items 
were handled 
Not described 
but it can be 
deduced how 
missing items 
were handled 
No clear how 
missing items 
were handled 
 
Patients were 
stable (evidence 
provided) 
Assumable that 
patients were 
stable 
Unclear if 
patients were 
stable 
Patients were NOT 
stable 
Content Validity 
Item 1 
 
 
Assessed if all 
items refer to 
relevant aspects 
of the construct 
to be measured 
 Aspects of 
construct to be 
measured poorly 
described AND 
this was not 
NOT assessed if all items 
refer to relevant aspects 
of the construct to be 
measured 
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Item 2 
 
 
 
 
Item 3 
 
 
 
Item 4 
 
 
 
 
Item 5 
taken into 
consideration 
Assessed if all 
items are relevant 
for the study 
population in 
adequate sample 
size (≥10) 
Assessed if all 
items are 
relevant for the 
study population 
in moderate 
sample size (5-9) 
Assessed if all 
items are relevant 
for the study 
population in 
small sample size 
(<5) 
NOT assessed if all items 
are relevant for the study 
population OR target 
population not involved 
Assessed if all 
items are relevant 
for the purpose 
of the application 
Purpose of the 
instrument was 
not described but 
assumed 
NOT assessed if 
all items are 
relevant for the 
purpose of the 
application 
 
Assessed if all 
items together 
comprehensively 
reflect the 
construct to be 
measured. 
 No theoretical 
foundation of the 
construct and this 
was not taken 
into 
consideration 
NOT assessed if all items 
together comprehensively 
reflect the construct to be 
measured 
No other 
important 
methodological 
flaws in the 
design or 
execution of the 
study. 
 Other minor 
methodological 
flaws in the 
design or 
execution of the 
study 
Other important 
methodological flaws in 
the design or execution 
of the study 
Structural Validity  
Item 3 
Described how 
missing items 
were handled 
Not described 
how missing 
items were 
handled 
Not clear how 
missing items 
were handled 
 
Hypothesis Testing 
Item 8 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) in a 
population 
similar to the 
study population 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) but 
not sure if these 
apply to the 
study population 
Some 
information on 
the measurement 
properties (or a 
reference to a 
study on 
measurement 
properties) of the 
comparator 
instrument(s) in 
any study 
population 
No information on the 
measurement properties 
of the comparator 
instrument(s) 
Responsiveness  
Item 14 
Statistical 
methods applied 
appropriate  
 Statistical 
methods applied 
NOT optimal 
Statistical methods 
applied NOT appropriate 
    
Study 6: 
Author: Lomond and Cote 
Title: Shoulder functional assessments in persons with chronic neck/shoulder pain and 
healthy subjects: reliability and effects of movement repetition 
Journal/source: IOS Press 
Origin: Canada   
Tested Properties: Test-retest/inter-rater reliability, measurement error and hypothesis 
testing.  
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Table 6: Quality Rating  
Measurement Property Excellent Good  Fair Poor  
Reliability (Test-retest) 
Item 3 
 
Item 7 
Adequate sample 
size (≥100) 
 
Good sample size 
(50-99) 
Moderate sample size 
(30-49) 
Small sample 
size (<30) 
 
Patients were 
stable (evidence 
provided) 
Assumable that 
patients were 
stable 
Unclear if patients 
were stable 
Patients were NOT 
stable 
Measurement Error  
Item 3 
 
 
Item 7 
 
 
Adequate sample 
size (≥100) 
 
 
Good sample size 
(50-99) 
 
 
Moderate sample size 
(30-49) 
 
Small sample 
size (<30) 
Patients were 
stable (evidence 
provided) 
Assumable 
patients were 
stable 
Unclear if patients 
were stable 
Patients were 
not stable 
Hypothesis Testing  
Item 4 
Multiple 
hypotheses 
formulated a 
priori 
Minimal number 
of hypotheses 
formulated a priori 
Hypotheses vague or 
not formulated but 
possible to deduce 
what was expected 
Unclear what 
was expected 
 
Study 7: 
Author: Manik Kulkarni 
Title: inter-rater and intra-rater reliability for the Single Arm Military Press Test on 
upper limb disability in adult females without neck pain   
Journal/source:  Physiotherapy Journal (unpublished) 
Origin: UK 
Tested Properties: Inter- and intra-rater reliability 
 
Table 7: Quality Rating 
Measurement Property  Excellent  Good  Fair  Poor  
Reliability (inter- and 
intra-rater) 
Item 7 
Patients were 
stable 
(evidence 
provided) 
Assumable that 
patients were 
stable 
Unclear if 
patients were 
stable 
Patients were 
NOT stable 
 
Study 8: 
Author: Vivek Jain 
Title: Inter-rater and intra-rater reliability of Single Arm Military Press (SAMP) in 
female subjects with neck pain  
Journal/source: International Journal of Physiotherapy and Rehabilitation 
(unpublished) 
Origin: UK  
Tested Properties: Inter- and intra-rater reliability 
 
Table 8: Quality Rating 
Measurement Property  Excellent  Good  Fair  Poor  
Reliability (inter- and 
intra-rater) 
Item 7 
Patients were 
stable 
(evidence 
provided) 
Assumable that 
patients were 
stable 
Unclear if patients 
were stable 
Patients were 
NOT stable 
 
Study 9: 
Author: Priya Patekar  
Title: Clinical utility of Single Arm Military Press (SAMP) Test in females with neck 
pain  
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Journal/source: Physiotherapy Journal (unpublished)  
Origin: UK 
Tested Properties: Construct validity (hypothesis testing).  
 
Table 9: Quality Rating 
Measurement Property  Excellent  Good  Fair  Poor  
Hypothesis Testing 
Item 4 
Multiple 
hypotheses 
formulated a 
priori 
Minimal number of 
hypotheses 
formulated a priori 
Hypotheses vague 
or not formulated 
but possible to 
deduce what was 
expected 
Unclear what 
was expected 
  
Study 10: 
Author: Rakhi Darne  
Title: Construct validity of Single Arm Military Press (SAMP) in females with neck 
pain  
Journal/source: International Journal of Physiotherapy and Rehabilitation 
(unpublished)   
Origin: UK 
Tested Properties: Construct validity (hypothesis testing).  
 
Table 10: Quality Rating 
Measurement Property  Excellent  Good  Fair  Poor  
Hypothesis Testing 
Item 8 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) in 
a population 
similar to the 
study 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) but 
not sure if these 
apply to the study 
population 
Some information 
on the 
measurement 
properties (or a 
reference to a study 
on measurement 
properties) of the 
comparator 
instrument(s) in 
any study 
population 
No information on 
the measurement 
properties of the 
comparator 
instrument(s) 
 
Study 11: 
Author: Balassoubramanien Toulassidharane  
Title: Construct validity of the Single Arm Military Press (SAMP) in a female non-
patient population   
Journal/source: International Journal of Physiotherapy and Rehabilitation 
(Unpublished)  
Origin: UK 
Tested Properties: Construct validity (hypothesis testing).  
 
Table 11: Quality Rating 
Measurement 
Property  
Excellent  Good  Fair  Poor  
Hypothesis 
Testing 
Item 8 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) in a 
population similar 
to the study 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) but 
not sure if these 
apply to the study 
population 
Some information on 
the measurement 
properties (or a 
reference to a study 
on measurement 
properties) of the 
comparator 
instrument(s) in any 
study population 
No information on 
the measurement 
properties of the 
comparator 
instrument(s) 
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Appendix 4 
 
SHU Ethical Approval for the Survey 
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Appendix 5 
Survey Instrument  
 
UK National Survey of Neck Pain 
Welcome 
 
Dear Colleague  
 
We would like to invite you to take part in this online survey on the 
topic: Clinical Management of Musculoskeletal Neck Pain. This 
survey is part of a collaborative research project investigating 
current physiotherapy management of neck pain within the UK.  
 
As you know, neck pain is a common musculoskeletal condition, 
which has substantial socioeconomic impact on patient and society. 
Although various approaches are advocated for the management of 
patients with neck pain, it is unclear which are most commonly and 
least commonly used. Your response will help us understand current 
physiotherapy practice, which will subsequently enable us to 
develop an appropriate programme of research. We anticipate that 
the results of this survey will be published.  
 
Please complete this survey if: 1) you are currently registered and 
practicing physiotherapy in the UK and 2) you have seen at least 
one case of neck pain in the last 6 months.  
 
Your responses are extremely valuable to us. We would be grateful 
if you could take the time to complete this survey. It should take 
around 5-10 minutes to complete. Please be aware that your 
responses will be treated in strict confidence and the data will be 
entered anonymously onto an electronic form of data analysis. 
Completion of this survey is voluntary.  
 
if you have queries regarding this survey you can email Ahmad 
Alreni at a.alreni@shu.ac.uk or Dr Sionnadh McLean at 
s.mclean@shu.ac.uk. Thank you for your time.  
 
Your sincerely  
 
Ahmad Alreni, PhD researcher, Centre for Health and Social Care 
Research, Sheffield Hallam University 
Dr Karen Kilner, Statistician, Centre for Health and Social Care 
Research, Sheffield Hallam University 
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Deborah Harrop, Information Scientist, Centre for Health and Social 
Care Research, Sheffield Hallam University 
Dr Sionnadh Mclean, Reader in Physiotherapy, Department of 
Allied Health Professions, Sheffield Hallam University.  
 
Section 1 
 
About you  
This information will in no way identify you or your responses. In this survey, all 
responses are treated strictly confidential.  
 
§ Are you  
• Male  
• Female  
 
§ Do you work  
• Exclusively in the National Health Service (NHS)  
• Exclusively in non-NHS setting (e.g. private practice/hospital, 
education/research)  
• A combination of NHS and non-NHS  
• Other setting  
Please specify: 
 
§ Years of practice  
• Less than 2 years   
• 2-5 years   
• 6-10 years  
• 11-15 years   
• 15+ years   
 
§ In which nation, do you practice clinically?  
• Scotland   
• Northern Ireland   
• Wales   
• England   
 
§ Have you completed any postgraduate training (MSc and /or PhD)?  
• No 
• Yes  
 Please specify: 
 
§ What proportion of your caseload is made up of patients with neck 
pain?  
• Less than 25% 
• 25-50% 
• 51-75%  
• more than 75%  
 
§ Do you have a special interest in neck pain?  
• No  
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• Yes  
Further comments:    
 
Section 2  
 
Treatment approaches to management  
In this section, we are interested in identifying the management 
approach/approaches you typically use for patients with non-specific neck pain. 
Non-specific neck pain is defined here as a dysfunction in the cervical 
structures NOT caused by any serious acute trauma (e.g. Whiplash Associated 
Disorder), systemic disease, neurological disorder (e.g. Cervical Radiculopathy, 
Nerve Root Compression) or inflammatory condition. 
 
Which management approach/approaches do you use most 
often for patients with non-specific neck pain?  
 
§ Therapeutic exercise 
If selected:  
 
Which exercise component/components do you use regularly for patients 
with non-specific neck pain? 
v General aerobic/strengthening/endurance exercise   
v Cervical strengthening exercise  
v Upper limb strengthening exercise  
v Cervical stretching exercise  
v Upper limb stretching exercise   
v Cervical stabilising exercise  
v Upper limb stabilising exercise  
v Balance exercise  
v Proprioception exercise for the eyes  
v Proprioception exercise for the cervical spine  
v Proprioception exercise for the upper limb  
v Other  
Please specify:  
 
Manual therapy (Manipulation/Mobilisation)  
If selected:  
 
Which manual therapy method/methods do you use regularly for 
patients with non-specific neck pain? 
 
v Maitland  
v Mulligan  
v Cyriax  
v Society of Orthopaedic Medicine  
v Kaltenborn  
v Manipulation (Grade V)  
v Other  
Please specify:  
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§ Electrotherapy  
If selected: 
 
Which electrotherapy method/methods do you use regularly for 
patients with NSNP?  
v Galvanic Current (DC)   
v Electrical Nerve Stimulation (ENS)  
v Pulsed Electromagnetic Fields (PEMF)    
v Transcutaneous Nerve Stimulation (TENS)   
v Repetitive Magnetic Stimulation (rMS)   
v Other  
Please specify:  
 
§ The McKenzie method (Mechanical Diagnosis and 
Therapy (MDT)/End-Range Exercise/Active Range of 
Motion Exercises (AROM)/Direction Preference 
Exercise/Unloaded Exercise)  
§ Therapeutic patient education (oral, written, Audio-visual, 
etc.)  
§ Massage therapy (all types)  
§ Acupuncture  
§ Traction  
§ Heat/cold   
§ Taping/strapping   
§ Hydrotherapy  
§ Feldenkrais   
§ Other management approach/approaches  
Please specify: 
 
Section 3 
 
Outcome measures  
In this section, we are interested in your use of outcome measures in the 
assessment/management of patients with non-specific neck pain.  
 
Do you use outcome measures in the 
assessment/management of patients with non-specific neck 
pain?  
No  
If selected: 
 
This is because  
§ Lack of time   
§ Lack of clear guidance about suitability of available measures   
§ Lack of access to information/knowledge about outcome measures   
§ Lack of resources (e.g. expensive to purchase)   
§ There is no need to use outcome measures for patients with NSNP  
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§ Other  
Please specify:  
 
Submit 
 
Yes  
If selected:  
 
This is because  
§ Medicolegal documentation requirement   
§ Fulfilling charting/documentation  
§ Setting treatment goals  
§ Communicating with patients   
§ Communicating with other healthcare professionals   
§ Marketing   
§ Research   
§ Other reasons  
Please specify:  
 
Your use of outcome measures for patients with non-specific 
neck pain is  
 
§ Routinely: >70% of cases  
§ Regularly: 51-70% of cases  
§ Sometimes: 11-50% of cases  
§ Rarely 1-10% of cases  
 
Which outcome instrument/instruments do you use most 
frequently for patients with non-specific neck pain?  
 
§ Patient-reported outcome measurements (PROMs)  
(Instruments that are subject-completed relaying on patient’s self-
perception of pain, mobility status and performance of daily 
activity)  
If selected:   
 
Which PROM scale/scales do you use for patients with non-
specific neck pain?  
 
 Routinely >70% 
Cases  
Regularly 
11-70% 
Cases  
Rarely 
1-10% 
Cases  
Never 
0% 
Cases  
Visual Analogue Scale (VAS)  
 
o  o  o  o  
Numeric Rating Scale (NRS)  
  
o  o  o  o  
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Pain Distress Scale  
 
o  o  o  o  
Pain Catastrophizing Scale (PCS)  
 
o  o  o  o  
Neck Disability Index (NDI)  
 
o  o  o  o  
Whiplash Disability Questionnaire  
 
o  o  o  o  
Bournemouth Questionnaire  
 
o  o  o  o  
Patient Specific Functional Scale (PSFS)   
 
o  o  o  o  
Disability of Arm, Shoulder and Hand 
(DASH)/QuickDASH  
 
o  o  o  o  
Northwick Park Neck Pain (NPQ)  
 
o  o  o  o  
Neck and Upper Limb Index (NULI)   
 
o  o  o  o  
Rapid Upper Limb Assessment (RULA)  
 
o  o  o  o  
Time Lost from Work  
 
o  o  o  o  
Work Limitation Scale  
 
o  o  o  o  
Work Distress Scale  
 
o  o  o  o  
SF-36/SF12  
 
o  o  o  o  
Euro-Qol/EQ5D  
 
o  o  o  o  
WHO-Brief  
 
o  o  o  o  
Nottingham Health Profile (NHP)  
 
o  o  o  o  
Fear of Movement Scales  
 
o  o  o  o  
Depression/Anxiety Scales 
 
o  o  o  o  
Patients Global Perceived Rating of 
Improvement or Satisfaction  
 
o  o  o  o  
o Other PROM scale  
Please specify:  
 
§ Performance–based/physical/functional measures  
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(Instruments that use tasks in clinical setting to measure a patient’s 
functional capacity)  
If selected: 
 
Which performance-based/physical/functional 
measure/measures do you use for patients with non-specific 
neck pain?  
 
 Routinely >70% 
Cases  
Regularly 
11-70% 
Cases  
Rarely 
1-10% 
Cases  
Never 
0% 
Cases 
Quantitative Sensory Test QST (e.g. 
vibrometry, touch, temperature)  
 
o  o  o  o  
Pain Algometry (e.g. pain pressure threshold 
tests)   
 
o  o  o  o  
Rating of Segmental Joint Mobility (Passive 
Accessory Motion Tests; Passive 
Physiological Motion Tests)  
 
o  o  o  o  
Goniometric Measures of Neck Motion  
 
o  o  o  o  
Inclinometer of Neck Motion   
 
o  o  o  o  
Movement Diagram  
 
o  o  o  o  
Neurological exam (e.g. dermatomes, 
myotomes, reflexes, etc.)  
 
o  o  o  o  
Neural dynamic testing (i.e. tests of neural 
mobility)  
 
o  o  o  o  
Neck Muscle Strength test (e.g. cervical 
isometric flexion, cervical isometric 
extension, etc.)   
 
o  o  o  o  
Neck muscle endurance testing (i.e. deep 
neck flexor endurance test)  
 
o  o  o  o  
Neck muscle stability testing (i.e. cranial-
cervical flexion testing)  
 
o  o  o  o  
Posture alignment measures (i.e. dynamic 
analysis of scapular muscle control in 
posture and movement)  
 
o  o  o  o  
Upper extremity muscle strength/endurance 
(i.e. The Single Arm Military Press (SAMP) 
test)  
o  o  o  o  
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Functional performance tests (i.e. Functional 
Impairment Test-Hand, and 
Neck/Shoulder/Arm (FIT-HaNSA)  
 
o  o  o  o  
Proprioception test (i.e. head and neck 
position sense (HNPS) testing)  
 
o  o  o  o  
Functional capacity assessment (e.g. timed 
weighted overhead test, timed supine capital 
flexion)  
o  o  o  o  
 
o Other physical or functional measure/measures  
 Please specify: 
 
Submit 
 
Your responses have been submitted 
 
Thank you for your time 
 
If you have any queries regarding this survey or would like to hear 
about the results you can email Ahmad Alreni at a.alreni@shu.ac.uk 
.  
 
Your responses are extremely valuable to us. We are looking for a 
UK sample of physiotherapists. if you know any other UK 
physiotherapists who are registered and practicing in the UK who 
could help with this survey, we would be grateful if you could forward 
on the link to this survey.  
 
Yours sincerely,  
 
Ahmad Alreni 
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Appendix 6 
Survey Banner 
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Appendix 7  
 
Tanta Universal Teaching Hospital Ethical Approval (SAMP test 
Validation 
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Appendix 8 
 
SHU Ethical Approval (SAMP test Validation) 
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Appendix 9  
 
Measuring upper limb disability in neck pain population: evaluation of 
the acceptability and feasibility of the Single Arm Military Press 
(SAMP) test 
 
Telephone Checklist: Preliminary Screening (Phone Screening) English and Arabic 
 
A list of patients who have had visits to the Rheumatology and Physical Therapy 
Medicine Department at Tanta Universal Teaching Hospital (Egypt) with a diagnosis 
indicating non-specific uncomplicated neck pain was obtained. 
 
The chief investigator telephoned all prospective participants to answer the following 
questions as follows:   
 
Hello, my name is Ahmad Alreni. I am phoning from Tanta Universal Teaching 
Hospital. We are working with Rheumatology and Physical Therapy Medicine 
Department to develop and evaluate health related outcome measure on patients 
suffering from neck pain.  
 
Would you like to hear about it?  
 
Recent research suggested that neck problems frequently associated with upper limb 
pain/disability. We want to develop a physical performance test (outcome measure) to 
evaluate the upper limb functional capacity and used in the assessment and during the 
management process of patients with neck pain. This will help us to identify and 
quantify any upper limb disability and cure it while treating neck pain, which will make 
neck pain patients to feel better and help them to cope better with normal daily activity. 
 
So, we are recruiting people with neck pain and dividing them into three groups based 
on their age group, occupation, weight/height and the severity of their neck pain.  
 
If you are interested in being involved in our study, you will be requested to attend one 
single assessment and testing session at Tanta Universal Teaching Hospital. In this 
session, you will be met by a member of our research team who will tell you more about 
the study, ask you to complete a questionnaire and carry out face-to-face assessment. If 
the testing procedure would be suitable and beneficial, you will be requested to perform 
a physical performance test for 30 seconds. This session will take up to 45-minute.   
 
Would you be happy to participate?  
  Yes  
  No  
If yes, may I ask you a few questions about your neck? This will help me to determine 
whether this testing procedure is suitable and good for you. Any information you give 
me will be kept confidential. 
 
1. Have you had your neck symptoms for longer than 2 weeks? (in weeks) 
(Acute/sub-acute or chronic pain)   
  Yes  
  No 
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2. Have you had any treatment to your neck in the last 3 months? 
 
(What diagnosis? What the practitioner told you about your neck problem) 
  
3. Are you planning to see anyone else for treatment?  
  Yes 
  No  
If yes, to postpone until after the testing. 
 
4. Do you have any other health problems such as dizziness, double vision, speech, 
swallowing, LOC (loss of consciousness)?  
  Yes  
  No  
(Exclude patient with any major health problems) 
 
5. Are you able to get on/off bed without help? 
  Yes  
  No  
 
6. Are you able to walk, drive or use public transport without help? 
  Yes  
  No  
 
7. Are you able to come to the new Tanta Universal Teaching Hospital? 
  Yes  
  No  
 
Thank you for taking the time to answer those questions. I can tell you that at this stage 
it would seem that:  
  
a. The testing procedure would be suitable and beneficial for you (Make 
Appointment) 
b. The testing procedure is not suitable for you (exclude this patient from the 
study).  
 
Making appointment (if a) 
Can you come to Tanta Universal Teaching Hospital on (day) at (time) for face-to-
face assessment, which be followed by the testing? Negotiate an appointment time.    
 
Study information sheet 
I would like to send you the study information sheet, where you will find more 
information about the study and the testing. Please read it and you may discuss your 
participation with your family and/or friends before attending the single face-to-face 
assessment and testing session: your address is… 
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 fo noitaulave :noitalupop niap kcen ni ytilibasid bmil reppu gnirusaeM
 sserP yratiliM mrA elgniS eht fo ytilibisaef dna ytilibatpecca eht
 tset )PMAS(
 
  ﺾﯾﺮﻤﻟا ﺺﯿﺨﺸﺗ ةرﺎﻤﺘﺳا
 
  :ﺺﺤﻔﻟا ﻦﻣ ﻰﻟوﻻا ﺔﻠﺣﺮﻤﻟا
 
   ﺎﻣو ﮫﻨﻣ ضﺮﻐﻟاو ﺚﺤﺒﻟا نﻮﻤﻀﻤﺑو ﻲﺑ ﺾﯾﺮﻤﻟا ﻒﯾﺮﻌﺗ ﻢﺘﯾ فﻮﺳ ﺔﯿﻔﺗﺎھ ﺔﻤﻟﺎﻜﻣ لﻼﺧ ﻦﻣ
 ﻰﻠﻋ ﮫﺘﻘﻓاﻮﻣ ﺪﻨﻋو ،ﺔﺒﻗﺮﻟا ﻢﻟا ﻲﻓ ﺔﻠﺜﻤﺘﻣ طوﺮﺸﻟا ﺾﻌﺑ ﺮﻓاﻮﺘﻟ ﺚﺤﺒﻟا ﺔﻨﯿﻋ ﻦﻤﺿ هرﺎﯿﺘﺧا ﺐﺒﺳ
  :ﺔﯿﻟﺎﺘﻟا ﺔﻠﺌﺳﻻا ﻰﻠﻋ ﺔﺑﺎﺟﻻا ﮫﻨﻣ ﺐﻠﻄﯾ ﺚﺤﺒﻟا ﺔﻨﯿﻋ ﻲﻓ كاﺮﺘﺷﻻا
 
  ؟ﻦﯿﻋﻮﺒﺳا ﻦﻣ لﻮطا ةﺪﻤﻟ ﺔﺒﻗﺮﻟا ﻲﻓ ﻢﻟا يأ ﻚﯾﺪﻟ ﻞھ – ١
 
 ﻻ
  ﻢﻌﻧ
 
   ؟ﺔﯿﺿﺎﻤﻟا رﻮﮭﺷ ثﻼﺜﻟا لﻼﺧ ﺖﺠﻟﻮﻋ ﻞھ – ٢
 
  ﻻ
  (ﺺﺨﺸﻤﻟا ﺺﺼﺨﺗ ﻮھ ﺎﻣ ،ﺺﯿﺨﺸﺘﻟا عﻮﻧ ﺎﻣ) ﻢﻌﻧ
 
  ؟ﺎﺒﯾﺮﻗ جﻼﻌﻟا ضﺮﻐﺑ ﺮﺧا ﺺﺼﺨﺘﻣ ﺔﯾؤﺮﻟ ﻂﻄﺨﺗ ﻞھ – ٣
 
  ﻻ
  (رﺎﺒﺘﺧﻻا ءاﺮﺟا ﺪﻌﺑ ﻞﯿﺟﺄﺘﻟا ﻰﺟﺮﯾ) ﻢﻌﻧ
 
  ؟ﻲﻋﻮﻟا ناﺪﻘﻓ وا ﺔﯾؤﺮﻟا جاودزا وا راوﺪﻟا ﻞﺜﻣ ىﺮﺧا ﺔﯿﺤﺻ ﻞﻛﺎﺸﻣ يأ ﻚﯾﺪﻟ ﻞھ – ٤
 
  ﻻ
  (ةﺮﯿﺒﻛ ىﺮﺧا ﻞﻛﺎﺸﻣ ﺔﯾﺪﻟ ﺾﯾﺮﻣ يأ دﺎﻌﺒﺘﺳا) ﻢﻌﻧ
 
  ؟ةﺪﻋﺎﺴﻣ نوﺪﺑ ﻲﻤﯿﻠﻌﺘﻟا ﺎﻄﻨط ﻰﻔﺸﺘﺴﻣ ﻰﻟا رﻮﻀﺤﻟا ﻰﻠﻋ ردﺎﻗ ﺖﻧا ﻞھ -٥
 
  (ﺔﯿﺤﺻ بﺎﺒﺳﻷ رﻮﻀﺤﻟا ﻊﯿﻄﺘﺴﯾ ﻻ ﺾﯾﺮﻣ يأ دﺎﻌﺒﺘﺳا) ﻻ
  ﻢﻌﻧ
 
  .ﺔﻠﺌﺳﻻا ﻰﻠﻋ ﺔﺑﺎﺟﻺﻟ ﮫﺘﻗو ﻦﻣ ءﺰﺟ ﮫﻋﺎﻄﻘﺘﺳﻻ ﺎﻨﻌﻣ ثﺪﺤﺘﻤﻟا ﺺﺨﺸﻟا ﺮﻜﺸﻧ
  ....... ﺔﻋﺎﺴﻟا ...... مﻮﯾ ﻲﻓ ﺎﻄﻨﻄﺑ ﺪﯾﺪﺠﻟا ﻲﻤﯿﻠﻌﺘﻟا ﻰﻔﺸﺘﺴﻤﻟا ﻰﻟا هرﻮﻀﺤﻟ ﺪﻋﻮﻣ ﺪﯾﺪﺤﺗ ﻊﻣ
 ﺔﻨﯿﻋ ﻲﻓ هرﺎﯿﺘﺧا بﺎﺒﺳاو ﮫﺗاءاﺮﺟإو ﺚﺤﺒﻟا ﻦﻋ ﺮﺜﻛأ تﺎﻣﻮﻠﻌﻣ لﺎﺳرﻹ ﮫﺑ صﺎﺨﻟا ناﻮﻨﻌﻟا ﺔﻓﺮﻌﻣ
 ﻲﺋﺎﮭﻨﻟا راﺮﻘﻟا ذﺎﺨﺗا ﻞﺒﻗ ﻦﯿﺑﺮﻘﻤﻟا ءﺎﻗﺪﺻﻻاو ﺔﻠﺋﺎﻌﻟا ﻊﻣ ﺚﺤﺒﻟا اﺬھ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا ﺔﺸﻗﺎﻨﻣو ﺚﺤﺒﻟا
  .ﺔﻛرﺎﺸﻤﻟا ﻲﻓ
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Appendix 10 
 
Measuring upper limb disability in neck pain population: evaluation of 
the acceptability and feasibility of the Single Arm Military Press 
(SAMP) test 
 
Patient Information Sheet (English and Arabic) 
 
We wish to invite you to participate in a research study. In order to have a clearer 
understanding of this research context, please read the following information sheet and 
do not hesitate to ask if there is anything that it not clear or you would like further 
information before you decide to take part.  
 
What is the purpose of this study?  
Neck pain is common, painful and many people report having trouble using their arm. 
Physiotherapists should try to measure the problems that people have when using their 
arm, so that they can advise patients how best to improve use of their arm.  
 
The aim of this study is to develop and evaluate a physical performance 
test/performance-based outcome measure, the Single Arm Military Press (SAMP) Test, 
which is easy to use, economical, quick (maximum 2 minutes to perform and score). 
Preliminary research suggested that SAMP test is promising upper limb outcome 
measure for neck pain patients. 
 
Why I have been invited?  
We are inviting patients, age 18 years or over, with non-specific neck pain to take part 
in this study. The patients we are looking for should be able to travel to the 
Rheumatology and Physical Therapy department/clinic at Tanta Universal Teaching 
Hospital without support. 
 
You have been invited to participate in this research program because of the type of 
neck pain you suffering from. If you are currently having treatment for your neck pain 
or had treatment in the past 3-month then you may be eligible for this study. 
 
What will happen if I decide to take part? 
If you are interested in being involved in this study, you will be asked to attend one 
single assessment and testing session, which will take up to 45 minutes. You will be 
requested to complete a questionnaire, which will give us information about your neck 
pain and your general physical and psychological well-being. This will be followed by 
face-to-face assessment to ensure that the testing procedure is suitable and beneficial for 
you. You will be then requested to sign a consent form to say that you agree to be 
involved with this study and complete the testing procedure.   
  
It is preferable if you can wear a suitable, sleeveless/half-sleeves top, during the session 
so that the shoulder and elbow joints can be observed. 
 
What do I have to do? 
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You will receive a complete demonstration and instruction of the test followed by 
warm-up and the test procedure, which will take up to 2-munites under direct 
supervision of a physiotherapist/physician. 
 
Do I have to participate in this study? 
 
‘Only if you want to’ 
 
Participation is voluntary, you do not have to participate or you may withdraw from the 
study at any time before attending the face-to-face assessment and testing. However, 
please let us know if you are unable to participate at least 24-hours before your 
appointment. You do not need to tell us why you do not want to participate.  
 
Are there any risks involved?   
There are no known risks. This research program is simply validating performance-
based outcome measure.  
 
You may experience some muscle soreness, which is completely normal following 
physical exercise and may last up to 72 hours.   
 
Confidentiality 
All information from this study will be kept entirely confidential. All consent forms and 
any other identifiable information will be destroyed once the study has been completed. 
You will be informed of the results of the research if you wish.   
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 fo noitaulave :noitalupop niap kcen ni ytilibasid bmil reppu gnirusaeM
 sserP yratiliM mrA elgniS eht fo ytilibisaef dna ytilibatpecca eht
 tset )PMAS(
 
  ﺚﺤﺒﻟا تاءاﺮﺟﻹ ﺔﻠﻣﺎﺷ تﺎﻣﻮﻠﻌﻣ
 
 ﺔﻠﻣﺎﺸﻟا تﺎﻣﻮﻠﻌﻤﻟا ﮫﻓﺮﻌﻣو ﻢﮭﻔﻟو ﺚﺤﺒﻟا اﺬھ ﺔﻨﯿﻋ ﻦﻣ ءﺰﺠﻛ ﺔﻛرﺎﺸﻤﻟﺎﺑ ﻢﻜﺗدﺎﯿﺳ ةﻮﻋﺪﺑ فﺮﺸﺘﻧ
 يأ كﺎﻨھ نﺎﻛ اذإ ﺎﻤﻋ لؤﺎﺴﺘﻟا ﻲﻓ ددﺮﺘﻟا مﺪﻋو ﺔﯿﻟﺎﺘﻟا تﺎﻣﻮﻠﻌﻤﻟا ةءاﺮﻗ ءﺎﺟﺮﺑ ﺚﺤﺒﻟا تاءاﺮﺟﻹ
  .ﺔﻛرﺎﺸﻤﻟا رﺮﻘﺗ نا ﻞﺒﻗ تﺎﻣﻮﻠﻌﻤﻟا ﻦﻣ ﺪﯾﺰﻣ وا ﺔﺤﺿاو ﺮﯿﻏ ﺔﻣﻮﻠﻌﻣ
 
  ؟ﺔﺳارﺪﻟا هﺬھ ﻦﻣ ضﺮﻐﻟا ﻮھ ﺎﻣ
 
 ،نﺎﯿﺣﻻا ﺾﻌﺑ ﻲﻓ ﺪﯾﺪﺷ ﻢﻟا ﻰﻟا ىدﺆﺗ ﻲﺘﻟاو ثوﺪﺤﻟا ﺔﻌﺋﺎﺷ ضاﺮﻣﻻا ﻦﻣ ﺔﺒﻗﺮﻟا ﻢﻟا نا
 لﺎﻤﻋﻻا ﺺﺧﻷﺎﺑو ﻒﺘﻜﻟاو عارﺬﻟا ماﺪﺨﺘﺳا ﻲﻓ ﺔﺑﻮﻌﺻ نوﺪﺠﯾ ﺔﺒﻗﺮﻟا ﻢﻟا ﻲﺑﺎﺼﻣ ﻢﻈﻌﻣو
 ﺔﺒﻗﺮﻟا ﻢﻟا جﻼﻋ ﻲﻓ ﺺﺼﺨﺘﻤﻟا ﺐﯿﺒﻄﻟا ﻰﻠﻋ ﺐﺟﻮﺘﯾ اﺬﻟ سأﺮﻟا ىﻮﺘﺴﻣ ﻰﻠﻋأ ىدﺆﺗ ﻲﺘﻟا
   .ﺪﯿﻟاو عارﺬﻟاو ﻒﺘﻜﻟا ﻲﻓ ﺔﻗﺎﻋﻻا ىﺪﻣ رﺎﺒﺘﺧﺎﺑ
 
 ﺪﯿﻟاو عارﺬﻟاو ﻒﺘﻜﻟا ﻲﻓ ﺔﻗﺎﻋﻻا سﺎﯿﻗ ﺔﻘﯾﺮط ﺮﯾﻮﻄﺗ ﻮھ ﺔﺳارﺪﻟا هﺬھ ءاﺮﺟا ﻦﻣ ضﺮﻐﻟا
  .ﺔﺒﻗﺮﻟا ﻢﻟا ﻰﺿﺮﻣ ﺪﻨﻋ
 
 ﺔﯿﻟﺎﺜﻣ ﺔﻘﯾﺮط ﻲھ (PMAS) سﺎﯿﻘﻟا ﺔﻘﯾﺮط نا ﺖﺘﺒﺛا ﺔﺜﯾﺪﺤﻟا ﺔﯿﻤﻠﻌﻟا ثﺎﺤﺑﻻا ﺾﻌﺑ
  .سﺎﯿﻘﻠﻟ
 
  ؟ﺚﺤﺒﻟا ﺔﻨﯿﻋ ﻲﻓ يرﺎﯿﺘﺧا ﻢﺗ اذﺎﻤﻟ
 
 ﻲﻓ ﻢﻟا ﻦﻣ ﻲﻧﺎﻌﺗو ﺔﻨﺳ ٨١ ﻦﻣ ﺮﺜﻛأ كﺮﻤﻋ ﻚﻧﻷ ﺚﺤﺒﻟا ﺔﻨﯿﻋ ﻦﻣ ءﺰﺠﻛ كرﺎﯿﺘﺧا ﻢﺗ ﺪﻘﻟ
  .ﺔﺒﻗﺮﻟا
 
  ؟ﺚﺤﺒﻟا اﺬھ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا ترﺮﻗ اذإ ثﺪﺤﯿﺳ اذﺎﻣ 
 
 حواﺮﺘﯾ ﺖﯿﻗﻮﺗ ﻲﻓ ةﺪﺣاو ةﺮﻣ رﻮﻀﺤﻠﻟ ﻰﻋﺪﺘﺴﻓ ﺔﺳارﺪﻟا هﺬھ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا ﻰﻠﻋ ﺖﻘﻓاو اذإ
  .ﺔﻘﯿﻗد ٥٤ :٠٣ ﻦﯿﺑ
 
 ﺔﻣﺎﻌﻟا ﺔﯿﺤﺼﻟا ﻚﺗﻻﺎﺣو ﺔﺒﻗﺮﻟا ﻢﻟﺄﺑ ﺔﺻﺎﺨﻟا ﺔﻠﺌﺳﻻا ﺾﻌﺑ ﻰﻠﻋ ﺔﺑﺎﺟﻻا ﻚﻨﻣ ﺐﻠﻄﯾ فﻮﺳ
  .تﺎﻧﺎﯿﺒﺘﺳﻻا ﺾﻌﺑ ءﻞﻣو
 
  ﺔظﻮﺤﻠﻣ .ﺔﻠﻣﺎﻛ عارﺬﻟا ﺔﯾؤﺮﻟ تﺮﺷ ﻲﺗ ﺔﻀﯾﺮﻤﻟا ىﺪﺗﺮﺗ نا :
 
  ؟رﺎﺒﺘﺧﻻا اﺬھ ﻲﻓ ﻞﻌﻓا نا ﻰﻠﻋ اذﺎﻣ
 
 ﺖﺤﺗ رﺎﺒﺘﺧﻻا ءادا ﻢﺛ ءﺎﻤﺣﻻا ﮫﯿﻠﯾ رﺎﺒﺘﺧﻼﻟ جذﻮﻤﻨﺑ ﺔﻋﻮﺒﺘﻣ ﺔﺤﺿاو تﺎﻤﯿﻠﻌﺗ ﻰﻘﻠﺘﺗ فﻮﺳ
  .ﺺﺼﺨﺘﻣ فاﺮﺷا
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  ؟ﺔﺳارﺪﻟا هﺬھ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا يروﺮﻀﻟا ﻦﻣ ﻞھ
  (ﺔﻛرﺎﺸﻤﻟا ﺖﻧا تدرا اذإ)
 
  .ءﺎﺸﺗ ﺎﻤﻨﯿﺣ بﺎﺤﺴﻧﻻا ﻚﻨﻜﻤﯾو ﺔﯿﻋﻮﻄﺗ ﺔﺳارﺪﻟا هﺬھ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا
 
 
  ؟ﺔﺳارﺪﻟا هﺬھ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا ﻦﻋ ﺞﺘﻨﺗ نا ﻦﻜﻤﯾ ﺮطﺎﺨﻣ يأ كﺎﻨھ ﻞھ
 
 ﻮھ يﺬﻟاو ﻂﯿﺴﺒﻟا ﻲﻠﻀﻌﻟا قﺎھرﻻا ﺾﻌﺒﺑ ﺮﻌﺸﺗ ﺪﻗ ﻦﻜﻟو قﻼطﻻا ﻰﻠﻋ ﺮطﺎﺨﻣ ﺪﺟﻮﺗ ﻻ
  .ءﺎﻔﺸﺘﺳﻼﻟ ﺔﻋﺎﺳ ٢٧ ﻚﻟذ قﺮﻐﺘﺴﯾ ﺪﻗو ﺔﯿﻧﺪﺒﻟا ﺔﻄﺸﻧﻻا ﺔﺳرﺎﻤﻣ ﺪﻌﺑ ثﺪﺤﯾ يﺬﻠﻟ ﺔﮭﺑﺎﺸﻣ
 
  :ﺔﯿﺻﻮﺼﺨﻟا
 
 قاروا ﻊﯿﻤﺟ ﺮﯿﻣﺪﺗ ﻢﺘﯾ فﻮﺳو ﺔﻣﺎﺗ ﺔﯾﺮﺳ ﻲھ ﺔﺳارﺪﻟا هﺬھ ﻲﻓ ﻰﺿﺮﻤﻟﺎﺑ ﺔﺻﺎﺨﻟا تﺎﻣﻮﻠﻌﻤﻟا ﻊﯿﻤﺟ
  .ﺔﺳارﺪﻟا ﻦﻣ ءﺎﮭﺘﻧﻻا دﺮﺠﻤﺑ ﻰﺿﺮﻤﻟا ﻦﻋ ىﺮﺧا تﺎﻣﻮﻠﻌﻣ ياو ﺔﻘﻓاﻮﻤﻟا
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Appendix 11 
 
Neck Disability Index (NDI) English and Arabic 
 
This questionnaire has been designed to give us information as to how your neck pain has 
affected your ability to manage in everyday life. Please answer every section and mark in 
each 
section only the one box that applies to you. We realise you may consider that two or more 
statements in any one section relate to you, but please just mark the box that most closely 
describes your problem. 
 
Section 1: Pain Intensity 
  I have no pain at the moment 
  The pain is very mild at the moment 
  The pain is moderate at the moment 
  The pain is fairly severe at the moment 
  The pain is very severe at the moment 
  The pain is the worst imaginable at the 
moment 
Section 2: Personal Care (Washing, 
Dressing, etc.) 
  I can look after myself normally without 
causing extra pain 
  I can look after myself normally but it 
causes extra pain 
  It is painful to look after myself and I am 
slow and careful 
  I need some help but can manage most 
of my personal care 
  I need help every day in most aspects of 
self-care 
  I do not get dressed, I wash with 
difficulty and stay in bed 
 
Section 3: Lifting 
  I can lift heavy weights without 
extra pain 
  I can lift heavy weights but it gives 
extra pain 
  Pain prevents me lifting heavy 
weights off the floor, but I can 
manage if they are 
conveniently placed, for example 
on a table 
  Pain prevents me from lifting 
heavy weights but I can manage 
light to medium 
weights if they are conveniently 
positioned 
  I can only lift very light weights 
  I cannot lift or carry anything 
 
Section 4: Reading 
  I can read as much as I want to with 
no pain in my neck 
  I can read as much as I want to with 
slight pain in my neck 
  I can read as much as I want with 
moderate pain in my neck 
  I can’t read as much as I want 
because of moderate pain in my 
neck 
  I can hardly read at all because of 
severe pain in my neck 
  I cannot read at all 
 
 
Section 5: Headaches 
  I have no headaches at all 
  I have slight headaches, which 
come infrequently 
  I have moderate headaches, which 
come infrequently 
  I have moderate headaches, which 
come frequently 
  I have severe headaches, which 
 
Section 6: Concentration 
  I can concentrate fully when I want 
to with no difficulty 
  I can concentrate fully when I want 
to with slight difficulty 
  I have a fair degree of difficulty in 
concentrating when I want to 
  I have a lot of difficulty in 
concentrating when I want to 
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come frequently 
  I have headaches almost all the 
time 
 
  I have a great deal of difficulty in 
concentrating when I want to 
  I cannot concentrate at all 
Section 7: Work  
  I can do as much work as I want to 
  I can only do my usual work, but no 
more 
   I can do most of my usual work, but 
no more 
  I cannot do my usual work 
  I can hardly do any work at all 
  I can’t do any work at all  
 
Section 8: Driving  
  I can drive my car without any neck 
pain 
  I can drive my car as long as I want 
with slight pain in my neck 
  I can drive my car as long as I want 
with moderate pain in my neck 
  I can’t drive my car as long as I want 
because of moderate pain in my neck 
  I can hardly drive at all because of 
severe pain in my neck 
  I can’t drive my car at all  
 
Section 9: Sleeping                                                                
  I have no trouble sleeping 
  My sleep is slightly disturbed (less 
than 1 hr sleepless) 
  My sleep is mildly disturbed (1-2 
hrs sleepless) 
  My sleep is moderately disturbed (2-
3 hrs sleepless) 
  My sleep is greatly disturbed (3-5 
hrs sleepless) 
  My sleep is completely disturbed (5-
7 hrs sleepless)  
 
Section 10: Recreation  
  I am able to engage in all my 
recreation activities with no neck 
pain at all  
  I am able to engage in all my 
recreation activities, with some pain 
in my neck  
  I am able to engage in most, but not 
all of my usual recreation activities 
because of pain in my neck  
  I am able to engage in a few of my 
usual recreation activities because of 
pain in my neck  
   I can hardly do any recreation 
activities because of pain in my neck  
  I can’t do any recreation activities at 
all  
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  ) ﺔﺒﻗﺮﻟا ﺔﻗﺎﻋإ سﺎﯿﻘﻣ IDN(
 
 ﻚﺘﺒﻗر ﻲﻓ ﺎﮭﺑ ﺮﻌﺸﺗ ﻲﺘﻟا ضاﺮﻋﻻا وا تﻻﺎﺤﻟا ﻦﻋ ﺔﻠﺌﺳﻻا ﻦﻣ ﺔﻠﺴﻠﺴﻟا هﺬھ ﺮﺴﻔﺘﺴﺗ
 ﻰﻠﻋ ءﺎﻨﺑ لاﺆﺳ ﻞﻛ ﻰﻠﻋ ﺐﯿﺠﺗ نا ءﺎﺟﺮﻟا .ﺔﻨﯿﻌﻣ تﺎطﺎﺸﻧ ﺔﯾدﺄﺗ ﻰﻠﻋ ﻚﺗرﺪﻗ ﻦﻋو
    ﺔﻗﺪﻟا ﻰﻟا بﺮﻗﻻا ﺔﺑﺎﺟﻻا ﻰﻟا ﻞﺑﺎﻘﻤﻟا ﻊﺑﺮﻤﻟا ﻲﻓ ﺔﻣﻼﻋ ﻊﺿﻮﺑ ﻚﺘﻟﺎﺣ
 
  ﻰﻟوﻻا ﺔﻋﻮﻤﺠﻤﻟا (ﺔﺒﻗﺮﻟا مﻻا ةﺪﺷ)
 
  ﻲﻟﺎﺤﻟا ﺖﻗﻮﻟا ﻲﻓ ﻢﻟا ﺪﺟﻮﯾ ﻻ 
  اﺪﺟ ﻂﯿﺴﺑ ﻞﻜﺸﺑ ﻢﻟا ﺪﺟﻮﯾ 
  ﻂﯿﺴﺑ ﻞﻜﺸﺑ ﻢﻟا ﺪﺟﻮﯾ 
  ﺪﯾﺪﺷ ﻢﻟا ﺪﺟﻮﯾ 
  اﺪﺟ ﺪﯾﺪﺷ ﻢﻟا ﺪﺟﻮﯾ 
  ةﺮﯿﺒﻛ ﺔﺟرﺪﺑ ﺪﯾﺪﺷ ﻢﻟا ﺪﺟﻮﯾ 
 
  (ﺦﻟا ..... مﺎﻤﺤﺘﺳﻻا ،ﺲﺑﻼﻤﻟا ﻊﻠﺧ ﻞﺜﻣ ﺔﯿﺼﺨﺸﻟا ﺔﯾﺎﻨﻌﻟا) ﺔﯿﻧﺎﺜﻟا ﺔﻋﻮﻤﺠﻤﻟا
 
  ﻢﻟﻻا ﻲﻓ ةدﺎﯾز نوﺪﺑ ﺔﯿﺼﺨﺸﻟا يرﻮﻣﺄﺑ ﻰﻨﺘﻋا نا ﻲﻨﻨﻜﻤﯾ 
  ﺔﯿﻓﺎﺿا مﻻا ﺐﺒﺴﯾ ﺔﻨﻜﻟو ﺔﯿﺼﺨﺸﻟا يرﻮﻣﺄﺑ ﻰﻨﺘﻋا نا ﻲﻨﻨﻜﻤﯾ 
  ﺺﯾﺮﺣو ءﻲﻄﺑ نﻮﻛا ﻲﻣﺎﯿﻗ ﺪﻨﻋو ﺔﯿﺼﺨﺸﻟا يرﻮﻣﺄﺑ ءﺎﻨﺘﻋﻻا ﻢﻟﺆﻤﻟا ﻦﻣ 
  ﺎﮭﺑ مﻮﻗا ىﺮﺧﻻا رﻮﻣﻻا ﺐﻠﻏاو رﻮﻣﻻا ﺾﻌﺑ ﻲﻓ ةﺪﻋﺎﺴﻤﻟا ﺾﻌﺑ ﻰﻟا جﺎﺘﺣا 
  ﺔﯿﺼﺨﺸﻟا ﺔﯾﺎﻨﻌﻟا رﻮﻣا ﻢﻈﻌﻣ ﻲﻓ ةﺪﻋﺎﺴﻤﻟا ﻰﻟا جﺎﺘﺣا ﺎﻧا 
 ﺔﺑﻮﻌﺼﺑ ﻲﮭﺟو ﻞﺴﻏاو ﺲﺑﻼﻤﻟا ءاﺪﺗرا ﻞﺜﻣ ﺔﯿﺼﺨﺸﻟا يرﻮﻣﺄﺑ ﺔﯾﺎﻨﻌﻟا ﻊﯿﻄﺘﺳأ ﻻ 
  ﺖﻗﻮﻟا لﻮط ﺮﯾﺮﺴﻟا ﻲﻓ ﻰﻘﺑأو
 
  (ﺪﯿﻟﺎﺑ ءﺎﯿﺷﻻا ﻊﻓر) ﺔﺜﻟﺎﺜﻟا ﺔﻋﻮﻤﺠﻤﻟا
 
  ﻲﻓﺎﺿإ ﻢﻟا نوﺪﺑ ﺔﻠﯿﻘﺜﻟا نازوﻻا ﻊﻓر ﻊﯿﻄﺘﺳأ 
  ﻲﻓﺎﺿإ ﻢﻟا ﺐﺒﺴﯾ ﻦﻜﻟو ﺔﻠﯿﻘﺜﻟا نازوﻻا ﻊﻓر ﻊﯿﻄﺘﺳأ 
 ﻰﻠﻋ ﺖﻧﺎﻛ اذإ ﺎﮭﻠﻤﺣ ﻦﻜﻟو ضرﻻا ﻦﻣ ﺔﻠﯿﻘﺜﻟا نازوﻻا ﻊﻓر ﻦﻣ ﻲﻨﻌﻨﻤﺗ ﺔﺒﻗﺮﻟا ﻢﻟﻻا 
  (ةﺰﯿﺑاﺮط ﻰﻠﻋ ةدﻮﺟﻮﻣ) ﺐﺳﺎﻨﻣ عﺎﻔﺗرا
 نازوﻻا ﻊﻓر ﻊﯿﻄﺘﺳأ ﻦﻜﻟو ضرﻻا ﻦﻣ ﺔﻠﯿﻘﺜﻟا نازوﻻا ﻊﻓر ﻦﻣ ﻲﻨﻌﻨﻤﺗ ﺔﺒﻗﺮﻟا مﻻا ا 
  (ةﺰﯿﺑاﺮط ﻰﻠﻋ ةدﻮﺟﻮﻣ) ﺐﺳﺎﻨﻣ عﺎﻔﺗرا ﻰﻠﻋ ﺖﻧﺎﻛ اذإ ﺔﻄﺳﻮﺘﻤﻟاو ﺔﻔﯿﻔﺨﻟا
  ﻂﻘﻓ اﺪﺟ ﺔﻔﯿﻔﺨﻟا نازوﻻا ﻊﻓر ﻊﯿﻄﺘﺳأ 
  ءﻲﺷ يأ ﻞﻤﺣ وا ﻊﻓر ﻊﯿﻄﺘﺳأ ﻻ 
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  (ةءاﺮﻘﻟا) ﺔﻌﺑاﺮﻟا ﺔﻋﻮﻤﺠﻤﻟا
  
  ﺔﺒﻗﺮﻟا ﻲﻓ مﻻا نوﺪﺑ ﺪﯾرا ﺎﻣ رﺪﻘﺑ ةءاﺮﻘﻟا ﻊﯿﻄﺘﺳأ 
  ﺔﺒﻗﺮﻟا ﻲﻓ ﺔﻔﯿﻔﺧ مﻻا دﻮﺟو ﻊﻣ ﺪﯾرا ﺎﻣ رﺪﻘﺑ ةءاﺮﻘﻟا ﻊﯿﻄﺘﺳأ 
  ﺔﺒﻗﺮﻟا ﻲﻓ ﺔﻄﺳﻮﺘﻣ مﻻا دﻮﺟو ﻊﻣ ﺪﯾرا ﺎﻣ رﺪﻘﺑ ةءاﺮﻘﻟا ﻊﯿﻄﺘﺳأ 
  ﺔﺒﻗﺮﻟا ﻲﻓ ﺔﻄﺳﻮﺘﻣ مﻻا دﻮﺟو ﺐﺒﺴﺑ ﺪﯾرا ﺎﻣ رﺪﻘﺑ ةءاﺮﻘﻟا ﻊﯿﻄﺘﺳأ ﻻ 
  ﺔﺒﻗﺮﻟا ﻲﻓ ﺔﯿﻟﺎﻋ مﻻا دﻮﺟو ﺐﺒﺴﺑ ﺔﺑﻮﻌﺼﺑ ةءاﺮﻘﻟا ﻊﯿﻄﺘﺳأ 
  قﻼطﻻا ﻰﻠﻋ ةءاﺮﻘﻟا ﻊﯿﻄﺘﺳأ ﻻ 
 
  (عاﺪﺼﻟا) ﺔﺴﻣﺎﺨﻟا ﺔﻋﻮﻤﺠﻤﻟا
 
  قﻼطﻻا ﻰﻠﻋ عاﺪﺻ ىﺪﻟ ﺪﺟﻮﯾ ﻻ 
  ﻢﻈﺘﻨﻣ ﺮﯿﻏ ﻞﻜﺸﺑ ﻲﺗﺄﯾو ﻒﯿﻔﺧ عاﺪﺻ ىﺪﻟ 
  ﻢﻈﺘﻨﻣ ﺮﯿﻏ ﻞﻜﺸﺑ ﻲﺗﺄﯾو ﻂﺳﻮﺘﻣ عاﺪﺻ ىﺪﻟ 
  ﻢﻈﺘﻨﻣ ﻞﻜﺸﺑ ﻲﺗﺄﯾو ﻂﺳﻮﺘﻣ عاﺪﺻ ىﺪﻟ 
  ﻢﻈﺘﻨﻣ ﻞﻜﺸﺑ ﻲﺗﺄﯾو ﻲﻟﺎﻋ عاﺪﺻ ىﺪﻟ 
  ﺎﺒﯾﺮﻘﺗ تﺎﻗوﻻا ﻞﻛ ﻲﻓ عاﺪﺻ ىﺪﻟ 
 
 ا (ﺰﯿﻛﺮﺘﻟا) ﺔﺳدﺎﺴﻟا ﺔﻋﻮﻤﺠﻤﻟ
 
  ﺔﺑﻮﻌﺻ يأ دﻮﺟو مﺪﻋ ﻊﻣ ﺪﯾرا ﺎﻣﺪﻨﻋ ﻲﻟﺎﻋ ﻞﻜﺸﺑ ﺰﯿﻛﺮﺘﻟا ﻲﻨﻨﻜﻤﯾ 
  ﺔﻄﯿﺴﺑ ﺔﺑﻮﻌﺻ دﻮﺟو ﻊﻣ ﺪﯾرا ﺎﻣﺪﻨﻋ ﻲﻟﺎﻋ ﻞﻜﺸﺑ ﺰﯿﻛﺮﺘﻟا ﻲﻨﻨﻜﻤﯾ 
  ﺰﯿﻛﺮﺘﻟا ﻲﻓ ﺔﻄﺳﻮﺘﻣ ﺔﺑﻮﻌﺻ ىﺪﻟ 
  ﺰﯿﻛﺮﺘﻟا ﻲﻓ ﺔﯿﻟﺎﻋ ﺔﺑﻮﻌﺻ ىﺪﻟ 
  ﺰﯿﻛﺮﺘﻟا ﻲﻓ اﺪﺟ ةﺮﯿﺒﻛ ﺔﺑﻮﻌﺻ ىﺪﻟ 
  قﻼطﻻا ﻰﻠﻋ ﺰﯿﻛﺮﺘﻟا ﻊﯿﻄﺘﺳأ ﻻ 
 
  ﺔﻋﻮﻤﺠﻤﻟا (ﻞﻤﻌﻟا) ﺔﻌﺑﺎﺴﻟا
 
  ىﺮﺧا ﺔﯿﻓﺎﺿا لﺎﻤﻋا يﺄﺑو ﻞﻤﻌﻟﺎﺑ مﺎﯿﻘﻟا ﻲﻨﻨﻜﻤﯾ 
  ﻂﻘﻓ دﺎﺘﻌﻤﻟا ﻞﻤﻌﻟﺎﺑ مﺎﯿﻘﻟا ﻲﻨﻨﻨﻜﻤﯾ 
  ﻂﻘﻓ دﺎﺘﻌﻤﻟا ﻞﻤﻌﻟا ﻢﻈﻌﻤﺑ مﺎﯿﻘﻟا ﻊﯿﻄﺘﺳأ 
  دﺎﺘﻌﻤﻟا ﻞﻤﻌﻟﺎﺑ مﺎﯿﻘﻟا ﻲﻨﻨﻨﻜﻤﯾ ﻻ 
  ﻞﻤﻋ يﺄﺑ مﺎﯿﻘﻟا اﺪﺟ ﺔﺑﻮﻌﺼﺑ ﻊﯿﻄﺘﺳأ 
  قﻼطﻻا ﻰﻠﻋ ﻞﻤﻋ يﺄﺑ مﺎﯿﻘﻟا ﻊﯿﻄﺘﺳأ ﻻ 
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  (ةدﺎﯿﻘﻟا) ﺔﻨﻣﺎﺜﻟا ﺔﻋﻮﻤﺠﻤﻟا
 
  ﺔﺒﻗﺮﻟا ﻲﻓ ﻢﻟﻻا يأ نوﺪﺑ ةرﺎﯿﺴﻟا ةدﺎﯿﻗ ﻊﯿﻄﺘﺳأ 
  ﺔﺒﻗﺮﻟا ﻲﻓ ﺔﻔﯿﻔﺧ ﻢﻟﻻا دﻮﺟو ﻊﻣ ةرﺎﯿﺴﻟا ةدﺎﯿﻗ ﻊﯿﻄﺘﺳأ 
  ﺔﺒﻗﺮﻟا ﻲﻓ ﺔﻄﺳﻮﺘﻣ ﻢﻟﻻا دﻮﺟو ﻊﻣ ةرﺎﯿﺴﻟا ةدﺎﯿﻗ ﻊﯿﻄﺘﺳأ 
  ﺔﺒﻗﺮﻟا ﻲﻓ ﺔﻄﺳﻮﺘﻣ ﻢﻟﻻا دﻮﺟو ﺐﺒﺴﺑ ةرﺎﯿﺴﻟا ةدﺎﯿﻗ ﻊﯿﻄﺘﺳأ ﻻ 
  ﺔﺒﻗﺮﻟا ﻲﻓ ﺔﯿﻟﺎﻋ ﻢﻟﻻا دﻮﺟو ﺐﺒﺴﺑ ةرﺎﯿﺴﻟا ةدﺎﯿﻗ ﺔﺑﻮﻌﺼﺑ ﻊﯿﻄﺘﺳأ 
  قﻼطﻻا ﻰﻠﻋ ةرﺎﯿﺴﻟا ةدﺎﯿﻗ ﻊﯿﻄﺘﺳأ ﻻ 
 
  (مﻮﻨﻟا) ﺔﻌﺳﺎﺘﻟا ﺔﻋﻮﻤﺠﻤﻟا
 
  مﻮﻨﻟا ﻲﻓ ﺔﻠﻜﺸﻣ يأ ىﺪﻟ ﺲﯿﻟ 
  مﻮﻨﻟا ءﺎﻨﺛا ﺔﻋﺎﺳ ﻦﻣ ﻞﻗا ةﺪﻤﻟ ﻂﯿﺴﺒﻟا ﻖﻠﻘﻟﺎﺑ ﺮﻌﺷا 
  مﻮﻨﻟا ءﺎﻨﺛا ﺔﻋﺎﺳ ٢ :ﺔﻋﺎﺳ ١ ﻦﯿﺑ حواﺮﺘﯾ يﺬﻟا ﻂﺳﻮﺘﻤﻟا ﻖﻠﻘﻟﺎﺑ ﺮﻌﺷا 
  مﻮﻨﻟا ءﺎﻨﺛا ﺔﻋﺎﺳ ٣ :ﺔﻋﺎﺳ ٢ ﻦﯿﺑ حواﺮﺘﯾ يﺬﻟا ﻂﺳﻮﺘﻤﻟا ﻖﻠﻘﻟﺎﺑ ﺮﻌﺷا 
  مﻮﻨﻟا ءﺎﻨﺛا ﺔﻋﺎﺳ ٥ :ﺔﻋﺎﺳ ٣ ﻦﯿﺑ حواﺮﺘﯾ يﺬﻟا ﻲﻟﺎﻌﻟا ﻖﻠﻘﻟﺎﺑ ﺮﻌﺷا 
  مﻮﻨﻟا ءﺎﻨﺛا ﺔﻋﺎﺳ ٧: ﺔﻋﺎﺳ ٥ﻦﯿﺑ حواﺮﺘﯾ يﺬﻟا ﺪﯾﺪﺸﻟا ﻖﻠﻘﻟﺎﺑ ﺮﻌﺷا 
 
  (ﺔﯿﮭﯿﻓﺮﺘﻟاو ﺔﯿﻋﺎﻤﺘﺟﻻا ﺔﻄﺸﻧﻻا) ةﺮﺷﺎﻌﻟا ﺔﻋﻮﻤﺠﻤﻟا
 
 ﻰﻠﻋ ﺔﺒﻗﺮﻟا ﻲﻓ ﻢﻟﻻا نوﺪﺑ ﺔﯿﮭﯿﻓﺮﺘﻟاو ﺔﯿﻋﺎﻤﺘﺟﻻا ﺔﻄﺸﻧﻻا ﻊﯿﻤﺟ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا ﻊﯿﻄﺘﺳأ 
  قﻼطﻻا
  ﺔﺒﻗﺮﻟا ﻲﻓ ﻢﻟﻻا ﺾﻌﺑ ﻊﻣ ﺔﯿﮭﯿﻓﺮﺘﻟاو ﺔﯿﻋﺎﻤﺘﺟﻻا ﺔﻄﺸﻧﻻا ﻊﯿﻤﺟ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا ﻊﯿﻄﺘﺳأ 
 ﻲﻓ ﻢﻟﻻا ﺐﺒﺴﺑ ﺔﯿﮭﯿﻓﺮﺘﻟاو ﺔﯿﻋﺎﻤﺘﺟﻻا ﺔﻄﺸﻧﻻا ﻊﯿﻤﺟ ﺲﯿﻟو ﻢﻈﻌﻣ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا ﻊﯿﻄﺘﺳأ 
  ﺔﺒﻗﺮﻟا
  ﺔﺒﻗﺮﻟا ﻲﻓ ﻢﻟﻻا ﺐﺒﺴﺑ ﺔﯿﮭﯿﻓﺮﺘﻟاو ﺔﯿﻋﺎﻤﺘﺟﻻا ﺔﻄﺸﻧﻻا ﻦﻣ ﻞﯿﻠﻗ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا ﻊﯿﻄﺘﺳأ 
 ﻲﻓ ﻢﻟﻻا ﺐﺒﺴﺑ ﺔﯿﮭﯿﻓﺮﺘﻟاو ﺔﯿﻋﺎﻤﺘﺟﻻا ﺔﻄﺸﻧﻻا ﻦﻣ ﻞﯿﻠﻗ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا ﺔﺑﻮﻌﺼﺑ ﻊﯿﻄﺘﺳأ 
  ﺔﺒﻗﺮﻟا
  قﻼطﻻا ﻰﻠﻋ ﺔﯿﮭﯿﻓﺮﺘﻟاو ﺔﯿﻋﺎﻤﺘﺟﻻا ﺔﻄﺸﻧﻻا ﻲﻓ ﺔﻛرﺎﺸﻤﻟا ﻊﯿﻄﺘﺳأ ﻻ 
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Appendix 12  
 
Measuring upper limb disability in neck pain population: evaluation of the 
acceptability and feasibility of the Single Arm Military Press (SAMP) test 
 
Face to Face Assessment (English and Arabic) 
 
Participant’s demographic information 
Assessment date  --/--/---- 
Participant name  
Participant ID number (in the study)    
Date of Birth --/--/---- 
Occupation  
Weight   
Height   
Telephone number  
Email address  
Home address  
 
• Where is your symptoms now? Complete the body chart. 
 
• How severe is your symptoms now?  
 
a. Neck pain/symptoms 
No pain 0 – 1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 worst possible pain (see 
Appendix 11) 
 
b. Upper limb pain/symptoms  
No pain 0 – 1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 worst possible pain (see 
Appendix 11) 
 
• Over the past 2 weeks are your symptoms: 
o Getting better 
o Getting worse 
o Same  
If worsening, in what way? (exclude deteriorating neurological condition e.g. cord sign, 
radiculopathy) 
 
• Were you involved in an accident which caused your pain? (exclude recent 
major trauma) 
 
• How long have you had your neck symptoms? In weeks ‘determine whether 
acute, sub-acute or chronic’ 
 
• How long ago did you first experience these symptoms? In weeks ‘determine 
recurrence’ and how it was treated? 
 
 75 
• Have you had any treatment such as physical therapy in the past three months?  
 
• Have you ever injured your shoulder, arm or hand substantially? exclude injuries 
which has resulted in current or prolonged disability 
• Is your weight steady? Exclude unintentional weight loss  
   
• Are you sleeping OK at night? Exclude severe pain at night  
 
• Are you having any problems with dizziness, double vision, speech, swallowing, 
LOC (loss of consciousness)? Exclude in accordance with the criteria  
 
• Do you have any general medical problems? If so, specify what type of 
problems? (Exclude vertebral artery problems) 
 
• Do you have any general medical problems? If so specify, (Exclude – severe 
rheumatoid arthritis, severe multiple sclerosis, cancer, osteoporosis, cardiac 
conditions, severe SOBOE, uncontrolled hypertension, postural hypotension, 
balance problems).  
 
If all answers confirmed eligibility and the NDI scored at least 10%, and patient still 
happy to proceed. Patient should sign the consent form and allocated for SAMP testing.  
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 fo noitaulave :noitalupop niap kcen ni ytilibasid bmil reppu gnirusaeM
 sserP yratiliM mrA elgniS eht fo ytilibisaef dna ytilibatpecca eht
 tset )PMAS(
 
  ﺺﺤﻔﻟا ﻦﻣ ﺔﯿﻧﺎﺜﻟا ﺔﻠﺣﺮﻤﻟا ) :(ﺾﯾﺮﻤﻟا رﻮﻀﺤﺑ
 
  ﺺﺤﻔﻟا مﻮﯾ ﺦﯾرﺎﺗ  .............\.........\..........
  ﺾﯾﺮﻤﻟا ﻢﺳا 
  ﺾﯾﺮﻤﻟا ﻢﻗر 
  ﺾﯾﺮﻤﻟا دﻼﯿﻣ ﺦﯾرﺎﺗ 
  ﺾﯾﺮﻤﻟا ﺔﻔﯿظو 
 نزﻮﻟا 
  لﻮﻄﻟا 
  ﺾﯾﺮﻤﻟا نﻮﻔﯿﻠﺗ ﻢﻗر 
  ﺾﯾﺮﻤﻟا ناﻮﻨﻋ 
  ﺚﺤﺒﻟا ﺔﻠﺣﺮﻣ 
 
  :لوﻻا لاﺆﺴﻟا
  (ﻖﻓﺮﻤﻟا ﻢﺴﺠﻟا ﻂﻄﺨﻣ لﺎﻤﻜﺘﺳا) ؟نﻻا ﻢﻟﻻا ﺪﺟﻮﯾ ﻦﯾا 
 
  :ﻲﻧﺎﺜﻟا لاﺆﺴﻟا
  ؟ﻢﻟﻻا ةﻮﻗ ىﺪﻣ ﺎﻣ
  
  :ﺔﺒﻗﺮﻟا ﻢﻟا
   ﻢﻟا ﺪﺟﻮﯾ ﻻ 0 - 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 01  ﻦﻜﻤﻣ ﻢﻟا ﻰﺼﻗا 
 
  :ﺪﯿﻟاو ﻒﺘﻜﻟاو عارﺬﻟا ﻢﻟا
   ﻢﻟا ﺪﺟﻮﯾ ﻻ 0 - 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 01  ﻦﻜﻤﻣ ﻢﻟا ﻰﺼﻗا 
 
  :ﺚﻟﺎﺜﻟا لاﺆﺴﻟا
  :ﺔﺒﻗﺮﻟا ﻢﻟا ﻦﯿﯿﺿﺎﻤﻟا ﻦﯿﻋﻮﺒﺳﻻا لﻼﺧ
  :ﻦﺴﺤﺗ
  (بﺎﺼﻋﻻاو يﺮﻘﻔﻟا دﻮﻤﻌﻟﺎﺑ ﺔﻄﺒﺗﺮﻤﻟا تﻻﺎﺤﻟا دﺎﻌﺒﺘﺳا) :ءﻮﺳ دادزا
  :ﻢﻟﻷا ﺲﻔﻧ
 
  :ﻊﺑاﺮﻟا لاﺆﺴﻟا
  ؟ثدﺎﺤﻟ ﺔﺠﯿﺘﻧ ﮫﺑ ﺮﻌﺸﺗ يﺬﻟا ﺔﺒﻗﺮﻟا ﻢﻟا ﻞھ
  :ﻻ
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  (ﺎﺜﯾﺪﺣ نﻮﺑﺎﺼﻤﻟا ﻰﺿﺮﻤﻟا دﺎﻌﺒﺘﺳا) :ﻢﻌﻧ
 
  :ﺲﻣﺎﺨﻟا لاﺆﺴﻟا
  (عﻮﺒﺳﻷﺎﺑ) ؟ﻦھاﺮﻟا ﺖﻗﻮﻟا ﻲﻓ ﺔﺒﻗﺮﻟا ﻢﻟﺄﺑ كرﻮﻌﺷ ةﺪﻣ ﺎﻣ 
 
  :سدﺎﺴﻟا لاﺆﺴﻟا
  (عﻮﺒﺳﻷﺎﺑ) ؟ﻰﻟوﻻا ةﺮﻤﻠﻟ ﺔﺒﻗﺮﻟا ﻢﻟﺄﺑ تﺮﻌﺷ ﻰﺘﻣ
  ................
 
  :ﻊﺑﺎﺴﻟا لاﺆﺴﻟا
  ؟ﺔﯿﺿﺎﻤﻟا رﻮﮭﺷ ثﻼﺜﻟا ﻲﻓ جﻼﻋ يأ ﺖﯿﻘﻠﺗ ﻞھ
  :ﻻ
  :ﻢﻌﻧ
 
  :ﻦﻣﺎﺜﻟا لاﺆﺴﻟا
  ؟ﺪﯿﻟا وا عارﺬﻟا وا ﻒﺘﻜﻟا ﻲﻓ ﺔﺑﺎﺻﻹ ﺖﺿﺮﻌﺗ نا ﻚﻟ ﻖﺒﺳ ﻞھ
  :ﻻ
  (ﺪﯿﻟا وا عارﺬﻟا وا ﻒﺘﻜﻟا ﻲﻓ ﺔﻗﺎﻋإ وا ﺪﯾﺪﺷ ﻢﻟﻷﺎﺑ نﻮﺑﺎﺼﻤﻟا دﺎﻌﺒﺘﺳا) :ﻢﻌﻧ
 
  :ﻊﺳﺎﺘﻟا لاﺆﺴﻟا
  ؟ﺖﺑﺎﺛ ﻚﻧزو ﻞھ 
  (ﺪﺼﻗ نوﺪﺑ نزﻮﻟا ﻲﻓ نﺎﺼﻘﻧ يأ دﺎﻌﺒﺘﺳا) :ﻻ
  :ﻢﻌﻧ
 
  :ﺮﺷﺎﻌﻟا لاﺆﺴﻟا
  ؟تﺎﺑاﺮﺿا نوﺪﺑ ﻼﯿﻟ مﺎﻨﺗ ﻞھ 
  :ﻢﻌﻧ       
  (ﻲﻠﯿﻠﻟا ﻢﻟﻻا دﺎﻌﺒﺘﺳا) :ﻻ       
 
  :ﺮﺸﻋ يدﺎﺤﻟا لاﺆﺴﻟا
  ؟ﻲﻋﻮﻟا ناﺪﻘﻓ وا ،ﺔﯾؤﺮﻟا جاودزا ،راوﺪﻟا ﻞﺜﻣ ﺔﯿﺤﺻ ﻞﻛﺎﺸﻣ يأ ﻚﯾﺪﻟ ﻞھ
  ﻻ 
  (ﺔﯿﺒﻄﻟا تﻼﻜﺸﻤﻟا هﺬھ ﻊﻣ ﻰﺿﺮﻤﻟا دﺎﻌﺒﺘﺳا) :ﻢﻌﻧ
 
 ﻰﻠﻋ ٪ ٠١ (IDN) ﺔﺒﻗﺮﻟا ﺔﻗﺎﻋإ سﺎﯿﻘﻣ ﺔﺠﯿﺘﻧو ﺾﯾﺮﻤﻟا رﺎﯿﺘﺧا ﺲﺳﻷ ﺔﻘﺑﺎﻄﻣ تﺎﺑﺎﺟﻻا ﺖﻧﺎﻛ اذإ
  .هءاﺮﺟاو ﺚﺤﺒﻟا ﺔﻨﯿﻋ ﻲﻓ كاﺮﺘﺷﻼﻟ ﮫﺘﻘﻓاﻮﻣ ﻰﻠﻋ ﺾﯾﺮﻤﻟا ﻊﯿﻗﻮﺗ ﻢﺘﯾ ﻞﻗﻻا
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Appendix 13 
 
Measuring upper limb disability in neck pain population: evaluation of 
the acceptability and feasibility of the Single Arm Military Press 
(SAMP) test 
 
Consent Form (English and Arabic) 
 
Name of the researcher: Ahmad Alreni 
 
1. I confirm that I have read and understand the information sheet dated 0 /0 /00 for 
the above research study and have had opportunity to ask questions.                
 
 
 
2.  I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving reason.                                                           
 
 
 
3. I agree to tack part in the above research study   
 
 
Name of the subject (BLOCK CAPITALS): 
 
…………………………………………… 
 
 
Signature:                             
……………………………………………Date: 
……………………… 
 
 
Signature of the researcher: 
 
…………………………………………… 
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 fo noitaulave :noitalupop niap kcen ni ytilibasid bmil reppu gnirusaeM
 sserP yratiliM mrA elgniS eht fo ytilibisaef dna ytilibatpecca eht
 tset )PMAS(
 
  ﺚﺤﺒﻟا ﮫﻨﯿﻋ ﻲﻓ كاﺮﺘﺷﻻا ﻰﻠﻋ ﺾﯾﺮﻤﻟا ﺔﻘﻓاﻮﻣ
 
  ﻲﻨﯾﺮﻌﻟا ﻦﯾﺪﻟا حﻼﺻ ﺪﻤﺣا :ﺚﺣﺎﺒﻟا ﻢﺳا
 
 ىﺪﻟ نﺎﻛو ﺚﺤﺒﻟا اﺬھ تاءاﺮﺟﺈﺑ ﺔﺻﺎﺨﻟا تﺎﻣﻮﻠﻌﻤﻟا ﺖﻤﮭﻓو تأﺮﻗ ﻲﻨﻧإ ﻰﻠﻋ هﺎﻧدا ﻊﻗﻮﻤﻟا ﺎﻧا ﺮﻗا .١
 ﻢﺗو ﺚﺤﺒﻟا تاءاﺮﺟا ﻲﻓ ىﺪﻟ ﺔﻀﻣﺎﻐﻟا ءاﺰﺟﻻا ﺾﻌﺑ ﻦﻋ رﺎﺴﻔﺘﺳﻻا ﻰﻠﻋ ةرﺪﻘﻤﻟا
    ﻲﺗارﺎﺴﻔﺘﺳا ﻰﻠﻋ ﺔﺑﺎﺟﻻا
           
 نوﺪﺑ ﮫﻨﻣ بﺎﺤﺴﻧﻻا ﻲﻓ ﻲﺗرﺪﻘﻣ ﻊﻣ ﺚﺤﺒﻟا اﺬھ ﻲﻓ ﺎﯿﻋﻮﻄﺗ كرﺎﺷا ﻲﻨﻧإ هﺎﻧدا ﻊﻗﻮﻤﻟا ﺎﻧا ﻢﮭﻔﺗا .٢
  بﺎﺒﺳا يأ ءاﺪﺑا
 
  ﺚﺤﺒﻟا اﺬھ ﺔﻨﯿﻋ ﻲﻓ كاﺮﺘﺷﻻا ﻰﻠﻋ ﻖﻓاوا .٣
 
 
  ............................................ :ﺾﯾﺮﻤﻟا ﻢﺳا
  ............................................ :ﻊﯿﻗﻮﺘﻟا
         ............................................  :ﺦﯾرﺎﺘﻟا
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Appendix 14 
 
Brief Warm-Up before SAMP Testing 
 
Shoulder Shrugs (10 reps) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shoulder Flexion (10 reps)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Starting position  End position  
Starting position  End position  
 81 
 
Range of Motion Exercise for the Neck 
 
 
Range of Motion Exercise for the Shoulder  
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Appendix 15 
 
SAMP Test Procedure 
 
Description and practical application of the SAMP test  
 
The SAMP test is a performance-based instrument that would be used for diagnostic 
purpose to measure the physical functioning, capacity, of the upper limb on a specific 
targeted population (patients with non-specific neck pain). The International 
Classification of Functioning, Disability and Health Categories Code is d430-d449: 
carrying, moving and handling object.  
 
The SAMP test is designed to assess the strength and endurance of the upper limb by 
counting the number of repetitions a patient can perform in 30 seconds. This is to enable 
clinicians in the field of neck pain to assess wide variations pertaining to the patients’ 
ability level with the possible scoring range between zero for those who cannot 
complete even one repetition, which indicate high level of pain/disability, to a high of 
30 or more for highly fit individual (McLean et al., 2010a). In addition, the 
administrative and respondent burden of the SAMP test protocol are minimal < 1 
minute, no formal instruction to obtain and the equipment required are only dumbbell 
and timer/stop watch.  
 
Test Equipment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SAMP test procedure  
 
The SAMP test is conducted in the standing position with the feet at the shoulder width, 
patient is requested to carry a dumbbell and lifted using their dominant hand to the 
shoulder level (see Starting Position). Patient is requested to repeat raising the hand 
with the dumbbell directly overhead by extending through the elbow (see End Position) 
and repeat this process as fast as possible for 30 seconds.   
 
 
 
 
 
½-kg, 1-kg and 1½-kg hand weight Stop watch 
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SAMP test standardised verbal instructions 
 
“For the purpose of this test, please do the best you can by raising your hand with the 
dumbbell overhead as fast as you can but do not push yourself beyond what you think is 
safe for you.  
1. Stand erect with your feet flat in the floor and at the shoulder width apart with 
the dumbbell at the shoulder level.    
2. On the signal to begin, raise your hand with the dumbbell overhead a full and 
then come back to the shoulder level. 
3. Keep going for 30 seconds and until I say stop 
4. Get ready and start” 
 
 Test Stopping Criteria 
 
The SAMP test should be continued for 30 seconds, but is terminated based on the 
following stopping rules: 
1. Participant stops or states it is too painful to continue. 
2. Participant is severely off pacing to the extent that they are unable to 
complete one repetition of the movement. 
3. Participant substitutes using trunk/whole body movement and cannot correct 
with feedback.  
4. The examiner believes that the participant is at risk of injury or adverse 
complication if test is to continue. 
 
Scoring:     
 
The number of valid (correct) repetitions with the 30 seconds. 
 
 
 
 
 
 
 
Starting position End position 
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Appendix 16 
 
Measuring upper limb disability in neck pain population: evaluation of 
the acceptability and feasibility of the Single Arm Military Press 
(SAMP) test 
 
Data Collection Sheet (English and Arabic) 
 
Assessment Date: 
Examiner Name: 
Group Number: 
Weight used:  
 
Patient ID 
Number  
SAMP Score reps/30-sec  Administration Time Completion Time 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SAMP score = number of repetitions in the 30-second, Administration time = 
description, demonstration, instructions and the 30-sec performance, Completion time 
= warm-up time and administration time.    
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 fo noitaulave :noitalupop niap kcen ni ytilibasid bmil reppu gnirusaeM
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  تﺎﻧﺎﯿﺒﻟا ﻊﻤﺟ ةرﺎﻤﺘﺳا
 
  .........................................  :رﺎﺒﺘﺧﻻا ءادا ﺦﯾرﺎﺗ
  .........................................  :ﺺﺣﺎﻔﻟا ﻢﺳا
  .......................................  :ﺔﻋﻮﻤﺠﻤﻟا ﻢﻗر
  .........................................  :مﺪﺨﺘﺴﻤﻟا نزﻮﻟا
 
  ﺾﯾﺮﻤﻟا ﻢﻗر  ث٠٣\ ت  رﺎﺒﺘﺧﻻا ﻦﻣز  رﺎﺒﺘﺧﻻا ﻰﻠﻜﻟا ﻦﻣﺰﻟا
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  ﺔﯿﻧﺎﺛ ٠٣ ﻰﻠﻋ تاراﺮﻜﺘﻟا دﺪﻋ = ث ٠٣ \ت •
 رﺎﺒﺘﺧﻻا ءادا ث ٠٣ + تﺎﻤﯿﻠﻌﺘﻟا ،جذﻮﻤﻧ ءادا ،رﺎﺒﺘﺧﻻا حﺮﺷ = رﺎﺒﺘﺧﻻا ﻦﻣز •
 رﺎﺒﺘﺧﻻا ﻦﻣز + ءﺎﻤﺣﻻا = رﺎﺒﺘﺧﻼﻟ ﻰﻠﻜﻟا ﻦﻣﺰﻟا  •
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Appendix 17 
 
Measuring upper limb disability in neck pain population: evaluation of the 
acceptability and feasibility of the Single Arm Military Press (SAMP) test 
 
Symptoms Severity Scale 
Severity Description of Experience 
10 - Worst Possible 
Pain 
I am in bed and can’t move due to my pain. I need someone to take me to 
emergency room to get help for my pain. 
9 – Extremely 
Sever Pain 
My Pain is all that I can think about. I can barely talk or move because of 
the pain. 
8 – Very Severe 
Pain  
My pain is so severe that it is hard to think of anything else. Talking and 
listening are difficult.  
7 – Severe Pain I am in pain all the time. It keeps me from doing most activities.  
6 – Distressing 
Pain 
I think about my pain all the time. I give up many activities because of my 
pain. 
5 – Distracting 
Pain 
I think about my pain most of the time. I cannot do some of the activities I 
need to do each day because of the pain.  
4 – Moderate pain  I am constantly aware of my pain but I can continue most activities.   
3 – Uncomfortable 
Pain 
My pain bothers me but I can ignore it most of the time.  
2 – Mild Pain  I have a low level of pain. I am aware of my pain only when I pay 
attention to it.  
1 – Slight Pain My pain is hardly noticeable.  
0 – No Pain I have no pain  
 
https://paindoctor.com/pain-scales/ 
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Appendix 18 
 
Measuring upper limb disability in neck pain population: evaluation of the 
acceptability and feasibility of the Single Arm Military Press (SAMP) test 
 
Patient Input after Testing (English and Arabic)  
(To be completed for each patient immediately after testing by the researcher) 
 
1. Now I am going to ask you about your symptoms after performing the SAMP 
test: 
• How severe is your neck pain/symptoms now?  
 
0 1 2 3 4 5 6 7 8 9 10 
0=No pain, 1=Slight pain, 2=Mild pain, 3=Uncomfortable pain, 4=Moderate pain, 5=Distracting pain, 
6=Distressing pain, 7=Severe pain, 8=Very severe pain, 9=Extremely severe pain, 10=The Worst 
Possible pain/Symptoms  
 
• How severe is your upper limb pain/symptoms now?  
 
0 1 2 3 4 5 6 7 8 9 10 
0=No pain, 1=Slight pain, 2=Mild pain, 3=Uncomfortable pain, 4=Moderate pain, 5=Distracting pain, 
6=Distressing pain, 7=Severe pain, 8=Very severe pain, 9=Extremely severe pain, 10=The Worst 
Possible pain/Symptoms  
 
2. Now I am going to ask you about your experience with the SAMP testing:  
• How light or heavy was the dumbbell you used in the SAMP testing 
procedure? 
 
1 2 3 4 5 6 7 8 9 
1=Extremely Light, 2=Very Light, 3=Moderately Light, 4= Slightly Light, 5=Neither light nor Heavy, 
6=Slightly Heavy, 7=Moderately Heavy, 8=Very Heavy, 9=Extremely Heavy 
 
• How easy or difficult was it to understand the instruction and perform 
the SAMP test? 
 
1 2 3 4 5 6 7 8 9 
1=Extremely Easy, 2=Very Easy, 3=Moderately Easy, 4=Slightly Easy, 5=Neither Difficult nor Easy, 
6=Slightly Difficult, 7=Moderately Difficult, 8=Very Difficult, 9=Extremely Difficult.  
 
• How easy or difficult was the SAMP test in relation to your ability to 
perform the procedure? 
  
1 2 3 4 5 6 7 8 9 
1=Extremely Easy, 2=Very Easy, 3=Moderately Easy, 4=Slightly Easy, 5=Neither Difficult nor Easy, 
6=Slightly Difficult, 7=Moderately Difficult, 8=Very Difficult, 9=Extremely Difficult.  
 
• How suitable or unsuitable was the SAMP test with regard to the time 
and effort used?  
 
1 2 3 4 5 6 7 8 9 
1=Highly Suitable, 2=Considerably Suitable, 3=Fairly Suitable, 4=Slightly Suitable, 5=Neither Suitable 
nor Unsuitable, 6=Slightly Unsuitable, 7=Fairly Unsuitable, 8=Considerably Unsuitable, 9=Completely 
Unsuitable.  
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 eht fo noitaulave :noitalupop niap kcen ni ytilibasid bmil reppu gnirusaeM
 tset )PMAS( sserP yratiliM mrA elgniS eht fo ytilibisaef dna ytilibatpecca
 
  ﺾﯾﺮﻤﻟا ىأر
 ؟نﻻا ﺔﺒﻗﺮﻟا مﻻا ﮫﺟرد ﻲھ ﺎﻣ •
 
 ٠ ١ ٢ ٣ ٤ ٥ ٦ ٧ ٨ ٩ ٠١
 ﻢﻟﻷا ﻦﻣ ﮫﺟرد ﻲﻠﻋا =٠١ ،ﻢﻟا ﺪﺟﻮﯾ ﻻ=٠
 
 ؟نﻻا ﻦﯿﻋارذاو ﻒﺘﻜﻟا مﻻا ﮫﺟرد ﻲھ ﺎﻣ
 
 ٠ ١ ٢ ٣ ٤ ٥ ٦ ٧ ٨ ٩ ٠١
 ﻢﻟﻷا ﻦﻣ ﮫﺟرد ﻲﻠﻋا =٠١ ،ﻢﻟا ﺪﺟﻮﯾ ﻻ=٠
 
 ؟مﺪﺨﺘﺴﻤﻟا ﻞﻘﺜﻟا ﮫﻟﻮﮭﺳ/ﺔﺒﺳﺎﻨﻣ ﺔﺟرد ﻲھﺎﻣ •
 
 ١ ٢ ٣ ٤ ٥ ٦ ٧ ٨ ٩
 ﺔﺑﻮﻌﺼﻟا ﻦﻣ ﮫﺟرد ﻲﻠﻋا=٩ ،ﺔﻟﻮﮭﺴﻟا ﻦﻣ ﮫﺟرد ﻲﻠﻋا=١
 
 ؟ءادﻷاو تﺎﻤﯿﻠﻌﺘﻠﻟ ﺔﺒﺴﻨﻟﺎﺑ رﺎﺒﺘﺧﻻا ﺔﺑﻮﻌﺻ/ﺔﺒﺳﺎﻨﻣ ﺔﺟرد ﻲھﺎﻣ •
 
 ١ ٢ ٣ ٤ ٥ ٦ ٧ ٨ ٩
 ﺔﺑﻮﻌﺼﻟا ﻦﻣ ﮫﺟرد ﻲﻠﻋا=٩ ،ﺔﻟﻮﮭﺴﻟا ﻦﻣ ﮫﺟرد ﻲﻠﻋا=١
 
 ؟رﺎﺒﺘﺧﻻا ادا ﻰﻠﻋ ﻚﺗرﺪﻘﻣ ﺐﻧﺎﺟ ﻦﻣ رﺎﺒﺘﺧﻻا ﺔﺒﺳﺎﻨﻣ ﺔﺟرد ﻲھﺎﻣ •
 
 ١ ٢ ٣ ٤ ٥ ٦ ٧ ٨ ٩
 ﺔﺑﻮﻌﺼﻟا ﻦﻣ ﮫﺟرد ﻲﻠﻋا=٩ ،ﺔﻟﻮﮭﺴﻟا ﻦﻣ ﮫﺟرد ﻲﻠﻋا=١
 
 ؟لوﺬﺒﻤﻟا دﻮﮭﺠﻤﻟاو مﺪﺨﺘﺴﻤﻟا ﺖﻗﻮﻠﻟ ﺔﺒﺴﻨﻟﺎﺑ رﺎﺒﺘﺧﻻا ﺔﺑﻮﻌﺻ/ﺔﺒﺳﺎﻨﻣ ﺔﺟرد ﻲھﺎﻣ •
 
 ١ ٢ ٣ ٤ ٥ ٦ ٧ ٨ ٩
 ﺔﺑﻮﻌﺼﻟا ﻦﻣ ﮫﺟرد ﻲﻠﻋا=٩ ،ﺔﻟﻮﮭﺴﻟا ﻦﻣ ﮫﺟرد ﻲﻠﻋا=١
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Appendix 19 
 
Measuring upper limb disability in neck pain population: evaluation of the 
acceptability and feasibility of the Single Arm Military Press (SAMP) test 
 
Examiner Input after testing (English and Arabic) 
(To be completed once only after the completion of the SAMP testing)  
 
Do you feel that:  
 
 Strongly 
Agree 
Agree Neither Agree 
or Disagree  
Disagree Strongly 
Disagree 
There is a need for extra training to 
understand the application of the SAMP 
test procedure  
 
     
There is a need for extra staff to support 
the application of the SAMP test 
procedure 
     
There is a need for any technological 
support when using the SAMP test for 
patients with neck pain 
 
     
 
1. How easy or difficult was it to provide explanation with demonstration of the 
SAMP test to patients? 
 
1 2 3 4 5 6 7 8 9 
1=Extremely Easy, 2=Very Easy, 3=Moderately Easy, 4=Slightly Easy, 5=Neither Difficult nor Easy, 
6=Slightly Difficult, 7=Moderately Difficult, 8=Very Difficult, 9=Extremely Difficult.  
 
2. How easy or difficult was it regarding the overall administration of the SAMP 
test? 
 
1 2 3 4 5 6 7 8 9 
1=Extremely Easy, 2=Very Easy, 3=Moderately Easy, 4=Slightly Easy, 5=Neither Difficult nor Easy, 
6=Slightly Difficult, 7=Moderately Difficult, 8=Very Difficult, 9=Extremely Difficult.  
 
3.   How appropriate or inappropriate was the SAMP test regarding resources 
needed (e.g. time, cost)?  
    
1 2 3 4 5 6 7 8 9 
1=Highly appropriate, 2=Considerably Appropriate, 3=Fairly Appropriate, 4=Slightly Appropriate, 
5=Neither appropriate nor Inappropriate, 6=Slightly Inappropriate, 7=Fairly Inappropriate, 
8=Considerably Inappropriate, 9=Completely Inappropriate.  
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 eht fo noitaulave :noitalupop niap kcen ni ytilibasid bmil reppu gnirusaeM
 tset )PMAS( sserP yratiliM mrA elgniS eht fo ytilibisaef dna ytilibatpecca
 
 ﺺﺣﺎﻔﻟا ىأر
 
 ﺾﻓرا
 هﻮﻘﺑ
 ﻻو ﺾﻓرا ﻻ  ﺾﻓرا
  ﻖﻓاوا
 ﻖﻓاوأ  ﻖﻓاوا
  هﻮﻘﺑ
 
 اﺬھ ماﺪﺨﺘﺳا ﻞﺟا ﻦﻣ صﺎﺧ ﺐﯾرﺪﺗ ﻲﻟا جﺎﯿﺘﺣا كﺎﻨھ     
  رﺎﺒﺘﺧﻻا
  رﺎﺒﺘﺧﻻا اﺬھ ماﺪﺨﺘﺳﻻ ﺮﺧا ﺺﺨﺷ ﻦﻣ هﺪﻋﺎﺴﻣ جﺎﯿﺘﺣا كﺎﻨھ     
 اﺬھ ماﺪﺨﺘﺳا ﻞﺟا ﻦﻣ ﮫﯿﺟﻮﻟﻮﻨﻜﺗ هﺪﻋﺎﺴﻣ ﻲﻟا جﺎﯿﺘﺣا كﺎﻨھ     
  رﺎﺒﺘﺧﻻا
 
  ؟جذﻮﻤﻨﻟا ءاداو تﺎﻤﯿﻠﻌﺘﻟا ﺐﻧﺎﺟ ﻦﻣ رﺎﺒﺘﺧﻻا ﺔﺑﻮﻌﺻ/رﺎﺒﺘﺧﻻا ﺔﺒﺳﺎﻨﻣ ﺔﺟرد ﻲھﺎﻣ
 
 ١ ٢ ٣ ٤ ٥ ٦ ٧ ٨ ٩
 ﺔﺑﻮﻌﺼﻟا ﻦﻣ ﮫﺟرد ﻲﻠﻋا=٩ ،ﺔﻟﻮﮭﺴﻟا ﻦﻣ ﮫﺟرد ﻲﻠﻋا=١
 
  ؟ﺔﺠﯿﺘﻨﻟا بﺎﺴﺣو ﺬﯿﻔﻨﺘﻟا ﺐﻧﺎﺟ ﻦﻣ رﺎﺒﺘﺧﻻا ﺔﺑﻮﻌﺻ/ﺔﺒﺳﺎﻨﻣ ﺔﺟرد ﻲھﺎﻣ
  
 ١ ٢ ٣ ٤ ٥ ٦ ٧ ٨ ٩
 ﺔﺑﻮﻌﺼﻟا ﻦﻣ ﮫﺟرد ﻲﻠﻋا=٩ ،ﺔﻟﻮﮭﺴﻟا ﻦﻣ ﮫﺟرد ﻲﻠﻋا=١
 
 ؟ﺔﯿﻟﺎﻤﻟا ﺔﻔﻠﻜﺘﻟاو مﺪﺨﺘﺴﻤﻟا ﺖﻗﻮﻟا ﺐﻧﺎﺟ ﻦﻣ رﺎﺒﺘﺧﻻا ﺔﺑﻮﻌﺻ/ﺔﺒﺳﺎﻨﻣ ﺔﺟرد ﻲھﺎﻣ
 
 ١ ٢ ٣ ٤ ٥ ٦ ٧ ٨ ٩
 ﺔﺑﻮﻌﺼﻟا ﻦﻣ ﮫﺟرد ﻲﻠﻋا=٩ ،ﺔﻟﻮﮭﺴﻟا ﻦﻣ ﮫﺟرد ﻲﻠﻋا=١
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Appendix 20  
     Descriptive Data for all Measures for SAMP Acceptability and Feasibility 
Group 1 SAMP Testing Using (½kg) 
Patient 
ID  
SAMP 
Admin Time 
/ Completion 
Time 
/Seconds 
SAMP 
Scores 
Mean=
20.7 
NDI 
Score  
Neck Pain/ symptoms Upper limb Pain/symptoms Patient 
Input 
(weight) 
 
Patient Input 
(Instruction/ 
Performance 
 
Patient 
Input 
(Ability 
to 
Perform) 
 
Patient 
Input 
(Time 
& 
Effort) 
 
Before 
Testing  
Immediat
ely After 
testing 
24 H 
After 
Testing  
Before 
Testing  
Immedi
ately 
After 
Testing  
24 H 
After 
Testing 
1 60/120 32 16% 3 3 2 1 3 1 1 1 1 1 
5 60/120 26 30% 4 5 3 1 4 1 1 1 1 1 
7 60/120 30 25% 4 4 2 1 3 1 1 1 1 1 
11 57/117 22 35% 4 4 3 1 4 1 1 1 1 1 
13 58/118 26 32% 4 5 4 1 3 1 1 1 1 1 
16 60/120 28 41% 5 5 3 1 4 1 1 1 1 1 
19 55/115 17 50% 5 8 5 3 5 3 1 2 1 1 
24 60/120 30 24% 4 5 3 2 5 1 1 1 1 1 
27 60/120 26 23% 4 6 4 2 4 1 1 1 1 1 
30 60/120 33é 15% 3 5 3 1 4 1 1 1 1 1 
31 58/118 20 17% 3 4 3 2 3 2 1 2 1 1 
32 57/117 20 19% 3 4 3 1 3 1 1 1 1 1 
33 56/116 19 30% 4 5 3 2 3 1 1 1 1 2 
34 58/118 21 30% 4 5 3 2 3 2 1 1 1 1 
35 54/114 16 35% 4 5 3 2 4 2 2 1 4 2 
36 50/110 11 52% 5 6 4 3 5 3 3 1 5 3 
37 50/110 15 36% 4 5 3 2 4 2 2 1 5 3 
38 50/110 11 55% 5 6 4 3 5 3 4 1 5 3 
39 50/110 14 34% 4 5 3 3 4 3 2 1 4 3 
40 55/115 16 30% 4 5 3 3 5 3 2 1 4 3 
41 50/110 10ê 75% 6 7 6 4 6 4 3 1 5 4 
42 52/112 15 50% 4 5 3 3 4 2 2 1 3 3 
43 50/110 15 58% 4 5 4 3 4 3 2 1 3 3 
SAMP: Single Arm Military Press, NDI: Neck and Disability Index, Admin Time: Administration Time (Description, demonstration, instruction and 
30S Performance). Completion Time (Warm-Up Time & Administration Time). ê=Minimum Score. é=Maximum Score.   
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Group 2 SAMP Testing Using (1-kg)  
Patient 
ID 
SAMP Admin 
Time / 
Completion 
Time /Seconds 
SAMP 
Scores  
Mean 
=15.88 
NDI 
Score  
Neck Pain/ symptoms Upper limb Pain/symptoms Patient 
Input 
(weight) 
 
Patient 
Input 
(Instruction
/ 
Performanc
e) 
 
Patient 
Input 
(Ability 
to 
Perform
) 
 
Patient 
Input 
(Time 
& 
Effort) 
 
Before 
Testin
g 
Immediat
ely After 
Testing 
24 
Hours 
After 
Testing 
Before 
Testing 
Immedi
ately 
After 
Testing 
24 
Hours 
After 
Testin
g 
3 60/60 24 27% 4 5 3 1 4 1 3 1 3 2 
6 60/60 23 36% 4 5 3 1 3 1 3 1 3 2 
8 60/60 22 29% 5 6 3 1 4 1 3 1 2 2 
10 55/60 17 48% 5 6 4 3 6 3 4 1 3 3 
14 60/60 25 28% 4 5 3 1 5 1 3 1 2 2 
17 60/60 26 25% 4 5 3 1 4 1 3 1 2 2 
21 60/60 26 28% 5 7 4 2 5 2 3 1 2 2 
22 60/60 24 35% 5 6 4 2 5 1 3 1 2 3 
25 60/60 25 26% 4 6 3 2 5 1 3 1 2 2 
29 60/60 27é 18% 3 4 2 1 4 1 2 1 2 1 
44 50/60 7 80% 6 7 5 4 7 4 5 1 6 6 
45 50/60 7 70% 5 6 4 3 6 3 6 1 7 6 
46 50/60 11 48% 4 6 3 3 5 3 4 1 4 3 
47 50/60 13 45% 3 5 3 2 5 2 4 1 4 3 
48 53/60 12 40% 4 5 3 2 4 2 4 1 5 2 
49 50/60 9 60% 5 6 4 3 5 3 5 1 6 4 
50 54/60 11 45% 4 5 3 3 4 3 5 1 6 4 
51 50/60 6ê 65% 5 7 5 4 7 4 7 1 7 6 
52 55/60 14 39% 4 6 4 2 4 2 4 1 4 2 
53 55/60 11 58% 5 6 4 3 5 3 4 1 5 3 
54 55/60 11 60% 5 6 4 3 5 3 5 1 5 4 
55 53/60 14 40% 4 5 3 2 4 2 4 1 5 2 
56 50/60 9 65% 5 7 5 4 7 4 5 1 4 3 
57 50/60 7 68% 5 6 4 4 7 4 6 1 6 5 
SAMP: Single Arm Military Press, NDI: Neck and Disability Index, Admin Time: Administration Time (Description, demonstration, instruction and 
30S Performance). Completion Time (Warm-Up Time & Administration Time). ê=Minimum Score. é=Maximum Score.   
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Group 3 SAMP Testing Using (1½-kg) 
Patient 
ID 
SAMP 
Admin Time 
/ Completion 
Time 
/Seconds 
SAMP 
Scores 
Mean 
=9.70 
NDI 
Score  
  
Neck Pain/ symptoms 
 
Upper limb Pain/symptoms 
 
Patient 
Input 
(weight) 
 
Patient Input 
(Instruction/ 
Performance) 
 
Patient 
Input 
(Ability 
to 
Perform) 
 
Patient 
Input 
(Time 
& 
Effort) 
 
Before 
Testing 
Immediat
ely After 
Testing 
24 H 
After 
Testing 
Before 
Testing 
Immedi
ately 
After 
Testing 
24 H 
After 
Testing 
2 50/60 9 29% 3 7 6 2 6 4 7 1 8 7 
4 50/60 13 27% 4 7 4 2 6 4 6 1 7 7 
9 50/60 11 25% 4 7 5 2 6 4 6 1 7 7 
12 52/60 16 35% 4 6 5 2 7 6 6 1 6 5 
15 55/60 15 39% 4 5 4 2 7 6 5 1 6 6 
18 55/60 14 42% 5 7 5 2 7 6 5 1 6 6 
20 55/60 17 30% 4 6 4 3 7 5 5 1 5 4 
23 50/60 12 50% 5 6 5 2 7 6 6 1 6 5 
26 55/60 14 40% 4 6 4 3 7 6 5 1 6 5 
28 60/60 20é 19% 3 5 3 0 4 4 4 1 5 5 
58 55/60 15 25% 4 5 4 2 6 5 5 1 6 6 
59 52/60 14 27% 4 5 4 3 6 5 5 1 6 6 
60 48/60 6 40% 5 6 5 3 6 5 8 1 8 7 
61 50/60 7 42% 5 6 5 2 7 6 8 1 8 8 
62 40/60 3 60% 5 8 7 3 7 7 9 1 9 9 
63 30/60 0ê 70% 5 7 5 3 6 4 9 1 9 9 
64 35/60 5 48% 5 6 5 2 6 6 8 1 8 8 
65 45/60 9 52% 5 6 6 3 6 5 7 1 7 7 
66 40/60 6 55% 5 6 5 3 6 5 8 1 8 7 
67 35/60 4 59% 5 6 5 3 7 6 8 1 8 8 
68 30/60 0ê 74% 4 6 5 3 5 3 9 1 9 9 
69 45/60 9 43% 4 6 5 3 6 5 7 1 7 7 
70 40/60 4 60% 5 7 6 3  6 8 1 8 7 
SAMP: Single Arm Military Press, NDI: Neck and Disability Index, Admin Time: Administration Time (Description, demonstration, instruction and 
30S Performance). Completion Time (Warm-Up Time & Administration Time). ê=Minimum Score. é=Maximum Score.   
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Appendix 21 
 
Measuring upper limb disability in neck pain population: evaluation of the 
reliability and validity of the Single Arm Military Press (SAMP) test 
 
Telephone Checklist: Preliminary Screening (Phone Screening) English and 
Arabic 
 
A list of patients who have had visits to the Rheumatology and Physical Therapy 
Medicine Department at Tanta Universal Teaching Hospital (Egypt) with a diagnosis 
indicating non-specific uncomplicated neck pain was obtained. 
 
All potential patient participants were telephoned to answer the following questions as 
follows: 
 
Hello, I am phoning from Tanta Universal Teaching Hospital. We are working with 
Rheumatology and Physical Therapy Medicine Department to develop and evaluate 
health related outcome measure on patients suffering from neck pain as well as healthy 
subjects.   
 
Would you like to hear about it?  
 
Recent research suggested that neck problems frequently associated with upper limb 
pain/disability. We want to develop a physical performance test (outcome measure) to 
evaluate the upper limb functional capacity and used in the assessment and during the 
management process of patients with neck pain. This will help us to identify and 
quantify any upper limb disability and cure it while treating neck pain, which will make 
neck pain patients to feel better and help them to cope better with normal daily activity. 
 
So, we are recruiting people with neck pain and healthy subjects. If you are interested in 
being involved in our study, you will be requested to attend: 
 
For patient participants: two testing sessions at Tanta Universal Teaching Hospital. In 
these sessions, you will be met by the study’s assessor who will tell you more about the 
study, ask you to complete questionnaires and carry out face-to-face assessment. If the 
testing procedure would be suitable and beneficial, you will be requested to perform a 
physical performance test for 30 seconds. Each session may take up to 45 minutes.    
 
For healthy subjects: one single assessment and testing session at Tanta Universal 
Teaching Hospital. In this session, you will be met by the study’s assessor who will tell 
you more about the study, ask you to complete questionnaires. If the testing procedure 
would be suitable, you will be requested to perform a physical performance test for 30 
seconds. This session may take up to 45 minutes.   
 
Would you be happy to participate?  
  Yes  
  No  
If yes, may I ask you a few questions about your neck? This will help me to determine 
whether this testing procedure is suitable and good for you. Any information you give 
me will be kept confidential. 
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Patient Participants:  
 
2. Have you had your neck symptoms for longer than 2 weeks? (in weeks) 
(Acute/sub-acute or chronic pain)   
  Yes  
  No 
 
8. Have you had any treatment to your neck in the last 3 months? 
(What diagnosis? What the practitioner told you about your neck problem) 
  
9. Are you planning to see anyone else for treatment?  
  Yes 
  No  
If yes, to postpone until after the testing. 
 
10. Do you have any other health problems such as dizziness, double vision, speech, 
swallowing, LOC (loss of consciousness)?  
  Yes  
  No  
(Exclude patient with any major health problems) 
 
11. Are you able to get on/off bed without help? 
  Yes  
  No  
 
12. Are you able to walk, drive or use public transport without help? 
  Yes  
  No  
 
13. Are you able to come to the new Tanta Universal Teaching Hospital? 
  Yes  
  No  
 
Healthy Subjects:  
 
1. Have you ever injured your head? 
  Yes  
  No 
 
2. Have you ever injured your neck? 
  Yes 
  No 
 
3. Have you ever injured your upper limb (Shoulder/Arm/Hand)? 
  Yes 
  No 
 
4. Over the past 3 months, have you had any neck and/or upper limb symptoms?  
  Yes  
  No  
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5. Are you having any problems with dizziness, double vision, speech, swallowing, 
LOC (loss of consciousness)? If so, please specify?  
 
6. Do you have any general medical problems? If so, please specify? 
 
Thank you for taking the time to answer those questions. I can tell you that at this stage 
it would seem that:  
  
c. The testing procedure would be suitable and beneficial for you (Make 
Appointment) 
d. The testing procedure is not suitable for you (exclude this patient from the 
study).  
 
Making appointment (if a) 
 
Can you come to Tanta Universal Teaching Hospital on (day) at (time) for face-to-
face assessment, which be followed by the testing? Negotiate an appointment time.    
 
Study information sheet 
 
I would like to send you the study information sheet, where you will find more 
information about the study and the testing. Please read it and you may discuss your 
participation with your family and/or friends before attending the single face-to-face 
assessment and testing session: your address is… 
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 eht fo noitaulave :noitalupop niap kcen ni ytilibasid bmil reppu gnirusaeM
 tset )PMAS( sserP yratiliM mrA elgniS eht fo ytidilav dna ytilibailer
 
  ﺾﯾﺮﻤﻟا ﺺﯿﺨﺸﺗ ةرﺎﻤﺘﺳا
 
  :ﺾﯾﺮﻤﻠﻟ   ﻦﻣ ﻰﻟوﻻا ﺔﻠﺣﺮﻤﻟا ﺺﺤﻔﻟا
 
   ﺎﻣو ﮫﻨﻣ ضﺮﻐﻟاو ﺚﺤﺒﻟا نﻮﻤﻀﻤﺑ ﺾﯾﺮﻤﻟا ﻒﯾﺮﻌﺗ ﻢﺘﯾ فﻮﺳ ﺔﯿﻔﺗﺎھ ﺔﻤﻟﺎﻜﻣ لﻼﺧ ﻦﻣ
 ﻰﻠﻋ ﮫﺘﻘﻓاﻮﻣ ﺪﻨﻋو ،ﺔﺒﻗﺮﻟا ﻢﻟا ﻲﻓ ﺔﻠﺜﻤﺘﻣ طوﺮﺸﻟا ﺾﻌﺑ ﺮﻓاﻮﺘﻟ ﺚﺤﺒﻟا ﺔﻨﯿﻋ ﻦﻤﺿ هرﺎﯿﺘﺧا ﺐﺒﺳ
  :ﺔﯿﻟﺎﺘﻟا ﺔﻠﺌﺳﻻا ﻰﻠﻋ ﺔﺑﺎﺟﻻا ﮫﻨﻣ ﺐﻠﻄﯾ ﺚﺤﺒﻟا ﺔﻨﯿﻋ ﻲﻓ كاﺮﺘﺷﻻا
 
  ؟ﻦﯿﻋﻮﺒﺳا ﻦﻣ لﻮطا ةﺪﻤﻟ ﺔﺒﻗﺮﻟا ﻲﻓ ﻢﻟا يأ ﻚﯾﺪﻟ ﻞھ – ١
 
 ﻻ
  ﻢﻌﻧ
 
   ؟ﺔﯿﺿﺎﻤﻟا رﻮﮭﺷ ثﻼﺜﻟا لﻼﺧ ﺖﺠﻟﻮﻋ ﻞھ – ٢
 
  ﻻ
  (ﺺﺨﺸﻤﻟا ﺺﺼﺨﺗ ﻮھ ﺎﻣ ،ﺺﯿﺨﺸﺘﻟا عﻮﻧ ﺎﻣ) ﻢﻌﻧ
 
  ؟ﺎﺒﯾﺮﻗ جﻼﻌﻟا ضﺮﻐﺑ ﺮﺧا ﺺﺼﺨﺘﻣ ﺔﯾؤﺮﻟ ﻂﻄﺨﺗ ﻞھ – ٣
 
  ﻻ
  (رﺎﺒﺘﺧﻻا ءاﺮﺟا ﺪﻌﺑ ﻞﯿﺟﺄﺘﻟا ﻰﺟﺮﯾ) ﻢﻌﻧ
 
  ؟ﻲﻋﻮﻟا ناﺪﻘﻓ وا ﺔﯾؤﺮﻟا جاودزا وا راوﺪﻟا ﻞﺜﻣ ىﺮﺧا ﺔﯿﺤﺻ ﻞﻛﺎﺸﻣ يأ ﻚﯾﺪﻟ ﻞھ – ٤
 
  ﻻ
  (ةﺮﯿﺒﻛ ىﺮﺧا ﻞﻛﺎﺸﻣ ﺔﯾﺪﻟ ﺾﯾﺮﻣ يأ دﺎﻌﺒﺘﺳا) ﻢﻌﻧ
 
  ؟ةﺪﻋﺎﺴﻣ نوﺪﺑ ﻲﻤﯿﻠﻌﺘﻟا ﺎﻄﻨط ﻰﻔﺸﺘﺴﻣ ﻰﻟا رﻮﻀﺤﻟا ﻰﻠﻋ ردﺎﻗ ﺖﻧا ﻞھ -٥
 
  (ﺔﯿﺤﺻ بﺎﺒﺳﻷ رﻮﻀﺤﻟا ﻊﯿﻄﺘﺴﯾ ﻻ ﺾﯾﺮﻣ يأ دﺎﻌﺒﺘﺳا) ﻻ
  ﻢﻌﻧ
 
  .ﺔﻠﺌﺳﻻا ﻰﻠﻋ ﺔﺑﺎﺟﻺﻟ ﮫﺘﻗو ﻦﻣ ءﺰﺟ ﮫﻋﺎﻄﻘﺘﺳﻻ ﺎﻨﻌﻣ ثﺪﺤﺘﻤﻟا ﺺﺨﺸﻟا ﺮﻜﺸﻧ
  ....... ﺔﻋﺎﺴﻟا ...... مﻮﯾ ﻲﻓ ﺎﻄﻨﻄﺑ ﺪﯾﺪﺠﻟا ﻲﻤﯿﻠﻌﺘﻟا ﻰﻔﺸﺘﺴﻤﻟا ﻰﻟا هرﻮﻀﺤﻟ ﺪﻋﻮﻣ ﺪﯾﺪﺤﺗ ﻊﻣ
 ﺔﻨﯿﻋ ﻲﻓ هرﺎﯿﺘﺧا بﺎﺒﺳاو ﮫﺗاءاﺮﺟإو ﺚﺤﺒﻟا ﻦﻋ ﺮﺜﻛأ تﺎﻣﻮﻠﻌﻣ لﺎﺳرﻹ ﮫﺑ صﺎﺨﻟا ناﻮﻨﻌﻟا ﺔﻓﺮﻌﻣ
 ﻲﺋﺎﮭﻨﻟا راﺮﻘﻟا ذﺎﺨﺗا ﻞﺒﻗ ﻦﯿﺑﺮﻘﻤﻟا ءﺎﻗﺪﺻﻻاو ﺔﻠﺋﺎﻌﻟا ﻊﻣ ﺚﺤﺒﻟا اﺬھ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا ﺔﺸﻗﺎﻨﻣو ﺚﺤﺒﻟا
  .ﺔﻛرﺎﺸﻤﻟا ﻲﻓ
  ﺺﺤﻔﻟا ﻦﻣ ﻰﻟوﻻا ﺔﻠﺣﺮﻤﻟا ءﺎﺤﺻﻸﻟ :
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  ؟ساﺮﻟا ﻲﻓ تﺎﺑﺎﺻإ ﻦﻣ ﻲﺿﺎﻤﻟا ﻲﻓ ﺖﯿﻧﺎﻋ ﻞھ .١
 
  ؟ﺔﺒﻗﺮﻟا ﻲﻓ تﺎﺑﺎﺻإ ﻦﻣ ﻲﺿﺎﻤﻟا ﻲﻓ ﺖﯿﻧﺎﻋ ﻞھ .٢
 
  ؟ﺪﯿﻟا وا عارﺬﻟا وا ﻒﺘﻜﻟا ﻲﻓ تﺎﺑﺎﺻإ ﻦﻣ ﻲﺿﺎﻤﻟا ﻲﻓ ﺖﯿﻧﺎﻋ ﻞھ .٣
 
  ؟ﺪﯿﻟا وا عارﺬﻟا وا ﻒﺘﻜﻟا وا ﺔﺒﻗﺮﻟا ﻲﻓ مﻻا ﻦﻣ ﺖﯿﻧﺎﻋ ﻞھ ،ﺔﯿﺿﺎﻤﻟا رﻮﮭﺷ ثﻼﺜﻟا ﻲﻓ  .٤
 
 وا ﺔﺟودﺰﻤﻟا ﺔﯾؤﺮﻟاو نﻮﯿﻌﻟا ﺔﻠﻠﻏز وا راوﺪﻟﺎﺑ ﺔﻄﺒﺗﺮﻣ ﻞﻛﺎﺸﻣ يأ ﻦﻣ ﻲﻧﺎﻌﺗ ﻞھ .٥
  ؟ﻞﯿﺻﺎﻔﺗ ﻲﻨﯿﻄﻋا ءﺎﺟر اﺬھ ثﺪﺣ ﻮﻟ ؟تاءﺎﻤﻏإو تﺎﻣرﻮﺗ وا مﻼﻜﻟا ﻲﻓ ﺔﺑﻮﻌﺻ
 
    ؟مﻮﻤﻌﻟا ﻲﻓ ﮫﯿﺒطو ﺔﯿﺤﺻ ﮫﻠﻜﺸﻣ يأ ﻦﻣ ﻲﻧﺎﻌﺗ ﻞھ .٦
 
 
 
  .ﺔﻠﺌﺳﻻا ﻰﻠﻋ ﺔﺑﺎﺟﻺﻟ ﮫﺘﻗو ﻦﻣ ءﺰﺟ ﮫﻋﺎﻄﻘﺘﺳﻻ ﺎﻨﻌﻣ ثﺪﺤﺘﻤﻟا ﺺﺨﺸﻟا ﺮﻜﺸﻧ
  ....... ﺔﻋﺎﺴﻟا ...... مﻮﯾ ﻲﻓ ﺎﻄﻨﻄﺑ ﺪﯾﺪﺠﻟا ﻲﻤﯿﻠﻌﺘﻟا ﻰﻔﺸﺘﺴﻤﻟا ﻰﻟا هرﻮﻀﺤﻟ ﺪﻋﻮﻣ ﺪﯾﺪﺤﺗ ﻊﻣ
 ﺔﻨﯿﻋ ﻲﻓ هرﺎﯿﺘﺧا بﺎﺒﺳاو ﮫﺗاءاﺮﺟإو ﺚﺤﺒﻟا ﻦﻋ ﺮﺜﻛأ تﺎﻣﻮﻠﻌﻣ لﺎﺳرﻹ ﮫﺑ صﺎﺨﻟا ناﻮﻨﻌﻟا ﺔﻓﺮﻌﻣ
 ﻲﺋﺎﮭﻨﻟا راﺮﻘﻟا ذﺎﺨﺗا ﻞﺒﻗ ﻦﯿﺑﺮﻘﻤﻟا ءﺎﻗﺪﺻﻻاو ﺔﻠﺋﺎﻌﻟا ﻊﻣ ﺚﺤﺒﻟا اﺬھ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا ﺔﺸﻗﺎﻨﻣو ﺚﺤﺒﻟا
  .ﺔﻛرﺎﺸﻤﻟا ﻲﻓ
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Appendix 22 
 
Measuring upper limb disability in neck pain population: evaluation of the 
reliability and validity of the Single Arm Military Press (SAMP) test 
 
Patient Information Sheet (English and Arabic)  
 
We wish to invite you to participate in a research study. In order to have a clearer 
understanding of this research context, please read the following information sheet and 
do not hesitate to ask if there is anything that it not clear or you would like further 
information before you decide to take part.  
 
What is the purpose of this study?  
Neck pain is common, painful and many people report having trouble using their arm. 
Physiotherapists should try to measure the problems that people have when using their 
arm, so that they can advise patients how best to improve use of their arm.  
 
The aim of this study is to develop and evaluate a physical performance 
test/performance-based outcome measure, the Single Arm Military Press (SAMP) Test, 
which is easy to use, economical, quick (maximum 2 minutes to perform and score). 
Preliminary research suggested that SAMP test is promising upper limb outcome 
measure for neck pain patients. 
 
Why I have been invited?  
We are inviting patients, age 18 years or over, with non-specific neck pain as well as 
healthy subjects to take part in this study. The patients we are looking for should be able 
to travel to the Rheumatology and Physical Therapy department/clinic at Tanta 
Universal Teaching Hospital without support. 
 
You have been invited to participate in this research program because of the type of 
neck pain you suffering from or not suffering from any pain at all. If you are currently 
having treatment for your neck pain, had treatment in the past 3-month or have never 
need treatment for your neck or upper limb then you may be eligible for this study. 
 
What will happen if I decide to take part? 
If you are interested in being involved in this study: 
 
Patient participants: 
You will be asked to attend two testing sessions, in which each may take up to 45 
minutes. You will be requested to complete two baseline questionnaires, which will 
give us more information about your neck and/or upper limb symptoms as well as your 
general physical and psychological well-being. This will be followed by face-to-face 
assessment to ensure that the testing procedure is suitable and beneficial for you. You 
will be then requested to sign a consent form (session 1 only) to say that you agree to be 
involved with this study and complete the testing for the first session.  
 
Healthy subjects: 
You will be asked to attend one single assessment and testing session, which may take 
up to 45 minutes. You will be requested to complete two baseline questionnaires, which 
will give us more information about your any neck and/or upper limb symptoms as well 
as your general physical and psychological well-being. This will be followed by face-to-
face  
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assessment to ensure that the testing procedure is suitable for you. You will be then 
requested to sign a consent form to say that you agree to be involved with this study and 
complete the testing procedure.   
 
It is preferable if you can wear a suitable, sleeveless/half-sleeves top, during the session 
so that the shoulder and elbow joints can be observed. 
 
What do I have to do? 
You will receive a complete demonstration and instruction of the test followed by 
warm-up and the test procedure, which will take up to 2-munites under direct 
supervision of a physiotherapist/physician. 
 
Do I have to participate in this study? 
 
‘Only if you want to’ 
 
Participation is voluntary, you do not have to participate or you may withdraw from the 
study at any time before attending the face-to-face assessment and testing. However, 
please let us know if you are unable to participate at least 24-hours before your 
appointment. You do not need to tell us why you do not want to participate.  
 
Are there any risks involved?   
There are no known risks. This research program is simply validating performance-
based outcome measure.  
 
You may experience some muscle soreness, which is completely normal following 
physical exercise and may last up to 72 hours.   
 
Confidentiality 
All information from this study will be kept entirely confidential. All consent forms and 
any other identifiable information will be destroyed once the study has been completed. 
You will be informed of the results of the research if you wish.   
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 eht fo noitaulave :noitalupop niap kcen ni ytilibasid bmil reppu gnirusaeM
 tset )PMAS( sserP yratiliM mrA elgniS eht fo ytidilav dna ytilibailer
 
  ﺚﺤﺒﻟا تاءاﺮﺟﻹ ﺔﻠﻣﺎﺷ تﺎﻣﻮﻠﻌﻣ
 
 ﺔﻠﻣﺎﺸﻟا تﺎﻣﻮﻠﻌﻤﻟا ﮫﻓﺮﻌﻣو ﻢﮭﻔﻟو ﺚﺤﺒﻟا اﺬھ ﺔﻨﯿﻋ ﻦﻣ ءﺰﺠﻛ ﺔﻛرﺎﺸﻤﻟﺎﺑ ﻢﻜﺗدﺎﯿﺳ ةﻮﻋﺪﺑ فﺮﺸﺘﻧ
 يأ كﺎﻨھ نﺎﻛ اذإ ﺎﻤﻋ لؤﺎﺴﺘﻟا ﻲﻓ ددﺮﺘﻟا مﺪﻋو ﺔﯿﻟﺎﺘﻟا تﺎﻣﻮﻠﻌﻤﻟا ةءاﺮﻗ ءﺎﺟﺮﺑ ﺚﺤﺒﻟا تاءاﺮﺟﻹ
  .ﺔﻛرﺎﺸﻤﻟا رﺮﻘﺗ نا ﻞﺒﻗ تﺎﻣﻮﻠﻌﻤﻟا ﻦﻣ ﺪﯾﺰﻣ وا ﺔﺤﺿاو ﺮﯿﻏ ﺔﻣﻮﻠﻌﻣ
 
  ؟ﺔﺳارﺪﻟا هﺬھ ﻦﻣ ضﺮﻐﻟا ﻮھ ﺎﻣ
 
 ،نﺎﯿﺣﻻا ﺾﻌﺑ ﻲﻓ ﺪﯾﺪﺷ ﻢﻟا ﻰﻟا ىدﺆﺗ ﻲﺘﻟاو ثوﺪﺤﻟا ﺔﻌﺋﺎﺷ ضاﺮﻣﻻا ﻦﻣ ﺔﺒﻗﺮﻟا ﻢﻟا نا
 لﺎﻤﻋﻻا ﺺﺧﻷﺎﺑو ﻒﺘﻜﻟاو عارﺬﻟا ماﺪﺨﺘﺳا ﻲﻓ ﺔﺑﻮﻌﺻ نوﺪﺠﯾ ﺔﺒﻗﺮﻟا ﻢﻟا ﻲﺑﺎﺼﻣ ﻢﻈﻌﻣو
 ﺔﺒﻗﺮﻟا ﻢﻟا جﻼﻋ ﻲﻓ ﺺﺼﺨﺘﻤﻟا ﺐﯿﺒﻄﻟا ﻰﻠﻋ ﺐﺟﻮﺘﯾ اﺬﻟ سأﺮﻟا ىﻮﺘﺴﻣ ﻰﻠﻋأ ىدﺆﺗ ﻲﺘﻟا
   .ﺪﯿﻟاو عارﺬﻟاو ﻒﺘﻜﻟا ﻲﻓ ﺔﻗﺎﻋﻻا ىﺪﻣ رﺎﺒﺘﺧﺎﺑ
 
 ﺪﯿﻟاو عارﺬﻟاو ﻒﺘﻜﻟا ﻲﻓ ﺔﻗﺎﻋﻻا سﺎﯿﻗ ﺔﻘﯾﺮط ﺮﯾﻮﻄﺗ ﻮھ ﺔﺳارﺪﻟا هﺬھ ءاﺮﺟا ﻦﻣ ضﺮﻐﻟا
  .ﺔﺒﻗﺮﻟا ﻢﻟا ﻰﺿﺮﻣ ﺪﻨﻋ
 
 ﺔﯿﻟﺎﺜﻣ ﺔﻘﯾﺮط ﻲھ (SPMA) سﺎﯿﻘﻟا ﺔﻘﯾﺮط نا ﺖﺘﺒﺛا ﺔﺜﯾﺪﺤﻟا ﺔﯿﻤﻠﻌﻟا ثﺎﺤﺑﻻا ﺾﻌﺑ
  .سﺎﯿﻘﻠﻟ
 
  ؟ﺚﺤﺒﻟا ﺔﻨﯿﻋ ﻲﻓ يرﺎﯿﺘﺧا ﻢﺗ اذﺎﻤﻟ
 
 ﻲﻓ ﻢﻟا ﻦﻣ ﻲﻧﺎﻌﺗو ﺔﻨﺳ ٨١ ﻦﻣ ﺮﺜﻛأ كﺮﻤﻋ ﻚﻧﻷ ﺚﺤﺒﻟا ﺔﻨﯿﻋ ﻦﻣ ءﺰﺠﻛ كرﺎﯿﺘﺧا ﻢﺗ ﺪﻘﻟ
  .ﺔﺒﻗﺮﻟا
 
  ؟ﺚﺤﺒﻟا اﺬھ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا ترﺮﻗ اذإ ثﺪﺤﯿﺳ اذﺎﻣ 
 
 حواﺮﺘﯾ ﺖﯿﻗﻮﺗ ﻲﻓ ةﺪﺣاو ةﺮﻣ رﻮﻀﺤﻠﻟ ﻰﻋﺪﺘﺴﻓ ﺔﺳارﺪﻟا هﺬھ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا ﻰﻠﻋ ﺖﻘﻓاو اذإ
  .ﺔﻘﯿﻗد ٥٤ :٠٣ ﻦﯿﺑ
 
 ﺔﻣﺎﻌﻟا ﺔﯿﺤﺼﻟا ﻚﺗﻻﺎﺣو ﺔﺒﻗﺮﻟا ﻢﻟﺄﺑ ﺔﺻﺎﺨﻟا ﺔﻠﺌﺳﻻا ﺾﻌﺑ ﻰﻠﻋ ﺔﺑﺎﺟﻻا ﻚﻨﻣ ﺐﻠﻄﯾ فﻮﺳ
  .تﺎﻧﺎﯿﺒﺘﺳﻻا ﺾﻌﺑ ءﻞﻣو
 
  ﺔظﻮﺤﻠﻣ .ﺔﻠﻣﺎﻛ عارﺬﻟا ﺔﯾؤﺮﻟ تﺮﺷ ﻲﺗ ﺔﻀﯾﺮﻤﻟا ىﺪﺗﺮﺗ نا :
 
  ؟رﺎﺒﺘﺧﻻا اﺬھ ﻲﻓ ﻞﻌﻓا نا ﻰﻠﻋ اذﺎﻣ
 
 ﺖﺤﺗ رﺎﺒﺘﺧﻻا ءادا ﻢﺛ ءﺎﻤﺣﻻا ﮫﯿﻠﯾ رﺎﺒﺘﺧﻼﻟ جذﻮﻤﻨﺑ ﺔﻋﻮﺒﺘﻣ ﺔﺤﺿاو تﺎﻤﯿﻠﻌﺗ ﻰﻘﻠﺘﺗ فﻮﺳ
  .ﺺﺼﺨﺘﻣ فاﺮﺷا
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  ؟ﺔﺳارﺪﻟا هﺬھ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا يروﺮﻀﻟا ﻦﻣ ﻞھ
  (ﺔﻛرﺎﺸﻤﻟا ﺖﻧا تدرا اذإ)
 
  .ءﺎﺸﺗ ﺎﻤﻨﯿﺣ بﺎﺤﺴﻧﻻا ﻚﻨﻜﻤﯾو ﺔﯿﻋﻮﻄﺗ ﺔﺳارﺪﻟا هﺬھ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا
 
 
  ﻦﻋ ﺞﺘﻨﺗ نا ﻦﻜﻤﯾ ﺮطﺎﺨﻣ يأ كﺎﻨھ ﻞھ ؟ﺔﺳارﺪﻟا هﺬھ ﻲﻓ ﺔﻛرﺎﺸﻤﻟا
 
 ﻮھ يﺬﻟاو ﻂﯿﺴﺒﻟا ﻲﻠﻀﻌﻟا قﺎھرﻻا ﺾﻌﺒﺑ ﺮﻌﺸﺗ ﺪﻗ ﻦﻜﻟو قﻼطﻻا ﻰﻠﻋ ﺮطﺎﺨﻣ ﺪﺟﻮﺗ ﻻ
  .ءﺎﻔﺸﺘﺳﻼﻟ ﺔﻋﺎﺳ ٢٧ ﻚﻟذ قﺮﻐﺘﺴﯾ ﺪﻗو ﺔﯿﻧﺪﺒﻟا ﺔﻄﺸﻧﻻا ﺔﺳرﺎﻤﻣ ﺪﻌﺑ ثﺪﺤﯾ يﺬﻠﻟ ﺔﮭﺑﺎﺸﻣ
 
  :ﺔﯿﺻﻮﺼﺨﻟا
 
 قاروا ﻊﯿﻤﺟ ﺮﯿﻣﺪﺗ ﻢﺘﯾ فﻮﺳو ﺔﻣﺎﺗ ﺔﯾﺮﺳ ﻲھ ﺔﺳارﺪﻟا هﺬھ ﻲﻓ ﻰﺿﺮﻤﻟﺎﺑ ﺔﺻﺎﺨﻟا تﺎﻣﻮﻠﻌﻤﻟا ﻊﯿﻤﺟ
  .ﺔﺳارﺪﻟا ﻦﻣ ءﺎﮭﺘﻧﻻا دﺮﺠﻤﺑ ﻰﺿﺮﻤﻟا ﻦﻋ ىﺮﺧا تﺎﻣﻮﻠﻌﻣ ياو ﺔﻘﻓاﻮﻤﻟا
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Appendix 23 
 
Measuring upper limb disability in neck pain population: evaluation of the 
reliability and validity of the Single Arm Military Press (SAMP) test 
 
Visual Analogue Scale (VAS) 0-10 SAMP Reliability and Validity 
Severity Description of Experience 
10 - Worst Possible 
Pain 
I am in bed and can’t move due to my pain. I need someone to take me to 
emergency room to get help for my pain. 
9 – Extremely 
Sever Pain 
My Pain is all that I can think about. I can barely talk or move because of the 
pain. 
8 – Very Severe 
Pain  
My pain is so severe that it is hard to think of anything else. Talking and listening 
are difficult.  
7 – Severe Pain I am in pain all the time. It keeps me from doing most activities.  
6 – Distressing 
Pain 
I think about my pain all the time. I give up many activities because of my pain. 
5 – Distracting 
Pain 
I think about my pain most of the time. I cannot do some of the activities I need 
to do each day because of the pain.  
4 – Moderate pain  I am constantly aware of my pain but I can continue most activities.   
3 – Uncomfortable 
Pain 
My pain bothers me but I can ignore it most of the time.  
2 – Mild Pain  I have a low level of pain. I am aware of my pain only when I pay attention to it.  
1 – Slight Pain My pain is hardly noticeable.  
0 – No Pain I have no pain  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 401 
 42 xidneppA
 
  noisreV cibarA seriannoitseuq HSAD
 
 
 
 
 
 
 إﻋﺎﻗﺎت اﻟﺬراع واﻟﻜﺘﻒ واﻟﻴﺪ
 
 1
 .devreser sthgir llA .6002 htlaeH & kroW rof etutitsnI ©
 fo loohcS / ASU ,XT ,ytisrevinU s'namoW saxeT ,yparehT lanoitapuccO fo loohcS ,ibiatolA demmahoM resaN fo ysetruoc noitalsnart cibarA
 .tiawuK ,ytisrevinU tiawuK ,yparehT lanoitapuccO
  
  ﺗﻌﻠﻴﻤﺎت 
  
ﻋѧѧѧﻦ ﺔ ﻣѧѧѧﻦ اﻷﺳѧѧѧﺌﻠﺔ ﻠﺗﺴﺘﻔﺴѧѧѧﺮ هѧѧѧﺬﻩ اﻟﺴﻠﺴѧѧѧ 
 ﻓѧﻲ اﻟﺘѧﻲ ﺗﺤѧﺲ ﺑﻬѧﺎ اﻷﻋѧﺮاض  /اﻟﺤѧﺎﻻت
 وﻋѧﻦ ﻣﻘѧﺪرﺗﻚ ، أو آﺘﻔѧﻚ، أو ﻳѧﺪكذراﻋѧﻚ
اﻟﺮﺟѧѧﺎء أن   .ﻋﻠѧѧﻰ ﺗﺄدﻳѧѧﺔ ﻧﺸѧѧﺎﻃﺎت ﻣﻌﻴﻨѧѧﺔ
 ﺳѧﺆال، ﺑﻨѧﺎًء ﻋﻠѧﻰ ﺣﺎﻟﺘѧﻚ آѧﻞﺗﺠﻴѧﺐ ﻋﻠѧﻰ 
  ﺧﻼل اﻷﺳﺒﻮع اﻟﻤﺎﺿﻲ،
 .و ذﻟﻚ ﺑﻮﺿﻊ داﺋﺮة ﺣѧﻮل اﻟѧﺮﻗﻢ اﻟﻤﻨﺎﺳѧﺐ 
ﻟﻔﺮﺻѧﺔ ﻟﺘﺄدﻳѧﺔ ﻧﺸѧﺎط ﻣѧﺎ إذا ﻟѧﻢ ﺗﺴѧﻨﺢ ﻟѧﻚ ا
 أن ﺗﻘѧّﺪر ء، ﻓﺎﻟﺮﺟﺎ ﺧﻼل اﻷﺳﺒﻮع اﻟﻤﺎﺿﻲ 
ﺑﺄﻓﻀﻞ ﻣﺎ ﺗﺴﺘﻄﻴﻊ ﻟﺘﺨﺘﺎر اﻟﺠﻮاب اﻷﻗﺮب 
ﻟѧﻴﺲ ﻋﻨﺪ إﺟﺎﺑﺘﻚ ﻋﻠѧﻲ اﻷﺳѧﺌﻠﺔ،  .إﻟﻰ اﻟﺪﻗﺔ 
ﻣﻬﻤѧѧѧًﺎ أي ﻳѧѧѧﺪ أو ذراع ﺗﺴѧѧѧﺘﺨﺪم ﻟﺘﻤѧѧѧﺎرس 
 ﺳѧѧѧﻮاء آﺎﻧѧѧѧﺖ اﻟﻴѧѧѧﺪ اﻟﻤﺼѧѧѧﺎﺑﺔ أو ﻧﺸѧѧѧﺎﻃﻚ
  .اﻟﺴﻠﻴﻤﺔ
اﻟﺮﺟﺎء أن ﺗﺠﻴﺐ ﺑﻨﺎًء ﻋﻠﻰ ﻣﻘﺪرﺗﻚ ﺑﻐѧﺾ 
. ﻟﻄﺮﻳﻘﺔ اﻟﺘﻲ ﺗѧﺆدي ﺑﻬѧﺎ اﻟﻌﻤѧﻞ اﻟﻨﻈﺮ ﻋﻦ ا 
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Appendix 25 
 
Measuring upper limb disability in neck pain population: evaluation of the 
reliability and validity of the Single Arm Military Press (SAMP) test 
 
Face to face assessment: (English and Arabic) 
 
Participant’s demographic information 
Assessment date  --/--/---- 
Participant name  
Participant ID number (in the study)    
Date of Birth --/--/---- 
Occupation  
Weight   
Height   
Telephone number  
Email address  
Home address  
 
• Where is your symptoms now? Complete the body chart. 
 
• How severe is your symptoms now?  
 
Neck pain/symptoms 
No pain 0 – 1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 worst possible pain (see 
Appendix 11) 
 
Upper limb pain/symptoms  
No pain 0 – 1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 worst possible pain (see 
Appendix 11) 
 
• Over the past 2 weeks are your symptoms: 
o Getting better 
o Getting worse 
o Same  
If worsening, in what way? (exclude deteriorating neurological condition e.g. cord sign, 
radiculopathy) 
 
• Were you involved in an accident which caused your pain? (exclude recent 
major trauma) 
 
• How long have you had your neck symptoms? In weeks ‘determine whether 
acute, sub-acute or chronic’ 
 
• How long ago did you first experience these symptoms? In weeks ‘determine 
recurrence’ and how it was treated? 
 
• Have you had any treatment such as physical therapy in the past three months?  
 
 109 
• Have you ever injured your shoulder, arm or hand substantially? exclude injuries 
which has resulted in current or prolonged disability 
• Is your weight steady? Exclude unintentional weight loss  
   
• Are you sleeping OK at night? Exclude severe pain at night  
 
• Are you having any problems with dizziness, double vision, speech, swallowing, 
LOC (loss of consciousness)? Exclude in accordance with the criteria  
 
• Do you have any general medical problems? If so, specify what type of 
problems? (Exclude vertebral artery problems) 
 
• Do you have any general medical problems? If so specify, (Exclude – severe 
rheumatoid arthritis, severe multiple sclerosis, cancer, osteoporosis, cardiac 
conditions, severe SOBOE, uncontrolled hypertension, postural hypotension, 
balance problems).  
 
If all answers confirmed eligibility and the NDI scored at least 10%, and patient still 
happy to proceed. Patient should sign the consent form and allocated for SAMP testing.  
 
 
 
 
 
 
 
 
 
 
 
 
 011 
 
 
 eht fo noitaulave :noitalupop niap kcen ni ytilibasid bmil reppu gnirusaeM
 tset )PMAS( sserP yratiliM mrA elgniS eht fo ytidilav dna ytilibailer
 
  ﺺﺤﻔﻟا ﻦﻣ ﺔﯿﻧﺎﺜﻟا ﺔﻠﺣﺮﻤﻟا ) :(ﺾﯾﺮﻤﻟا رﻮﻀﺤﺑ
 
  ﺺﺤﻔﻟا مﻮﯾ ﺦﯾرﺎﺗ  .............\.........\..........
  ﺾﯾﺮﻤﻟا ﻢﺳا 
  ﺾﯾﺮﻤﻟا ﻢﻗر 
  ﺾﯾﺮﻤﻟا دﻼﯿﻣ ﺦﯾرﺎﺗ 
  ﺾﯾﺮﻤﻟا ﺔﻔﯿظو 
 نزﻮﻟا 
  لﻮﻄﻟا 
  ﺾﯾﺮﻤﻟا نﻮﻔﯿﻠﺗ ﻢﻗر 
  ﺾﯾﺮﻤﻟا ناﻮﻨﻋ 
  ﺚﺤﺒﻟا ﺔﻠﺣﺮﻣ 
 
  :لوﻻا لاﺆﺴﻟا
  (ﻖﻓﺮﻤﻟا ﻢﺴﺠﻟا ﻂﻄﺨﻣ لﺎﻤﻜﺘﺳا) ؟نﻻا ﻢﻟﻻا ﺪﺟﻮﯾ ﻦﯾا 
 
  :ﻲﻧﺎﺜﻟا لاﺆﺴﻟا
  ؟ﻢﻟﻻا ةﻮﻗ ىﺪﻣ ﺎﻣ
  
  :ﺔﺒﻗﺮﻟا ﻢﻟا
   ﻢﻟا ﺪﺟﻮﯾ ﻻ 0 - 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 01  ﻦﻜﻤﻣ ﻢﻟا ﻰﺼﻗا 
 
  :ﺪﯿﻟاو ﻒﺘﻜﻟاو عارﺬﻟا ﻢﻟا
   ﻢﻟا ﺪﺟﻮﯾ ﻻ 0 - 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 01  ﻦﻜﻤﻣ ﻢﻟا ﻰﺼﻗا 
 
  :ﺚﻟﺎﺜﻟا لاﺆﺴﻟا
  :ﺔﺒﻗﺮﻟا ﻢﻟا ﻦﯿﯿﺿﺎﻤﻟا ﻦﯿﻋﻮﺒﺳﻻا لﻼﺧ
  :ﻦﺴﺤﺗ
  (بﺎﺼﻋﻻاو يﺮﻘﻔﻟا دﻮﻤﻌﻟﺎﺑ ﺔﻄﺒﺗﺮﻤﻟا تﻻﺎﺤﻟا دﺎﻌﺒﺘﺳا) :ءﻮﺳ دادزا
  :ﻢﻟﻷا ﺲﻔﻧ
 
  :ﻊﺑاﺮﻟا لاﺆﺴﻟا
  ؟ثدﺎﺤﻟ ﺔﺠﯿﺘﻧ ﮫﺑ ﺮﻌﺸﺗ يﺬﻟا ﺔﺒﻗﺮﻟا ﻢﻟا ﻞھ
  :ﻻ
  (ﺎﺜﯾﺪﺣ نﻮﺑﺎﺼﻤﻟا ﻰﺿﺮﻤﻟا دﺎﻌﺒﺘﺳا) :ﻢﻌﻧ
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  :ﺲﻣﺎﺨﻟا لاﺆﺴﻟا
  (عﻮﺒﺳﻷﺎﺑ) ؟ﻦھاﺮﻟا ﺖﻗﻮﻟا ﻲﻓ ﺔﺒﻗﺮﻟا ﻢﻟﺄﺑ كرﻮﻌﺷ ةﺪﻣ ﺎﻣ 
 
  :سدﺎﺴﻟا لاﺆﺴﻟا
  (عﻮﺒﺳﻷﺎﺑ) ؟ﻰﻟوﻻا ةﺮﻤﻠﻟ ﺔﺒﻗﺮﻟا ﻢﻟﺄﺑ تﺮﻌﺷ ﻰﺘﻣ
  ................
 
  :ﻊﺑﺎﺴﻟا لاﺆﺴﻟا
  ؟ﺔﯿﺿﺎﻤﻟا رﻮﮭﺷ ثﻼﺜﻟا ﻲﻓ جﻼﻋ يأ ﺖﯿﻘﻠﺗ ﻞھ
  :ﻻ
  :ﻢﻌﻧ
 
  :ﻦﻣﺎﺜﻟا لاﺆﺴﻟا
  ؟ﺪﯿﻟا وا عارﺬﻟا وا ﻒﺘﻜﻟا ﻲﻓ ﺔﺑﺎﺻﻹ ﺖﺿﺮﻌﺗ نا ﻚﻟ ﻖﺒﺳ ﻞھ
  :ﻻ
  (ﺪﯿﻟا وا عارﺬﻟا وا ﻒﺘﻜﻟا ﻲﻓ ﺔﻗﺎﻋإ وا ﺪﯾﺪﺷ ﻢﻟﻷﺎﺑ نﻮﺑﺎﺼﻤﻟا دﺎﻌﺒﺘﺳا) :ﻢﻌﻧ
 
  :ﻊﺳﺎﺘﻟا لاﺆﺴﻟا
  ؟ﺖﺑﺎﺛ ﻚﻧزو ﻞھ 
  (ﺪﺼﻗ نوﺪﺑ نزﻮﻟا ﻲﻓ نﺎﺼﻘﻧ يأ دﺎﻌﺒﺘﺳا) :ﻻ
  :ﻢﻌﻧ
 
  :ﺮﺷﺎﻌﻟا لاﺆﺴﻟا
  ؟تﺎﺑاﺮﺿا نوﺪﺑ ﻼﯿﻟ مﺎﻨﺗ ﻞھ 
  :ﻢﻌﻧ       
  (ﻲﻠﯿﻠﻟا ﻢﻟﻻا دﺎﻌﺒﺘﺳا) :ﻻ       
 
  :ﺮﺸﻋ يدﺎﺤﻟا لاﺆﺴﻟا
  ؟ﻲﻋﻮﻟا ناﺪﻘﻓ وا ،ﺔﯾؤﺮﻟا جاودزا ،راوﺪﻟا ﻞﺜﻣ ﺔﯿﺤﺻ ﻞﻛﺎﺸﻣ يأ ﻚﯾﺪﻟ ﻞھ
  ﻻ 
  (ﺔﯿﺒﻄﻟا تﻼﻜﺸﻤﻟا هﺬھ ﻊﻣ ﻰﺿﺮﻤﻟا دﺎﻌﺒﺘﺳا) :ﻢﻌﻧ
 
 ﻰﻠﻋ ٪ ٠١ (IDN) ﺔﺒﻗﺮﻟا ﺔﻗﺎﻋإ سﺎﯿﻘﻣ ﺔﺠﯿﺘﻧو ﺾﯾﺮﻤﻟا رﺎﯿﺘﺧا ﺲﺳﻷ ﺔﻘﺑﺎﻄﻣ تﺎﺑﺎﺟﻻا ﺖﻧﺎﻛ اذإ
  .هءاﺮﺟاو ﺚﺤﺒﻟا ﺔﻨﯿﻋ ﻲﻓ كاﺮﺘﺷﻼﻟ ﮫﺘﻘﻓاﻮﻣ ﻰﻠﻋ ﺾﯾﺮﻤﻟا ﻊﯿﻗﻮﺗ ﻢﺘﯾ ﻞﻗﻻا
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Appendix 26 
 
Measuring upper limb disability in neck pain population: evaluation of the 
reliability and validity of the Single Arm Military Press (SAMP) test 
 
Study Consent Form (English and Arabic) 
 
Name of the researcher: Ahmad Alreni 
 
1. I confirm that I have read and understand the information sheet dated 0 /0 /00 for 
the above research study and have had opportunity to ask questions.                
 
 
 
2.  I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving reason.                                                           
 
 
 
3. I agree to tack part in the above research study   
 
 
Name of the subject (BLOCK CAPITALS): 
 
…………………………………………… 
 
 
Signature:                             
……………………………………………Date: 
……………………… 
 
 
Signature of the researcher: 
 
…………………………………………… 
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 tset )PMAS( sserP yratiliM mrA elgniS eht fo ytidilav dna ytilibailer
 
  ﺚﺤﺒﻟا ﮫﻨﯿﻋ ﻲﻓ كاﺮﺘﺷﻻا ﻰﻠﻋ ﺾﯾﺮﻤﻟا ﺔﻘﻓاﻮﻣ
 
 
  ﻲﻨﯾﺮﻌﻟا ﻦﯾﺪﻟا حﻼﺻ ﺪﻤﺣا :ﺚﺣﺎﺒﻟا ﻢﺳا
 
 ىﺪﻟ نﺎﻛو ﺚﺤﺒﻟا اﺬھ تاءاﺮﺟﺈﺑ ﺔﺻﺎﺨﻟا تﺎﻣﻮﻠﻌﻤﻟا ﺖﻤﮭﻓو تأﺮﻗ ﻲﻨﻧإ ﻰﻠﻋ هﺎﻧدا ﻊﻗﻮﻤﻟا ﺎﻧا ﺮﻗا .١
 ﻢﺗو ﺚﺤﺒﻟا تاءاﺮﺟا ﻲﻓ ىﺪﻟ ﺔﻀﻣﺎﻐﻟا ءاﺰﺟﻻا ﺾﻌﺑ ﻦﻋ رﺎﺴﻔﺘﺳﻻا ﻰﻠﻋ ةرﺪﻘﻤﻟا
    ﻲﺗارﺎﺴﻔﺘﺳا ﻰﻠﻋ ﺔﺑﺎﺟﻻا
           
 نوﺪﺑ ﮫﻨﻣ بﺎﺤﺴﻧﻻا ﻲﻓ ﻲﺗرﺪﻘﻣ ﻊﻣ ﺚﺤﺒﻟا اﺬھ ﻲﻓ ﺎﯿﻋﻮﻄﺗ كرﺎﺷا ﻲﻨﻧإ هﺎﻧدا ﻊﻗﻮﻤﻟا ﺎﻧا ﻢﮭﻔﺗا .٢
  بﺎﺒﺳا يأ ءاﺪﺑا
 
  ﺚﺤﺒﻟا اﺬھ ﺔﻨﯿﻋ ﻲﻓ كاﺮﺘﺷﻻا ﻰﻠﻋ ﻖﻓاوا .٣
 
 
  ............................................ :ﺾﯾﺮﻤﻟا ﻢﺳا
  ............................................ :ﻊﯿﻗﻮﺘﻟا
         ............................................  :ﺦﯾرﺎﺘﻟا
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Appendix 27 
 
Measuring upper limb disability in neck pain population: evaluation of the 
reliability and validity of the Single Arm Military Press (SAMP) test 
 
Data Collection Sheet (English and Arabic) 
Assessment Date: 
Examiner Name: 
Group Number: 
Weight used:  
 
Patient ID 
Number  
SAMP Score reps/30-sec  Administration Time Completion Time 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SAMP score = number of repetitions in the 30-second, Administration time = 
description, demonstration, instructions and the 30-sec performance, Completion time 
= warm-up time and administration time.    
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  تﺎﻧﺎﯿﺒﻟا ﻊﻤﺟ ةرﺎﻤﺘﺳا
 
  .........................................  :رﺎﺒﺘﺧﻻا ءادا ﺦﯾرﺎﺗ
  .........................................  :ﺺﺣﺎﻔﻟا ﻢﺳا
  .......................................  :ﺔﻋﻮﻤﺠﻤﻟا ﻢﻗر
  .........................................  :مﺪﺨﺘﺴﻤﻟا نزﻮﻟا
 
  ﺾﯾﺮﻤﻟا ﻢﻗر  ث٠٣\ ت  رﺎﺒﺘﺧﻻا ﻦﻣز  رﺎﺒﺘﺧﻻا ﻰﻠﻜﻟا ﻦﻣﺰﻟا
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  ﺔﯿﻧﺎﺛ ٠٣ ﻰﻠﻋ تاراﺮﻜﺘﻟا دﺪﻋ = ث ٠٣ \ت •
 رﺎﺒﺘﺧﻻا ءادا ث ٠٣ + تﺎﻤﯿﻠﻌﺘﻟا ،جذﻮﻤﻧ ءادا ،رﺎﺒﺘﺧﻻا حﺮﺷ = رﺎﺒﺘﺧﻻا ﻦﻣز •
 رﺎﺒﺘﺧﻻا ﻦﻣز + ءﺎﻤﺣﻻا = رﺎﺒﺘﺧﻼﻟ ﻰﻠﻜﻟا ﻦﻣﺰﻟا •
  
 
 
 
